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The recent increase in availability of next generation sequencing methodologies 
has led to extensive analysis of the genome of Clostridium difficile.  In contrast, 
protein expression analysis, crucial to the elucidation of mechanisms of disease, 
has severely lagged behind.  In this study, in-depth proteomic analysis of three 
strains of varying virulence, demonstrated previously in an animal model, has 
been undertaken against a background of the sequenced genomes.  Strain B-1 is 
a historic, virulent, ribotype 005 clone, strain A represents the emerging 
hypervirulent 027 ribotype, while strain Tra5/5, ribotype 001, is of low 
virulence.
To undertake a comprehensive overview of the expressed proteome, both 1D 
and 2D gel electrophoresis were used to separate and display the protein 
content of each isolate.  This was coupled to MALDI-TOF and LC-MS/MS mass 
spectrometry for protein identification.  A total of 888 different proteins were 
characterised by comparative analysis of isolates grown in parallel for 64 hours 
on blood agar. Of these, only 38% were shared between all isolates.  An 
additional 350, 243 and 398 proteins were detected from broth cultures, and the 
use of a hexapeptide bead library, designed to capture low abundance proteins, 
led to the detection of a further 148, 127, and 171 proteins in strains A, B-1 and 
Tra5/5 respectively.
Relative differential expression was investigated using Differential In Gel 
Electrophoresis (DIGE), and five proteins were shown to have a statistically 
higher concentration in strain A, twelve in strain B-1 and eight in strain Tra5/5.  
A number of these were surface proteins, with selected S-layer proteins found to 
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be up-regulated in each strain, and the flagellar protein, FliC, up-regulated in 
both A and B-1. Furthermore, differential post-translation modification events 
were seen in flagellar and S-layer proteins.
In-vivo expression of these proteins was mapped using Western blotting.
Immunodetection of the majority of these, including FliC and the high 
molecular weight S-layer protein, were conserved between the three strains, but
a notable series of immunoreactive protein spots were present in strains A and 
Tra5/5 but not B-1, most likely corresponding to an additional S-layer protein 
present in the genomes these strains, but not that of B-1.
Protein expression differences for a number of previously proposed virulence 
proteins were evident between strains, including toxin B, sporulation, flagella 
and the S-layer proteins, metabolic enzymes, stress response proteins and ABC 
transporters.  This study strongly supports the view that the virulence of 
Clostridium difficile is multifactorial, and that a number of related factors, 
although not directly required for pathogenicity, may serve to modulate the 
virulence of individual strains.
v
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Chapter 1 – Introduction
1.1 – Clostridium difficile
Clostridium difficile is a nosocomial pathogen responsible for a range of 
gastrointestinal associated symptoms including severe diarrhoea and 
pseudomembranous colitis (PMC) (Larson et al, 1978; Kelly and Lamont, 1998).  
It was first identified in 1935 from the stool samples of healthy new born infants 
(Hall and O'Toole, 1935).  However, it was not until nearly 40 years later that it 
was confirmed as pathogenic, when two groups simultaneously identified it as 
the aetiological agent of antibiotic-associated pseudomembranous colitis 
(PMC)(Bartlett et al, 1978; Larson et al, 1978).  In the late 1980s, C. difficile
emerged as a problematic hospital acquired infectious agent, frequently 
associated with antibiotic treatment (Larson and Borriello, 1990).  In recent 
years, there has been an increase in number and severity of nosocomial 
infections, as well as an increase in community care acquired infections, leading 
to this pathogen becoming an important focus for research (Rupnik et al, 2009). 
1.1.1 – Pathogenicity
C. difficile is a rod-shaped, Gram-positive, anaerobic, spore-forming bacterium.  
Although several putative virulence factors have been identified, two major 
toxins, identified in the early 80s (Bartlett et al, 1980) and produced by many C. 
difficile strains are thought to be the main cause of infection associated 
pseudomembranous colitis.    Toxin A (308kDa) and toxin B (270kDa) show high 
sequence and functional homology to each other, and to other large clostridial
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toxins, and are among the largest bacterial toxins known (Voth and Ballard, 
2005). Both toxin A and toxin B have been shown to be cytotoxic, with toxin B 
showing a 1000-fold greater cytotoxicity than toxin A (Sullivan et al, 1982), 
although their respective roles in the disease causing mechanism have long been 
disputed.
Originally, toxin A was thought to be the main cause of pathogenicity, as it was 
shown to cause haemorrhagic fluid secretion in ligated rabbit ileal loops where 
toxin B did not (Mitchell et al, 1986; Lima et al, 1988).An early study by Lyerly et 
al suggested that although toxin B alone was insufficient to cause disease in 
healthy intestinal tissue, it may gain access to underlying tissues in previously 
damaged areas, and exacerbate disease (Lyerly et al, 1985).  Subsequently 
however, toxin A-negative, toxin B-positive strains that are capable of causing 
fluid accumulation in ligated ilea l loop assays and disease in the hamster model 
have been identified (Borriello et al, 1992), and have been isolated from patients 
with C. difficile infection (CDI) (Alfa et al, 2000).  The role of toxin B has 
remained controversial, with both toxins being shown to independently disrupt 
T84 human intestinal cells (Hecht et al, 1992).  More recently, work by Lyras et al
(2009), both in a hamster model and in-vitro cell lines, showed that it is toxin B, 
not toxin A, that is essential for virulence (Lyras et al, 2009).  However, Kuehne 
et al (2010) showed that strains producing both toxins together, or either toxin 
alone, were virulent.   Hence the mechanisms of interaction of toxin A and toxin 
B still remain unclear. 
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The two toxins have similar modes of action, mediating their effects through 
glucosylation of small GTP binding proteins such as Rho, Rac and Cdc42, 
thereby interrupting actin cytoskeleton assembly (Borriello, 1998, Voth and 
Ballard, 2005).  This leads to loss of cell structural integrity as well as 
interrupting GTPase signalling pathways and triggering apoptosis.
The two toxin genes, tcdA and tcdB are located on a 19.6kb genetic locus know as 
the pathogenicity locus (PaLoc) (Figure 1.1).  This region also encodes three 
additional open reading frames, tcdR, tcdE and tcdC and has been found to be 
highly conserved between toxigenic strains (Hammond and Johnson, 1995). 
Figure 1.1 – The Pathogenicity locus (PathLoc) of Clostridium difficile (adapted from 
Poxton et al, 2001).  TcdB and tcdA encode toxins B and A respectively.  TcdR
encodes a positive regulator of toxin production, tcdC encodes a negative regulator of 
toxin production, and tcdE encodes a holin like protein.
Hundsberger et al established that transcription of tcdC is high during early 
exponential growth phase, whereas transcription of tcdR, tcdB, tcd E and tcdA is 
low at this point, and high during late stationary phase leading to the 
suggestion that tcdC encodes a negative regulator of the toxin genes 
(Hundsberger et al, 1997).  TcdR is a small open reading frame upstream of the 
two toxin genes encoding a 22kDa protein that shows sequence identity to DNA 
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binding proteins (Moncrief et al, 1997).  Moncrief et al investigated the promoter 
functionality of this protein, and suggested it acts as a positive regulator of toxin 
production.  More recently, tcdE has been shown to exhibit homology to holins 
(Tan et al, 2001) and may act as a lytic protein to facilitate the release of the 
toxins from C. difficile.
It has been shown that emerging 027 clone strains exhibit deletions in the tcdC
gene leading to truncation of the TcdC protein, which may cause the observed 
increase in toxin production in epidemic 027 strains (Deneve et al, 2009; Warny
et al, 2005).  However, the mechanism of toxin regulation is not fully 
understood, and many other factors appear to affect toxin production (Dupuy et 
al, 2008).   In addition, the large variation in the toxinotypes of pathogenic C. 
difficile strains indicates that toxin production is only one aspect of virulence, 
and that many interacting pathways play a role in the pathogenicity of this 
organism, and so the increased severity of the emerging strains is likely to be 
multifactorial (Rupnik, 2008).
Some strains of C. difficile produce an additional binary toxin with actin-specific 
ADP-ribosyltransferase activity.  First identified in 1988 (Popoff et al, 1988), the 
prevalence of binary toxin in disease causing C. difficile isolates varies (Geric et 
al, 2003; Spigaglia and Mastrantonio, 2004), but it has been suggested that 
CDAD caused by binary toxin producing strains is more frequently associated 
with community-acquired infection and increased abdominal pain (Barbut et al, 
2005).  A recent report by Schwan et al (2009) (Schwan et al, 2009)has suggested 
that binary toxin induces microtubule proliferation.  These form protrusions at 
5
the epithelial cell surface which interact with the bacterial cells, thereby 
increasing adherence.  Epidemic 027 ribotype strains have been shown to 
harbour the binary toxin encoding genes (Stabler et al, 2009) and produce 
detectable levels of the toxin (Warny et al, 2005).
The identity and roles of the other C. difficile virulence factors are less well 
understood.  Clostridium difficile has the ability to produce endospores, which
play a pivotal role in the transmission of disease, and so sporulation, and 
subsequent germination processes, may also be key for virulence.  Bacterial
spores are resistant to many chemical and physical agents including heat, high 
pressure, desiccation, UV, acids and alcohols (Setlow, 2007).  This allows them 
to persist within a hospital environment, and making outbreaks increasingly 
difficult to control. In addition, C. difficile spores have been shown to be resistant 
to many hospital cleaning products, some of which appear to increase 
sporulation of epidemic strains (Fawley et al, 2007). It has been suggested that 
hypervirulent 027 ribotypes produce significantly more spores, earlier, than non 
027 strains (Merrigan et al, 2010) and to have an increased sporulation rate 
(Akerlund et al, 2008).  Sporulation and germination mechanisms for the model 
organism Bacillus subtilis are well established, but less well understood in 
Clostridial species.  The sporulation initiation pathway has recently been 
investigated (Underwood et al, 2009), and differences between the pathways of 
B. subtilis and C. difficile shown, confirming that although bacillus is a useful 
model, it cannot be used to directly draw conclusions about the importance of 
sporulation and germination factors in C. difficile.
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Adhesion is a critical early step in host colonisation, and it has been 
demonstrated that different C. difficile strains of varying virulence exhibit 
variation in their ability to colonise and adhere to the gastrointestinal tract in the 
hamster model (Borriello et al, 1988b).  This has been disputed however, and 
Waligora et al found no difference in the adherence of toxigenic and non-
toxigenic strains, suggesting that earlier observed variation was in mucosal 
association rather than true cell adherence (Waligora et al, 1999).  .A number of 
cell surface proteins coordinating adhesion of the bacterial cell to the gut wall 
have been identified, although the full mechanism has not been elucidated.  
These include adhesins such as Cwp66 (Waligora et al, 2001), surface layer (S-
layer) proteins, cell wall proteins and the flagella as well as a number of S-layer 
protein paralogs (Wright et al, 2005).  Stress response proteins (Henderson et al, 
2006) and hydrolytic and proteolytic enzymes (Seddon et al, 1990) have also 
been linked to virulence.
1.1.2 – Epidemiology
In recent years, the rate and severity of CDI has been increasing due to a 
previously uncommon 027 ribotype.  Such strains are also classified as 
restriction endonuclease analysis type BI, and North American pulsed field gel 
electrophoresis type NAP1, and have caused geographically dispersed 
outbreaks of severe CDAD globally (McDonald et al, 2005) .   Ribotype 027 was 
first linked with severe outbreaks in Quebec in the early 2000s (Loo, 2006) but 
was uncommon before 2000 (Hubert et al, 2007), accounting for fewer than 1% of 
US C. difficile isolates (McDonald et al, 2005).  This ribotype has now been 
detected in all Canadian provinces, and at least 40 states in the US (O'Connor et 
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al, 2009).  In addition, by 2008, this 027 ribotype had been detected in 16 
European countries, causing major outbreaks in many including Belgium, 
Germany, Finland, France, Ireland, Luxembourg, the Netherlands, Switzerland 
and the United Kingdom (Kuijper et al, 2008; Freeman et al, 2010)
The first major outbreak in the UK caused by ribotype 027 was at Stoke-
Mandeville hospital between October 2003 and June 2004, and involved 174 
cases (Anonymous, 2005; Smith A., 2005).  A second outbreak occurred between 
October 2004 and June 2005 involving 160 new cases.  The large increase in CDI 
in recent years has put a huge strain on hospitals and residential care facilities.  
The large outbreaks at Stoke-Mandeville hospital led to an investigation by the 
United Kingdom Healthcare Commission which made a number of 
recommendations, including changes in the reporting of C. difficile cases.  In 
England, reporting of Clostridium difficile in patients over 65 became mandatory 
in 2004, and this was extended to include all patients over the age of two in 
April 2005.  This enhanced surveillance has helped to combat the rise in cases, 
with a marked decrease in the number of cases reported since 2007 (Freeman et 
al, 2010).
1.1.3 – Typing of C. difficile
Various typing methods have been described to distinguish between different C. 
difficile strains, however, no universally accepted method for typing, and 
subsequent nomenclature, of C. difficile isolates exists.  The vast array of 
different typing methods available complicates the picture and there is therefore 
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a need for a common typing method which is reproducible across different 
laboratories.
Originally, typing methods focused on phenotypic properties of different 
strains, most notably serogrouping (Delmee et al , 1985).  Other phenotypic 
methods include phage typing (Sell et al, 1983) and whole cell pyrolysis mass 
spectrometry analysis (Cartmill et al, 1992).  Immunochemical fingerprinting of 
the EDTA extracted surface proteins was successfully used by Poxton et al (1984) 
to confirm C. difficile as an infectious agent, and that the spread of a single strain
was responsible for an outbreak.  However, as molecular methodologies have 
improved, molecular typing systems have been preferentially used.  
The gold standard for bacterial typing is generally pulsed field gel 
electrophoresis, usually in conjunction with restriction endonucleases (Li et al, 
2009).  Chromosomal DNA digests are prepared with an infrequently cutting 
restriction enzyme, to give 10-20 fragments.  These fragments differ in size 
between strains, and gel electrophoresis separates the resulting fragments for 
strain identification.  Pulsed field GE applies alternating electric fields at 
different angles, increasing the resolution of bands to give sufficient sensitivity 
to distinguish between small size differentials of large DNA fragments making 
this a highly discriminatory typing technique.  However, problems have been 
reported in using this technique for C. difficile, particularly due to degradation of 
DNA for several strains from serogroup G (Kristjansson et al, 1994; Bidet et al, 
2000).   
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Restriction enzymes are also used for typing by restriction endonuclease 
analysis (REA).  In this technique, frequently cutting restriction enzymes are 
used, generating hundreds of fragments, which are then resolved by agarose gel 
electrophoresis.  This has been shown to be highly discriminatory and 
universally applicable (Clabots et al, 1993), but the resulting gel pattern is highly 
complex and strain identification by visual assessment is difficult.
Another commonly used method is PCR ribotyping, which distinguishes strains 
according to polymorphisms in the 16S-32S rRNA spacer region. Gurtler (1993) 
first used PCR to amplify this spacer region in C. difficile, and produced DNA 
fingerprints which distinguished 14 different ribotypes from a set of 24 isolates.
This method was subsequently modified by O’Neill et al (1996) who simplified 
the extraction process and modified the primers used for PCR, to allow this 
method to be used for routine typing of C. difficile isolates.  It was suggested that 
due to the speed and simplicity of this method, and the problems with DNA 
degradation during PFGE, ribotyping is the most discriminatory and 
reproducible method for typing C. difficile isolates (Bidet et al, 2000). However, 
PCR –ribotyping still did not discriminate between isolates within some 
serogroups, and reproducibility of the agarose gel electrophoresis between 
laboratories has been low.  However, in 2008, capillary gel sequencing was used 
to develop this technique further (Indra et al, 2008).  This use of capillary gel 
sequencing instead of agarose gel electrophoresis, removes many of the 
problems associated with comparison of typing results between different 
laboratories, increasing the potential of ribotyping as a universal tool for typing 
C. difficile isolates.
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A centrally funded Clostridium difficile Ribotyping Network is available for 
England and Northern Ireland, allowing rapid typing of strains responsible for 
Clostridium difficile associated disease (CDAD) cases 
(http://www.hpa.org.uk/ProductsServices/InfectiousDiseases/LaboratoriesAndR
eferenceFacilities/ClostridiumDifficileRibotypingNetworkForEngland/). This 
has enabled monitoring of strains responsible for epidemic outbreaks, endemic 
infection, and reoccurrence of disease, and allowed the changing epidemiology 
of C. difficile infections to be scrutinised.  The emergence of highly infectious, 
previously uncommon, 027 ribotype strains have been linked to the epidemic 
spread of infection (McDonald et al, 2005).
Multiple-locus variable number tandem repeat analysis (MLVA) is a technique 
that uses PCR amplification of specific loci, which contain repeated DNA 
sequences that vary in copy number between strains (Van den Berg et al, 2007).  
These regions rapidly evolve, so this technique can be particularly useful in 
mapping outbreaks.  
A number of other techniques have also been used for typing, including 
toxinotyping (Rupnik et al, 1998), where strains are distinguished based on 
polymorphisms in the tcdA and tcdB toxin genes, and amplified fragment 
length polymorphism (AFLP) (Klaassen et al, 2002), where whole cell DNA is 
digested with specific restriction endonucleases, and restriction site-specific PCR 
amplification used to generate profiles distinguishable between strains.  
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The vast array of typing techniques complicates the epidemiological picture of 
C. difficile infection.  Different techniques have different pros and cons, and are 
often useful in different situations.  For example, rapid methods such as MLVA 
or AFLP are good for monitoring outbreak situations, where as more 
reproducible methods such as PCR ribotyping or PFGE are required for larger 
scale or multi-centre epidemiological studies.  As more worldwide studies into 
this complicated pathogen are being undertaken, the need for a universally 
reproducible typing method is growing.
The genome of a Clostridium difficile reference strain, known as 630, was 
sequenced in 2006 (Sebaihia et al, 2006).  Since then, in order to better 
understand reasons for the variation in virulence of strains, the genomes of 
other strains have also been sequenced including a virulent 027 ribotype 
(Stabler, 2009) and the three isolates of varying virulence selected for genome 
sequencing at the HPA and used in this project (unpublished data).  However, 
this has given only limited insight into factors responsible for varying virulence. 
Many of the differences between strains with differential pathogenic profiles are 
subtle, and are likely to be manifested in the expression of potential virulence 
factors. Microarray analysis has also been used to identify elements of the 
genome being actively transcribed (Sebaihia et al, 2006; ) which gives an 
additional level of information as to the genes being expressed within a given 
strain.  However, due to mRNA turnover and degradation, this does not 
necessarily correspond to levels of proteins present, and cannot be used to 
quantify differences in levels of protein expression, which can only be done by 
investigating the proteome.  Therefore, the use of proteomic techniques to 
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investigate protein expression differences is of particular value in identifying 
factors which may be responsible for variation on virulence profiles of different 
isolates.  In order to fully understand the variation between strains, and 
elucidate factors responsible for increased virulence of some strains, the use of a 
combination of techniques is invaluable.  This study aims to increase 
understanding of proteomic variation between different C. difficile strains of 
varying virulence.
1.2 - Proteomics
Proteomics can be defined as the large-scale investigation of all the proteins 
within a particular sample, particularly their structure and function.  The term 
‘proteomics’ was coined in 1997 as an analogy of ‘genomics’ for the large-scale 
study of genes (James, 1997) where the ‘proteome’ is the entire complement of 
proteins in a given sample (Wilkins et al, 1996) . The proteome, unlike the 
genome, is a highly dynamic concept, varying enormously according to tissue, 
stage of growth, environmental conditions, and disease state, so by definition, 
an organism will have many different ‘proteomes’ throughout its lifecycle.
One of the great advantages of proteomics is that it gives an insight into the real-
time biochemical changes occurring within a cell, which cannot be determined 
from genetic data.  For example, it can be used to monitor changes within a cell 
over time, where different proteins are expressed at different points on a growth 
curve, but the genetic information remains constant.  Proteomics can therefore 
be used in microbiology to monitor subtle expression differences between 
different strains of the same organism which have very similar genetic makeup.  
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In recent years, proteomics has been increasingly used in the field of 
microbiology, particularly in microbial characterisation (Shah, 2010).  
Pathogenic strains which express virulence factors can, for example, be 
distinguished from non-pathogenic strains which do not.  Proteomics can also 
be used to identify different virulence factors in strains which have differing 
pathogenic potential, but very similar genome sequences.
Mass Spectrometry (MS) and the subsequent comparison of peptide mass 
fingerprints against a comprehensive database have become firmly established 
as successful proteomics techniques for the identification of unknown proteins.   
However, in order to be used successfully for complex samples such as 
microbial cell protein extracts, the upstream protein separation techniques are 
crucial.  Common methods of separation prior to MS identification include 
chromatography and polyacrylamide gel electrophoresis (PAGE).
1.3 - Proteomic techniques
1.3.1 Protein identification
PAGE based methods have been well described as tools for bacterial proteomics 
(Antelmann and Hecker, 2010).  Two dimensional gel electrophoresis allows 
separation and visualisation of large numbers of proteins from a complex 
protein sample such as a bacterial whole cell protein extract.  Proteins are 
separated in the first dimension according to isoelectric point (pI) and in the 
second dimension according to mass, and visualised by staining.  Individual 
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proteins are seen as separate spots on the gel, and can be excised for trypsin 
digestion and protein identification by mass spectrometry, usually Matrix 
Assisted Laser Desorption Ionisation – Time of Flight (MALDI-TOF) MS.   This 
gives rise to a so called ‘reference map’ with large numbers of proteins mapped 
and identified, and allows comparison of different samples.  Two dimensional 
reference mapping allows identification of only 10 – 30% of the most abundant 
proteins in the proteome (Cordwell et al, 2001), but has been successfully 
employed for proteomic analysis of a large range of bacteria (Encheva et al, 
2005), (Bernardini et al, 2007a); (Riedel et al, 2006); (Eymann et al, 2004), 
including the Clostridium species C. perfringens (Alam et al, 2009) and C. 
acetobutylicum (Sullivan and Bennett, 2006).  
More sensitive mass spectrometry methodologies, such as Liquid 
Chromatography quadrapole mass spectrometry (LC-MS/MS), can be used to 
identify a large number of different proteins from a complex peptide mixture.  
Separation prior to digestion is then less critical, so LC-MS/MS can be coupled 
with 1D gel electrophoresis, instead of requiring the time consuming and 
technically difficult 2D gel electrophoresis.  The increased sensitivity of the mass 
spectrometry methods allows proteins expressed at levels below that visualised 
on 2D gels to be indentified (Cordwell et al, 2001).  Moreover, it does not limit 
the pI range of the proteins which can be identified as is the case with 2D gel 
electrophoresis.
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1.3.2 Differential in gel electrophoresis
Two dimensional reference mapping can be used to separate and identify many 
of the components of complex protein samples.  However, direct comparison of
2D gel images is problematic.  Variation in electric and pH fields, temperatures 
and gel polymerisation can affect protein migration, which makes meaningful 
comparisons of 2D profiles of different samples difficult.  In order to overcome
this problem, different protein samples can be labelled with different fluorescent 
dyes, and run together on the same 2D gel.  This eliminates gel to gel differences 
and allows direct comparison and relative quantification of samples.  
Fluorescent labelling of protein samples prior to 2D electrophoresis was already 
an established technique, but the development of the cyanine dyes used in DIGE 
analysis allowed differently labelled samples to be run on the same gel (Unlu et 
al, 1997).  These CyDyes are matched for size and pI and do not disturb the 
relative migration of proteins during electrophoresis, but are fluorescently 
distinct, allowing separate visualisation of each labelled sample.  They are also 
more sensitive than many post-staining techniques, so allow visualisation of 
lower abundance proteins (Karp et al, 2008).  This technology has been 
successfully used in a number of areas, including comparisons of bacterial 
pathogens such as salmonella (Encheva et al, 2009), and listeria (Van de Velde et 
al, 2009).
1.3.3 ProteoMiner treatment
One of the major drawbacks of the classical proteomic methodology involving 
2D gel electrophoresis followed by identification using mass spectrometry is the 
relatively small proportion of the proteome it reveals (Cordwell et al, 2001)
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(Righetti et al, 2003).  Only the more abundant proteins can be visualised on 2D 
gels, and identification by MALDI-TOF mass spectrometry requires a relatively 
large amount of protein, therefore much of the so-called ‘deep proteome’, 
comprising the less abundant proteins, remains obscure.  The use of more 
sensitive LC-MS/MS techniques increases coverage, but many proteins still go 
undetected.  Many potential virulence factors are thought to be expressed at 
low levels and hence masked by the relatively large levels of a few, highly 
abundant, protein components.  Therefore any insights into variations in the 
deep proteome, which can comprise up to 50% of the total proteome (Righetti 
and Boschetti, 2008), would be of particular interest.  
A variety of pre-fractionation techniques can be used to increase the coverage of 
the proteome, or to target specific sub-sets of proteins.  These include the classic 
centrifugal cell-fractionation scheme as well as a range of chromatographic and 
electrophoretic separation techniques, targeting techniques, and abundant 
protein depletion tools.
One of the most commonly used depletion tools is the immuno-subtraction of 
most abundant species via antibody columns (Pieper et al, 2003). These have 
been most successfully used for serum or plasma samples where a small 
number of highly abundant protein species constitute the majority of the 
protein present,  masking many of the proteins present at lower abundance 
(Echan et al, 2005; Pernemalm et al, 2009), but are less useful for complex 
bacterial protein extracts where commercial columns are not available.  Other 
affinity capture methods target specific subsets of lower abundance proteins. 
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Examples include the capture of glyco-proteins using lectins (Hirabayashi, 2008; 
Pernemalm et al, 2009), capture of phosphoproteins using iron affinity (Sun et al, 
2005), and pair-wise protein-protein interactions, such as in yeast 2-hybrid 
systems (Li et al, 2004).
Chromatographic approaches extensively explored by Fountoulakis’ group 
include affinity chromatography on heparin gels (Fountoulakis and Takacs, 
1998), hydrophobic interaction chromatography (Fountoulakis et al, 1999b) and 
hydroxyapatite chromatography (Fountoulakis et al, 1999a).  Electrophoretic 
pre-fractionation techniques include acrylamide gel based methods such as the 
classical one and two dimensional gel electrophoresis, and gel-free isoelectric 
focusing.
Many of these methods have major drawbacks. Immunodepletion runs the risk 
of co-depletion of minor proteins alongside the affinity ligands.  Column 
chromatography relies on the availability of the relevant columns, and elution 
of samples from chromatographic columns requires huge amounts of salts, so 
eluted fractions are often dilute and require concentration steps.  Moreover, 
they are incompatible with downstream IEF/IPG first dimensional steps due to 
the high salt concentrations.  Pre-fractionation allows detection of a greater 
proportion of proteins, but within each fraction, there still exists the inherent 
problem that low abundance proteins are masked by those present at higher 
concentrations, so complex protein samples of high dynamic range cannot be 
fully explored.
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A different approach to solving this problem utilises a combinatorial library of 
hexapeptide ligands to capture and ‘amplify’ the low abundant proteins while 
simultaneously reducing the relative concentration of abundant species 
(Boschetti and Righetti, 2008).  The concept of immobilising a peptide library on 
beads in a ‘one bead, one peptide’ approach dates back to 1991 when Lam et al
(Lam et al, 1991) described the development of such a library to investigate 
ligand-acceptor binding affinities.  This approach was only more recently 
applied to the field of proteomics and the exploration of the low abundant 
proteome (Thulasiraman et al, 2005) and the supporting technology is now 
being developed by BioRad and is commercially available under the name 
‘ProteoMiner’.
The ProteoMiner technology comprises a library of hexapeptide ligands 
immobilised on resin beads.  These are synthesised using a ‘split, couple, 
recombine’ solid-phase peptide synthesis methodology pioneered by Merrifield 
(Merrifield, 1965), in which resin  beads are split into fractions, and each 
fraction of beads coupled to a different amino acid before the fractions are 
pooled and randomised.  These steps are repeated to give the required number 
of amino acids per peptide.  Using the 20 natural amino acids, and 6 coupling 
steps, this will create a hexapeptide library containing 206, or 64 million, 
different combinations of peptide ligand (Thulasiraman et al, 2005).  Due to the 
hugely diverse nature of protein-protein interactions, such a vast library would 
be expected to contain a ligand which binds specifically to each protein in any 
given sample.  The beads containing ligands binding to the most abundant 
proteins will rapidly become saturated, and excess protein will flow through 
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and be discarded, whereas trace proteins will continue to bind to the 
corresponding immobilised ligand, which may never reach saturation.  The 
bound proteins are eluted from the beads, resulting in a protein sample in 
which the concentration of the low abundant proteins has been greatly 
increased in comparison to the highly abundant proteins.   This technique has 
been successfully used to identify a number of additional proteins in biological 
samples such as urine (Castagna et al, 2005), serum (Sennels et al, 2007), and bile 
(Guerrier et al, 2007) as well as to identify trace impurities on natural and 
recombinant biopharmaceuticals (Fortis et al, 2006).  
1.3.4 Western blotting
Clostridium difficile is a highly ubiquitous organism, and its spores are found in a 
wide range of habitats within the environment.  However, it is the interaction of 
the organism with the host that mediates its virulence and pathogenicity.  A 
number of the potential virulence factors identified in the literature are proteins 
mediating bacterial-host interactions such as adhesion (Pechine et al, 2005a).  
Hence, some of the most interesting subsets of the C. difficile proteome are those 
proteins interacting with the host cells, which are often targets for the host 
immune systems.
Western blotting using host serum can identify those proteins from a complex 
bacterial extract which are recognised by the host serum antibodies, and so 
identify proteins potentially involved in interaction with the host cells.  Two 
dimensional Western blotting has been successfully used previously to identify 
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immunoreactive cell surface proteins in Clostridium difficile (Wright et al, 2008), 
but has not been used previously with whole cell protein extracts.
1.4 - Aims and Objectives of the present study
While there has been a wealth of information on the genome of Clostridium 
difficile, the proteome by contrast has not been widely characterised.  Recent 
studies have looked at the cell surface proteins of the 630 reference strain 
(Wright et al, 2005), and analysed the proteins from strain 630 spores (Lawley et 
al, 2009).  However, no analysis of cellular proteins, or comparative analysis of 
proteomic differences between isolates of varying virulence has so far been 
described, and was therefore a major aim of this study.  
Three strains were selected for comparative analysis, belonging to different 
ribotypes, and with different pathogenic potentials. Strain A is a highly virulent 
clone isolated from the 2005 Stoke-Mandeville outbreak, and was chosen as an 
emerging epidemic 027 ribotype.   Strain B-1 is a highly virulent, ribotype 005 
clone isolated from a patient with pseudomembranous colitis in the early 1980s, 
whereas strain Tra5/5, a 001 ribotype clone, is much less virulent in the hamster 
model, and was isolated from the faeces of a healthy infant.  The 630 reference 
strain was also used for comparison in some instances, as it has been well 
characterised in the literature.  These strains were selected to reflect 
evolutionary changes of this pathogen over time, as well as allowing 
investigation of differences between isolates of varying virulence.
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The genomes of the three strains chosen for this analysis have recently been 
sequenced within the Department for Bioanalysis and Horizon Technologies at 
the Health Protection Agency Centre for Infections (unpublished data).  
Therefore another aim of the present study was to map the proteomic data to 
the genetic information to gain a better insight into the biology of this species.
To undertake this work, two separate approaches were used, firstly 1D SDS-
PAGE coupled with LC-MS/MS using an LTQ-orbitrap (Thermo Fisher 
Scientific, San Jose, USA), and secondly 2D SDS-PAGE coupled with MALDI-
TOF MS using a MALDI-TOF Reflectron (Waters, Milford, USA).  Differential in 
gel electrophoresis (DIGE) was used to compare the reference maps, and give 
some relative quantification of expression, and the ProteoMiner beads were 
used to attempt to increase coverage of the low abundance proteome.  In 
addition, Western blotting of the protein extracts with serum samples was 
carried out to identify proteins that illicit an antibody immune response.
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Chapter 2 – Materials and Methods
2.1 – Optimisation of Protein Extraction
2.1.1 – Bacterial Strains
Three Clostridium difficile isolates with varying biological and virulence spectra 
were used in this study alongside the 630 reference strain (Sebaihia et al, 2006). 
Strain B-1 was isolated from a patient with pseudomembranous colitis 
(Borriello and Barclay, 1985), and was shown to be highly virulent by 
comparative analysis of C. difficile strains in 1987 (Borriello et al, 1987).  
Extracellular toxin A levels were over 195ng/ml in Bactotryptose broth, while 
the maximum titre of toxin B was 1:40,960 following growth in tryptic nitrate 
broth, as detected in VERO cells .  The strain was highly virulent in hamsters 
pre-treated with clindamycin, with all of the animals challenged dead or 
moribund within 48 hours (Borriello et al, 1987). B-1 cells were shown to be 
hydrophilic (Krishna et al, 1996), to produce a number of hydrolytic enzymes 
including chondroitin-4-sulphatase, hyaluronidase, heparinase and collagenase 
(Seddon et al, 1990), to show evidence of mucosal adherence (Borriello et al, 
1988b), flagella and motility (Tasteyre et al, 2000a), and to posses capsule 
(shown by staining and electron microscopy) (Davies and Borriello, 1990), but 
not fimbrae (Borriello et al, 1988a).  
The second strain, Tra5/5, was isolated in 1982 from the faeces of a healthy 
infant (Larson et al, 1982).  It is of lower virulence (demonstrated by number of 
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animals killed after inoculation) with a significantly lower toxin A 
concentration than for strain B-1 (~25ng/ml), but the same maximum titre of 
toxin B, 1:40,960 following growth in tryptic nitrate broth, as detected in VERO 
cells (Borriello et al, 1987).  Tra5/5 has also been shown to be hydrophilic 
(Krishna et al, 1996), and to produce the same range of hydrolytic enzymes as B-
1 (chondroitin-4-sulphatase, hyaluronidase, heparinase and collagenase 
(Seddon et al, 1990).  It shows evidence of fimbrae (Borriello et al, 1988a) and 
capsule formation (Davies and Borriello, 1990), but the mucosal adherence and 
presence of flagella has not been determined for this strain.  
The third strain, designated A (donated by M. Wilcox, Leeds Teaching 
Hospitals), was isolated from the Stoke-Mandeville outbreak, associated with 
the emergence of the ‘hypervirulent’ ribotype 027 (Anonymous, 2005;Smith A., 
2005).  There have been fewer biochemical studies undertaken to characterise 
isolates of this outbreak, but it has been reported that these epidemic 027 strains 
produce higher levels compared to other ribotypes (toxin A, 848µg/L, toxin B 
180µg/L (Warny et al, 2005)).  They were shown to be motile (Stabler et al, 2009), 
and resistant to a number of antibiotics including fluoroquinolones, 
chloramphenicol and erythromycin (Stabler et al, 2009).  The ribotypes of strains 
A, B-1 and Tra5/5have been analysed and confirmed as 027, 005 and 001 
respectively in our laboratory.
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2.1.2 – Growth Curves
Growth curves were determined in order to establish a time scale for optimum 
protein synthesis.  Starter cultures in fastidious anaerobic broth (FAB) were 
prepared and used to incubate 25ml FAB to an optical density of 0.01-0.03 at 
600nm.  Absorbencies were read every 4 hours to produce a growth curve for 
each of the three strains.
2.1.3 – Growth conditions
Cells from each strain were taken from beads stored at -80ºC, plated onto 
Columbia blood agar (CBA) or fastidious anaerobe agar (FAA), and revived 
overnight at 37ºC in anaerobic conditions.  Colonies from these plates were then 
used to inoculate fastidious anaerobe broth (FAB), or sub-cultured onto CBA or 
FAA to be used for protein extraction. Anaerobic conditions were maintained 
using anaerobic sachets (Oxoid, Basingstoke, UK).
2.1.4 – Extraction methods
There is no universal method for the extraction of proteins from 
microorganisms. Consequently, a number of different methods of protein 
extraction were compared using both broth and plate cultures.  For each 
method the cell pellet was resuspended in lysis buffer (8M Urea, 2% CHAPS, 
40mM Tris base) or 50mM phosphate buffer depending on downstream 
applications.  The phenylmethanesulphonylfluoride (PMSF) protein inhibitor 
was added (0.5-1mM) and cells kept on ice throughout the process to reduce 
proteolysis.  
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i) - FastPrep method  
Washed glass beads (≤ 106 µm) (Sigma-Aldrich, Dorset, UK) were added to 
approximately 1/3 sample volume, and samples were shaken on a FastPrep
System (MP Biomedicals, Illkirch, France) for two runs of 60 seconds at 4m/s, 
and incubated on ice.  For larger cell pellets, this was repeated up to five times, 
with five minute incubations on ice between each 2 x 60s run.  Samples were 
centrifuged for 30 minutes at 21,000g, 4ºC, to remove cell debris.  Protein 
extracts were stored at -20ºC.
ii) - Mickle Cell Disintegrator method
Washed glass beads (≤ 106 µm) (Sigma-Aldrich, Dorset, UK) were added to 
approximately 1/3 sample volume and samples were disrupted using the Mickle 
Cell Disintegrator (Mickle Laboratory Engineering, Guidford, UK) for 15 minutes 
before incubation at -80ºC for 15 minutes.  This was repeated, and samples were 
then centrifuged for 30 minutes at 21,000g, 4ºC, to remove cell debris, and 
protein extracts stored at -20ºC.
iii) - French press method
Resuspended samples were passed through the French Press (Thermo Fisher 
Scientific, San Jose, USA) three times, then centrifuged for 30 minutes at 21,000g, 
4ºC to remove cell debris.  Protein extracts were stored at -20ºC.
2.1.5 - 1D gel electrophoresis
Single dimension gel electrophoresis was carried out using the NuPAGE® gel 
system (Invitrogen, Paisley, UK).  NuPAGE® LDS sample buffer (4µl) and 
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NuPAGE® sample reducing agent (1.6µl) was added to 5µg protein sample and 
made up to 16µl with distilled water.  Each sample was then loaded onto a 
sample well of a NuPAGE® 10% (w/v) bis tris gels alongside 1µg Protein 
Molecular Weight Standards (P-6649 Molecular Probes, Invitrogen, Paisley, UK).  
Gels were run in NuPAGE® MES SDS running buffer for 35 minutes, 200V, 
120mA, 25W.  Proteins were fixed in 10% (v/v) glacial acetic acid, 40% (v/v) 
methanol for 1 hour prior to staining with SYPRO® Ruby Protein Gel stain 
(BioRad, Hemel Hempstead, UK) overnight in the dark.  Gels were destained in 
7% (v/v) acetic acid, 10% (v/v) methanol for 30 minutes before scanning by the 
Ettan DIGE imager (GE Healthcare, Chalfont St Giles, UK).  Gels were post-
stained with Brilliant Blue G-colloidal (Sigma, St Louis, USA) (0.1% (w/v) 
Brilliant Blue G, 0.29 M phosphoric acid and 16% saturated ammonium 
sulphate) according to the manufacturer’s protocol. 
2.2 – Protein Identification
2.2.1 – Protein Identification I – 2D Reference mapping
2.2.1.1 - Growth conditions for standard protein extracts
All strains were grown on Columbia blood agar (CBA) at 37ºC.  Anaerobic 
conditions were maintained using anaerobic sachets (Oxoid, Basingstoke, UK).  
Cells were harvested for protein extraction after 64 hours, when the majority of 
cells were estimated to be in stationary phase, and optimum reproducible 
protein profiles generated. 
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2.2.1.2 - Preparation of standard whole cell protein extract
The growth from CBA plates was harvested after 64 hours. Cells were 
resuspended in lysis buffer (8M Urea, 2% CHAPS, 40mM Tris base) containing 
PMSF protease inhibitor (0.5-1mM) for cell lysis and protein extraction. Washed 
glass beads (≤ 106 µm) (Sigma-Aldrich, Dorset, UK) were added to the cell 
suspension, and homogenisation was performed on the FastPrep System (MP 
Biomedicals, Illkirch, France).  Samples were shaken for 2 runs of 60 seconds at 
4m/s, and incubated on ice before centrifugation for 30 minutes at 21,000g, 4ºC, 
to remove cell debris.  The protein concentration of the lysates was determined 
using Bradford’s assay, where protein lysates were diluted 1:20 and incubated 
1:50 with Bradford’s reagent for 10 – 30 minutes. Absorbance was read at 
630nm and compared to a standard bovine serum albumin (BSA) curve to 
estimate the protein concentration.  Protein extracts were stored at -20ºC.
2.2.1.3 - 2D gel electrophoresis
After being treated with the GE 2D clean up kit (GE Healthcare, Chalfont St 
Giles, UK) according to the manufacturer’s protocol, proteins were resuspended 
in DIGE lysis buffer (30mM Tris, 2M Thiourea, 7M Urea 4% (w/v) CHAPS).  50-
100µg protein was diluted to 100µl with rehydration buffer (7 M Urea, 2 M 
Thiourea, 2% (w/v) CHAPS, 0.5%(v/v) IPG Buffer, 0.002% (v/v) bromophenol 
blue, 2.8mg/ml DTT) and loaded onto hydrated immobiline dry strips (18cm) 
for isoelectric focussing.  These were run overnight before equilibration with 
DTT (6 M Urea, 75mM Tris-HCl pH 8.8, 29.3% (v/v) glycerol, 2% (w/v) SDS, 
0.002% (v/v) bromophenol blue, 65mM DTT) for 15 minutes followed by 
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Iodoacetamide (6 M Urea, 75mM Tris-HCl pH 8.8, 29.3%(v/v) glycerol, 2% 
(w/v) SDS, 0.002%(v/v) bromophenol blue, 135mM Iodoacetamide) for 15 
minutes.  The second dimension was run on 10% acrylamide gels (22 x 24 cm x 
1 mm) for 6 hours.  Proteins were fixed in 10% (v/v) glacial acetic acid, 40% (v/v) 
methanol for 1 hour prior to staining with SYPRO ruby Protein Gel stain 
overnight in the dark.  Gels were destained in 7% (v/v) acetic acid, 10% (v/v)  
methanol for 30 minutes before being scanned using the Ettan DIGE imager (GE 
Healthcare, Chalfont St Giles, UK).  Gels were then post-stained with Brilliant 
Blue G-colloidal (Sigma-Aldrich, Gillingham, UK) (0.1% (w/v) Brilliant Blue G, 
0.29 M phosphoric acid and 16% saturated ammonium sulphate) so that spots 
could be visualised for manual picking.
2.2.1.4 - In-gel digestion 
Spots from 2D gels were destained in 25mM ammonium bicarbonate, in 50% 
(v/v) methanol, until no blue colour remained.  Gel plugs were then dehydrated 
with two 10 minute incubations in 100% acetonitrile, and air dried for 10 
minutes before reduction in 10mM DTT in 25mM ammonium bicarbonate (30 
minutes at 60ºC), and alkylation in 55mM IAA in 25mM ammonium 
bicarbonate, (45min in the dark).  The plugs were washed three times in 25mM 
ammonium bicarbonate and dehydrated as above, before the digestion step.  
10µl trypsin in 25mM ammonium bicarbonate solution (10ng/µl) was added to 
each gel plug, and the plate was incubated at 37ºC for 16 hours overnight.  
Peptides were extracted in 0.05% (v/v) trifluoroacetic acid (TFA), 50% (v/v) 
acetonitrile (10µl) for direct spotting onto MALDI plates for MALDI-TOF 
analysis, or 0.1% (v/v) TFA for LC-MS analysis.
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2.2.1.5 - MALDI-TOF mass spectrometry analysis
After tryptic digestion, 0.7µl of each peptide solution was co-crystallised on the 
target plate with 0.7µl matrix solution (10mg/ml α-cyano-4-hydroxycinnamic 
acid in 49.5% (v/v) acetonitrile, 49.5% (v/v) ethanol, 0.001% (v/v) TFA).  Peptides 
masses were measured on a MALDI-TOF Reflectron (Waters, Milford, USA) 
equipped with a 337nm nitrogen laser.  Analysis was performed in positive ion 
mode.  Peptide masses were collected over a m/z range of 800-3000 Da, and 
1.8µg/ml rennin in 0.1% (v/v) TFA was used to lock mass the instrument.  Raw 
data files were then compared with protein sequence data from the National 
Centre for Biotechnology Information (NCBI) database, and a redundant 
database comprising strains A, B-1,Tra5/5 and 630, using the online Mascot 
Wizard software (http://www.matrixscience.com/wizard.html).  One missed 
cleavage per peptide was allowed, and a mass tolerance of 150 ppm was used. 
Carbamydomethylation of cysteine was specified as a fixed modification, and 
oxidation of methionine as a variable modification.  A MASCOT score greater 
than 54 was significant (p<0.05), but protein identifications with scores lower 
than 54 were considered positive if they also showed a minimum of 6 matched 
peptides or a sequence coverage of over 25% (as described previously (Encheva
et al, 2009)).
2.2.2 – Protein identification II – LC-MS/MS
2.2.2.1 - 1D gel electrophoresis
As above (2.1.5)
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2.2.2.2 - In-gel digestion
1D gel lanes were cut into 12 bands and each band was destained and digested 
as above.  Peptides were extracted in 0.1% (v/v) TFA for LC-MS analysis.
2.2.2.3 - LC-MS/MS mass spectrometry analysis
The peptide mixtures from tryptic digestion of gel bands from 1D PAGE  were 
separated and analysed using an Ultimate 3000 Dionex nano/capillary HPLC 
system (Dionex (UK) Ltd., Camberley, UK) coupled with a Thermo LTQ 
Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, USA). 
Trypsin-digested peptides (5 µl) were cleaned and desalted on a reversed phase 
trap column (PepMap C18, 300 µm i.d. x 5 mm, 3µm, 100 Å, (Dionex (UK) Ltd., 
Camberley, UK)), separated on a nano C18 analytical column (PepMapC18, 75 
µm i.d. x 15 cm, 3µm, 100 Å, (Dionex (UK) Ltd., Camberley, UK)), followed by 
analysis of separated peptides with electrospray tandem mass spectrometry 
(MS/MS) on the LTQ Orbitrap mass spectrometer. 
Settings for the LC-MS/MS were as follows: peptide mixtures were initially 
trapped on the reversed phase trap column using isocratic of 100% solvent A 
(2% acetonitrile, 0.1% formic acid in water) at a flow rate of 25 µl/min. 
Subsequent separation was performed on the analytical C18 nano column using 
a 45-minute gradient of 5 to 45% solvent B (90% acetonitrile, 0.1% formic acid in 
water) versus solvent A, then to 90% B for an additional 5 minutes with a flow 
rate of 300nl/min. The mass spectrometer was operated in a data-dependent 
mode to automatically switch between MS and MS/MS acquisition. The full 
survey scan (m/z 440–2000) was acquired in the Orbitrap with a resolution of 
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60,000 at m/z 400, which was followed by six MS/MS scans in which the most 
abundant peptide precursor ions detected in the preceding survey scan were 
dynamically selected and subjected for collision-induced dissociation (CID) to 
generate MS/MS spectra, which were later searched against appropriate 
databases to assign identities to proteins. 
The electrospray voltage was set at 1.5 kV, the ion source capillary voltage and
temperature were set at 35 V and 200ºC, respectively. Tube lens was 105 V and 
the normalised collision energy was 35% for MS/MS. Enhanced mass accuracy 
was achieved using a background polydimethycyclosiloxane ion with m/z = 
445.120025 was used as ‘lock mass’. Real time recalibration on the ‘lock mass’ by 
corrections of mass shift removed mass error associated with calibration of the 
mass scale. A mass accuracy of 1-5 parts per million (ppm) was routinely 
maintained during data acquisition. 
The raw data files were matched against a theoretical tryptic digest of the 
resulting proteins of a redundant C. difficile database containing genomic data 
from strains A, B-1 and Tra 5/5 and the 630 reference strain using the MASCOT 
daemon software (Matrix Science, London, UK), with a tolerance of two missed 
cleavages.  A peptide mass tolerance of 10 PPM  for the parent ion, and 0.50 Da 
for the fragment ions was specified, allowing for carbamidomethylation of 
cysteine as a fixed modification, and oxidation of methionine as a variable 
modification.  The software program, Scaffold (Proteome software, Portland, 
USA) was used to verify and compare protein identifications between strains.   
A minimum of two peptides was required for protein identification, although 
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identifications based on only one peptide were considered valid if the detected 
peptide was present in the translated genome of the relevant strain.  
Identifications of non-annotated hypothetical proteins were given putative 
functions by finding similar proteins in the NCBI database BLAST.  Where 
possible, identifications were matched to the equivalent protein identification 
from the 630 reference strains, allowing redundant proteins to be identified and 
removed.
2.2.2.4 - BLAST searching of protein sequences against the unfinished 
genomes of each strain
The sequence of each identified protein was searched against each unfinished 
genome using the pBLAST stand alone protein BLAST search, with tab 
deliminated outputs and an e-value threshold of 10-5.  Default settings were 
used for all other parameters.  The percentage identification and e-values for 
each protein against each genome was recorded, and a percentage identification 
greater than 75% was taken to indicate the presence of the corresponding gene 
in a strain.  Protein sequences were also BLAST searched against the 630 
reference strain genome.
2.2.3. – Protein Identification III – DIGE analysis
2.2.3.1 – CyDye labelling of protein samples
Protein samples were cleaned using the GE 2D clean up kit according to the
manufacturer’s protocol and resuspended in DIGE lysis buffer.  Protein 
samples were diluted to 5µg/µl and the pH adjusted to 8.0 if necessary, before 
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minimal labelling with 400pmol CyDye per 50µg protein (CyDye DIGE Fluor, 
GE Healthcare, Chalfont St Giles, UK).  CyDye was reconstituted according to 
the manufacturer’s protocol with 5µl Dimethyl formamide (DMF)(Aldrich, 
anhydrous, 99.8% pure, Sigma-Aldrich, Gilliangham, UK), to give a 1mM stock 
solution.  CyDye stock was mixed with DMF (1:1.5) to give 400µM labelling 
solution.  400pmol of CyDye (1µl labelling solution) was added per 50µl protein 
sample, vortexed briefly, spun down and incubated on ice for 30 minutes in the 
dark.  1µl 10mM lysine was added per 50µl protein sample to stop the reaction 
and the samples incubated on ice in the dark for a further 10 minutes before use 
or storage.
2.2.3.2 – 2D DIGE
The CyDye labelled protein samples were diluted with an equal volume of 
rehydration buffer (7 M Urea, 2 M Thiourea, 2% (w/v) CHAPS, 0.5% (v/v) IPG 
Buffer, 0.002% (v/v) bromophenol blue, 2.8mg/ml DTT)  before being pooled, 
and the pooled samples then run on the first and second dimensions as 
described above (2.2.1.3).  
2.2.3.3 – Experimental setup
Two biological replicates for each of the three strains were used, giving six 
samples in total.  An internal standard of a mix of all six samples was run on 
each gel, alongside two individual samples.  Gels were run for each strain 
against the two other strains, and repeated with the biological replicates to give 
a total of four profiles for each strain.  Each biological replicate was labelled 
with both Cy3 and Cy5 during the experiment.  Spot detection, spot alignment, 
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and statistical analysis of the relative protein concentrations between the strains 
was carried out using the Progenesis SameSpots software (Nonlinear Dynamics, 
Newcastle, UK).
2.3 - ProteoMiner Treatment
2.3.1 - Growth Conditions
Large amounts of protein were required for ProteoMiner treatment, so a much 
larger-scale approach was adopted.  The three strains, A, B-1 and Tra5/5, were 
grown in batches of 3 x 500ml Fastidious Anaerobic broth (FAB) for 24 hours at 
37ºC.  Anaerobic conditions were maintained using anaerobic sachets (Oxoid, 
Basingstoke, UK).  As controls, 100µl culture was plated onto Columbia blood 
agar plates and incubated under anaerobic or aerobic conditions.  If anaerobic 
controls were positive and aerobic controls were negative, cells were harvested 
by centrifugation at 8,000g, 4ºC, for 30 minutes.
2.3.2 - Protein extraction methods and comparison
Cells were washed three times in 1x TE buffer or until the extrapolysaccharide
layers were depleted, then resuspended in 50mM phosphate buffer containing 
0.5mM PMSF for cell lysis and protein extraction.  Glass beads were added to 
the cell suspension, and homogenisation was carried out on the FastPrep System 
(MP Biomedicals, Illkirch, France).  Samples were shaken for 60 seconds at 4m/s, 
and incubated on ice for five minutes.  This was repeated five times before 
centrifugation for 30 minutes at 21,000g, 4ºC, to remove cell debris.  The protein 
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concentration of the lysates was determined using Bradford’s assay.  Protein 
extracts were stored at -20ºC.  For each strain, it was necessary to pool several 
extractions in order to generate sufficient protein for ProteoMiner treatment.
2.3.3 - ProteoMiner treatment
The pooled protein extracts were divided into two technical controls, and each 
15ml protein extract was treated with an ‘E-bead’ amino terminus hexapeptide 
library (250µl), followed by an ‘SE-bead’ carboxylated library (280µl).  Dry 
beads were rehydrated by incubation with dH2O containing approximately 5% 
EtOH for 5 minutes with end-to-end rotation, then centrifuged for 1 minute at 
4000 rmp, and the supernatant discarded.  The beads were then equilibrated by 
washing in 20x PBS buffer (5 minutes, pH 6-8), followed by 5 minute washes in 
dH2O and 1x PBS.  After equilibration, an equal volume of 1x PBS was added to 
the bead to give a 50% slurry, which was distributed into 15ml tubes to give the 
required volume of beads in each tube, before the beads allow to settle and the 
supernatant discarded.
Protein extracts were added to the E-bead hexapaptide libraries, and incubated 
for 1.5 hours, with rotation, at 4ºC.  The supernatant was recovered by 
centrifugation at 4,000g for 1 minute, added to the SE-bead hexapeptide library, 
and incubated as before.  Again, the supernatant was removed, and the two 
hexapeptide bead libraries with bound proteins were resuspended in 1x PBS, 
transferred to spin columns and washed a further 5 times with 1x PBS.   Waste 
PBS was removed by centrifugation at 4,000g for 1 minute, and the beads 
incubated with elution buffer (8M Urea, 2% CHAPS, 50mM citric acid) for 10 
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minutes to dissociate bound proteins from the hexapaptide bead libraries.  The 
eluant was collected by centrifugation at 4,000g for 1 minute.  The elution 
process was repeated a further two times, and the three eluant fractions from 
each library pooled.
The total eluant was halved, and the first fraction frozen for 2D clean up.  The 
second fraction was dialysed against 0.1M ammonium bicarbonate for LC-MS 
and further analysis.
2.2.4 - Dialysis of treated samples
Samples were injected into dialysis membranes (Slide-A-Lyzer 3.5K dialysis 
cassettes (0.5 - 3.0 ml sample volume), Pierce, Rockford, USA) and incubated in 
a 2L beaker of 0.1M ammonium bicarbonate overnight at 4ºC.  The buffer 
solution was then changed and the membranes incubated for a further two 
hours at 4ºC before the sample was removed, aliquoted and stored at -20 ºC.
2.3.5 - 2D gel electrophoresis
After being treated with the GE 2D clean up kit according to the manufacturer’s 
protocol, 50-100µg protein was diluted to 100µl with rehydration buffer  and 
run on the first and second dimension as described above.  Gels were post-
stained with Sigma Brilliant Blue G-colloidal so that spots could be visualised 
for manual picking.  In gel digestion, MALDI-FOF MS and 1D GE followed by 
LC-MS/MS were all carried out as described above (2.2.1.3).
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2.4 - Western Blotting
Proteins were separated by 1D or 2D electrophoresis as described above.
2.4.1 - Protein transfer
Proteins were not fixed or stained in the gels used for Western blotting.  Gels 
were imaged after running, and then equilibrated in Towbin transfer buffer 
(25mM Tris, 192mM Glycine, 0.1% SDS, 20% methanol) for five minutes.   For 
each gel, 4 sheets of blotting paper and 1 of hybond nitrocellulose membrane 
(GE Healthcare, Chalfont St Giles, UK) were cut to the size of the gel.  For 1D 
gels (6x8cm) approximately 10ml Towbin transfer buffer per sheet was used, 
and for 2D gels (20x20cm) approximately 50ml Towbin transfer buffer per sheet 
was used.  The nitrocellulose membrane was pre-wetted with distilled water, 
then soaked in Towbin transfer buffer for 5 minutes.
Protein transfer was carried out on a TE77 semi-dry blotting unit (Invitrogen, 
Paisley, UK).  Transfer from 1D gels was carried out at 45mA for 1 hour, and 
transfer from 2D gels was carried out at 320mA for 1 hour.
After transfer, membranes were stained or imaged to ensure transfer was 
complete.  
2.4.2 - CyDye labelling
CyDye labelling was carried out as described for the DIGE analysis above.
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2.4.3 - Staining
If protein samples had been labelled with CyDye before electrophoresis, gels 
could be imaged before transfer and membranes imaged after transfer without 
the need for staining.  If protein samples were unlabelled, two gels were run in 
parallel, one gel fixed, stained and imaged as described above, and the other 
used for transfer.  After transfer the membrane could be imaged using either 
Ponceau S solution or Sypro Ruby blot stain. 
i) Ponceau S solution
After blotting, the membrane was stained with Ponceau S solution (0.1% in 5% 
Acetic Acid) for approximately 10 minutes until proteins become visible.  The 
membrane was the destained in 5% TCA before blocking and probing.
ii) Sypro Ruby Blot strain
After blotting, the membrane was immersed in 7% acetic acid, 10% Methanol 
for 15 minutes with shaking, before being rinsed in distilled water for 5 
minutes, four times.  The membrane was incubated in Sypro Ruby blot stain 
(Invitrogen, Paisley, UK) for 15 minutes in the dark, then washed 4-6 times in 
distilled water to remove excess dye before imaging.
2.4.4 - Probing of Western blots
After transfer, membranes were rinsed in 0.01M PBS/Tween (0.138M NaCl, 
0.0027M KCl, 0.05% Tween 20, (Sigma)) before being blocked with 1% BSA/PBS 
(0.138 M NaCl, 0.0027M KCl, 1%(w/v) BSA, (Sigma-Aldrich, Gillingham,UK)).  
Between incubation steps, membranes were washed in PBS/Tween for three 
39
times 5 minutes.  Once conditions had been optimised, antisera were used at a 
dilution of 1:10,000 in 0.5% BSA, 0.01M PBS, and primary antibodies detected 
using cy5 labelled anti-rabbit IgG (AbCam, Cambridge, UK) or anti-human IgG 
(AbCam, Cambridge, UK) at a dilution of 1:10,000 in 0.5% BSA, 0.01M PBS).  All 
incubations were carried out for at least 3 hours at room temperature, and 
between incubations membranes were washed in PBS/Tween for three times 5 
minutes.  
The small (70mm x 90mm) membranes from 1D gels were incubated in 10ml 
antibody solution in plastic incubation boxes, giving good detection of 
immunoreactive proteins.  However, incubating large 200mm x 200mm 
membranes in plastic 2D gel boxes required approximately 30 ml antibody 
solution to cover the membrane, so lower volume alternatives were considered.  
Hybridisation tubes were trialled.   130mm x75mm Hybritube-20 (GIBCO-BRL, 
Invitrogen, Paisley, UK) tubes were trialled vertically, and 240mm x 120mm 
mm HYBAID tubes were trialled horizontally in a rotating hybridisation oven 
(Thermo-Fisher Scientific, San Jose, USA).  This required only 13 or 15 ml 
antibody solution respectively, and improved the detection of immunoreactive 
proteins.  However, the diameter of the hybridization tubes meant that the 
membrane within the tube overlapped, which could affect the access of the 
antibody to the bound proteins.  Therefore hybridization bags (240mm x 
250mm) were used.  15ml antibody solution was required, and the bags 
incubated on a circular tube rotator. 
Membranes were imaged on the Ettan DIGE imager (GE Healthcare, Chalfont St 
Giles, UK).
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2.4.5 – Antibodies used
i) Primary antibodies 
 Rabbit polyclonal to horse serum (H8890, Sigma, Gillingham, UK)
 Rabbit serum (N. Fairweather, Imperial College, London) - antibodies raised 
against Clostridium difficile strain 630 by injecting rabbits with a heat killed 
preparation of whole bacterial cells.
 Human serum (I.R. Poxton, University of Edinburgh) - pooled serum samples 
from patients;
A) Cases – symptomatic, toxin-positive and culture-positive
B) Carriers – asymptomatic, culture positive, toxin-variable
C) Controls – asymptomatic, toxin-negative, culture-negative
Controls were matched for age, and were in the same wards as patients in 
groups A and B.
ii) Secondary antibodies 
 Cy3 labelled goat polyclonal to Rabbit IgG (Ab6939, AbCam, 
Cambridge, UK)
 Cy5 labelled goat polyclonal to Rabbit IgG (Ab6564, AbCam, Cambridge, 
UK)
 Cy3 labelled goat polyclonal to Human IgG (Ab6957, AbCam, 
Cambridge, UK)
 Cy5 labelled goat polyclonal to Human IgG (Ab6561, AbCam, 
Cambridge, UK)
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Chapter 3 – Results
3.1 – Growth Curves and Optimisation of Protein Extraction
3.1.1 - Growth Curves
In order to confirm that the three strains progress through the growth cycle at a 
similar rate, growth curves were derived and compared.  To obtain a complete 
curve, but not interrupt anaerobic conditions too often, replicates were used 
and optical densities measures at different time intervals.  Readings were 
pooled and averaged to give the growth curve shown in Figure 3.1.
Figure 3.1 – A growth curve comparing growth rates of the three different strains of 
Clostridium difficile, A, B-1 and Tra5/5. Strains were grown in Fastidious Anaerobic 
Broth (FAB) and optical densities at 600nm taken at a number of different time 
intervals. Six replicates were used for each strain, and the time points the optical 
densities were read were varied for different sets of  replicates to get a range of 














readings across the growth curve.  Readings for all replicates were combined and 
averaged.
The three strains were found to follow similar growth curves and enter 
stationary phase after 14 hours (Figure 3.1), so cultures of different strains 
grown for the same length of time are likely to be in the same phase of growth.  
This minimises the possibility that any differences observed in protein 
concentration are due to phase expression variations, and allows any strain-to-
strain expression differences to be detected.
3.1.2 - Extraction method
A number of different methods are available for extracting proteins from 
bacterial cultures.  In order to determine the most straightforward and 
reproducible extraction protocol, three different methods were compared, The 
French Press (Thermo Fisher Scientific), the Mickle beater (Mickle Engineering)
and the Fast Prep (MP Biomedicals).  Proteins were extracted from cultures 
grown on CBA plates for 24 hours.
Insufficient protein was generated by the French Press method for downstream 
application due to the absence of a micro pressure cell, so this method was 
discounted.  Comparable amounts of protein were obtained using Mickle and 
Fast Prep methodologies, and the protein profiles of the extracts were similar 
(Figure 3.2).  The Fast-Prep method was the quickest and most straightforward, 
and so was used in all subsequent extractions.
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Figure 3.2 – Comparison of Coomassie Brilliant Blue stained 1D protein profiles of 
Mickle and Fast Prep extractions.  Strains were grown on Columbia Blood Agar (CBA) 
and protein extractions are shown alongside a molecular ladder for sizing.
3.1.3 - Growth conditions
For comparison of expression levels between strains, a standard protein extract 
with a reproducible and extensive profile was required.  To determine the best 
growth conditions to achieve this, whole cell protein extractions from a number 
of different cultures grown for different lengths of time, and in different media, 
were compared.  
Firstly, extractions from broth cultures at different points on the growth curve 
were compared (Figure 3.3).
The protein profiles of cultures grown for different lengths of time do not vary 
enormously, but additional proteins are clearly visible in extracts from cultures 
grown for 36 hours, when according to the growth curves, cultures are in 
stationary phase.  The most abundant proteins of ~35 and 45 kDa are likely to 
correspond to the S-layer proteins.












2 – Strain B-1, fast-prep
3 – Strain A, fast-prep
4 – Strain Tra5/5, fast-prep
5 – Markers
6 – Strain B-1, Mickle
7 – Strain A, Mickle
8 – Strain Tra5/5, Mickle
5    6    7   8    
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Figure 3.3 – Comparison of Sypro Ruby stained 1D protein profiles of extractions from 
broth (FAB) cultures grown for different lengths of time.  Arrows indicate the position of 
probable S-layer proteins.
Figure 3.4 – Comparison of Coomassie Brilliant Blue stained 1D protein profiles of 
extractions from plate cultures (CBA) and broth cultures (FAB) incubated for 24 hours.
1    2    3    4         5    6    7    8        9   10   11   12
Lanes
1 – Strain B-1, 6 hours
2 – Strain B-1, 16 hours
3 – Strain B-1, 24 hours
4 – Strain B-1, 36 hours
5 – Srain A, 6 hours
6 – Strain A, 16 hours
7 – Strain A, 24 hours
8 – Strain A, 36 hours
9 – Srain Tra5/5, 6 hours
10 – Strain Tra5/5, 16 hours
11 – Strain Tra5/5, 24 hours
12 - Strain Tra5/5, 36 hours
Lanes
1 – Markers
2 – Strain B-1, plates
3 – Strain A, plates
4 – Strain Tra5/5, plates
5 – Strain B-1, broth
6 – Strain A, broth
7 – Strain Tra5/5, broth
1    2    3    4   5    6    7
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Profiles of extracts from broth cultures and plate cultures were compared (Figure
3.4).  The most notable difference in the plate and broth extracts is that the S-
layer proteins are less abundant in the broth extracts than the plate extracts.  
However, a greater number of proteins are visible in the plate extracts.  
Extraction from plates is simple and straightforward, and allows the presence of 
contaminants to be detected easily.  It does not require the centrifugation and 
washing steps necessary in extraction from broth culture, so fewer cells are lost.   
As the extracts from plate culture appeared to give more extensive profiles, this 
was chosen for the standard extracts.  
Cultures grown on Columbia Blood Agar (CBA) and Fastidious Anaerobe Agar 
(FAA) were compared, and found to give comparable profiles (Figure 3.5).  More 
proteins were visible in the extracts grown for 64 hours (Figure 3.5), so these 
were chosen for the standard extractions.
Figure 3.5 – Comparison of Sypro Ruby stained 1D protein profiles of extractions from 
strain A cultures grown on CBA and FAA for 18 and 64 hours.
1   2   3   4  
Lanes
1 – Strain A, 18 hours, FAA
2 – Strain A, 18 hours, CBA
3 – Strain A, 64 hours, CBA
4 – Strain A, 64 hours, FAA
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3.2 – Protein Identification
3.2.1 – Protein Identification I – 2D Reference Mapping
The standard protein extracts from plates were compared to extractions from 
broth culture by 2D gel electrophoresis (Figure 3.6) to confirm that the plate 
extractions gave reproducible and extensive 2D, as well as 1D, profiles.  A large 
number of protein spots, and good resolution, was obtained for both extraction 
methods, so the standard plate extractions were used for reference mapping.
The 2D protein profiles of the three strains were similar, showing consistent size 
and pI range, and comparable number of protein spots.  
To determine the 2D conditions which give the best spot resolution for mapping 
and subsequent MALDI-TOF-MS, gels were run using a variety of first 
dimension pH ranges (Figure 3.7).  Very few basic proteins were resolved on any 
gels, and the 4-7 pH range gave the best resolution of the greatest number of 
proteins, so this pH range was used for the reference maps.  
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Figure 3.6 - Comparison of Sypro Ruby stained 2D gel profiles of standard plate (CBA, 
64h) and broth (FAB, 24h) extractions for strains A, B-1 and Tra5/5. Samples were run 
in triplicate, but only one replicate for each sample is shown here. In all cases profiles of 
proteins expressed differed between growth conditions, but many protein spots were 
visualised in both extracts.
i) - Strain B-1 protein extract 
from broth culture
ii) - Strain B-1 protein extract 
from plate culture
iii) - Strain A protein extract 
from broth culture
iv) - Strain A protein extract 
from plate culture
v) - Strain Tra5/5 protein 
extract from broth culture
vi) - Strain Tra5/5 protein 
extract from plate culture
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Figure 3.7 - Comparisons of the strain B-1 standard protein extract separated by 2D gel 
electrophoresis using different pH ranges for the first dimension. The sample was run in 
duplicate at each pH range, but only one replicate is shown here. The 4-7 pH range 
shown in ii) gives the best spot resolution
i )– pH range 3-10
ii) – pH range 4-7
iii) – pH range 6-11
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One picking gel was chosen per strain for creation of the reference maps (Figures 
3.8, 3.9, 3.10).   Protein spots were excised manually before being subjected to in-
gel digestion with trypsin and identification by MALDI-TOF MS.  
Identifications are shown with MASCOT scores, peptide coverage and number 
of matched peptides in Appendix Table A1.  A MASCOT score greater than 54 
was significant (p<0.05), but protein identification with scores lower than 54 
were considered positive if they also showed a minimum of six matched 
peptides or a sequence coverage of over 25%.
For strain A, 192 spots were picked from the gel (Figure 3.8), of which 107 spots 
(56%) were identified by MALDI-TOF MS (Appendix A1). Seven spots consisted 
of two or more different proteins and a total of 80 different proteins were 
identified on the strain A reference map.
One hundred and sixty eight spots were picked from the gel for strain B-1 
(Figure 3.9), of which, 126 (75%) were identified by MALDI-TOF MS (Appendix 
A1).  Seven of these consisted of two or more different proteins.  A total of 95 
different proteins were identified on the strain B-1 reference map.
For strain Tra5/5, 192 spots were picked (Figure 3.10).  Of these, 158 (82%) were 
identified by MALDI-TOF MS (Appendix A1), and seven consisted of two or 












































































































































































Figure 3.8 – Spots picked for in-gel digestion and identification on the strain A 
reference map. Identifications are shown in Appendix A1.  Each spot was assigned an 
identity letter, A-P, and number 1-12 as they were excised. To a certain extent, spots in 
the same position on different maps were given the same identity number, but variation 
between gels means this is not always the case.   Surface and virulence proteins are 
highlighted in red, and the S-layer proteins corresponding to the SlpA gene product of 










































































































































Figure 3.9 – Spots picked for in-gel digestion and identification on the strain B-1
reference map. Identifications are shown in Appendix A1.  Identity prefixes were 
assigned as in Figure 3.8.  Surface and virulence proteins are highlighted in red, and 
the S-layer proteins corresponding to the SlpA gene product of the 630 reference strain 







































































































































































Figure 3.10 – Spots picked for in-gel digestion and identification on the strain Tra5/5
reference map. Identifications are shown in Appendix A1.  Identity prefixes were 
assigned as in Figure 3.8.  Surface and virulence proteins are highlighted in red, and 
the S-layer proteins corresponding to the SlpA gene product of the 630 reference strain 
are highlighted by boxes.
A breakdown of the types of proteins identified in each strain is shown in Table 
3.1.
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Table 3.1 – Major types of proteins identified in each strain by both 1D-LC-MS/MS 
analysis and 2D MALDI-TOF MS analysis.
Hypothetical 
proteins












1D 2D 1D 2D 1D 2D 1D 2D 1D 2D 1D 2D 1D 2D
Strain A 79 6 48 7 358 57 73 6 31 1 41 2 629 80
Strain B-1 107 0 45 4 361 74 81 9 27 3 43 2 664 92
Strain Tra 5/5 36 12 23 4 271 81 49 11 17 1 29 3 425 112
A total of 154 different proteins were identified using 2D GE separation 
followed by MALDI-TOF MS.  Only 29% of these were detected in all strains, 
the majority of which were metabolic enzymes. In addition, three regulatory 
proteins, one ribosomal proteins and the flagellin protein (FliC) were identified 
in all strains.  A large proportion (44%) of identified proteins, were detected in 
only one of the three strains, including a stage IV sporulation protein A, and a 
putative flagella hook associated protein found in strain A only, an S-layer 
protein and the flagella hook protein found in strain B-1 only, and a surface 
protein found in strain Tra5/5 only.  The majority of hypothetical proteins 
identified were not common to all strains.
Additional proteins of interest identified include cell surface proteins (putative 
S-layer proteins) and a sporulation protein Spo0A found in strains A and Tra5/5 
but not B-1, and a surface protein found in B-1 and A but not Tra5/5.
3.2.2 – Protein Identification II – LC-MS/MS
LC-MS/MS has greater sensitivity than MALDI-TOF MS so was used alongside 
2D reference mapping in order to increase the coverage of the proteome.  The 
standard protein extracts were separated by 1D gel electrophoresis and each gel 
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lane cut into 12 bands (Figure 3.11), digested with trypsin and sized by LC-
MS/MS. Protein identifications were obtained using MASCOT, and the results of 
the three strains compared using the Scaffold software (Proteome Software).  
Identifications are shown, along with the number of matched peptides, in 
Appendix A2 and an outline of the differences between strains shown in Figure 
3.12.
Figure 3.11 – Coomassie stained 1D gel used for LC-MS/MS analysis.  Lanes 1 and 8 
are the molecular marker, lanes 2 and 3 are biological replicates of strain B-1 extract, 
lanes 4 and 5 are biological replicates of strain A extract and lanes 6 and 7 are 
biological replicates of strain Tra5/5 extract.  Each lane was cut into 12 bands, as 
shown for lane 7, for digestion and identification.
1            2     3          4    5           6     7         8
55
Total = 862 identified proteins
Figure 3.12 – A Venn diagram showing the distribution of proteins identified by LC-MS 
analysis according to the strains in which they were identified.
The 1D Gel electrophoresis LC-MS/MS workflow identified a total of 862 
proteins, 734 (85%) of which had not been identified from the 2D reference 
maps.  Many of the additional proteins identified by 1D LC-MS/MS had 
predicted pI values outside the range of the 2D gels, and the predicted masses 
of the proteins had a larger range from 4 kDa to 308 kDa.  
For strain A, 629 proteins were identified, only 66 of which were seen on the 
strain A reference map.  For strain B-1, 664 proteins were identified, 80 of which 
were detected on the 2D reference map, and for strain Tra5/5, fewer proteins 
were identified by LC-MS/MS (425).  Ninety of these were confirmed by 
detection on 2D reference mapping.  










Fewer proteins were identified by LC-MS/MS in strain Tra5/5 than in the other 
two strains for each general category of protein (Table 3.1).  The same trend was 
not seen in the MALDI-TOF MS data, where more proteins were identified in 
strain Tra5/5 than in the other two strains.   Both analytical methods identified a 
higher proportion of surface or virulence proteins in strain A than in the other 
two strains.  By LC MS/MS analysis, 4.8% of the proteins detected in strain A 
were surface or virulence proteins compared to 4.1% and 4.0% of the proteins 
identified in strains B-1 and Tra5/5, and by MALDI-TOF MS analysis, this was
(7.5%) compared with (5.3%) and (4.3 %) for strains A, B-1 and Tra5/5 
respectively.
Surface and virulence proteins are likely to play an important role in 
determining the degree of pathogenicity of a strain, and so these proteins were 
examined in detail and are shown in red in Figures 3.8, 3.9 and 3.10.  The 2D 
profiles of the surface and virulence proteins for the three strains are fairly 
similar, and comprise a number of the most abundant proteins.
No toxins were identified on the 2D reference maps which may be because large 
proteins are poorly resolved by 2D gel electrophoresis.  Problems with
visualising toxins by 2D GE have been reported previously (Mukherjee et al, 
2002).  LC-MS/MS analysis detected toxin A in all three strains, but toxin B was 
detected in strains A and B-1 only.  Flagellin (FliC) was identified in all three 
strains by both MALDI-TOF MS and LC-MS/MS.  On each 2D map, the flagellin 
protein was identified as a series of spots in the bottom right-hand quarter of 
the gel (the red spots with the M preface, Figures 3.8, 3.9 and 3.10), indicating 
post-translational modifications.    The flagellar hook protein was identified in 
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strain B-1 and strain A, but was not detected at all in strain Tra5/5.  A number of 
flagellar proteins including motor switch proteins, an M-ring protein and two 
flagellar biosynthesis proteins were detected in strain B-1, but neither of the 
other two strains, and a flagellar export protein was found only in strain A.  In 
addition, a putative methyl accepting chemotaxis protein, gi|115249554, was 
detected in strains A and B-1 but not Tra5/5, and an additional chemotaxis 
protein, gi|115249265, was seen only in strain B-1.  A number of sporulation 
proteins were identified in each strain, with spo0A and spoIIIJ associated 
protein identified in all three strains.  Additional sporulation proteins were 
detected in strains A and B-1 but not Tra5/5.
Twenty surface proteins were identified.  Stand alone BLAST was used to 
match the different proteins between strains, and each S-layer protein is shown 
in Table 3.2 with percentage homology scores and identification numbers for 
each strain, and the corresponding identification number for the equivalent 
protein from strain 630, used as a reference.  Due to the large sequence variation 
of surface proteins, particularly S-layer proteins, some detected proteins, such 
as SLP16, do not match to the 630 genome with high homology.  Some of these 
matched to more than one different protein in the 630 reference strain with low 
sequence homology, or vice versa.  In this case, homology is shown to more 
than one protein.
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Table 3.2 – Blast results of all the surface proteins identified. The percentage 
identification score to protein with highest homology is shown for each strain, and the 
630 reference strain, along with the strains in which they were detected (I-strains in 
which the protein were identified by LC-MS/MS; (II)– strains in which the protein was 
identified by MALDI-TOF). The protein highlighted in red shows the highest sequence 
homology to the S-layer protein of the 630 reference strain.
S-layer protein































BASYS03016 99.6 BASYS03260 99.7 BASYS02886 99.8 A, B-1, 
Tra5/5
-


































BASYS00545 100 BASYS01194 100 BASYS00987 100 A, B-1
-




BASYS03070 58.9 BASYS03265 79.5 BASYS02894 79.2 A, B-1
(Tra5/5)
10 cell surface 
protein
gi|115251839 BASYS03018 98.4 BASYS03262 98.8 BASYS02891 99.0 A, B-1
-






BASYS02646 100 BASYS02247 100 A, B-1
-
12 Cell surface 
protein






























































BASYS03075 98.3 BASYS03273 97.8 BASYS02901 99.0 B-1
-
18
putative cell wall 
hydrolase gi|115252630
















BASYS03074 99.1 BASYS03272 99.1 BASYS02900 99.1 A
-
Eight of these surface proteins, SLP1, SLP2, SLP3, SLP4, SLP5, SLP6, SLP9 and 
SLP16 were detected in all three strains.  Six of these showed highly conserved 
sequences between strains (>95% sequence homology), however SLP9 and 
SLP16 showed great sequence variability.  Four additional proteins SLP7, SLP8, 
SLP10 and SLP11, were identified in strains A and B-1, but not Tra5/5.  All of 
these showed highly conserved sequences between strains.  Two proteins were
identified in strain A and Tra5/5 but not B-1.  SLP12 which showed high 
sequence homology between strains, and SLP13 which showed a highly 
conserved sequence between strains A and Tra5/5, but only matched with low 
homology to strain B-1.  This match was to the same protein (BASYS03079) as 
SLP12, indicating that the corresponding gene to this S-layer protein may not be 
present in the genome of strain B-1.
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One protein was detected in strains Tra5/5 and B-1 but not A, and showed a 
highly conserved sequence between the strains.  Three proteins were detected 
in strain A only, one in strain B-1 only and one in strain Tra5/5 only, all of 
which had highly conserved sequences between strains.
The protein showing the highest homology to the 630 SlpA (CD2793, 
gi|115251846) is numbered 16 in Table 3.2 above and highlighted in red.  This 
was identified in all three strains by LC-MS/MS, and on all three reference maps 
as spots A1 in strain B-1, and spots A1 and F6 in strains A and Tra5/5 (boxed 
spots, Figures 3.8, 3.9 and 3.10).  The protein numbered 13 in Table 2 above 
(gi|115251844) was also identified in the reference maps for strains A and 
Tra5/5 as the spot J12 (Figures 3.9 and 3.10), but was not present in strain B-1.  
This protein was also not detected in strain B-1 by LC-MS/MS, but was in the 
other two strains, and as mentioned above, the corresponding gene may not be 
presenting the B-1 genome.   
The 19 membrane proteins identified were also investigated further and are 
shown in Table 3.3 below.  None of these were detected on the 2D reference 
maps.  All membrane proteins showed high homology across the three strains.  
The highest numbers of membrane proteins were detected in strain A, and the 
fewest membrane proteins were detected in strain Tra5/5. Seven proteins were 
detected in all three strains, five were found in strains A and B-1 only, a further 
six were detected only in strain A, and one was detected only in strain B-1.
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Table 3.3 – Blast results of all the membrane proteins identified. The percentage 
identification score to protein with highest homology is shown for each strain, and the 
630 reference strain, along with the strains in which they were detected.










membrane protein gi|115249895 BASYS01231
100
BASYS00503
100 BASYS01023 100 A, B-1, 
Tra5/5
2 putative 
membrane protein gi|115249537 BASYS00828
99.7
BASYS00886
100 BASYS00635 100 A, B-1, 
Tra5/5
3 putative 
membrane protein gi|115250814 BASYS02178
100 BASYS01975 100 BASYS01851 100 A, B-1, 
Tra5/5
4 putative 
membrane protein gi|115249847 BASYS01180
100
BASYS00559
100 BASYS00973 100 A, B-1, 
Tra5/5
5 putative 
membrane protein gi|115249032 BASYS00357
99.7
BASYS00019
99.7 BASYS00024 99.7 A, B-1, 
Tra5/5
6 putative 
membrane protein gi|115251110 BASYS02508
100
BASYS02247
99.8 BASYS02109 100 A, B-1, 
Tra5/5
7 putative 
membrane protein gi|115250415 BASYS01679
100
BASYS01493
100 BASYS01426 100 A, B-1, 
Tra5/5
8 putative 
membrane protein gi|115252518 BASYS00063
100
BASYS03812
100 BASYS03601 100 A, B-1
9 putative 
















BASYS01579 99.3 BASYS01394 100 BASYS01331 99.9 A, B-1
12 putative 
membrane protein gi|115250109
BASYS01377 99.2 BASYS01225 99.7 BASYS01159 99.7 A, B-1
13 putative 
membrane protein gi|115249794
BASYS01126 100 BASYS00613 100 BASYS01972 99.8 B-1
14 putative 
membrane protein gi|115250974 BASYS02381
99.8
BASYS02095
100 BASYS00920 100 A
15 putative 



































Although the 1D gel electrophoresis LC-MS methodology is more sensitive and 
led to the identification of a greater number of proteins, there were still 26 
proteins identified in the 2D reference maps which were not identified at all by 
the LC-MS methodology, listed in Appendix A3, along with identification 
numbers, masses and a MASCOT identification score for each strain.  These
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include an indolepyruvate oxidoreductase subunit and a formate-
tetrahyrdrofolate  ligase which were present as abundant spots on all three 2D 
reference maps.  Other proteins identified on the reference maps but not 
detected by LC-MS/MS were a number of other metabolic enzymes, a flagellar 
hook associated protein, and two transcription regulatory factors.
Those proteins identified as present in one strain only by LC-MS/MS were then 
analysed in more detail.  
1D GE LC-MS/MS analysis identified 132 proteins which were present only in 
strain A (Table 3.4), 30 of which (23%) were hypothetical proteins with no 
putative function.  Fifteen of the proteins with putative function were surface 
proteins or potential virulence factors including six putative membrane 
proteins, five sporulation related proteins, two surface proteins, one putative 
cell wall hydrolase and a flagella export protein.  In addition, 65 of the 
functional proteins were metabolic enzymes, ten were transporter related 
proteins, 11 were regulatory proteins and one ribosomal protein was detected in 
strain A only.
1D GE LC-MS/MS analysis identified 161 proteins present only in strain B-1, 56 
of which (35%) were hypothetical proteins with no putative function (Table 3.5).  
Of the functional proteins detected only in strain B-1, 12 were surface proteins 
or potential virulence factors including two cell surface proteins, one putative 
membrane protein, three sporulation proteins and six flagellar related proteins.  
In addition, 68 metabolic enzymes, five transported proteins, 17 regulatory 
proteins and three ribosomal proteins were detected in strain B-1 only.
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1D GE LC-MS/MS analysis identified 45 proteins present in only strain Tra5/5, 
only six of which (13%) were hypothetical with no putative function (Table 3.6).  
Proteins present in the Tra5/5 strain only include a cell surface protein, 33 
metabolic enzymes, three regulatory proteins and two transporter proteins. 
To determine whether these differences in protein expression between the 
strains were due to genotypic or phenotypic variation, the sequences of proteins 
detected in one strain only were searched against the predicted gene products of 
the unfinished genomes of each strain using stand alone BLAST, to determine 
whether the corresponding genes were present in the genome.  The percentage 
identification and e-value scores for each protein against each genome are 
shown in Tables 3.4, 3.5 and 3.6.
The majority of the proteins identified in only one strain matched to gene 
products from all three genomes with high homology i.e. a percentage id greater 
that 90% (bold scores Tables 3.4, 3.5 and 3.6).  Those that did not, were mainly S-
layer proteins or hypothetical proteins.
Of the 132 proteins identified only in strain A, 121 (92%) matched to gene 
products from all three genomes with a high homology (Table 3.4).  Those that 
didn’t include a surface protein (sta_BASYS03271) which matched to strain 
Tra5/5 with high homology, but lower homology (65%) to strain B-1.  Four 
proteins (two hypothetical proteins, an acytransferase and a thymidylate 
synthase) showed homology to strain A but none to strains B-1 and Tra5/5.  One 
conserved hypothetical protein showed 100% homology to strains A and B-1 but 
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much lower (32%) homology to strain Tra5/5.  The others, two hypothetical 
proteins, a putative lipoprotein, a putative glycoxylase and a transcriptional 
regulator showed high homology to strain A, but lower homology to the other 
two strains.
Of the 161 proteins identified only in strain B-1, 135 (84%) matched to gene 
products from all three genomes with high homology (Table 3.5).  Of those that 
didn’t, four were from the strain B-1 phages, so did not match any of the strains 
with high homology.  The S-layer precursor protein stb_BASYS03072 matched 
to strain B-1 with high homology, but much lower homology to strains A and 
Tra 5/5.  Ten hypothetical proteins match to strain B-1 with high homology, but 
show no match to either of the other two strains.  Two putative phage proteins 
and a hypothetical protein matched to both strains A and B-1 with high 
homology, but much lower homology to strain Tra5/5.  The remaining six 
proteins showed high homology to strain B-1 but lower homology to A and 
Tra5/5.
Of the 45 proteins identified only in strain Tra5/5, 43 (96%) matched to gene 
products from all three genomes with high homology (Table 3.6).  The two that 
don’t are hypothetical proteins, and match to strain Tra5/5 with high homology, 
but much lower homology (25-30%) to strains A and B-1.
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Table 3.4 – Proteins identified in strain A only showing BLAST percentage identification 
and e-value scores to each of the three strains.









putative bifunctional protein: 
peroxiredoxin/chitinase 630_gi|115250474 100 0 99.86 0 99.86 0
294 putative membrane protein 630_gi|115250974 99.78 0 100 0 99.78 0
306
probable proton-dependent 
oligopeptide transporter 630_gi|115251316 100 0 100 0 100 0
307 putative cell wall hydrolase 630_gi|115252630 99.81 0 100 0 99.42 0
319






















































protein 630_gi|115249915 99.42 0 99.61 0 99.61 0
488
putative pyruvate formate-lyase 














490 putative oxidoreductase 630_gi|115249453 99.15 0 99.72 0 100 0




















115249567 100 0 99.53 0 99.53 0







497 putative protein translocase 630_gi|115251854 100 5.00E- 100 5.00E- 100 5.00E-
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binding protein [Clostridium 






115251113 100 0 99.82 0 99.82 0
























D-ornithine aminomutase E 
component 630_gi|115249457 99.86 0 100 0 100 0
608
putative sugar-phosphate 
kinase 630_gi|115249217 98.57 0 99.76 0 99.76 0
609
ABC transporter, ATP-binding 
protein 630_gi|115251510 99.46 0 99.73 0 99.73 0

















putative stage II sporulation 








putative aromatic amino acid 




Acetyltransferase GNAT Family sta_BASYS03656 100
1.00E-
97 - - - -
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inosine-uridine preferring 
nucleoside hydrolase 630_gi|115250725 99.69 0 99.69 0 99.38 0

















putative fumarate hydratase, 























protein 630_gi|115252354 99.72 0 100 0 100 0
683
putative penicillin-binding 
protein 630_gi|115250180 99.5 0 99.9 0 99.9 0









aldolase 630_gi|115251648 100 0 99.71 0 100 0
67









symporter family protein 630_gi|115251595 98.92 0 99.57 0 99.57 0
695 putative lipoate-protein ligase 630_gi|115250695 99.39 0 99.7 0 99.7 0




























156 - - - -
733
E3 component of acetoin 
dehydrogenase enzyme system 
(dihydrolipoyl dehydrogenase) 630_gi|115249042 99.48 0 99.48 0 99.83 0
734 flagellar export protein 630_gi|115249272 99.42 0 99.42 0 99.42 0












































putative ferrous ion transport 
protein 630_gi|115250558 100
5.00E-
115 99.86 0 100 0
































127 99.82 0 100 0



























































dehydratase 630_gi|115252479 99.69 0 100 0 100 0
755
putative RNA/single-stranded 
















































































PTS system, mannitol-specific 
IIbc component 630_gi|115251389 99.79 0 99.58 0 99.37 0
815




and IMP cyclohydrolase 630_gi|115249231 99.41 0 100 0 100 0














818 cell surface protein 630_gi|115251848 99.06
1.00E-
166 99.06 0 99.06 0


















































835 putative signaling protein 630_gi|115250461 99.65
1.00E-
80 99.83 0 99.83 0
836
putative molybdenum cofactor 









93 100 0 100 0




















PyrR bifunctional protein 
includes: pyrimidine operon 








842 tryptophanyl-tRNA synthetase 630_gi|115251661 99.7
3.00E-
97 99.7 0 100 0






oligopeptide ABC transporter, 







































transcriptional regulator 630_gi|115252242 99.17 0 99.83 0 99.83 0


























































signal peptide [Clostridium 
difficile QCD-66c26] sta_BASYS00235 100
4.00E-


















(115251870) 100 0 100 0 100 0
869
ydgP, 1509321-1509890 



































879 arginyl-tRNA synthetase 630_gi|115249727 100 0 100 0 100 0
881
putative multidrug efflux 
pump, membrane protein 630_gi|115251459 99.9 0 100 0 99.8 0














894 aspartokinase 630_gi|115250358 99.75 0 100 0 100 0
897
ABC transporter, ATP-
binding/permease protein 630_gi|115250108 100 0 100 0 100 0
899 putative sensor histidine kinase 630_gi|115251546 99.78 0 99.89 0 100 0
905 penicillin-binding protein 630_gi|115249798 99.5 0 99.87 0 99.6 0
907 putative gluconate permease 630_gi|115250781 100 0 100 0 100 0
916
DeoR-family transcriptional 










PTS system, mannitol-specific 



















927 putative AMP-binding protein 630_gi|115252027 97.62 0 98.7 0 98.49 0
928
putative histidyl-tRNA 
synthetase 630_gi|115251792 100 0 99.76 0 100 0
929 sta_BASYS02525-R sta_BASYS02525 100 0 99.74 0 99.74 0
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Table 3.5 – Proteins identified in strain B-1 only showing BLAST percentage 
identification and e-value scores to each of the three strains.










































0003 - - - - - -

































































630_gi|115250838 99.37 0 100 0 99.69 0
sta_BASYS02203











































































































phosphoribosyltransferase 630_gi|115252499 100 0 100 0 100 0


















































No  c. difficile match by BLAST stb_BASYS00477 100
1.00E-
172



















BASYS03056 stb_BASYS03056 100 0

















signal recognition particle 
protein 630_gi|115250286 99.56 0 99.78 0 99.78 0








acetyl-coenzyme A carboxylase 


















fliN, 608925-609239 (Clockwise) 
Hypothetical Protein fliN










































































583 cell surface protein 630_gi|115251849 97.77 0 98.25 0 99.04 0
584
PTS system, maltose and 
glucose-specific IIbc component 630_gi|115252085 100 0 99.81 0 99.81 0
585



















































Putative phage regulatory 










































rffG, 606774-607757 (Clockwise) 
Hypothetical Protein rffG
(dTDP-glucose 4,6-dehydratase) sta_BASYS00584 100 0 97.86 0 97.86 0


















subunit A 630_gi|115250062 99.37 0 99.84 0 99.76 0
626
putative tRNA modification 






























































acetyl-coenzyme A carboxylase 

































No match to BLAST stb_BASYS01737 100
6.00E-
45


















deoxyheptonate aldolase and 













No match by BLAST stb_BASYS03069 100
2.00E-
83









hydroxymethyltransferase 630_gi|115251778 99.28 0 99.76 0 99.76 0
693 conserved hypothetical protein 630_gi|115250202 100 0 100 0 100 0
696
putative phage positive 

























































putative cell wall hydrolase
stb_BASYS01250




































DNA polymerase III subunit 
gamma/tau 630_gi|115249019 99.82 0 100 0 100 0
709
dihydroorotate dehydrogenase 
electron transfer subunit 630_gi|115249195 100
3.00E-





phosphodiesterase 630_gi|115249706 99.37 0 99.83 0 99.68 0










































small chain 630_gi|115252653 100 0 100 0 100 0










Transferase Group 2 Family 
Protein
sta_BASYS00599 

































RNA polymerase sigme-54 
factor
sta_BASYS03664
(115252233) 100 0 100 0 100 0
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synthase III 630_gi|115250212 100 0 100 0 100 0



















783 putative exported protein 630_gi|115251537 99.43 0 99.43 0 100 0
784
coenzyme A biosynthesis 
bifunctional protein 630_gi|115251643 99.5 0 99.75 0 99.75 0






































(115249256) 98.26 0 100 0 100 0
794
trehalose-6-phosphate 
hydrolase 630_gi|115252145 99.64 0 100 0 99.64 0























































glycerate mutase 630_gi|115251833 99.82 0 99.65 0 99.65 0
806
putative DNA repair protein 






























putative ATP-dependent RNA 
helicase
stt_BASYS00904
(115249778) 100 0 100 0 100 0
814
putative ferrous iron transport 







864 prolyl-tRNA synthetase 630_gi|115249052 99.82 0 100 0 100 0








putative DNA polymerase III, 


































(115250058) 100 0 98.74 0 99.22 0
878 phosphoglycerate kinase 630_gi|115252230 99.75 0 100 0 100 0














(115249322) 100 0 98.99 0 98.49 0
888
chromosomal replication 















893 conserved hypothetical protein 630_gi|115251465 100 0 100 0 100 0






No match by BLAST stb_BASYS03068 100 0
902








904 putative helicase 630_gi|115250059 99.59 0 99.86 0 100 0
79








































recombination and repair 




921 putative esterase 630_gi|115250430 99.3 0 99.65 0 99.12 0
80
Table 3.6 – Proteins identified in strain Tra5/5 only showing BLAST percentage 
identification and e-value scores to each of the three strains.





























subunit of oxidoreductase 630_gi|115251153 99.73 0 99.87 0 100 0
378
putative electron transfer 
protein 630_gi|115252303 100 0 100 0 100 0
380 asparaginyl-tRNA synthetase 630_gi|115251299 100 0 100 0 100 0
451









deoxyheptonate aldolase and 
chorismate mutase 630_gi|115250878 99.7 0 100 0 100 0
527
putative FAD-binding subunit 
















542 putative aminopeptidase 630_gi|115250096 98.92 0 99.35 0 99.78 0
547 threonine synthase 630_gi|115251172 99.39 0 99.8 0 99.59 0
572
putative radical SAM family 
protein 630_gi|115251801 99.56 0 99.56 0 99.56 0
591
phosphoglucomutase/phospho
mannomutase mutase 630_gi|115249128 99.79 0 99.57 0 99.57 0
592 conserved hypothetical protein 630_gi|115250761 99.72 0 100 0 100 0
593
N-carbamoyl-L-amino acid 
hydrolase 630_gi|115251081 99.75 0 99.51 0 99.75 0



















phosphate phospholyase) 630_gi|115250881 99.72 0 99.44 0 99.72 0
658
putative ATP/GTP-binding 
protein 630_gi|115249805 99.06 0 99.53 0 100 0
690
P-protein includes: chorismate 
mutase and prephenate 
dehydratase 630_gi|115250882 97.99 0 98.74 0 99.5 0
691
UDP-N-acetylmuramate--L-
alanine ligase 630_gi|115252579 100 0 100 0 100 0
81









protein 630_gi|115250362 99.55 0 99.77 0 99.77 0




ligase 630_gi|115251706 99.12 0 99.78 0 99.56 0
731
putative GTP 
















































putative DNA mismatch repair 
protein 630_gi|115249725 99.49 0 99.75 0 99.75 0
822 DNA repair protein 630_gi|115249030 99.78 0 100 0 100 0
823 putative hydantoinase 630_gi|115250762 100 0 99.73 0 99.74 0







825 cinserved hypothetical protein 630_gi|115251677 99.56 0 99.78 0 99.56 0

















(115249228) 100 0 100 0 100 0
866 hydrogenase 630_gi|115252370 100 0 100 0 100 0











type I restriction-modification 







phospholipid synthase 630_gi|115249187 99.75 0 99.49 0 99.49 0
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925 cell surface protein 630_gi|115251246 100 0 100 0 100 0
3.2.3 – Protein Identification III – DIGE Analysis
In order to accurately compare the 2D profiles of the different strains, DIGE 
analysis was used.  Two biological replicates of the standard protein extracts 
from the three strains were labelled with fluorescent CyDyes, and run alongside 
a pooled protein standard containing a mixture of all protein samples in the
experiment, as shown in Table 3.7 below.
Table 3.7 – Experimental setup and sample labelling for the 2D DIGE experiment.  
Gel Dye
Cy2 Cy3 Cy5
1 Pooled Standard Strain B-1 rep1 Strain A rep1
2 Pooled Standard Strain A rep1 Strain Tra5/5 rep1
3 Pooled Standard Strain Tra5/5 rep1 Strain B-1 rep1
4 Pooled Standard Strain B-1 rep2 Strain A rep2
5 Pooled Standard Strain A rep2 Strain Tra5/5 rep2
6 Pooled Standard Strain Tra5/5 rep2 Strain B-1 rep2
Gels were imaged immediately after electrophoresis, and the images from each 
gel in the experiment shown in Figure 3.13 below.
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Figure 3.13(i) – DIGE image gel 1.  The Cy2 channel (blue) is the internal standard 
containing a mix of protein extracts from all strains. The Cy3 channel (green) is a 
protein extract from strain B-1(biological rep 1), and the Cy5 channel (red) a protein 
extract from strain A (biological rep 1). Spots appear white where all channels overlap.  
Examples of differentially expressed proteins are shown in the yellow boxes, with a 
surface protein gi|115251884 in box 1, the LMW SLP in box 2, flagellin in box 3 and  
the HMW SLP shown in box 4. The surface protein and the LMW SLP are clearly 
present in the A strain (red) but not the B-1 strain (green).  The HMW SLP and the 
series of flagellin spots are clearly migrating differently in the two strains.
4
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Figure 3.13(ii) – DIGE image gel 2.  The Cy2 channel (blue) is the internal standard 
containing a mix of protein extracts from all strains. The Cy3 channel (green) is a 
protein extract from strain A (biological rep 1), and the Cy5 channel (red) a protein 
extract from strain Tra5/5 (biological rep 1). Spots appear white where all channels 
overlap.  Examples of differentially expressed proteins are shown in the yellow boxes
as described in Figure 3.13(i).  The surface protein in box 1 and the LMW-SLP (box 2) 
show clear migration differences between the A and Tra5/5 strains, whereas the HMW 






Figure 3.13(iii) – DIGE image gel 3.  The Cy2 channel (blue) is the internal standard 
containing a mix of protein extracts from all strains. The Cy3 channel (green) is a 
protein extract from strain Tra5/5 (biological rep 1), and the Cy5 channel (red) a protein 
extract from strain B-1 (biological rep 1). Spots appear white where all channels 
overlap.  Examples of differentially expressed proteins are shown in the yellow boxes
as described in Figure 3.13(i).  The surface protein and LMW SLP (box 1 and 2) are 
present in strain Tra5/5 (green) but not strain B-1 (red) and the HMW SLP (box 4) 
clearly shows migration differences between the strains.  The series of flagellin spots 






Figure 3.13(iv) – DIGE image gel 4.  The Cy2 channel (blue) is the internal standard 
containing a mix of protein extracts from all strains. The Cy3 channel (green) is a 
protein extract from strain B-1 (biological rep 2), and the Cy5 channel (red) a protein 
extract from strain A (biological rep 2). Spots appear white where all channels overlap.  
Examples of differentially expressed proteins are shown in the yellow boxes as 
described in Figure 3.13(i).  The same variations in protein expression can be seen as 






Figure 3.13(v) – DIGE image gel 5.  The Cy2 channel (blue) is the internal standard 
containing a mix of protein extracts from all strains. The Cy3 channel (green) is a 
protein extract from strain A (biological rep 2), and the Cy5 channel (red) a protein 
extract from strain Tra5/5 (biological rep 2). Examples of differentially expressed
proteins are shown in the yellow boxes as described in Figure 3.13(i).  The same 






Figure 3.13(vi) – DIGE image gel 6.  The Cy2 channel (blue) is the internal standard 
containing a mix of protein extracts from all strains. The Cy3 channel (green) is a 
protein extract from strain Tra5/5 (biological rep 2), and the Cy5 channel (red) a protein 
extract from strain B-1 (biological rep 2). Spots appear white where all channels 
overlap.  Examples of differentially expressed proteins are shown in the yellow boxes
as described in Figure 3.13(i).  The surface protein (box 1) is not visible in either strain, 
but other migration differences are the same as those for gel 3 (Figure 3.13(iii)).
Yellow box 1 highlights an S-layer protein (gi|126700407) with a 43.7 fold 
greater concentration in strain A, and a normalised volume of 5.4 compared to 
0.1 for strain B-1 and 0.5 for strain Tra5/5.  The same protein was also identified 
as a different spot, up-regulated in strain Tra5/5 with a 33.4 fold greater 






compared to 0.1 for strain B-1 and 0.8 for strain A.  This protein was identified 
on the reference maps of strain A and Tra5/5 (spot J12, Figures 3.8 and 3.10) but 
not B-1.
The yellow boxes, 2 and 4 show the S-layer protein most similar to the SlpA of 
the 630 reference strain (gi|126700409), corresponding to the mature high 
molecular weight SLP and the low molecular weight SLP.  In both boxes, this 
protein has migrated differently between strains, due to the difference in 
molecular weight and pI arising from the large variation in amino acid 
sequence.  On the reference maps, this protein was identified as one spot in the 
profile of strain B-1 (spot A1, Figure 3.9) but two spots in strains A and Tra5/5 
(spots A1 and F6 Figures 3.8 and 3.10). Yellow box 2 highlights this second spot, 
F6.  The spot shows a 19.1 fold greater concentration in strain A, and a 
normalised volume of 3.5 compared to 0.2 for strain B-1 and 0.2 for strain 
Tra5/5.  The equivalent spot for the Tra5/5 version of this LMW SLP shows a 9.6 
fold greater concentration in strain Tra5/5 and a normalised volume of 1.3 
compared to 0.1 in strain B-1 and 0.3 in strain A.
Yellow box 3 highlights the differences in the modified flagellin proteins of the 
B-1 and A strains, where the series of Cy3 and Cy5 labelled proteins are clearly 
visible as separate spots which have migrated differently within the gel.  This 
suggests that the modification process is different between the strains.
The images from all six gels were aligned, and statistical concentration 
differences between different strains analysed using the SameSpots software
(Progenesis).  A total of 453 proteins were matched across the standards of all 
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six gels.  Proteins with an anova value of p<0.05 and a greater than ±2-fold 
difference were considered to differ significantly between the strains.  
Correlation analysis was used on the 112 spots which met these criteria in order 
to compare expression profiles between strains.   As shown below, 28 proteins 
showed a significantly greater concentration in the B-1 strain, a different 28 
showed significantly greater concentration in the A strain and 21 proteins 
showed a significantly greater concentration in the Tra5/5 strain.  The DIGE 
images were then matched to the picking gels used for the reference maps 
(Figures 3.8, 3.9 and 3.10) to identify these proteins.  The ranks, anova scores, fold 
increase and normalised volumes of these significant proteins are shown in 
Appendix A4.
Of the 28 spots with significantly higher concentration in the A strain (p<0.05, 
fold difference >±2), 15 (54%) matched to spots on the reference map (Figure 
3.14).  Ten of these had been identified by MASCOT, as five different proteins 
(Table 3.8), leading to identification of 36% of the significant spots.  Of these 
spots of interest, the S-layer protein spots J12 (Figure 3.8, Table 3.8, 
sta_BASYS03267) and F6 (Figure 3.8, Table 3.8, sta_BASYS03269) showed the 
highest fold differences of 43.7 and 19.1 respectively.  Five different spots 
(marked as M2, M4-M7 in Figure 3.8) were identified as flagellin, with fold 
differences ranging from 6.4 to 4.3, and an ABC transporter protein (marked as 
F5 in Figure 3.8) was identified with a lower fold difference of 2.5.
91
Figure 3.14 – Protein spots with statistically significantly higher concentration in strain 
A.  The proteins identified as up-regulated in strain A by correlation analysis were 
matched to the ‘picking gel’ used to create the strain A reference map.  The numbers 
indicate the rank of the protein, with protein 1 showing the greatest fold difference 
between the strains (Appendix A4)
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(CounterClockwise) Hypothetical Protein 
BASYS03269 (Cell Surface Protein) sta_BASYS03269  
52 and 7 
respectively
F5






(CounterClockwise) Hypothetical Protein 
BASYS03267 (cell surface protein (putative 
S-layer protein precursor)) sta_BASYS03267
1
L5
glyA, 3392427-3391183 (CounterClockwise) 
Hypothetical Protein glyA (putative serine 




fliC, 615650-616609 (Clockwise) 
Hypothetical Protein fliC (flagellin subunit) sta_BASYS00598
61, 39, 60, 64 
and 49 
respectively
Of the 28 protein spots with significantly higher concentration in the B-1 strain 
(p<0.05, fold difference >±2), 17 (71%) were matched to spots on the B-1 
reference map (Figure 3.15).  All but three of these had been identified by 
MASCOT, as ten different proteins (Table 3.9), leading to identification of 61% of 
the significant spots.  Of these spots, the greatest fold difference of 22.6 was 
seen in the S-layer protein spot A1 (Figure 3.9, Table 3.9, stb_BASYS03072).  Four 
flagellin spots had a significantly higher concentration in strain B-1, with the 
spots marked M1 and M3 on Figure 3.9 showing a 21.1 and 22.4 fold increase 
respectively. Three spots (marked as D5-D7 on Figure 3.9), identified as ABC 
transporter binding proteins, showed fold differences of 4.6, 6.7 and 6.6. In 
addition, a number of metabolic proteins were up-regulated in strain B-1, 
including a pyruvate-flavodoxin oxidoreductase (spots B1 and B2, Figure 3.9) 
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with fold differences of 4.2 and 6.7 and an alcohol dehydrogenase (spot I2, 
Figure 3.9) with a large fold difference of 12.2. 
Figure 3.15 – Protein spots with statistically significantly higher concentration in strain 
B-1.  The proteins identified as up-regulated in strain B-1 by correlation analysis were 
matched to the ‘picking gel’ used to create the strain B-1 reference map. The numbers 
indicate the rank of the protein, with protein 1 showing the greatest fold difference 
between the strains (Appendix A4).
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Table 3.9 – Protein spots with significantly higher concentration in strain B-1. Legend –
(x2) indicates that one spot picked from the reference map was identified as two spots 






(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072
4 and 36 
respectively
B1 and B2 pyruvate-flavodoxin oxidoreductase
630_gi|115251733|e
mb|CAJ69568.1|   
65 and 34 
respectively
D5 and D6



















glycine reductase complex component B 





adhE, 3383815-3381161 (CounterClockwise) 
Hypothetical Protein adhE ( aldehyde-
alcohol dehydrogenase includes: alcohol 








83 and 70 
respectively







fliC, 615650-616609 (Clockwise) 
Hypothetical Protein fliC (flagellin subunit) stb_BASYS00368
6, 10, 5 and 
41 
respectively
Twenty-one spots showed a significantly higher concentration in strain Tra5/5 
(p<0.05, fold difference >±2), only 48% of which matched to spots on the Tra5/5 
reference map (Figure 3.16).  All of these had been identified using MASCOT 
(Table 3.10), as eight different proteins.   Again, the largest fold difference of 33.4 
was seen in an S-layer protein, spot J12 (Figure 3.10, Table 3.10, stt_BASYS02896).  
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Three spots from the DIGE images were matched to an additional S-layer 
protein marked spot F6 on Figure 3.10 (Table 3.10, stt_BASYS00983) with high 
fold differences of 10.4, 9.6 and 8.8.  Similarly to strain B-1, some metabolic 
proteins showed a higher concentration in strain Tra5/5 including an 
oxidoreductase (marked as spot B5 on Figure 3.10) with a 2.4 fold difference,
and a dehydrogenase (marked as spot L10 on Figure 3.10) identified as two 
spots with fold differences of 3.5 and 3.8.
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Figure 3.16 – Protein spots with statistically significantly higher concentration in strain 
Tra5/5.
The proteins identified as up-regulated in strain Tra5/5 by correlation analysis were 
matched to the ‘picking gel’ used to create the strain Tra5/5 reference map. The 
numbers indicate the rank of the protein, with protein 1 showing the greatest fold 
difference between the strains (Appendix A4).
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Table 3.10 – Protein spots with significantly higher concentration in the Tra5/5 strain.
Legend – (x2) or (x3) indicates that one spot picked from the reference map was 
identified as two or three spots by the SameSpots image analysis software. Two protein 
identifications indicate that one spot on the reference map was identified as two 





ydbK, 2906795-2903256 (CounterClockwise) 







(CounterClockwise) Hypothetical Protein 
BASYS02898 (Cell Surface protein)
stt_BASYS02
898
19, 15 and 21 
respectively
F12
ycgM, 996287-997189 (Clockwise) Hypothetical 





BASYS01847, 1900865-1901566 (Clockwise) 






leuS, 2716913-2714493 (CounterClockwise) 
Hypothetical Protein leuS (leuS, 3140547-
3138127 (CounterClockwise) Hypothetical 






(CounterClockwise) Hypothetical Protein 






caiA, 448917-450062 (Clockwise) Hypothetical 




74 and 190 
respectively
cfa, 188449-187262 (CounterClockwise) 





During this analysis, different spots showing significant differences between 
strains by the correlation analysis were often identified as the same protein on 
the reference maps, such as the flagellin protein (BASYS02546) in strain B-1 
which matched to four different spots with significantly higher concentrations 
in strain B-1, and the S-layer protein F6 (gi|126700409) in strain Tra5/5 which 
matched to three different spots that showed significantly higher concentration 
in strain Tra5/5.
A total of five different up-regulated proteins were identified in strain A, 12 in 
strain B-1 and eight in strain Tra5/5.  In order to confirm that the difference in 
concentration of these up-regulated proteins was due to regulatory rather than 
genomic differences, the presence of the corresponding genes in all three 
genomes was verified.  The amino acid sequences of the identified proteins 
were therefore matched to in silico gene products from the unfinished genomes 
using BLAST searching.  Each protein sequence was matched against the gene 
products of each of the three genomes in turn to confirm the presence of the 
corresponding gene in the genome.  Percentage identification and e-values for
each match are shown in Table 3.11 below.
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Table 3.11 – Percentage identification scores and e-values for BLAST comparison of 
the sequences of differentially expressed proteins with each of the three genomes.  
Scores highlighted in bold are considered significant and indicate the presence of the 
corresponding gene in the genome.  Lower scores indicate considerable sequence 
variation between strains.






Strain Protein %id e %id e %id e
A
A1, F6 - sta_BASYS03269 
BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical 
Protein BASYS03269 (Cell Surface 
Protein) 100 0 52.71
4.00E
-106 88.71 0
F5 - 630_gi|15249887 
ABC transporter, substrate-binding 




Protein BASYS03267 (cell surface 
protein (putative S-layer protein 






Protein glyA (putative serine 
hydroxymethyltransferase) 100 0 99.52 0 99.52 0
M2-M7 - sta_BASYS00598
fliC, 615650-616609 (Clockwise) 









A1, A8 - stb_BASYS03072




-113 100 0 52.91
2.00E
-113
B1, B2 - 630_gi|11521733
pyruvate-flavodoxin oxidoreductase 100 0 99.41 0 99.58 0
D5, D6 - 630_gi|115249872
oligopeptide ABC transporter, substrate-
binding lipoprotein 99.8 0 100 0 100 0
100
B-1
D7 - 630_gi|115251723 
oligopeptide ABC transporter, substrate-
binding protein 99.61 0 99.42 0 99.81 100
D9 - 630_gi|115251404
glycine/sarcosine/betaine reductase 
complex component C beta subunit 99.8 0 100 0 100 0
G10 - 630_gi|115251407
glycine reductase complex component B 




Protein adhE ( aldehyde-alcohol 
dehydrogenase includes: alcohol 
dehydrogenase and pyruvate-formate-
lyase deactivase ) 99.21 0 100 0 99.89 0
J7, J8 - 630_gi|115249184
putative oxidoreductase, acetyl-CoA 
synthase subunit 100 0 100 0 100 0
K5 - 630_gi|115251209
radical SAM-superfamily protein 100 0 100 0 100 0
M1-M5 – stb_BASYS00368
fliC, 615650-616609 (Clockwise) 












Protein ydbK (pyruvate-flavodoxin 




Protein BASYS02898 (Cell Surface 




ycgM, 996287-997189 (Clockwise) 










(Clockwise) Cytoplasmic Protein 












Protein leuS (leuS, 3140547-3138127 
(CounterClockwise) Hypothetical 




Protein BASYS02896 (cell surface 
protein (putative S-layer protein 




caiA, 448917-450062 (Clockwise) 
Hypothetical Protein caiA (acyl-CoA 
dehydrogenase, short-chain specific) 100 0 100 0 100 0
L10 – stt_BASYS00186
cfa, 188449-187262 (CounterClockwise) 
Hypothetical Protein cfa (cyclopropane-
fatty-acyl-phospholipid synthase) 99.24 0 100 0 100 0
Of all the proteins deemed significant by the SameSpots software, the S-layer 
proteins were the only sequences which did not match with high homology to a 
predicted gene product from all of the three genomes. 
Three of the six proteins with significantly higher concentration in strain A 
matched to predicted gene products in all three genomes with high homology, 
i.e. a percentage identification greater that 80% (scores highlighted in bold Table 
3.11).  However, the S-layer proteins BASYS01133 and BASYS01135, did not.  
Both these proteins showed high homology (89% and 99% respectively) to 
predicted gene products from strain Tra5/5, but much lower homology (53% 
and 36% respectively) to predicted gene products from strain B-1.  There is an 
obvious anomaly in that the ABC transporter (F5) found to be unregulated in 
strain A matched with high homology to strains B-1 and Tra5/5 but not to A, 
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despite the fact the protein was detected in strain A.  This ABC transporter 
seems to be conserved in a number of C. difficile strains, including similar 027 
ribotype strains, so it seems unlikely that it would not be present in A.  The 
individual peptides on which the identification was based were therefore 
searched against each of the genomes using stand-alone BLAST with the 
recommended parameters for short sequences.  Again, the peptides all matched 
to the same protein sequence with high homology in strains B-1 and Tra5/5.  For 
strain A, however, the peptides matched to a number of different proteins with 
low homology.  The corresponding DNA sequence of this protein was then 
searched against the completed genome of strain A.  Only 44 out of ~1000 
nucleotides for the corresponding gene sequence were matched to the genome, 
indicating that the gene was not present in the genome.  However, in the raw, 
un-annotated sequence data, the whole gene could be matched with high 
homology by BLAST.  This indicates that when the sequences were reassembled 
using a newer version of the Roche assembly program ‘Newbler’ it didn’t 
assemble some sequence data, which included this protein.  This may be 
because it was a region considered to be of low sequence quality by the 
algorithm.  The corresponding gene was nevertheless confirmed in all three 
strains.
Of the ten proteins with significantly higher concentration in strain B-1, nine 
matched to gene products from all three genomes with a high homology, but 
again, the S-layer protein did not.  BASYS00187 showed a percentage 
identification of only 53% to gene products from both strains A and Tra5/5.
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For strain Tra5/5, six of the eight significantly up-regulated proteins matched to 
gene products of all three genomes with high homology.  The S-layer protein 
BASYS02999 showed high homology to strain A, with a percentage 
identification of 89%, a much lower percentage identification of 53% to strain B-
1.  BASYS02997 also showed high homology to strain A (98% identification) but 
a much lower homology to strain B-1 with a percentage identification score of 
only 37%.
3.3 – ProteoMiner Treatment
In order to increase the detection of low abundance proteins, and hence improve 
proteome coverage, protein extracts were treated with the ProteoMiner 
hexapeptide bead libraries.  Two technical replicates of whole cell broth extracts 
were treated sequentially with an amino-terminus ‘E-bead’ hexapeptide library, 
and a carboxy-terminus ‘SE-bead’ library.  Proteins were then eluted from the 
columns to give three different extracts; crude protein extracts, an E-bead eluate 
and an SE-bead eluate.  These protein extracts were then compared to determine 
whether additional proteins were detected in the ProteoMiner treated samples.
3.3.1 Differences in 1D profiles
Firstly, the 1D gel profiles for treated and untreated samples were compared in 
order to assess the effects of the treatment (Figure 3.17).
The differences between the crude and ProteoMiner treated protein extracts
were similar for each of the three strains.  The extracts treated with the amino 
terminal E-bead library showed a similar profile to the crude samples, although 
some of the stronger bands, most notably that of ~55kDa, likely to correspond to 
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the highly abundant glutamate dehydrogenase, appear reduced in the E-bead 
treated samples.  The two S-layer proteins of ~45 kDa and ~36 kDa are still, 
however, by far the most abundant proteins in the E-bead treated fractions, and 
their relative concentration does not appear to have been greatly altered by the 
treatment.
In contrast, the extracts treated by the carboxy-terminal SE-bead library have a 
markedly different 1D gel profile from the crude samples.  The SE-bead treated 
extracts show a far smaller range in protein abundance, with the concentration 
of the S-layer proteins greatly reduced in comparison with both the crude and 
E-bead treated extracts.  They also appear to show an increase in concentration 
of lower molecular weight proteins.
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Figure 3.17 – Comparison of the Sypro Ruby stained 1D profiles of both ProteoMiner 
treated fractions with crude protein extracts for each of the three strains.
Lanes 1, 12, 13 and 19 contain a ladder of molecular markers. Lanes 2-6 correspond to 
the B-1 strain, with 2 being a B-1 crude protein extract, 3 + 4 E-bead treated B-1 
extracts and 5 + 6 SE-bead treated B-1 extracts. Lanes 7-11 correspond to the A strain, 
with 7 being a crude A strain protein extract, 8 + 9 E-bead treated A extracts, and 10 + 
11 SE-bead treated A extracts.  Lanes 14-18 correspond to a second gel, showing the
Tra5/5 strain extracts.  Lane 14 contains a crude Tra5/5 strain protein extract, lanes 15 
+ 16 are E-bead treated Tra5/5 extracts and lanes 17 + 18 are SE-bead treated Tra5/5 
extracts.
3.3.2 Differences in 2D profiles
The ProteoMiner treated and crude extracts were then compared by 2D gel 
electrophoresis (Figure 3.18).













Figure 3.18 – 2D gel electrophoresis of ProteoMiner treated and crude protein extracts 
for each of the three strains.
For each of the three strains, crude, E-bead treated and SE-bead treated extracts were 
separated by 2D gel electrophoresis.  The protein spots were visualised with SYPRO 
ruby protein stain.  Areas of the gels showing additional proteins in treated samples are 
highlighted in blue boxes for E-bead treated fractions and red boxes for SE-bead 
treated fractions.
There are additional proteins present on the 2D gels of the ProteoMiner treated 
samples which are not visible on the gel profiles of crude extracts (Figure 3.18).  
Moreover, the additional proteins visualised in the E-bead and SE-bead treated 










The protein extracts eluted from the SE-bead library with carboxylated terminal 
residues particularly show an increase of protein spots visible in the basic 
region of the gel compared with both the crude and E-bead treated fractions, as 
shown clearly by the positions of the red boxes on the SE-bead treated gels 
(Figure 3.18).  Many of these are proteins of lower molecular mass, again 
confirming the differences in the 1D gel profiles (Figure 3.17).  A number of 
these newly visualised proteins were picked from the gels for MALDI-TOF MS 
identification.
3.3.3 - Additional proteins identified in treated extracts by MALDI-TOF MS
For each strain, 48 additional spots were picked from the 2D gels of 
ProteoMiner treated fractions for MALDI-TOF mass spectrometry 
identification.  These spots are shown in Figures 3.19(i)-3.19(vi). The majority of 
spots were recovered from the basic region of the gel, as these were considered 
of greater interest, having not previously been visualised on reference maps.  
For strain A, two SE-bead treated fraction profiles were chosen for spot picking, 
and for strains B-1 and Tra5/5, one E-bead treated fraction and one SE-bead 
treated fraction were used for spot picking.
108
Figure 3.19(i) – Additional protein spots for the strain A treated extracts excised from 
gel A, SE-bead fraction 1.  Gels were post-stained with Brilliant Blue and the gel plugs 
were then digested for identification by MALDI-TOF MS.  The additional proteins in the 






















Figure 3.19(ii) – Additional protein spots for the strain A treated extracts excised from 
gel B, SE-bead fraction 2.  Gels were post-stained with Brilliant Blue and the gel plugs 


























Figure 3.19(iii) – Additional protein spots for the strain B-1 treated extracts excised 
from gel C, E-bead fraction.  Gels were post-stained with Brilliant Blue and the gel 





























Figure 3.19(iv) – Additional protein spots for the strain B-1 treated extracts excised 
from gel D, SE-bead fraction.  Gels were post-stained with Brilliant Blue and the gel



















Figure 3.19(v) – Additional protein spots for the strain Tra5/5 treated extracts excised 
from gel E, E-bead fraction.  Gels were post-stained with Brilliant Blue and the gel 





















Figure 3.19(vi) – Additional protein spots for the strain Tra5/5 treated extracts excised 
from gel F, SE-bead fraction.  Gels were post-stained with Brilliant Blue and the gel 
plugs were then digested for identification by MALDI-TOF MS.
For each strain, additional proteins were identified from the 2D profiles of the 
treated samples, some of which had not previously been identified on proteome 
reference maps of the strains.
For strain A, only 25 of the 48 additional spots picked from the 2D gels of 
ProteoMiner treated fractions were identified by MALDI-TOF MS.  Thirteen 
different proteins were identified (Table 3.12), only three of which had 


























proteins detected by MALDI-TOF MS in the ProteoMiner treated fractions.  
Eight of these had previously been identified in the standard plate extracts using 
LC-MS/MS, but two proteins, a putative sugar-phosphate dehydrogenase and a 
terminase small subunit, have only been detected in the ProteoMiner treated 
strains.
For strain B-1, 43 of the 48 additional protein spots picked from the ProteoMiner 
2D gels were identified by MALDI-TOF MS as 19 different proteins (Table 3.13).  
Six of these had been previously identified on the 2D reference maps, giving an 
additional 13 proteins detected by 2D reference mapping using ProteoMiner 
treatment.  Of these 13 extra identifications, all had been previously identified 
in the standard plate extracts using LC-MS/MS. 
For strain Tra5/5, 36 of the additional 48 spots picked from the ProteoMiner 
treated 2D gels were identified by MALDI-TOF MS as a total of 14 different 
proteins (Table 3.14).  Only four of these had previously been identified by 2D 
reference mapping, giving an extra ten proteins detected by MALDI-TOF MS in 
ProteoMiner treated samples.  Nine of these had been previously identified 
using LC-MS/MS, but one protein, 50S ribosomal protein L19, had only been 
detected in the ProteoMiner treated samples. 
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Table 3.12 – Strain A proteins identified by MALDI-TOF mass spectrometry from 
ProteoMiner treated protein extracts with MASCOT identification scores (A), theoretical 
mass (B) and pI (C), percentage peptide coverage (D) and number of matched 
peptides (E).  Proteins shown in bold had not previously been identified on reference 
maps





rpsC, 424475-425290 (Clockwise) 
30S ribosomal protein S3
630_gi|115249083|




rplA, 405111-405809 (Clockwise) 
50S ribosomal protein L1
630_gi|115249066|





(Clockwise) Stage 0 sporulation 
protein A homolog
630_gi|115250247|





(Clockwise) Hypothetical Protein 
BASYS00470
630_gi|115249126|
emb|CAJ66937.1| 62 27031 6.38 38 6
5 B7
D7 tellurium resistance protein
630_gi|115250846|
emb|CAJ68670.1| 89 21416 6.85 61 12
6 B8
D8 putative DNA-binding protein
630_gi|115249180|












emb|CAJ67220.1| 108 41469 5.88 50 17
9 C6
C7
C10 50S ribosomal protein L4
630_gi|115249078|
emb|CAJ66889.1| 89 23747 9.96 52 8
10
C8 50S ribosomal protein L5
630_gi|115249089|













emb|CAJ67216.1| 74 44491 5.18 35 10
13 B1
B3
1, 1756344-1756784 (Clockwise) 
Terminase small subunit stb_BASYS01719  60 16768 5.4 42 7
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Table 3.13 – Strain B-1 proteins identified by MALDI-TOF mass spectrometry from 
ProteoMiner treated protein extracts with MASCOT identification scores (A), theoretical 
mass (B) and pI (C), percentage peptide coverage (D) and number of matched 
peptides (E).  Proteins shown in bold had not previously been identified on reference 
maps.

























rpsC, 83439-84254 (Clockwise) 
30S ribosomal protein S3
630_gi|115249083|
emb|CAJ66894.1| 46 30401 10.33 26 7
4
A6
rplA, 64076-64774 (Clockwise) 
50S ribosomal protein L1
630_gi|115249066|
emb|CAJ66877.1| 62 24791 9.41 43 9
5
A7
rplC, 80301-80930 (Clockwise) 50S 
ribosomal protein L3
630_gi|115249077|
emb|CAJ66888.1| 117 22370 9.95 56 15
6 A8
B5
rpsD, 93776-94351 (Clockwise) 
30S ribosomal protein 
630_gi|115249105|




rplD, 80930-81583 (Clockwise) 
Hypothetical Protein rplD
630_gi|115249078|


















emb|CAJ67216.1| 77 44491 5.18 29 9
10 B1
B2 50S ribosomal protein L10
630_gi|115249067|




(CounterClockwise) 30S ribosomal 
protein 
630_gi|115251194|






emb|CAJ67899.1| 70 30887 5.8 28 8
13
C4




emb|CAJ67219.1| 40 42966 5.27 15 5
14 manganese-dependent inorganic 
pyrophosphatase
630_gi|115249342|





emb|CAJ69518.1| 89 49681 6.51 28 13
16
C12 50S ribosomal protein L15
630_gi|115249096|
emb|CAJ66907.1| 58 16142 10.44 52 9
17
D1 cell surface protein
630_gi|115251764|
emb|CAJ69599.1| 60 72030 8.89 33 15
18
D6 tellurium resistance protein
630_gi|115250846|





(Clockwise) Stage 0 sporulation 
protein A homolog
630_gi|115250247|
emb|CAJ68068.1| 166 30888 6.33 83 18
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Table 3.14 – Strain Tra5/5 proteins identified by MALDI-TOF mass spectrometry from 
ProteoMiner treated protein extracts with MASCOT identification scores (A), theoretical
mass (B) and pI (C), percentage peptide coverage (D) and number of matched 
peptides (E).  Proteins shown in Bold had not previously been identified on reference 
maps.
Strain Tra 
















C6 putative subunit of oxidoreductase
630_gi|115249126|
emb|CAJ66937.1 123 27031 6.38 56 11
3
A8
putative GTP-binding protein 630_gi|115251683|
emb|CAJ69518.1 225 49681 6.51 58 25
4
A11
50S ribosomal protein L10 630_gi|115249067|
emb|CAJ66878.1 137 19581  6.2 80 15
5 B1
C10 50S ribosomal protein L4
630_gi|115249078|












30S ribosomal protein S3 630_gi|115249083|
emb|CAJ66894.1| 153 30401 10.33 59 17
8
B6
30S ribosomal protein S4 630_gi|115249105|




emb|CAJ67895.1| 146 41390 5.71 55 17
10
C1 cell surface protein
630_gi|115251764|












(Clockwise) Stage 0 sporulation 
protein A homolog 630_gi|115250247|




50S ribosomal protein L1
630_gi|115249066|
emb|CAJ66877.1|




rplS, 1334033-1334383 (Clockwise) 
50S ribosomal protein L19
630_gi|115250291|
emb|CAJ68113.1
84 13287 10.84 60 12
Few additional surface or virulence proteins were detected in the 2D profiles of 
treated strains, but 2D GE followed by MALDI-TOF MS identified one 
sporulation potein, Spo0A in the treated extracts of all three strains, whereas 
previously it had not been detected in strain B-1, and an additional cell surface 
protein (gi|115251764) in strains B-1 and Tra5/5 but not A.  These had both been 
identified in the standard plate extracts by LC-MS/MS.
3.3.4 Additional proteins identified in treated extracts by LC-MS/MS
In order to get a more in-depth picture of the changes occurring due to the 
ProteoMiner treatment, the 1D gel profiles of crude and treated extracts (Figure 
3.17) were cut into 12 bands, and each band subject to in-gel digestion before 
sizing on the LTQ-orbitrap quadrapole mass spectrometer for a more sensitive 
identification of proteins present in each fraction.  The raw data files were 
searched against a redundant database of strains A, B-1, Tra5/5 and the 
reference strain 630 using MASCOT.  Protein identifications were exported from 
scaffold and all those identification which were false were deleted.  As with 
other mascot identifications, all protein identifications based on 1 peptide only 
were verified by searching the corresponding peptide against the translated 
genome of the corresponding strain.  If the peptide was present in the relative 
strain, the identification was considered valid.  If the peptide was not present, 
the identification was discarded.  The identified proteins are shown in 
Appendices A5, A6 and A7.
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For strain A, a total of 664 proteins were identified by Scaffold, 19 of which were 
discarded as false identifications.  After redundancy was removed, 643 
identifications were confirmed as shown in Figure 3.20 below.
Figure 3.20 – A Venn diagram to show the breakdown of proteins identified in the 
strain A crude and ProteoMiner treated extracts by LC-MS/MS.  If a protein was 
present in one replicate, it was considered to be present in the sample.  Identifications, 



















For strain B-1, a total of 558 proteins were identified by Scaffold, 54 of which 
were discarded as false identifications.  After removing redundancy, 503 
identifications were confirmed as shown in Figure 3.21 below.
Figure 3.21 – A Venn diagram to show the breakdown of proteins identified in the 
strain B-1 crude and ProteoMiner treated extracts by LC-MS/MS.  If a protein was 
present in one replicate, it was considered to be present in the sample.  Identifications, 



















For strain Tra5/5, a total of 622 proteins were identified by Scaffold, 22 of which 
were discarded as false identifications.  After redundancy was removed, 599 
identifications were confirmed as shown in Figure 3.22 below.
Figure 3.22 – A Venn diagram to show the breakdown of proteins identified in the 
strain Tra5/5 crude and ProteoMiner treated extracts by LC-MS/MS.  If a protein was 
present in one replicate, it was considered to be present in the sample.  Identifications, 


















3.3.4.1 - Comparison of LC-MS/MS data for broth and standard plate extracts
The protein samples treated with the ProteoMiner bead libraries were extracted 
from broth cultures whereas the standard protein extracts used for protein 
mapping and 1D LC-MS/MS were from plate culture.  Growth conditions have a 
large effect on protein expression, so the proteins detected in the crude broth 
extracts by LC-MS/MS were compared to the proteins detected in plate extracts 
by LC-MS/MS.
In strain A, 360 proteins were identified from the plate extracts which were not 
detected in the broth extracts used for ProteoMiner treatment, and in strains B-1 
and Tra5/5 it was 428 and 235 proteins respectively.  This constituted 57%, 64% 
and 55% respectively of the total proteins detected in the standard plate extracts
The additional proteins detected in the broth extract used for ProteoMiner 
treatment but not in the standard plate extracts were then looked at in more 
detail and are shown in the Table 3.15 below
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Table 3.15 – Proteins detected in crude broth samples but not the standard plate 
extracts.  
Additional proteins detected in broth extracts but not standard 
plate extracts
Strain A Strain B-1 Strain Tra5/5
All samples 81 48 97
E and Crude 54 45 37
E only 36 42 50
E and SE 16 14 37
SE only 74 30 49
SE and Crude 11 3 11
Crude only 78 61 117
Total (% of total 
proteins detected in 
broth extracts)
350 (54%) 243 (48%) 398 (66%)
For strain A, 350 proteins were identified in the broth extracts which were not 
detected in the standard plate extracts, of which 126 were found only in 
ProteoMiner treated samples.  For strain B-1, 243 proteins were identified in the 
broth extracts which were not detected in the standard extracts, of which 86 
were seen only in ProteoMiner treated fractions.  For strain Tra5/5, 398 proteins 
were identified in the broth extracts which were not detected in the standard 
plate extracts, 136 of which were found only in the ProteoMiner treated 
samples.  
3.3.4.2 - Affects of ProteoMiner treatment on the broth extracts
The protein identifications from the crude broth extracts and E-bead and SE-
bead treated samples were investigated in more detail to determine how many 
additional proteins were detected after ProteoMiner treatment
A total of 148 additional proteins were present in strain A after ProteoMiner 
treatment that were not detected in the crude protein extract.  These included 46 
identified only in the E-bead treated fraction, 83 identified only in the SE-bead 
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treated fraction, and 19 identified in both treated fractions.  Of these, eight were 
surface or virulence proteins, including one sporulation protein (Spo0B-
assosiated GTP-binding protein-gi|115250196) found in both E-bead and SE-
bead treated fractions and not detected in the standard plate extracts for this 
strain. Two sporulation proteins (gi|115251680, gi|115250981), four cell surface 
proteins (gi|115251032, gi|115251842, gi|115250795, gi|115250166) and a 
flagellar protein (gi|115249243) were found in the SE-bead treated fraction only.  
The flagellar protein and one of the surface proteins (gi|115251032) were not 
detected at all in the standard plate extracts.  There were also three ABC 
transporter proteins found only in ProteoMiner treated samples.  However, 138 
proteins present in the crude extract were lost after treatment.  
A total of 127 additional B-1 proteins were present after ProteoMiner treatment 
that were not detected in the crude protein extract.  These included 60 identified 
only in the E-bead treated fraction, 38 identified only in the SE-bead treated 
fraction, and 29 identified in both treated fractions.  The flagellin subunit was 
found in both the E-bead and SE-bead treated fractions, and two surface 
proteins (gi|115251847 and gi|115251846) were found only in the SE-bead 
treated fraction. One of these (gi|115251847) had not previously been identified 
in strain B-1 in the standard plate extracts.  However, 113 (22%) of the proteins 
identified in the crude extract were lost after ProteoMiner treatment.
In strain Tra5/5, a total of 171 additional proteins were present in the 
ProteoMiner treated samples which were not detected in the crude broth 
extracts.  These included 58 proteins identified only in the E-bead treated 
fraction, 58 identified only in the SE-bead treated fractions, and 54 identified in 
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both ProteoMiner treated fractions.  A sporulation protein (gi|115252560) found 
only in the E-bead treated fraction and not identified in the standard plate
extracts for this strain, a cell surface protein (gi|115251842) found in both 
treated fractions and detected in the standard plate extracts, and two 
sporulation related proteins (gi|115250981, gi|115250196) and a putative 
flagellar protein (gi|115249264) found in only the SE-bead treated fraction, only 
one of which (gi|115250196) had been seen in the standard plate extracts for this 
strain.  The putative flagellar protein (gi|115249264)  was not detected in any of
the standard plate extracts. However, 148 (25%) of the proteins identified in the 
crude extract were lost after ProteoMiner treatment including the pilin protein 
detected in strain Tra5/5 in the crude broth samples but not in the standard 
plate extracts or the ProteoMiner treated samples.  Pilin was not seen in any 
samples of the other two strains.
3.4 – Western Blotting
3.4.1 – Horse Serum
In order to optimise the Western blotting procedures, horse serum was used as a 
protein sample.  A rabbit anti-horse primary antibody was used (SIGMA) in 
conjunction with a goat polyclonal to rabbit IgG secondary antibody.  CyDye 
labelled secondary antibodies were used rather than chemiluminescent 
methodologies, because of their compatibility with the Ettan Dalt imager.
Dot blots with serial dilutions of primary antibody (rabbit anti-horse) were 
incubated with Cy3 labelled secondary antibody (goat polyclonal to rabbit IgG) 
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at 1:20,000, 1:10,000 and 1:5000 and shown in Figure 3.23 below.  There was a 
range of concentrations of both primary and secondary antibodies that allowed 
easy visualisation of immunoreactive proteins.
1/50 1/100 1/500 1/1000 1/2000 1/4000
1/50 1/100 1/500 1/1000 1/2000 1/4000
1/5000 1/5000 1/8000 1/8000 1/10000 1/10000
i) Primary antibody (rabbit anti-horse) dilutions used in dot blots
ii) Dot blots of the primary antibody dilutions (i) with a range of concentrations of 
Secondary Antibody (goat polyclonal to rabbit IgG)
Figure 3.23 – Dot Bots of varying concentrations of primary and secondary antibodies 
used for Western blotting of horse serum proteins. The different primary antibodies 
used are shown in (i), and blots of these dilutions incubated at three different 
concentrations of secondary antibody are shown in (ii).
In order to optimise blotting conditions, serial dilutions of the horse serum (5µl) 
were run on duplicate 12% NuPage gels alongside a molecular ladder (Protein 
Molecular Weight Standards (Molecular Probes P-6649)).  These proteins were 
detected with the rabbit anti-horse primary antibody, and the Cy3 labelled anti-
1:20,000 1:10,000 1:5000
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rabbit secondary antibody.  Different staining and labelling methods were 
trialled, and a protocol optimised.
Where proteins were unlabelled, two gels were run in parallel.  One gel was 
fixed and stained with Sypro Ruby, and the proteins from the second gel were 
electro-transferred to nitrocellulose membrane using a current of 45mA for 1
hour.  Transfer was confirmed by staining the membrane with Ponceau S 
solution or SYPRO Ruby blot stain before probing with primary and secondary 
antibodies.    
i) Total protein ii) Immunoreactive proteins
Figure 3.24 –1D Western blots of horse serum dilutions probed with rabbit anti-horse.  
Protein sample - 5µl serial dilution of horse serum; Primary antibody – Rabbit anti-
horse, 1:2000 dilution, incubated for 2hours; Secondary antibody – Cy3 labelled goat 
anti-rabbit, 1:10,000 dilution, overnight incubation.  (i) Total protein stained with 
Ponceau S post-blotting;  (ii) Cy5-labelled immunoreactive proteins.
Firstly, unlabelled serial dilutions of horse serum proteins were separated, 
blotted to nitrocellulose membrane and probed with primary and secondary 
antibodies (Figure 3.24).  As expected, all horse serum proteins were recognised
1   2   3   4   5   6    7   8   9   10  11  12 1   2    3   4   5    6    7   8   9  10  11  12
Lanes
1,12 – Markers
2, 7 – 1:5 dilution
3, 8 – 1:10 dilution
4, 9 - 1:20 dilution
5, 10 - 1:50 dilution
6, 11 - 1:100 dilution
129
by the antibodies, but there was also some non-specific binding to the marker 
proteins (Figure 3.24).  The smallest protein in the molecular markers was 
Aprotinin from horse muscle, so would be expected to be recognised by the 
anti-horse primary antibody.  However, this was not the only marker protein to 
be recognised by labelled antibodies.  
In order to determine the extent of the non-specific binding, Clostridium difficile
protein extracts were used as a negative control (Figure 3.25), as they should not 
be recognised by the rabbit anti-horse primary antibody.  After probing, all the 
horse serum proteins had been recognised by the antibodies (Figure 3.25), and 
there was no non-specific binding to the Clostridium difficile extracts.
Figure 3.25 – 1D Western blots of horse serum and C. difficile protein extracts, probed 
with an anti-rabbit primary antibody.  Protein sample - 5µl serial dilution of horse serum, 
or 5µg Clostridium difficile protein extract; Primary antibody – Rabbit anti-horse, 1:5000 
dilution, incubated for 2hours; Secondary antibody – Cy3 labelled goat anti-rabbit, 
1:20,000 dilution, 2hour incubation.  (i) Total protein from second, SYPRO strained gel; 
(ii) Cy5 labelled secondary antibodies from blot.




3 – serum 1:5 dilution
4 - C.difficile
5 – serum 1:10 dilution
6 - C.difficile
7- serum 1:20 dilution
8 - C.difficile
9 – serum 1:50 dilution
10 - C.difficile
11 – serum 1:100 dilution
i) Total protein                 ii) Immunoreactive proteins
1    2   3    4    5   6   7    8    9   10  11 
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In order to visualise total protein and immunoreactive proteins together, the 
membrane was stained with Sypro Ruby before probing.  Cy3 has the same 
emission wavelength as Sypro Ruby, so Cy5 labelled secondary antibodies were 
used instead.  Using the Ettan DALT, two wavelengths can be scanned at the 
same time, so immunoreactive proteins can be matched to total protein quickly 
and easily in the same image (Figure 3.26). Total protein stained with Sypro is 
visible in green, and the Cy5 labelled secondary antibodies are visible in red.  
Where the two overlap, the protein bands appear yellow.  When proteins are 
bound strongly by the antibodies, they appear red, although on separate 
images, the corresponding green bands can still be visualised (Figure 3.26).
Figure 3.26 – Blots of Sypro Ruby stained horse serum and Clostridium difficile
extracts probed with rabbit anti-horse.
Lanes – 1+8 protein markers, 2+4+6 – 5µg Clostridium difficile extract, 3+5+7 - 5µg 
horse serum protein.  Primary antibody – Rabbit anti-horse, 1:5000 dilution, incubated 
for 2hours; Secondary antibody – Cy5 labelled goat anti-rabbit, 1:20,000 dilution, 2hour 
incubation.  (i) Total protein blot strained with SYPRO ruby blot stain; (ii) SYPRO 
channel and CY5 channel imaged together; (iii) Immunoreactive proteins, Cy5 labelled 
secondary antibody.
1      2     3      4      5      6      7      8 1      2     3      4      5      6      7      8 1      2     3      4      5      6      7      8 
i) Total protein,                     ii) Simultaneous image         iii) Immunoreactive proteins, 
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In order to improve the sensitivity of the staining of the total protein samples, 
both the horse serum and the C. difficile proteins extracts were labelled with Cy2
(Figure 3.27).  This allows the total protein profile to be visualised in the gel 
before transfer, in the membrane after transfer, and together with the secondary 
antibody in the same image after probing, as Cy2 and Cy5 have different 
emission wavelengths.  This saves time and resources as there is no need for 
duplicate gels, and, due to the high sensitivity of CyDyes, allows greater 
visualisation of the total protein.
Figure 3.27 – 1D Western blots of CyDye labelled horse serum and Clostridium difficile
extracts probed with rabbit anti-horse.  Lanes – 1+8 protein markers, 2+4+6 – 5µg Cy2 
labelled Clostridium difficile extract, 3+5+6- 5µg Cy2 labelled horse serum protein;  
Primary antibody – Rabbit anti-horse, 1:5000 dilution, incubated for 2hours; Secondary 
antibody – Cy5 labelled goat anti-rabbit, 1:20,000 dilution, 2hour incubation.  (i) Total 
protein extract labelled with Cy2 before electrophoresis; (ii) Cy2 and Cy5 channel 
imaged together; (iii) Immunoreactive proteins, Cy5 labelled secondary antibody.
1      2     3      4      5      6      7      8 1      2     3      4      5      6      7      8 1      2     3      4      5      6      7      8 
i) Total protein,                   ii) Simultaneous image          iii) Immunoreactive proteins
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3.4.2 – Rabbit Serum
Rabbit serum was obtained from Professor Neil Fairweather at Imperial College 
London.  Antibodies against Clostridium difficile strain 630 were raised by 
injecting rabbits with a heat killed preparation of whole bacterial cells.
The rabbit serum had previously been used at a 1:20,000 dilution (personal 
communication) and dot bots were used to confirm this was the optimal serum 
concentration (Figure 3.28).  The dot blots indicated that a higher concentration 
would be optimal, but good results for 1D Western blots were obtained with 
both a 1:10,000 and 1:20,000 dilution as discussed below.
Protein extracts of the three different Clostridium difficile cells were separated by 
1D gel electrophoresis, and the rabbit serum was used as the primary antibody 
at the 1:20,000 dilution suggested.  The anti- rabbit IgG secondary antibody was 
used at the same concentration as above (1:20,000).  Protein transfer was 
confirmed by Sypro straining, and immunoreactive proteins visualised by the 
labelled secondary antibodies.  A number of immunoreactive proteins were
recognised by the rabbit serum, and there was a clear difference in the 
immunoreactive proteins in strain B-1 compared to strain A and Tra5/5 (Figure
3.28).
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i) Total protein, SYPRO. ii) Immunoreactive proteins, Cy5.
Figure 3.28 – 1D Western blots of unlabelled C. difficile extracts probed with rabbit 
serum.  Lanes - 1+8 molecular ladder, 2+3 - 5µg Clostridium difficile strain Tra5/5 
extract, 4+5 - 5µg Clostridium difficile strain A extract, 6+7– 5µg Clostridium difficile B-1 
extract. Primary antibody - Rabbit serum, 1:20,000 dilution, incubated for 2hours; 
Secondary antibody – Cy5 labelled goat anti-rabbit, 1:20,000 dilution, 2hour incubation. 
(i) Total protein strained with SYPRO; (ii) Immunoreactive proteins recognised by Cy5 
secondary antibodies. 
The C. difficile proteins extracts were labelled as above with Cy2 before 
electrophoresis to allow total proteins and immunoreactive proteins to be 
visualised together (Figure 3.29).
1           2   3             4       5            6       7            8 1            2   3             4       5            6       7            8
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Figure 3.29 – 1D Western blots of Cy2 labelled Clostridium difficile protein extracts 
probed with rabbit serum.  Lanes – 1+2 - 5µg Cy2 labelled Clostridium difficile strain 
Tra5/5 extract, 3+4 - 5µg Cy2 labelled Clostridium difficile strain A extract 5+6 - 5µg 
Cy2 labelled Clostridium difficile strain B-1 extract. Primary antibody – Rabbit serum, 
1:20,000 dilution, incubated for 2hours; Secondary antibody – Cy5 labelled goat anti-
rabbit, 1:20,000 dilution, 2hour incubation. (i) Total protein extract labelled with Cy2 
before electrophoresis; (ii) Cy2 and Cy5 channel imaged together; (iii) immunoreactive 
proteins, Cy5 labelled secondary antibody.
The best 1D gel result was obtained using a higher concentration of primary 
antibody in 10 mM EDTA (Figure 3.30). 
1     2         3     4           5     6    1     2         3     4           5     6    1     2         3     4           5     6    
i) Total protein,                    ii)  Simultaneous image          iii) Immunoreactive proteins
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i) ii) iii)
Figure 3.30 – Cy2 labelled protein extracts probed with rabbit serum using EDTA
Protein sample - 5µg Cy2 labelled Clostridium difficile protein extract from three 
different strains.  Membranes were blocked with 1% BSA overnight; Primary antibody –
Rabbit serum, 1:10,000 dilution in 0.01M PBS Tween, 0.5% BSA, 10mM EDTA, 
incubated for 6 hours.  Membranes were washed 3 x 5 minutes in 0.01M PBS Tween; 
Secondary antibody – Cy5 labelled goat anti-rabbit, 1:20,000 dilution in 0.01 M PBS 
Tween , 0.5% EDTA, 2 hour incubation.  (i) Total protein extract labelled with Cy2 
before electrophoresis; (ii) Cy2 and Cy5 channel imaged together; (iii) Immunoreactive 
proteins, Cy5 labelled secondary antibody 
Because of the complexity of the whole cell protein extracts, it is difficult to tell 
which protein band matches the immunoreactive proteins, so identification is 
problematic, but visualising both the total protein extract and the 
immunoreactive proteins together allows some identification of those proteins 
recognised by the rabbit immune system by determining
approximate molecular weights from the molecular markers (Figure 3.31).  
Although the markers are not Cy5 labelled, so cannot be visualised with the 
CyDye labelled proteins, the profiles of the C. difficile extracts can be matched to 
1    2    3    1    2    3 1    2    3
Lanes
1 – Strain Tra5/5
2 – Strain A
3 – Strain B-1
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those run alongside markers to give approximate sizes, as shown below (Figure 
3.31). 
Figure 3.31 – 1D Western blotting profiles of each strain matched to the molecular 
markers to determine approximate molecular weights of the immunoreactive proteins
detected. The immunorective protein profile shown in Figure 3.30 (ii)  was matched to  
a Sypro stained strain A whole cell protein extract next to a molecular marker ladder (i).  
This allows the Cy2 stained whole cell protein extracts in blot (ii) (shown in red) to be 
matched to the extract in blot (i) to give approximate sizes of the immunoreactive bands 
(Cy5 labelled secondary antibody shown in green).  Immunoreactive bands are 



















Tra5/5,    A,      B-1
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The high molecular weight S-layer protein was expected to be ~ 45 kDa, and the 
low molecular weight S-layer protein was expected to be ~35 kDa (Calabi et al, 
2001).  Immunoreactive protein bands corresponding to high abundance 
proteins can be seen at both these approximate positions, corresponding to 
several proteins of ~45kDa and two strongly reactive proteins of approximately 
35 kDa.  In addition, immunoreactive bands of approximately 85 kDa, 65 kDa, 
55 kDa, and 30 kDa were present.  The band at ~85kDa was present only in 
strain Tra5/5, while the band at ~65 kDa was present in strains Tra5/5 and A but 
not strain B-1.  The band at ~30 kDa may correspond to flagellin, which has a 
similar predicted mass.  The S-layers and flagellin are surface proteins, and may 
interact with the host and be recognised by the immune system.
It is difficult to distinguish between 1D gel bands, so 2D Western blotting was 
carried out to allow immunoreactive protein profiles to be matched to the 2D 
proteome reference map for each strain.  Due to the large size of the 2D 
membranes (20x20cm), incubation with primary antibody in staining trays 
necessitated a much larger volume of liquid (~30ml) than the 1D blots,  
requiring a large amount of serum.  It was also difficult to ensure incubation of 
the whole membrane, as the liquid tended to concentrate in the centre of the 
tray.  Therefore, different incubation methods were tried, in order to minimise 
the amount of serum required for each blot, but maximise binding of the 
primary and secondary antibodies.
Hybridization tubes required only ~10ml antibody solution, but neither stand-
alone tubes nor those rotating in a hybridisation oven gave consistent antibody 
binding patterns.  However, hybridisation bags only required marginally more 
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antibody solution (~15ml), and, when incubated with rotation, consistently gave 
good antibody binding profiles.  Therefore, hybridisation bags were used as the 
method of choice.
For each strain, four reproducible Western blots were selected.  The SameSpots 
software (Non-Linear) was used to define the protein spots and align the Cy2 
labelled total protein images between the four blots.  Each spot was manually 
examined in turn to determine whether it was detected in the Cy5 (secondary 
antibody) channel.  Immunoreactive spots were then matched to the reference 
map picking gel for identification. 
The four Western blots used for immunoreactive protein identification in strain 
A are shown in Figure 3.32 below.   A total of 565 spots were identified across all 
the images.  Twenty-one spots were manually edited to better match the protein 
patterns, and 24 spots were tagged as immunoreactive.  These spots were then 
matched to the reference map picking gel using the SameSpots algorithms for 
identification (Figure 3.33).
Thirteen of the 24 immunoreactive spots were matched to identifications from 
the 2D reference maps, as ten different immunoreactive proteins (Table 3.16)
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Figure 3.32(i) – The four repeat 2D Western blots used in statistical analysis of the 
immunoreactive proteins detected in strain A.  Total Cy2 labelled protein is shown in 
red, Cy5 labelled secondary antibodies in green, and overlaps appear yellow.  The 
same pattern of clearly immunoreactive protein spots can be seen in each image, and 
these are shown in more detail in Figure 3.32 (ii).
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Figure 3.32(ii) –One 2D Western blotting image showing the immunoreactive proteins 
detected in strain A by binding of Cy5 labelled secondary antibody.  A notable set of 
immunoreactive protein spots detected in strain A and Tra5/5 but not B-1 is highlighted 
by the box.
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Figure 3.33 – Proteins highlighted as immunoreactive in strain A were matched by the 
Samespots software to the reference map picking gel for identification.  Identifications 
are shown in Table 3.16.  Blue areas indicate the placement of the immunoreactive 
spots, and the identification numbers assigned by the Samespots software, based on 
rank, are shown.
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Table 3.16 – Identification of the immunoreactive protein spots in strain A by alignment 
to the reference map.  
Anova scores and fold differences are shown for each immunoreactive protein spot, 
and where spots were successfully aligned, the reference map spot and protein 
identification is shown.





1631 2.163e-006 16.5 J11 none none
1634 2.013e-005 12.6 J12 sta_BASYS03267 BASYS03267, 3473846-3471975 
(CounterClockwise) Hypothetical Protein 
BASYS03267 (cell surface protein (putative S-
layer protein precursor))
66427 6.2
836 1.800e-004 14.2 -
594 2.570e-004 38.3 -
1154 6.039e-004 19.1 -
745 6.686e-004 3.1 -
976 6.818e-004 17.6 -
1361 6.836e-004 8.4 -
573 0.002 33.5 -
1643 0.007 2.3 E6 none none
E2 sta_BASYS00306 yjiR, 302052-300856 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino acid 
aminotransferase)
44997 5.12
E8 sta_BASYS02042 yceH, 2127930-2129066 (Clockwise) 
Uncharacterized protein yceH (putative tellurite 
resistance protein)
43643 5.09
837 0.012 2.0 E1 sta_BASYS00306 yjiR, 302052-300856 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino acid 
aminotransferase)
44997 5.12
D2 sta_BASYS00396 (tuf1, 402179-403372 (Clockwise) Elongation 
factor Tu (elongation factor TU) 44226 4.94
652 0.048 4.6 J2 sta_BASYS01060 BASYS01060, 1118805-1120724 (Clockwise) 
Hypothetical Protein BASYS01060 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase)
69693 5.5
918 0.059 8.5 -
977 0.188 3.1 -
967 0.241 1.3 M6 sta_BASYS00598 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC
34354 6.51
710 0.246 1.7 D5 none none
D6 none none
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985 0.360 2.1 M5 sta_BASYS00598 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin)
34354 6.51
1638 0.439 1.1 D7 none none
1651 0.456 1.5 A1 sta_BASYS03269 BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical Protein 
BASYS03269 (S-layer)
80379 4.83
1652 0.495 1.3 M11 630_gi|115249239|emb|
CAJ67052.1|
putative flagellar hook-associated protein 48018 4.94
1653 0.532 1.7 M2 sta_BASYS00598 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC
34354 6.51
645 0.698 1.0 J4 sta_BASYS01060 BASYS01060, 1118805-1120724 (Clockwise) 
Hypothetical Protein BASYS01060 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase)
69709 5.5
817 0.778 1.7 A1 sta_BASYS03269 BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical Protein 
BASYS03269 (S-layer)
80379 4.83
1011 0.886 1.1 M1 sta_BASYS01346 paaH, 1444341-1445186 (Clockwise) 
Hypothetical Protein paaH (3-hydroxybutyryl-
CoA dehydrogenase)
30887 5.8
948 0.899 1.1 -
816 0.931 1.5 A1 sta_BASYS03269 BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical Protein 
BASYS03269 (S-layer)
80379 4.83
Four reproducible Western blots for strain B-1 were used for SameSpots 
analysis (Figure 3.34).  A total of 461 spots were identified across the images 
which were manually examined to see if they showed any immunoreactivity.  
Eleven spots were edited, and 43 were tagged as immunoreactive.  These spots 
were then matched to the reference map picking gel (Figure 3.35). Twenty-eight 
of the 43 immunoreactive spots were identified from the 2D reference maps as 
18 different immunoreactive proteins (Table 3.17).
144
   
    
Figure 3.34(i) – The four repeat 2D Western blots used in statistical analysis of the 
Immunoreactive proteins detected in strain B-1.  Total Cy2 labelled protein is shown in 
red, Cy5 labelled secondary antibodies in green, and overlaps appear yellow.  Again 
the pattern of immunoreactive spots is reproducible and is shown in more detail in (ii).
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Figure 3.34(ii) – One 2D Western blotting image showing the immunoreactive proteins 
detected in strain B-1 by binding of Cy5 labelled secondary antibody. The area lacking 
the notable set of spots detected in strain A and Tra5/5 but not B-1 is highlighted by the 
box.
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Figure 3.35 – Proteins highlighted as immunoreactive in strain B-1 were matched by 
the SameSpots software to the reference map picking gel for identification.  
Identifications are shown in Table 3.17. Blue areas indicate the placement of the 
immunoreactive spots, and the identification numbers assigned by the Samespots 
software, based on rank, are shown.
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Table 3.17 – Identification of the immunoreactivve protein spots in strain B-1 by 
alignment to the reference map.  
Anova scores and fold differences are shown for each immunoreactive protein spot, 
and where spots were successfully aligned, the reference map spot and protein 
identification is shown.





1271 1.124e-007 7.3 D5 stb_BASYS00533 oligopeptide ABC transporter, substrate-
binding lipoprotein 58649 5.43
1862 1.306e-006 8.1 -
1296 4.242e-006 7.5 D6 stb_BASYS00533 oligopeptide ABC transporter, substrate-
binding lipoprotein 58649 5.43
3397 2.077e-005 6.6 F4 stb_BASYS02565 thioredoxin reductase 34471 4.91
1315 8.533e-005 6.8 D6 stb_BASYS00533 oligopeptide ABC transporter, substrate-
binding lipoprotein 58649 5.43
D7 stb_BASYS02898 oligopeptide ABC transporter, substrate-
binding protein 58299 5.36
3396 1.531e-004 19.7 -
3404 5.696e-004 4.6 -
3421 0.001 2.8 -
1874 0.002 27.5 -
1297 0.004 7.3 -
1865 0.010 2.7 D4 stb_BASYS01043 rpsA, 1080759-1082033 (Clockwise) 
Hypothetical Protein rpsA (putative 30S 
ribosomal protein S1) 48454 5.02
1418 0.022 1.6 D10 stb_BASYS01667 aegA, 1712608-1714002 (Clockwise) 
Hypothetical Protein aegA (putative 
glutamate synthase NADPH small chain) 50234 5.12
3429 0.034 1.8 E9 stb_BASYS02338  elongation factor Ts 33290 5.21
E10 none none
1646 0.040 2.0 E4 stb_BASYS00983 isocaprenoyl-CoA:2-hydroxyisocaproate 
CoA-transferase 44491 5.18
1831 0.042 5.7 M9 stb_BASYS00368 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) 34339 7.82
1954 0.044 4.6 F6 stb_BASYS00349 flagellar hook protein 34568 5.24
1980 0.045 3.9 -
2044 0.049 1.8 M12 stb_BASYS01116 3-hydroxybutyryl-CoA dehydrogenase 30887 5.8
M4 stb_BASYS00368 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) 34339 7.82
1895 0.061 2.2 -
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2164 0.070 5.5 M12 stb_BASYS01116 3-hydroxybutyryl-CoA dehydrogenase 30887 5.8
1807 0.087 5.1 M10 stb_BASYS00368 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) 34339 7.82
1878 0.091 1.8 F5 stb_BASYS00514 ABC transporter, substrate-binding 
lipoprotein 36159 5.4
1637 0.099 2.1 -
1928 0.099 1.1 -
1403 0.115 2.5 -
3434 0.117 3.4 -
1619 0.141 2.0 E5 stb_BASYS01117 acetyl-CoA acetyltransferase 41005 5.2
F1 stb_BASYS00980 subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase 42966 5.27
2068 0.163 2.6 -
3432 0.172 2.2 M1 stb_BASYS00368 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) 34339 7.82
1964 0.173 2.7 M3 stb_BASYS00368 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) 34339 7.82
1956 0.187 2.6 M4 stb_BASYS00368 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) 34339 7.82
1351 0.200 2.9 D6 stb_BASYS00533 oligopeptide ABC transporter, substrate-
binding lipoprotein 58649 5.43
D7 stb_BASYS02898 oligopeptide ABC transporter, substrate-
binding protein 58299 5.36
910 0.217 1.9 C10 stb_BASYS02649 glyS, 3040737-3038671 (CounterClockwise) 
Hypothetical Protein glyS (glycyl-tRNA 
synthetase beta chain) 78491 4.97
3431 0.223 4.7 M10 stb_BASYS00368 fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) 34339 7.82
1363 0.234 3.3 D7 stb_BASYS02898 oligopeptide ABC transporter, substrate-
binding protein 58299 5.36
2101 0.234 1.8 M12 stb_BASYS01116 3-hydroxybutyryl-CoA dehydrogenase 30887 5.8
1717 0.277 1.1 E8 stb_BASYS01826 putative tellurite resistance protein 43646 5.09
3441 0.326 1.4 A1 stb_BASYS03072 BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 64664 4.76
1904 0.338 1.3 -
1399 0.426 1.1 -
3444 0.456 1.4 E6 stb_BASYS00210 NAD-specific glutamate dehydrogenase 46271 5.16
E6 stb_BASYS04027 putative amino acid aminotransferase 44997 5.12
E6 stb_BASYS01452 aspartate aminotransferase 45066 5.1
E2 stb_BASYS04027  putative amino acid aminotransferase 44997 5.12
2120 0.501 1.0 M12 stb_BASYS01116 3-hydroxybutyryl-CoA dehydrogenase 30887 5.8
1689 0.628 1.6 -
3428 0.820 1.1 E1 stb_BASYS04027  putative amino acid aminotransferase 44997 5.12
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The four strain Tra5/5 Western blots used in SameSpots analysis are shown in 
Figure 3.36 below.  A total of 421 spots were matched across the images and
examined for any immunoreactivity.  58 spots were manually edited to better fit 
the 2D protein profile, and 33 spots were tagged as immunoreactive and 
matched to the reference map picking gel (Figure 3.37). Twenty-three of 33 
immunoreactive spots were identified from the 2D reference maps as a total of 
18 different proteins. 
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Figure 3.36(i) – The four repeat 2D Western blots used in statistical analysis of the 
Immunoreactive proteins detected in strain Tra5/5.  Total Cy2 labelled protein is shown 
in red, Cy5 labelled secondary antibodies in green, and overlaps appear yellow.  
Immunoreactive proteins are shown in detail in (ii).
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Figure 3.36(ii) – One 2D Western blotting image showing the immunoreactive proteins 
detected in strain Tra5/5 by binding of Cy5 labelled secondary antibody.  Again, the 
series of immunoreactive spots present in strains A and Tra5/5 but not B-1 is 
highlighted within the box.
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Figure 3.37 – Proteins highlighted as immunoreactive in strain Tra5/5 were matched by 
the SameSpots software to the reference map picking gel for identification.  
Identifications are shown in Table 3.18. Blue areas indicate the placement of the 
immunoreactive spots, and the identification numbers assigned by the Samespots
software, based on rank, are shown.
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Table 3.18 – Identification of strain Tra5/5 immunoreactive proteins from reference 
maps.  Anova scores and fold differences are shown for each immunoreactive protein 








protein MW pI 
2542 2.215e-006 6.3 A5 stt_BASYS00466 fixB, 450899-451936 (Clockwise) Hypothetical 
Protein fixB (electron transfer flavoprotein 
alpha-subunit) 57353 5.03
1359 1.328e-004 4.2 K1 stt_BASYS00861 BASYS00861, 866100-867794 (Clockwise) 
Hypothetical Protein BASYS00861 (formate--
tetrahydrofolate ligase) 60894 5.53
7153 4.216e-004 3.6 -
2243 6.695e-004 4.6 E4 stt_BASYS00460 frc, 444475-445674 (Clockwise) Hypothetical 
Protein frc (isocaprenoyl-CoA:2-
hydroxyisocaproate CoA-transferase) 44491 5.18
7180 0.001 5.1 J11 stt_BASYS02456 BASYS02456, 2546072-2544243 
(CounterClockwise) Hypothetical Protein 
BASYS02456 (indolepyruvate oxidoreductase 
subunit) 68911 5.65
7187 0.002 2.8 F1 stt_BASYS01130 atoB, 1171926-1173158 (Clockwise) 
Hypothetical Protein atoB (acetyl-CoA 
acetyltransferase) 43350 5.56
E5 stt_BASYS01130 atoB, 1171926-1173158 (Clockwise) 
Hypothetical Protein atoB (acetyl-CoA 
acetyltransferase) 43350 5.56
1188 0.002 4.7 J3 stt_BASYS00858 BASYS00858, 862861-864780 (Clockwise) 
Hypothetical Protein BASYS00858 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase) 69693 5.5
2734 0.007 4.9 M8 stt_BASYS00250 fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC 34339 7.82
7192 0.012 3.3 -
2006 0.012 1.7 -
1312 0.021 4.6 -
1054 0.021 7.4 J12 stt_BASYS02896 BASYS02896, 3045252-3043381 
(CounterClockwise) Hypothetical Protein 
BASYS02896 (cell surface protein 66363 6.47
1288 0.024 13.6 -
2182 0.024 1.3 E1 stt_BASYS03814 yjiR, 4076689-4075493 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino 
acid aminotransferase) 44997 5.12








protein MW pI 
2065 0.045 2.2 A1 stt_BASYS02898 BASYS02898, 3050518-3048248 
(CounterClockwise) Hypothetical Protein 
BASYS02898 (S-layer) 80379 4.83
872 0.051 21.6 J10 none
7196 0.055 24.7 J12 stt_BASYS02896 BASYS02896, 3045252-3043381 
(CounterClockwise) Hypothetical Protein 
BASYS02896 (cell surface protein (putative S-
layer protein precursor)) 66363 6.47
1474 0.056 4.9 P11 none
944 0.058 31.0 J12 stt_BASYS02896 BASYS02896, 3045252-3043381 
(CounterClockwise) Hypothetical Protein 
BASYS02896 (cell surface protein (putative S-
layer protein precursor)) 66363 6.47
2313 0.065 1.5 E6,E2,E
8
stt_BASYS03814 yjiR, 4076689-4075493 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino 
acid aminotransferase) 44997 5.12
E2 stt_BASYS03814 yjiR, 4076689-4075493 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino 
acid aminotransferase) 44997 5.12
E8 stt_BASYS02589 hisC, 2688605-2689708 (Clockwise) 
Hypothetical Protein hisC (putative 
histidinol-phosphate aminotransferase) 42016 5.09
1450 0.065 3.1 -
7209 0.072 1.9 A1 stt_BASYS02898 BASYS02898, 3050518-3048248 
(CounterClockwise) Hypothetical Protein 
BASYS02898 80379 4.83
2750 0.089 2.9 M7 stt_BASYS00250 fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC 34339 7.82
7225 0.121 1.5 N5 stt_BASYS01129 paaH, 1171051-1171896 (Clockwise) 
Hypothetical Protein paaH (3-
hydroxybutyryl-CoA dehydrogenase) 30887 5.8
N6 stt_BASYS01129 paaH, 1171051-1171896 (Clockwise) 
Hypothetical Protein paaH (3-
hydroxybutyryl-CoA dehydrogenase) 30887 5.8
2235 0.134 1.4 E3 stt_BASYS00188 gluD, 189677-190942 (Clockwise) NAD-
specific glutamate dehydrogenase 46271 5.16
1001 0.225 3.6 J2
J3 stt_BASYS00858 BASYS00858, 862861-864780 (Clockwise) 
Hypothetical Protein BASYS00858 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase) 69693 5.5
2129 0.434 1.1 E1 stt_BASYS03814 yjiR, 4076689-4075493 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino 
acid aminotransferase) 44997 5.12
3402 0.469 2.1 -
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7166 0.496 1.1 P10 stt_BASYS03698 lysS, 3955558-3954029 (CounterClockwise) 
Lysyl-tRNA synthetase (lysyl-tRNA 
synthetase) 58539 5.12
2895 0.652 1.5 F5 stt_BASYS00458 ldhA, 443798-442800 (CounterClockwise) 
Hypothetical Protein ldhA ((R)-2-
hydroxyisocaproate dehydrogenase) 36552 5.07
2861 0.850 1.3 M3 stt_BASYS00250 fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC 34339 7.82
1552 0.956 1.6 D5 stt_BASYS01605 aegA, 1647197-1648591 (Clockwise) 
Hypothetical Protein aegA (putative 
glutamate synthase NADPH small chain) 50248 5.12
D6 stt_BASYS02768  yddS, 2891711-2893306 (Clockwise) 
Hypothetical Protein yddS (oligopeptide ABC 
transporter, substrate-binding protein) 58299 5.51
3.4.3 – Human Serum
Once a reliable platform for Western blotting with rabbit serum had been 
established, Western blotting was carried out with human patient sera to try to 
determine differences in the immune responses of patients with infections of 
varying severity against the three strains.
Pooled serum samples from patients were obtained from Professor Ian Poxton 
at the University of Edinburgh.  For each pool, five different serum samples 
from the following groups of patients were used.
D) Cases – symptomatic, toxin-positive and culture-positive
E) Carriers – asymptomatic, culture positive, toxin-variable
F) Controls – asymptomatic, toxin-negative, culture-negative
Controls were matched for age, and were in the same wards as patients in 
groups A and B.
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The same protocol was used for Western blotting of the human serum samples 
as used for the rabbit serum samples.  The secondary antibody used was a Cy5 
labelled goat polyclonal to human IgG.
In order to ensure that the anti-human secondary antibody bound to the human 
serum at the same concentrations as the anti-rabbit secondary antibody bound 
to the rabbit serum, a series of dot blots were carried out at a number of 
dilutions of serum (Figure 3.38) Membranes were blocked with 1% BSA for 1 
hour before incubation with either 1:10,000 or 1:20,000 dilution of secondary 
antibody.
1/100 1/100 1/50 1/50
1/500 1/500 1/200 1/200
1/2000 1/2000 1/1000 1/1000
1/10000 1/10000 1/5000 1/5000
1/50000 1/50000 1/20000 1/20000
Figure 3.38(i) – Serial dilutions of serum (primary antibody) used in dot blots.
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Figure 3.38(ii) – Dot blots of each serum sample, serially diluted as in (i) and incubated 
with the relevant secondary antibody (Cy5 anti-rabbit or Cy5 anti-human) at two 
different concentrations. 
All three human serum samples showed comparable immunoreactivity to the 
anti-human secondary anti-body to that of the rabbit serum to anti-rabbit 
secondary antibody.  However, probing the blots using the human serum at a 
1:10,000 dilution, as used successfully for the rabbit serum, gave no results, so 
greater concentrations of human serum were used.
Rabbit serum Human serum Pool A






Five µg Cy2 labelled protein samples from each of the three Clostridium difficile
strains were separated by 1D gel electrophoresis, and the proteins transferred to 
nitrocellulose membrane as previously.  
Membranes were blocked overnight with 1% BSA, incubated with human 
serum at 1:1000 dilution for 2 hours, and then incubated with secondary 
antibody at a dilution of 1:10,000 for 2 hours.
Firstly, the pool A serum from symptomatic patients was used as the primary 
antibody (Figure 3.39).
Figure 3.39 – Western blotting of C. difficile protein extracts probed with human serum 
pool A.  i) Total protein extract labelled with Cy2 before electrophoresis; ii)
Immunoreactive proteins bound by Cy5 labelled secondary antibody.




3+4 – strain B-1
5 – empty
6+7 – strain A
8 – empty 





No C. difficile proteins were bound by the serum antibodies, but non-specific 
binding to the marker proteins (aprotinin from horse muscle and lysozyme 
from chicken egg) was observed.  The marker proteins of smaller sizes are 
present at high quantity which may explain this non-specific interaction.  There 
was also substantial straining at the gel front (Figure 3.39).
Incubation time, concentration of the Clostridium difficile protein extracts, and 
dilution factor of the human serum and secondary antibody were all varied, but 
only the same, non-specific interactions were seen.
Western blots were then carried out with the serum pool B (carriers). 
Membranes were blocked overnight with 1% BSA, incubated with human 
serum pool B at 1:2000 dilution for 2 hours, and then incubated with secondary 
antibody at a dilution of 1:10,000 for 2 hours (Figure 3.40).
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i)    ii)
iii)
Figure 3.40 - Western blotting of C. difficile protein extracts probed with human serum 
pool B.  (i) Total protein extract labelled with Cy2 before electrophoresis; (ii) 
Immunoreactive proteins bound by Cy5 labelled secondary antibody; (iii) Both channels 
visualised at once.
There was a distinct immunoreactive protein band present in strains A and 
Tra5/5, but not B-1 (Figure 3.40) which may correspond to the band of ~66 kDa 
seen in strains A and Tra5/5 but not B-1 in the rabbit serum blots.
However, this pattern of bands could not be repeated.  Different concentrations 
of primary and secondary antibody were tried, along with the use of EDTA in 
the antibody solution, but no immunoreactive bands were detected in further 
blotting experiments.  Again, substantial staining at the gel front was observed.
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3+4 – strain B-1
5 – empty
6+7 – strain A
8 – empty 




Finally, the Western blots were run with the control serum, pool C.  Membranes 
were blocked overnight with 1% BSA, incubated with human serum pool C at 
1:2000 dilution for 2 hours, and then incubated with secondary antibody at a 
dilution of 1:10,000 for 2 hours.
No immunoreactive bands were detected at all using the pool C serum (Figure 
3.41), although the same staining at the gel front was observed.
Figure 3.41 – Western blotting of C. difficile protein extracts probed with human serum 
pool C. (i) Total protein extract labelled with Cy2 before electrophoresis; 




3+4 – strain B-1
5 – empty
6+7 – strain A
8 – empty 
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Chapter 4 – Discussion
To date, the proteome of Clostridium difficile has not been widely characterised.  
Previous work has focused on single protein/enzyme analysis, most frequently 
on the toxins, but two studies have adopted a wider proteomic approach to 
characterise this organism.  The cell surface proteins of strain 630 have been 
characterised (Wright et al, 2005), as has the composition of spores from that 
strain (Lawley et al, 2009).  In addition, proteins released during high toxin 
production have been examined and compared for different strains.  (Mukherjee
et al, 2002).
These reports have highlighted a number of secreted proteins, and cell surface
located proteins that are likely to be important for adhesion and bacterial – host 
interaction, as well as proteins involved in sporulation and germination 
pathways.  However, no analysis of cellular protein composition, or 
comparative analysis of proteomic differences between isolates of varying 
virulence has so far been described.  This study utilised a combination of gel 
based proteomic methodologies coupled with MALDI-TOF and LC-MS/MS 
mass spectrometry to compare the whole-cell proteomes of three C. difficile
isolates of different ribotypes and virulence, and from different epidemiological 
backgrounds.  Such gel-based proteomic techniques provide powerful tools for 
the separation and identification of individual components of complex protein 
mixtures, such as bacterial whole cell extracts, and have been reviewed as a 
successful strategy for use on protein samples from Gram-positive bacteria by 
Hecker et al (Antelmann and Hecker, 2010; Hecker et al, 2008).  
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4.1 – Growth Curves and optimisation of Protein Extraction
Unlike the static genome, the proteome of an organism is dynamic and will vary 
enormously depending on growth phase and environmental conditions.  
Therefore, when undertaking comparative proteomic analysis of different 
strains, it is essential to control for these variables as much as possible, to allow 
true strain-to-strain differences to be detected.  In addition, it is desirable to 
maximise the coverage of the proteome so a greater proportion of proteins can 
be compared.  Hence the preparation of the whole cell protein extracts is of the 
utmost importance, and optimisation is key.
Plate cultures grown for 64 hours and extraction using the Fast-Prep system 
gave extensive and reproducible profiles as well as being a simple and 
straightforward protocol, so these were used as the standard extracts (Figure
3.5).  When extracting from plate cultures it cannot be determined exactly what 
phase of growth cells are in, and a wide range of cells in different growth phases 
are likely to be present.  This may explain why plate cultures gave more 
extensive profiles.  
For this project, the standard protein extracts aimed to maximise the proportion 
of the proteome detected, hence the use of plate cultures.  The three strains were 
found to grow and progress through the growth cycle at comparable rates, so 
cultures incubated for the same length of time under the same conditions could 
be considered to be in the same phase.
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It would be expected that after 64 hours of growth, some sporulation would 
occur.  However, the protein extraction techniques were optimised for 
vegetative cells, and the standard plate extracts show similarity to published 
whole cell protein profiles of vegetative cells, and little similarity to protein 
extracts from purified spores (Lawley et al, 2009), indicating the vegetative 
proteome is dominant.  Sporulation proteins identified were nevertheless 
examined in detail, to see if differences in the sporulation timing or mechanism 
were indicated between strains.
4.2 – Protein Identification
4.2.1 – Reference mapping
Although 2D reference mapping identifies only 10 – 30% of the most abundant 
proteins in the proteome (Cordwell et al, 2001), it has been the methodology of 
choice for proteomic analysis of a large range of bacteria (Encheva et al, 2005);
(Bernardini et al, 2004) (Riedel et al, 2006); (Eymann et al, 2004), including the 
clostridial species C. perfringens (Alam et al, 2009) and C. acetobuylicum (Sullivan 
and Bennett, 2006).  Reference mapping is especially useful in identifying 
differences between protein profiles.
Between 80 and 120 proteins were identified per strain using MALDI-TOF MS, 
but only a low proportion (29%) of all identified proteins were detected in all 
three strains, the majority of which were abundant metabolic enzymes. Many 
proteins were identified in one strain only, including a number of potential 
virulence factors such as sporulation, flagellar and S-layer proteins, with a 
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greater proportion of these proteins of interest detected in the highly virulent 
strain A than the other two strains.  
Reference mapping using MALDI-TOF provides a visual profile of many 
components of the proteome, but has some drawbacks.  Protein separation is 
key, as MALDI does not easily identify mixtures of proteins.  A maximum of 
about three proteins can be identified from one sample.  MALDI is also only 
useful in identifying highly abundant proteins, hence the small proportion of 
the proteome detected here.  
It is difficult to determine whether observed strain to strain difference reflects 
true expression difference, or is partially a consequence of the difficulties 
associated with reference mapping, so additional analysis using LC-MS/MS was 
used to increase coverage of the proteome and confirm expression differences.
4.2.2 – LC-MS/MS
LC-MS/MS is a more sensitive technique which allows identification of many 
proteins from a complex mixture, so can be used with 1D GE instead of 
requiring 2D electrophoresis, and can also detect proteins present at much lower 
concentrations. 
LC-MS/MS analysis greatly improved the coverage of the proteome, with more 
than 80% of the proteins identified by this method not detected by MALDI-TOF 
MS.  In particular, many additional proteins with theoretical mass and pI values 
outside the range of the 2D gel electrophoresis were identified.  However, 
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almost 40% of the proteins identified were still detected in one strain only, 
indicating that there are expression differences between the strains.
Both LC-MS/MS and reference mapping indicated that a greater proportion of 
potential virulence factors were present in strain A than in the other two strains, 
suggesting that the reported hypervirulence of this strain may have a proteomic 
basis.  A number of additional sporulation and cell surface proteins were 
detected in strain A but not the other two strains, as well a several putative 
membrane proteins. A number of flagellar proteins were detected only in strain 
B-1, and only one potential virulence factor, a cell surface protein, was identified 
only in strain Tra5/5.
Given that strains A and B-1 have both been shown to be highly virulent, but 
strain Tra5/5 is a low virulence strain, proteins identified in strains A and B-1 
but not Tra5/5 are of interest.  Most notably, these include toxin B, one of the 
main Clostridium difficile disease causing agents.  The flagellar hook protein and 
flagellar basal body protein were also not detected in Tra5/5 indicating 
differences in flagellar structure.  A number of ABC transporter proteins were 
found in A and B-1 but not Tra5/5, as were four cell surface proteins, all of 
which showed high homology between strains. 
In total, 16.50% of the predicted ORFs from strain A, 16.65% of the predicted 
ORFs in strain B-1, and 11.64% of the predicted ORFs in strain Tra5/5 have been 
confirmed in this study by protein identification.   This is a larger proportion of 
identifications than has often been reported based on 2D reference mapping 
alone (Encheva et al, 2005); (Riedel et al, 2006), and a similar proportion of 
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identifications to that reported for similar, whole cell protein extracts in Bacillus 
subtilis (21%) (Eymann et al, 2004) and Neisseria meningitidis (13%) (Bernardini et 
al, 2007b).  
Despite the increased sensitivity of LC-MS/MS identification, it should be noted 
that there was still a subset of 26 proteins identified by reference mapping that 
were not detected by LC-MS/MS, highlighting the importance of using a range 
of techniques to increase coverage of the bacterial proteome.
However, the use of 1D GE in conjunction with LC-MS/MS limits identification 
to those proteins compatible with gel electrophoresis.  To improve proteome 
coverage further, gel free identification methods should be considered.
4.2.3 – DIGE analysis
Although many proteins have been identified on the reference maps, direct 
comparison of 2D gel profiles is problematic. Differences in the amount of 
protein loaded, and individual variation in the running of the gels can 
complicate gel to gel comparisons, making meaningful evaluation of these 
reference maps difficult.  
Differential in-gel electrophoresis allows different protein samples to be run on 
a single gel, eliminating the experimental differences and allowing direct 
comparison (Unlu et al, 1997), and was used here to analyse the 2D reference 
maps.  DIGE can also be coupled with 2D reference mapping to glean 
quantitative information for proteins with respect to an internal reference 
sample (Hecker et al, 2008); (Encheva et al, 2009); (Rathsam et al, 2005), as done in 
this analysis where a number of proteins showing statistically significant 
differences in expression levels between strains were identified.
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Five proteins were shown to have statistically higher concentration in strain A, 
twelve in strain B-1 and eight in strain Tra5/5.  A number of these were surface 
proteins, with different S-layer proteins found have higher concentration in 
each strain, and the flagellin protein showing statistically greater abundance in 
both A and B-1.
The S-layer protein with the highest homology to the SlpA gene product from 
the 630 reference strain (gi|115251846), showed significantly different 
expression between the three isolates investigated here.  However, as 
highlighted in the yellow box 4, Figure 3.13, this protein migrated differently in 
different samples.  It has previously been reported that the S-layer proteins of 
different isolates show a high degree of variation (McCoubrey and Poxton, 
2001); (Calabi et al, 2001); (Pechine et al, 2005b) and the genomic data for the 
three strains in this study indicates that this is true of the SlpA genes of A, B-1 
and Tra5/5.  The large divergence in amino acid sequence of this protein leads to 
different predicted mass and pI values for each strain, with predicted pI values 
of 4.83, 4.76 and 4.79, and predicted masses of 80428 Da, 64703 Da and 79922 Da 
for the S-layer protein of A, B-1 and Tra5/5 respectively.   Therefore, the 
concentration differences highlighted by the software are likely to be due to 
differences in migration rather than true variation in expression. 
Interestingly, this protein is present as two spots on the reference maps of 
strains A (A1, F6, Figure 8) and Tra5/5 (A1, F6, Figure 10), but only one on the 
map of strain B-1 (A1, Figure 9), indicating that there are modification 
differences between the strains.  The SlpA gene product is cleaved post-
translationally to give two mature proteins of ~45kDa (the high molecular 
169
weight S-layer protein) and ~35kDa (the low molecular weight S-layer protein ) 
(Calabi et al, 2001).  The positions of the SlpA homologous proteins on the 2D 
profiles correspond to these approximate sizes, and similar 2D profiles of S-
layer proteins have been shown previously (Mukherjee et al, 2002).  Here, the 
spot corresponding to the low molecular weight S-layer protein (LMW SLP) is 
missing from the profile of strain B-1.  The LMW SLP has also been shown by 
DIGE to be upregulated in both strains A and Tra5/5 with respect to each other, 
as well as with respect to B-1, but again this is likely to be due to amino acid 
variation causing migration differences.
4.3 – ProteoMiner treatment
The identification strategies discussed so far have a major drawback, in that 
they can only detect a fairly small proportion of the proteome.  The huge 
dynamic range of proteins in a highly complex sample such as the C. difficile cell 
extracts used here, mean that proteins present at low abundance may not be
detected.  In order to try to increase coverage of this ‘deep proteome’, samples 
were treated with a hexapeptide bead library, the ProteoMiner beads (BioRad).  
ProteoMiner has been successfully used on a number of biological fluids 
(Guerrier et al, 2007); (Castagna et al, 2005); (Sihlbom et al, 2008), but has not 
been widely used on bacterial extracts, although some success has been reported 
with E. coli whole cell extracts (Thulasiraman et al, 2005).
One of the challenges of using this technology on bacterial extracts is the large 
amount of protein required to sufficiently decrease the dynamic range of the 
sample.   It was impractical to generate such large amounts of protein extracts
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from plate cultures as was done for the standard protein extracts, so large scale 
broth cultures were used instead.  
Environmental conditions, and hence growth media, have a significant effect on 
protein expression (Cordwell et al, 2001).  Here, more than 50% of the proteins 
identified by LC-MS/MS in the standard plate extracts from each strain were not 
detected in the broth extracts used for ProteoMiner treatment (57% in strain A, 
64% in strain B-1 and 55% in strain Tra5/5).  In addition, approximately 50% of 
the proteins identified in the broth extracts were not detected in the standard 
plate extracts (54% for strain A, 48% for strain B-1 and 66% for strain Tra5/5).  
This underlines the fact that consistency of growth conditions is key when 
comparing protein samples, and that the additional investigation of extracts 
from cultures grown in different media can greatly increase the coverage of the 
proteome.  
However, of the additional proteins identified from the broth cultures, 36% in 
strain A, 35% in strain B-1 and 34% in strain Tra5/5, were not detected in the 
crude protein extracts, and were only identified after ProteoMiner treatment.  
These may correspond to lower abundance proteins, and so may also be 
expressed in the standard plate extracts, but at a concentration below detection 
levels.
When determining the value of ProteoMiner treatment for the enhanced 
detection of low abundance proteins, the treated fractions were compared to 
crude extracts to see how many additional proteins were identified.  Previously, 
the percentage of proteins found after treatment which were not detected in 
untreated samples has been reported to be 38% for bile extracts (Guerrier et al, 
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2007), and 65% for Urinary protein extracts (Castagna et al, 2005), and the 
number of peaks identified by SELDI-TOF-MS increased from 48 in crude 
plasma samples, to 330 after treatment with beads (Sihlbom et al, 2008).  In all 
these studies, larger numbers of proteins were detected after treatment than 
before.  Conversely, in this study, fewer proteins were identified in the 
ProteoMiner treated fractions than the crude extracts for each strain.  However, 
there were additional subsets of proteins present in the treated fractions not 
seen in the crude extracts.  
Additional proteins were visible in both the 1D and 2D gel profiles of treated 
fractions that were not seen in those of the crude broth extracts. Moreover, the 
additional proteins visualised in the amino-terminal E-bead and carboxy-
terminal SE-bead treated fractions appear to be different, indicating that both 
libraries have roles in the exploration of the so-called deep proteome.  This is 
also true of the proteins identified by LC-MS/MS, where different subsets of 
proteins were detected in the E-bead and SE-bead treated fractions. In this 
study, the use of N-terminal E-bead libraries allowed the detection of an 
additional 65, 88 and 112 proteins not seen in the crude extracts for strains A, B-
1 and Tra5/5 respectively, comprising 10%, 17% and 19% of the total number of 
proteins identified, and the sequential use of the carboxy-terminal SE-bead 
library identified 83, 38 and 58 additional proteins not seen in any other 
fraction, comprising 13%, 8% and 10% of total proteins detected in each strain.  
In total, 23% of proteins found in strain A, 25% of proteins found in strain B-1, 
and 29% of proteins found in strain Tra5/5 were only detected after 
ProteoMiner treatment.  This is a lower percentage than has been reported 
previously for biological fluids.
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In each strain, the majority of additional protein spots picked from the 2D gel 
profiles of treated extracts and identified by MALDI-TOF MS had not been seen 
on the reference maps of the standard plate extracts.  This suggests that 
ProteoMiner treatment has decreased the dynamic range of protein expression, 
and increased the relative concentration of these lower abundance proteins, so 
they are now detectable by 2D reference mapping.  However, as discussed 
above, the ProteoMiner treated samples were extracted from broth culture 
rather than plate culture, so it would be expected that different proteins would 
be expressed anyway (as seen from the LC-MS/MS protein identifications).  The 
majority of additional proteins had been identified in the standard plate extracts 
by LC-MS/MS supporting the idea that they were present in the standard plate 
extracts but at too low a concentration to be detected by MALDI-TOF MS.    
The protein extracts eluted from the SE-bead library with carboxylated terminal 
residues particularly show an increase of protein spots visible in the basic 
region of the gel compared with both the crude and E-bead treated fractions, as 
shown clearly by the positions of the red boxes on the SE bead treated gels 
(Figure 3.18). This has also been seen in a number of other biological samples 
treated with complimentary libraries (Righetti and Boschetti, 2008: Guerrier et al
2007).  These basic proteins are notoriously difficult to resolve on 2D gels 
(Antelmann and Hecker, 2010), and so were of particular interest.  Therefore a 
larger pH range (3-10) was used for the 2D gel profiles of these broth samples 
than was used for the standard plate extracts (pH 4-7).  Of the additional 
proteins identified from the 2D profiles of the ProteoMiner treated samples, five 
from strain A, seven from strain B-1 and six from strain Tra5/5 had theoretical 
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pI values outside the 4-7 pH range used for the 2D reference map gels, another 
reason why they would not have been detected.  
In order to determine whether greater numbers of basic proteins were detected 
in the SE bead treated fraction by LC-MS/MS, theoretical pI values were 
obtained for each protein identified in the treated fraction of strain A using the 
ExPASy pI calculator tool (http://expasy.org/tools/pi_tool.html).  The same 
trend was seen in this data, with 31% of the proteins detected in E-bead treated 
fractions, but not the crude fraction, showing a theoretical pI greater than seven, 
whereas 41% of the additional proteins detected in the SE-bead treated fraction 
only, were predicated to be basic with a pI greater than seven.
The additional proteins seen after ProteoMiner treatment included a large 
proportion of ribosomal proteins, particularly for the 2D MALDI-TOF 
methodology where 40% additional proteins is strain A, 54% of the additional 
proteins in strain B-1 and 60% of the additional proteins in strain Tra5/5 were 
ribosomal proteins.  This was less marked for the LC-MS/MS analysis where 
only 5% of the additional proteins detected after ProteoMiner treatment in 
strain A, 11% in strain B-1 and 5% in strain Tra5/5 were ribosomal.  Ribosomal 
proteins would not be expected to be of particularly low abundance, but appear 
to have been much concentrated by treatment with the ProteoMiner libraries, 
and their detection particularly greatly increased by 2D reference mapping after 
ProteoMiner treatment.  This may be because the ribosomal complex is not fully 
disrupted during the extraction process, but further treatment with the 
ProteoMiner libraries disrupts the complex, solubilising individual ribosomal 
proteins and so allowing them to be visualised.  Alternatively, it may be that the 
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basic nature of the ribosomal proteins makes visualisation hard, as the basic 
regions of 2D gels are far less easily resolved.  The carboxy-terminal SE-bead 
library may stabilise the visualisation of these proteins on the 2D gel.  
Only a small number of additional surface and virulence proteins were 
identified after ProteoMiner treatment, and the majority of those had also been 
previously identified in the standard plate extracts.  2D GE followed by MALDI-
TOF MS identified one sporulation protein, Spo0A in the treated extracts of all 
three strains, whereas on the reference maps it was only seen in strains A and 
Tra5/5.  An additional cell surface protein (gi|11525176) was detected in strains 
B-1 and Tra5/5 but not A.  These had both been identified in the standard plate 
extracts by LC-MS/MS.   LC-MS/MS analysis on the broth samples identified 
additional cell surface, sporulation and flagellar proteins in the treated fractions 
of each strain which were not identified in the crude extracts.  Most of these had 
been identified in the standard plate extracts, but some were newly detected in 
each strain.  
It is interesting that with the large variation in proteins detected in the standard 
plate and broth extracts, the surface and virulence proteins expressed remained 
broadly constant.  Clostridium difficile is a highly adaptable organism, with the 
capacity to survive in various habitats both within a host and in the 
environment.  Spore formation plays a key role in allowing this pathogen to 
persist in hostile environments, but the ability to retain its surface proteins and 
virulence factors under varying conditions of growth may help it to colonise a 
wide range of hosts.
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It has been reported previously that some proteins species detected in crude 
samples are not present after ProteoMiner treatment (Thulasiraman et al, 2005).   
This number has been reported to be ~7% of  abundant urine proteins (Castagna
et al, 2005), 5% of red blood cell proteins and 13% of platelets extracted proteins 
(Righetti and Boschetti, 2008).  This is likely to happen if the hexapeptide library 
does not contain a suitable ligand for a particular protein, preventing it binding 
to the beads, and hence excluding it from the treated fraction.  Alternatively, it 
may be that the protein – peptide complex is governed by a strong association 
constant which is incompatible with the eluting agents used.  In this study, 28% 
of the proteins identified in the crude extract of strain A, 30% of proteins in the 
crude extract from strain B-1 and 34% of proteins from the crude extract of 
strain Tra5/5 were not detected in the ProteoMiner treated fractions, a higher 
proportion than has been previously described.  It is possible that a larger 
number of proteins in the hugely complex bacterial extract do not have 
corresponding ligands within the library, so fewer proteins are captured on the 
beads.  Alternatively, there may be more proteins forming very strong 
interactions with the bead library, preventing elution.
Recent work by Keidel et al (2010) indicated that the proposed mode of action 
of the ProteoMiner bead library may be false, and that instead of specific 
interactions with the hexapeptide library, hydrophobic interactions are the most 
important forces binding proteins to the ProteoMiner beads.  Similar results 
were seen after treatment with ProteoMiner beads and a number of 
chromatographic Sepabeads, indicating that the same proteins are bound by 
both, despite the supposed differences in interaction chemistry (Keidel et al, 
2010).  This may explain why there is still a large range in protein 
concentrations seen on the 2D gel profiles, and may also help to explain why 
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such large numbers of proteins were lost from the crude sample after 
ProteoMiner treatment.  If the mechanism of protein binding to the bead 
libraries is different from that proposed (Thulasiraman et al, 2005), then it may 
be that fewer proteins than expected bind to the library.
4.4 – Western Blotting
Another key factor in the pathogenicity of Clostridium difficile and many other 
bacteria, is the interaction of the organism with the host, and its ability to evade 
detection by the host immune system.  Serum levels of IgA and IgM were found 
to be significantly higher in asymptomatic carriers of C. difficile than 
symptomatic patients suffering from Clostridium difficile associated disease 
(CDAD) (Mulligan et al, 1993), indicating that the immune response of the host 
plays a key role in preventing illness.  
Toxin A is known to be highly immunogenic, and high levels of antibodies in 
response to toxin A has been shown to significantly reduce risk of recurrent C. 
difficile infection (Kyne et al, 2001).  This is now the basis of Toxoid vaccines, 
which induce immune responses against toxins A and B, as treatment in 
recurrent CDAD (Sougioultzis et al, 2005).  However, immune responses against 
a number of other proteins have previously been reported (Pechine et al, 2005a); 
(Ausiello et al, 2006); (Drudy et al, 2004), and analysis of reactive proteins by 
western blotting can help to identify proteins that interact with the host, and 
may be potential virulence factors.
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A number of Clostridium difficile proteins have been reported to be recognised by 
the immune system.  Antibody levels of Cwp66 (N-terminus), FliC, FliD and a 
fibronectin-binding protein, Fbp68, were found to be higher in a control group 
than a group of C. difficile-colonised patients, suggesting that a defence 
mechanism of the host against these proteins could affect the course of infection 
(Pechine et al, 2005a).  The exposed part of the flagella has also been shown to be 
highly immunogenic (Pechine et al, 2005b).
During this analysis, a number of proteins from each strain were recognised by 
the rabbit serum raised against the reference 630 strain.  The flagellin protein 
FliC and the HMW SLP are strongly immunoreactive as has been reported 
previously (Pechine et al, 2005a); (Drudy et al, 2004).  However, western blotting 
with human sera was unsuccessful.  Two dimensional western blotting of cell 
wall proteins with human sera has been published, and the S-layer proteins 
identified as immunoreactive, along with a number of other cell wall proteins 
(Wright et al, 2008).  The serum samples used in this analysis had been analysed 
previously for antibody responses (Sanchez-Hurtado et al, 2008), and 
surprisingly, levels of IgG and IgM for most antigens were similar between the 
three groups of patients, indicating that there was little difference in the 
immune responses to infection of the symptomatic and asymptomatic patients.  
Western blotting was carried out with these serum samples, and the serum 
pooled from symptomatic cases reacted with more protein bands than the 
serum from asymptomatic carriers or controls.  However these results could not 
be reproduced here. 
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During this analysis, one dimensional western blotting with both rabbit and 
human serum showed an area of strong antigen detection at the gel front 
(Figures 3.29, 3.39, 3.40 and 3.41).  This may be due to small fragments of 
peptides or lipocarbohydrates (lipoteichoic acid-like molecules), which have 
previously been suggested to be immunoreactive (Sharp and Poxton, 1986).   
However this was not seen by 2D western blotting.
Western blotting using human serum is often problematic, hence the majority of 
studies into immunoreactive proteins of C. difficile have been done with other 
methodologies, such as ELISA (Pechine et al, 2005b); (Ausiello et al, 2006);
(Drudy et al, 2004).  One of the reasons for this is the complexity of the human 
immune response.  Many antibodies to a wide range of antigens are present 
within the serum, which can mask the reactivity of antigens present at low 
levels.   This may explain the lack of immunoreactive observed here with human 
serum samples, whereas the use of rabbit serum raised directly against C. 
difficile, which would be expected to contain a much higher concentration of 
antibodies against this pathogen, identified a number of immunoreactive 
protein bands.
At least six protein bands reactive to rabbit sera were seen in each strain by 1D 
western blotting, some of which are likely to correspond to more than one 
protein of the same size.  An additional strongly reactive band of ~66kDa was 
seen in strains A and Tra5/5 which was absent in strain B-1.  2D western blotting 
allowed some of these proteins to be identified by matching of reactive profiles 
to the 2D reference maps.
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A number of the immunoreactive proteins were conserved between the three 
strains, with the flagellin protein, FliC, and the high molecular weight S-layer 
protein (HMW SLP) clearly present on the reactive profiles of each strain.  In 
addition, a number of reactive spots were present in the centre of the western 
blot of each strain showing similar mass to the HMW SLP, but a more basic pI.  
These were matched to a putative amino acid aminotransferase, an elongation 
factor T, isocaprenoyl-CoA:2-hydroxyisocaproate CoA-transferase, and 
glutamate dehydrogenase.  Interestingly, the latter is currently used as an in 
vitro diagnostic test for C. difficile.  The most noticeable difference between the 
profiles of the three strains was the series of spots in the top right hand corner of 
the western blot profiles of strains A and Tra5/5, but not strain B-1.  This series 
of spots are likely to correspond to the band at ~66kDa seen in the 1D western 
blot profiles of the same strains, and was matched to the cell surface protein, 
gi|115251844, detected in strains A and Tra5/5 but not B-1.
Correct alignment of immunoreactive profile and whole cell extracts was 
difficult.  The use of two Fluorescent dyes which could be visualised together 
helped this considerably, but there were still problems in matching 
immunorective proteins to reference maps, particularly those reactive proteins 
which appear to be of low abundance and cannot be visualised on the whole cell 
protein extracts.    Therefore, many of the identifications of immunoreactive 
proteins at this stage can only be tentative.
4.5 – Biological Significance
Strains B-1 and Tra5/5 were chosen for this analysis due to the wealth of 
biochemical data available for these isolates.  There is less extensive biochemical 
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data available for strain A, but the number of studies using 027 ribotype strains 
is increasing.  Previously reported virulence factors for strains B-1 and Tra5/5 
were examined in greater detail, and compared to the proteins detected in each 
strain (Table 4.1).
Table 4.1 – Previously described biochemical data for reported virulence factors of C. 
difficile and the corresponding proteins detected1. (Borriello et al, 1987); (Krishna et al, 
1996) (Borriello et al, 1988b; Seddon et al, 1990; Tasteyre et al, 2000a) (Davies and 
Borriello, 1990) (Borriello et al, 1988a) (Stabler et al, 2009; Warny et al, 2005)2
Strain B-1 Strain Tra5/5 Strain A
Bio. data Proteins Bio. data Proteins Bio. data Proteins
Virulence high - low - High -
Toxin A >195 ng/ml + ~25ng/ml + 848µg/L +















Fimbrea - - + Pilin * n/a -





n/a FliC Flagella 
hook
Motility + 2 
chemotaxis 
proteins
n/a - + 1 chemotaxis 
protein




















1 For full lists of detected proteins see Appendix Tables A1and A2
2 For full references see section 2.1.2.  
3 Table 3.2.  Corresponds to spot J12, Figure 3.8 and Figure 3.10.
* Detected in broth samples only
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The virulence factors described in Table 4.1 are discussed in more detail below, 
along with some other previously reported virulence factors.
4.5.1 - Toxins
All three strains examined in this study showed an intact pathogenicity locus by 
genome sequencing (personal communication), so would be expected to 
produce toxin A and toxin B (Hammond and Johnson, 1995).  
Both toxins A and B were identified by 1D GE LC-MS/MS analysis, but not on 
the 2D reference maps.  This is likely to be due to the large size of these proteins 
(270 and 308 kDa) making them difficult to resolve by gel electrophoresis.  
Similar problems with visualising the toxins on gels were reported previously 
by Mukherjee et al (2002).  By LC-MS/MS, toxin A was identified in all strains, 
but interestingly, toxin B was not detected in strain Tra5/5.  This may indicate 
that strain Tra5/5 produces lower levels of toxin B than the other two strains, 
although strains Tra5/5 and B-1 have been shown previously to produce 
comparable amounts of toxin B in vitro (Borriello et al, 1987).  The same 
variation was seen in both the standard plate extracts and the broth extracts 
used for ProteoMiner treatment, with toxin A being present in the broth extracts 
of all three strains, while toxin B was pesent only in strains A and B-1 but not in 
strain Tra5/5. No binary toxin was detected in any of the strains under any 
growth conditions.
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Toxins A and B are produced in response to stress, including temperature 
(Karlsson et al, 2003).  Toxin production has been shown to be growth 
dependent (Hundsberger et al, 1997) with levels of transcripts of both toxin A 
and toxin B staying low during logarithmic growth, but high during stationary 
phase. Toxin production is also affected by available nutrients and has been 
shown to be repressed by glucose (Dupuy and Sonenshein, 1998), induced by 
biotin limitation (Yamakawa et al, 1998) and varies according to amino acid 
composition of the growth medium (Haslam et al, 1986).  All three strains have 
been grown under the same conditions, so lack of detectable toxin B in Tra5/5 
cannot be attributed to differences in growth conditions.  Despite being grown 
on nutrient rich Colombia blood agar, all strains produced toxin A.  
The role toxin B plays in the virulence of C. difficile is still disputed (Lyras et al, 
2009; Kuehne et al, 2010), but it has been shown to disrupt epithelial integrity in 
the host cells (Hecht et al, 1992) and function as a potent enterotoxin in its own 
right (Savidge et al, 2003).    If, under both sets of growth conditions used here, 
strain Tra5/5 does not produce toxin B, despite the in tact pathogenicity locus, it 
may go some way to explaining the observed lower virulence of this strain in 
the hamster model.  However, as Tra5/5 has been shown to produce comparable 
levels of toxin B to strain B-1 under some in vitro conditions, it would be 
interesting to see how toxin levels between these two strains compared under 
other growth conditions.  
It has previously been reported that the 027 ribotype strains produce higher 
levels of toxin than less epidemic strains due to mutation in the tcdC negative 
regulator.  Although both toxins A and B were detected in the 027 ribotype 
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strain A and the less epidemic strain B-1, no quantitative information can be 
gleaned from the LC-MS/MS analysis performed here, so expression levels of 
toxin between strains cannot be compared.
4.5.2 – Sporulation
Clostridial species, like bacilli, have the ability to form endospores in response 
to hostile environments as a means to survive, so can be considered to have two 
distinct lifecycle phases with a very different set of ORFs expressed in each.   
The mechanism of spore formation and the spore structure of Bacillus subtilis
have been well characterised, but the equivalent mechanisms in clostridia are 
poorly understood.
In Bacillus subtilis, DNA-macroarray analysis suggested that 61% of predicted 
ORFs are significantly expressed in vegetative cells (Eymann et al, 2004).
The genome of the 630 strain of C. difficile contains 60 predicted 
sporulation/germination proteins (Sebaihia et al, 2006), and the protein 
composition of spores and vegetative cells have been shown to be very different, 
with ~336 proteins identified as components of purified spores (Lawley et al, 
2009).  The standard protein profiles here resemble the vegetative proteome 
rather than the proteome of purified spores (Lawley et al, 2009) but it is likely 
that a number of spores are present in the cultures used for extract.  A number 
of proteins present in extracts of purified spores were also detected in the 
standard extracts during this analysis.  Stress response proteins were detected, 
including rubrerythrins and tellurium resistance proteins, found in all strains, 
and a putative catalase, found only in strain A.  Ribosomal components, 
chaperones and proteases have also been shown to be abundant in spores.  
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Fewer chaperones were identified here than in the spore extracts, four compared 
to 16, but a large number of ribosomal components were detected, particularly 
after ProteoMiner treatment. 
The presence of these proteins in the standard extracts may indicate that spores 
present in the standard plate cultures have been disrupted by the extraction 
process and spore proteins are present in the extract.  Alternatively, these 
proteins could be ubiquitously expressed during both vegetative growth and in 
spores.  Infection of a host is stressful for the pathogen, so it is likely that a 
number of stress response proteins are also produced during vegetative growth.
Spo0A is an essential factor in sporulation initiation in both B. subtilis (Piggot 
and Hilbert, 2004) and C. difficile, where it has also been shown to be linked to 
toxin production in C. difficile (Underwood et al, 2009).  In this analysis, it was 
found in all three strains in both broth and plate extracts.  The other sporulation 
protein identified in all strains in both the plate and broth samples was an 
SpoIIIJ associated protein.  SpoIIIJ activates the transcription factor sigma G, 
which is required for sporulation, but it has been shown that SpoIIIJ is also 
ubiquitously expressed in vegetative cells (Serrano et al, 2003).
In bacillus, the sigma F regulator becomes active immediately after asymmetric 
cell division in the daughter cell destined to become the prespore (Piggot and 
Hilbert, 2004), a stage of sporulation termed stage II.  Until division, this protein 
is held inactivated by the anti-sigma F factor, which was detected in all three 
strains, indicating the majority of cells within the culture were not yet 
sporulating.  One additional putative stage II sporulation protein was found in 
strain A.
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Interestingly, an Spo0B associated protein was detected in each of the three 
strains, but the Spo0B protein from bacilli does not appear to have any 
homologues within the C. difficile genome.  Instead, spo0A appears to be directly 
phosphorylated by orphan kinases (Underwood et al, 2009) only one putative 
sensor histidine kinase was detected in this analysis 630_gi|115251546 and this 
was only found in strain A.
A number of latter stage sporulation proteins stage IV and V were detected in 
different strains.
In bacillus, the mature spore consists of a core, housing the chromosomes and 
surrounded by a lipid membrane.  This is then surrounded by the cortex, a thick 
layer of peptidoglycan followed by a multilayered structure called the coat 
(Driks, 1999).  Two spore structural proteins were identified, but only in strain 
A, a putative spore coat protein, and a Spore Cortex protein.  This may indicate 
that there are sporulation differences and that more cells within the strain A 
culture have progressed along the sporulation pathway.  Alternatively, strain A 
may produce these structural spore proteins in greater abundance, or at 
different times to the other two strains.   Emerging 027 ribotype strains have 
been reported to show increased sporulation rates compared to non-epidemic 




S-layers have been identified in hundreds of different species from all areas of 
the bacterial kingdom, and have been shown to be essential for the virulence of 
some bacterial pathogens such as Aeromonas salmonicida and Campylobacter fetus
(Sara and Sleytr, 2000).  The S-layer of Clostridium difficile is unusual, in that it 
consists of two subunits forming a lattice structure, whereas the majority of 
bacterial S-layers consist only of one (Sara and Sleytr, 2000).  Most Clostridium 
difficile strains express a high molecular weight (HMW) protein and a low 
molecular weight (LMW) protein, which are derived from a single gene, slpA 
(Calabi et al, 2001) and cleaved post-translationally. The protein precursor 
contains a typical signal sequence indicating that it is translocated across the 
membrane via the general secretory pathway before cleavage occurs (Calabi et 
al, 2001).  
During this analysis, the SlpA protein was identified in all strains, and showed 
considerable amino acid variation between strains, and only around 50% 
homology between strains by BLAST..  The data from the reference maps and 
DIGE analysis suggests that LMW-SLP is not present in the strain B-1 extract, 
indicating that the cleavage event could be different in strain B-1 to the other 
two strains.  A similar variation in the SLP protein has been seen by Calabi and 
Fairweather who identified a strain, designated 167, which showed an unusual 
S-layer 1D profile (Calabi and Fairweather, 2002).  A predominant protein of 
39kDa representing the HMW SLP was detected, but only minimal amounts of 
the predicted, 20kDa LMW protein was seen.  The un-cleaved pre-protein of this 
strain had a predicted molecular mass of 62,312 Da, lower than that of other 
isolates, which is similar to the predicted mass for strain B-1 (64,703Da).  The 
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authors proposed that the lack of LMW SLP could be due to rapid degradation 
of this subunit, and showed that this did not affect the pathogenicity or cellular 
viability of the strain.  A different S-layer lattice system may be employed in 
this, and the B-1 strain.
The HMW SLP shows homology to the Bacillus family of autolysins (CwlB and 
CwbA) with N-acetyl muramoyl-L-alanine amidase activity (Karjalainen et al, 
2001) particularly in the predicted cell wall binding domain.  HMW SLP has also 
been shown to have amidase activity (Calabi et al, 2001).   Multiple homologues 
to the SlpA gene encoding the S-layer protein have been found within the 
genome which show similarity in the CwlB-like domain, and may have similar 
surface functions. 
Calabi et al (2001) identified 29 ORFs encoding proteins showing homology to 
this autolysin. Many of these ORFs were clustered near SlpA, and others were 
located throughout the genome.  In-depth analysis of six of these ORFs showed 
them to be expressed in growing cultures by RT-PCR.  In Campylobacter fetus
several genetic SLP cassettes have been identified (Dworkin and Blaser, 1997), 
but only a single gene is expressed at a given time, whereas the paralogues in C. 
difficile were found to be expressed concurrently (Calabi et al, 2001). 
It has been reported that the SlpA gene is located on a locus containing 17 open 
reading frames, 11 of which encode proteins containing domains homologous to 
the postulated cell wall anchoring domain of SlpA, (Karjalainen et al, 2001).  The 
structure and organisation of this locus suggests that these genes could be co-
transcribed and form an operon (Savariau-Lacomme et al, 2003), and the 
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similarity of the SlpA homologues to the cell wall anchoring domain of the B. 
subtilis autolysin (Karjalainen et al, 2001)  suggests modular evolution and gene 
duplication from a common ancestor of B. subtilis and C. difficile.
Well characterised components of this genetic locus include Cwp66 
(gi|115251842) and Cwp84 (gi|115251840). Cwp66 has been shown to act as an 
adhesion in heat-shocked cells (Waligora et al, 2001) and is thought to undergo 
similar cleavage events to SlpA. Cwp84 is located immediately downstream of 
Cwp66 and encodes a putative cysteine protease. It has been suggested that 
Cwp84 plays a role in maturation of SlpA into the HMW and LMW SLPs, as 
genetic knockout mutants expressed only the uncleaved SlpA precursor.  
However, it was shown not to directly play a critical role in disease as the 
mutant strains were still capable of causing disease in the hamster model (Kirby
et al, 2009)
The SlpA locus also contains the SecA translocase gene, encoding an essential 
component of the general secretory pathway, the route by which SlpA is 
thought to be exported.  The two genes are adjacent to one another, indicating 
that the two may be transcribed together (Calabi et al, 2001).   
In this analysis, 10 surface proteins from this genetic locus were detected, 
including SlpA, Cwp66 and Cwp84.  It has been reported previously that 
Cwp66 and Cwp84 are transcribed only in the early exponential phase, but in 
this study they were identified in the standard extracts grown for 64 hours in all 
three strains, when the majority on cells are in stationary phase. The SecA 
translocase was also identified in all strains.
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This genetic locus was examined in more detail, and the genomic information 
from strains A, B-1 and Tra5/5 was compared to that of strain 630 (Figure 4.1)
using the progressive Mauve algorithm (Darling et al, 2010).
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Figure 4.1– Organisation of open reading frames in the SlpA operon for strains A, B-1, 
Tra5/5 and the 630 reference strain.  The 37kb fragment described by Karjalainen et al 
(2001) was looked at in detail and the 17 ORFs encoded within this fragment are shown 
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areas of homology between the strains, with the height of the bar representing the level 
of homology. Genes containing more variation, such as the SlpA gene, show white 
areas within the yellow.  The SlpA gene is shown in red in all strains, and highlighted in 
green in strain 630, the gene encoding the putative S-layer protein (gi|115251844) is 
shown in orange.  Hypothetical or putative ORFs are shown in grey.  Arrows above the 
genes show the direction of transcription, and where the arrow is shown in blue, the 
corresponding protein was detected in this analysis.  CSP notates genes encoding cell 
surface proteins (Slp homologues).  The genetic fragment for strain B-1 shows 
considerable differences to the other three genomes, with an insertion of approximately 
58 Kb, in the position shown by the black lines bisecting this genome above.  This 
insertion contains 50 ORFs, the majority of them putative and uncharacterised. 
The majority of ORFs in this genetic locus were found in all strains, with the 
exception of a small hypothetical ORF (CD2790), encoding a hypothetical 
protein of 235aa,  and the adjacent ORF (CD2791) encoding the 623aa putative S-
layer protein (gi|115251844), which, as discussed above (Table 3.2), was 
detected in strains A and Tra5/5 but not B-1.  This protein corresponds to the 
reference map spot J12 which was detected in strains A and Tra5/5 but not B-1 
by both MALDI-TOF MS and LC-MS/MS, and shown to be upregulated in these 
strains compared to strain B-1 by DIGE.
These ORFs appear to have been deleted from this locus in strain B-1.  In 
addition, in strain B-1, this genetic locus includes an insertion of approximately 
58Kb between the ORFs of Cwp66 and Cwp84, containing 50 ORFs, most  of 
which are putative or uncharacterised.  However, this does not seem to block 
the transcription of these ORFs, as many of them, including Cwp66, Cwp84, 
SecA and SlpA, were confirmed by the detection of the corresponding proteins.
192
Therefore, genetically, as well as proteomically, strain B-1 appears to show a 
markedly different profile to the other two strains with regard to S-layer and 
surface proteins.
The S-layer proteins from Clostridium difficile have been shown to induce an 
inflammatory response (Ausiello et al, 2006) and detectable levels of anti-SLP 
antibodies have been found in human sera (Drudy et al, 2004).  Higher levels of 
IgM antibodies were found in asymptomatic patients than in those that went on 
to develop CDAD, and patients suffering from recurrent CDAD had 
significantly lower IgM levels than those suffering a single episode of infection, 
suggesting that strain specific antibody response to SLPs might be important in 
clinical outcome of infection.
The HMW protein is fairly conserved among strains, but the LMW protein 
shows considerable variation between different C. difficile isolates (McCoubrey 
and Poxton, 2001); (Calabi et al, 2001).  Cross immunoreactivity was seen 
between the HMW proteins, but not the LMW proteins (Calabi et al, 2001).  In 
this study, the HMW protein is strongly immunoreactive, but the spots 
corresponding to the LMW protein in strains A and Tra5/5 (figures) do not react 
with the serum primary antibody, indicating that there is a high divergence 
from the corresponding 630 protein against which the rabbit serum was raised.  
The divergence of this LMW SLP may help the pathogen evade host immune 
systems.  
SLP homologues have also been shown to trigger immune responses, so the 
immunoreactive spots were compared to the theoretical mass and pI values of 
these proteins.  Despite high interstrain variability of the Cwp66 gene, antibodies 
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against this protein recognised Cwp66 from different isolates.  Cwp66 has a 
predicted molecular weight of 67kDa, so could correspond to the band at 
~65kDa on the 1D Western blot, and the series of spots on the 2D Western blot 
that were present in strains A and Tra5/5 but not B-1.  This protein was detected 
in all strains, but as it showed homology between strains A and Tra5/5, and 
much lower homology to strain B-1, it is possible that Cwp66 from B-1 is 
different enough to escape detection by the Cwp66 antibody raised against the 
630 protein.  It is possible that this series of spots corresponds to a number of 
different homologues, all of which exhibit variability in B-1 preventing cross 
reactivity.
Cwp84 is highly conserved and has been shown to be strongly immunoreactive 
(Pechine et al, 2005b).  Cwp84 has a predicted molecular weight of 87kDa.  There 
was a faintly immunoreactive band visible in the 1D Western blot with rabbit 
serum that appeared to be present in strain Tra5/5 but not the other two strains 
which may correspond to this protein.  However, as it was detected in all three 
strains, and was highly conserved, it would be expected that if this band 
corresponded to Cwp84, it would be present in all strains.   
Alternatively, the series of immunoreactive spots seen in strains A and Tra5/5 
but not B-1 could correspond to the additional S-layer protein gi|115251884, 
which has been discussed above and is present in the genomes of these strains 
but not that of B-1.  This protein could undergo a modification event, causing it 
to appear as a series of spots.  It was identified as a single spot on the reference 
maps, but it is possible that additional spots were obscured by other, non 
immunoreactive, proteins, so can only be seen on the reactive profile.
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This analysis indicates that the S-layer proteins, and SLP homologues are similar 
in amino acid composition and reactivity in the hypervirulent strain A and the 
low virulent Tra5/5, but that strain B-1 exhibits a markedly different surface 
protein profile.  B-1 shows different expression and modification of the SlpA 
protein, in that the LMW SLP was not detected in this strain.  In addition it 
exhibits genetic variation, with differences in the organisation of the SlpA locus 
in this strain, including the absence of the gene encoding the surface protein 
gi|115251844, and an adjacent small hypothetical ORF.  The fact that the B-1 
strain does not appear to express the LMW SLP, and shows a different genetic S-
layer profile, supports previous conclusions suggesting that although the S-layer 
is likely to be important in adhesion and interaction with the host, many other 
factors must be involved in virulence determination.  
Four cell surface proteins were detected in the virulent strains A and B-1, but 
not in the low virulence Tra5/5 strain.  Only one of the genes encoding these 
proteins was located in close proximity to SlpA and none of them have been 
previously described in detail in the literature.  One protein (SLP11, 
gi|115251237) was identified as a cell wall hydrolase with homology to the 
CwlD N-acetylmuramoyl-L-alanine amidase protein family involved in 
degradation of peptidoglycan.  It has been suggested that in bacillus, this 
protein plays a role in the production of spore-specific peptidoglycans (Gilmore
et al, 2004), so may play a role during sporulation.  Two proteins, gi|115249861
(313aa) and gi|115251839 (525aa) contain three putative cell wall binding motifs 
(CW-binding repeat 2), which are found in multiple copies in surface proteins 
including amidase enhancers and adhesions, as well as LytB-like cell wall 
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binding domains.  The presence of these domains has led to their classification 
of putative surface proteins, and indicates that these proteins may play a role in 
adhesion.  The fourth protein, gi|115251764, is slightly larger (656aa) and as well 
as containing three copies of the CW-binding repeat 2 and two LytB cell wall 
binding motifs, this protein contains an L,D-transpeptidase catalytic domain of 
the YkuD superfamily.  This family of proteins can act as transpeptidases, 
giving rise to an alternative pathway for peptidoglycan cross-linking.  This can 
give bacteria resistance to beta-lactam antibiotics, as the beta-lactam sensitive 
penicillin binding proteins that usually catalyse the final peptidoglycan cross 
linking stages of cell wall synthesis, are no longer required (Biarrotte-Sorin et al, 
2006).
If these proteins are indeed not produced in the lower virulence Tra5/5 strain, or 
produced at reduced levels compared to the more virulent B-1 and A strains, 
this could indicate that there is a difference in the adhesive properties, or 
peptidoglycan crosslinking and degradation properties of this strain.  This may 
even affect the antibiotic resistance profile of Tra5/5.  These differences may play 
a role in the reduced virulence of Tra5/5 compared to strains B-1 and A.
4.5.4 – Flagella and motility
Flagella are cell surface structures found on many bacterial species.  The 
structure is made up of three main parts, a basal body, functioning as a motor, a 
torsion hook and a hollow filament making up the flagellum tail, and flagella 
have been shown to contribute to pathogenesis in a range of bacteria in a 
number of ways (Ramos et al, 2004).  
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Firstly, flagella confer motility, allowing access of the pathogen to mucosal 
tissues.  Secondly, flagella can act as an adhesin.  Crude preparations of 
Clostridium difficile flagella have been shown to associate with the cecal mucus of 
mice, and non-flagellate strains of C. difficile associate with cecal tissue at a rate 
that is 10-fold lower than that of flagellate strains (Tasteyre et al, 2001).  Finally, 
it has been suggested that flagella can play a role in sensing of environmental 
conditions, such as ‘wetness’ (Wang et al, 2005) and hence may control 
expression of genes and virulence factors under certain conditions (Boin et al, 
2004).
Flagellin or FliC, the main protein component of the fillment, was identified as a 
series of different spots on each 2D gel, indicating post-translational 
modification.  However, DIGE analysis showed different protein migration 
between the three strains.  The amino acid sequence of flagellin is highly 
conserved between the three strains, and similar to that of strain 630, as deduced 
from genome sequencing (personal communication).  FliC from strains A and 
Tra5/5 shows a 29aa insertion at the sequence start, which is not present in 
strains B-1 or 630.  The flagellin of strains B-1 and Tra5/5 is otherwise identical, 
and shows two amino acid differences to the flagellin protein from strain A, 
with a serine at position 188 instead of threonine, and asparagine at position 227 
instead of aspartic acid.  This high level of homology means that the difference 
in flagellin migration is unlikely to be due to amino acid differences, suggesting 
that variation in the modification process between strains causes the difference 
in spot position.   Similar changes in flagellin protein migration have been seen 
in Campylobacter jejuni, with proteins from a putative flagellar 
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glycosyltransferase knock out mutant migrating at a less acidic pI within the gel 
than those with an active glycosyltransferase (van Alphen et al, 2008).  
Glycosylation of flagella has been shown to be important in many bacterial 
species, affecting motility, adhesion and pathogenesis (Logan, 2006).  It was 
recently shown that the flagellin of Clostridium diffile is glycosylated in the 
central, surface exposed region, and that glycosylation is required for filament 
assembly and subsequent motility (Twine et al, 2009).  Variation in the glycans 
of different strains was observed, indicating that glycosylation differences are 
likely to be responsible for the migration differences observed.  
Differences in the flagellar-associated glycosytransferases have been shown 
between epidemic O27 ribotypes and non-epidemic strains (Stabler et al, 2009), 
again indicating that the glycosylation process may vary between isolates, and 
that this may have an affect on virulence.  Differences in the adjacent genes to 
the flagellar-associated gene loci between the epidemic O27 ribotypes and the 
reference 630 strain have been observed to include an additional glycosyl 
transferase.  These glycosylation differences may be responsible for the 
observed difference in motility, with the O27 ribotype strains showing greater 
motility than the 630 reference strain (Stabler et al, 2009).  A difference in 
modification (most likely glycosylation) of FliC between strains A and B-1 can 
be clearly seen by the differential migration shown by DIGE and, given the 
previous observations in other epidemic 027 ribotype, may contribute to the 
enhanced virulence of this strain.
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Flagella proteins have been implicated in attachment of C. difficile to the mucus 
layer of the intestine, as well as the caecal wall (Tasteyre et al, 2001) and so are 
considered to enhance C. difficile virulence.  If, as seems probable, the difference 
in flagellin migration is due to differential glycosylation, this could affect 
structure and function of the flagella, altering the role played in motility and 
adhesion.  This could contribute to the differences in virulence between the 
different strains. In addition, the flagellar hook protein was not identified in 
strain Tra5/5, indicating the structure of the flagella basal body in the low-
virulence strain Tra5/5 could also be different.  A number of other flagellar 
proteins notably flagellar motor switch proteins, were detected in strain B-1 
only, again suggesting difference in the flagellar structure of the three strains.
Comparative genomic assays have indicated that flagella production and 
motility may not be a common feature for Clostridium difficile isolates, and that 
flagellar gene loci are not necessarily conserved among virulent strains (Stabler
et al, 2006). It was reported previously, by RT-PCR, that FliC is expressed in both 
flagellate and non-flagellate strains (Tasteyre et al, 2000b), so it is possible that 
strain Tra5/5 is non-flagellate, despite the detection of the FliC protein.  In 
addition, FliC was not found to be up-regulated in strain Tra5/5 by DIGE, 
whereas it was for the other two strains.  Data on the motility and flagella 
production of this strain has not previously been reported, but if this strain is 
indeed non-flagellate, for example due to differences in the basal body and 
hook, it could go some way in explaining the low virulence reported for this 
strain.  The presence or absence of flagella in this strain could be verified by 
Electron Microscopy.
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Another component to bacterial motility is chemotaxis, which regulates the 
movement of bacteria towards an attractant or away from a repellent.   It has 
previously been shown that gut mucus of animals and humans acts as a 
chemoattractant for C. difficile (Boriello and Bhatt R, 1995)}, making chemotaxis 
proteins potential virulence factors for this organism, as has been shown for 
other organisms such as Vibrio cholerae (Boin et al, 2004).  Two chemotaxis proteins 
were identified by this analysis, but neither was detected in strain Tra5/5, again 
suggesting motility of this, less pathogenic, strain may be different.
  4.5.5 – Additional proteins of interest
Hydrolytic enzyme production has previously been linked to virulence in C. 
difficile (Seddon et al, 1990) and strains B-1 and Tra5/5 have been shown to 
produce chondroitin-4-sulphatase, hyaluronidase, heparinase and collagenase.  
However none of these enzymes were detected during this analysis.  Similarly, 
proteins making up the capsule, which has also been linked to virulence, and 
shown to be present in strains B-1 and Tra5/5 (Davies and Borriello, 1990), were 
not detected here.
Fimbriae have been reported in C. difficile, although their role in virulence is 
disputed (Borriello, 1998).  Here, the pilin protein making up fimbriae was 
detected in the low virulence strain Tra5/5 only, and in the protein extracts from 
broth, not the standard plate extracts.  This suggests that under the standard 
conditions used here, none of the three strains are expressing fimbriae to a 
detectable level.
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Infection of a host by a bacterial pathogen causes stress to both the host and 
invading organism, and it has been proposed that this stress induces chaperones 
and heat shock proteins which may play a role in infection.  The roles of 
chaperones in bacterial infection has been reviewed (Henderson et al, 2006) and 
this class of proteins have been shown to be involved in adhesion for a number 
of organisms.  Evidence for the role of the chaperone Hsp60 as an adhesion in C. 
dificile has been presented (Hennequin et al, 2001).
This analysis identified three heat shock proteins in all three strains, the 60 kDa 
chaperonin (Hsp60 630_gi|115249204), Hsp90 630_gi|115249282 and a putative 
GrpE 630_gi|115251516.  Hsp90 and GrpE were also identified in all strains in 
broth, whereas Hsp60 was only found in strain A in broth extracts.
Another class of protein found to be up-regulated in the virulent A and B-1 
strains but not in the less virulent Tra5/5 strain are the ABC transporter 
substrate binding proteins.  Such proteins have been shown to function as 
adhesins, and potentially linked to virulence in a number of bacterial species 
including Campylobacter jejuni (Leon-Kempis et al, 2006) and Neisseria 
meningitidis (Li et al, 2009).  Again, these proteins may play a role in attachment 
of the bacteria to the host cells during an infection.  Interestingly, more transport 
related proteins were found in strain A than in strains B-1 and Tra5/5 (31, 27 and 
17 respectively).  Eight ABC transporter proteins were identified in the A strain 
only, but fewer were identified uniquely in strains B-1 and Tra5/5, four and two 
respectively.  This may give rise to different adhesive properties between the 
strains.
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In depth examination of virulence factors has identified a number of strain to 
strain differences which could contribute to the varying virulence of the three 
isolates discussed here.  The association between C. difficile and CDAD was first 
demonstrated over 30 years ago by Larson et al (1978)(Larson et al, 1978), and by 
analogy with other toxin producing species, and the conclusion was reached 
that the toxins are the sole determinates of C. difficile pathogenicity.  Strain B-1 
used here is derived from this study, and this, and other strains, were 
subsequently used in a number of studies in which this view was reinforced.  
Both animal models and tissue culture methods were devised to assess 
virulence, and some 30 years later, these remain the most widely accepted 
standards.  Although a toxin detection kit is now available, its sensitivity in 
direct faecal samples is poor, and it does not differentiate between toxins A and 
B.  However, the association between toxin production and pathogenicity 
profiles of Clostridium difficile is still not fully understood, and a plethora of 
virulence factors are likely to mediate host colonisation, adhesion, proliferation 
and disease progression.  
Apart from the S-layer proteins, most of these factors remain poorly 
characterised, largely due to the lack of appropriate techniques.  Proteomics 
offers new approaches to detect toxins directly and opportunities to study other 
potential virulence factors across a broad range of isolates, to asses their relative 
contribution.
The data presented here confirms that the pathogenicity of this organism is not a 
simple process, and that many potential virulence factors, although not required 
to cause disease, may contribute to the process.  It addition, roles of the 
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commensal gut flora and the host immune response, not discussed in detail 
here, are likely to be crucial in determining the outcome of infection.  As this 
organism continues to cause outbreaks in hospitals around the world, placing 
additional burden on healthcare facilities, ongoing research in this area, and the 
continuing attempt to elucidate the virulence determinants of C. difficile will 
continue for the foreseeable future.  Proteomics should be included as an 
essential component of these programmes.  
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Conclusion
Clostridium difficile is a very diverse species, as has been widely reported in the 
literature.  Recent advances in sequencing technology have accelerated the 
acquisition of a wealth of genomic data for this organism and has provided 
further evidence of the large genetic variation between different strains (He et al, 
2010; Sebaihia et al, 2006; Stabler et al, 2006; Stabler et al, 2009).  Full genome 
analysis has shown a large number of mobile genetic elements and a high rate of 
mutation and gene acquisition from a range of organisms from the commensal 
gastrointestinal flora such as Bacteroides, Enterococcus, Fusobacterium and 
Ruminococcus (DBHT, manuscript in preparation).  
There has been a changing pattern of epidemiology in circulating strains 
(Freeman et al, 2010), with notable changes in the antibiotic resistance profiles of 
newly emerging isolates.  Many of these differences will be manifested, and 
hence more readily apparent, in the proteome.  Prior to this study, no in-depth 
proteomic analysis of this organism had been undertaken.  
The proteomic tools used for these analyses are highly technically challenging, 
laborious, time consuming and costly, and therefore, the number of strains that 
can be included in such a study is limited.  New nanoscale methods are 
developing for rapid, direct analysis.  This will facilitate a wider coverage of 
strains.  The recent shift in predominant strains from the 027 ribotype 
increasingly towards the 078 ribotype can be studied to help elucidate the 
selective pressures that drive the transition within genetic populations and lead 
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to new virulent clonal types.  The present study will provide a sound scientific 
framework from which further studies may be developed.
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Appendices
Table A1 – Identifications of protein spots picked from 2D reference maps with 
MASCOT identification scores (A), theoretical mass (B) and pI (C), percentage peptide 
coverage (D) and number of matched peptides (E).  Any spot number not shown did 
not give rise to an identification.
Strain A
Spot Protein ID no A B C D E
A1
BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical Protein 
BASYS03269 sta_BASYS03269  141 80379 4.83 40 28
A2
atpA, 68761-67259 (CounterClockwise) ATP 
synthase subunit alpha sta_BASYS00075 70 54688 4.91 24 11
A3 stage IV sporulation protein A
630_gi|115251680|
emb|CAJ69515.1| 77 56373 4.97 32 13
A5 electron transfer flavoprotein alpha-subunit
630_gi|115249407|
emb|CAJ67222.1| 125 57353 5.03 51 15
A6 (R)-2-hydroxyisocaproate dehydrogenase
630_gi|115249400|
emb|CAJ67215.1| 108 36552 5.07 55 14
A7 electron transfer flavoprotein beta-subunit
630_gi|115249406|
emb|CAJ67221.1| 131 28767 4.87 78 15
A8
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072 105 64664 4.76 41 16
A10
BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical Protein 
BASYS03269 sta_BASYS03269 88 80379 4.83 28 15
A11 acyl-CoA dehydrogenase, short-chain specific
630_gi|115249405|
emb|CAJ67220.1| 89 41009 6.41 40 10
A12
caiA, 763783-764928 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) sta_BASYS00745 170 41469 5.88 69 25
B1
ydbK, 3330872-3327333 (CounterClockwise) 
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase) sta_BASYS03153  80 130112 5.39 21 20
B2
ydbK, 3330872-3327333 (CounterClockwise) 
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase) sta_BASYS03153 116 130112 5.39 28 29
B3
ydbK, 3330872-3327333 (CounterClockwise) 
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase)
630_gi|115251733|
emb|CAJ69568.1| 137 130112 5.39 29 30
B4
ydbK, 3330872-3327333 (CounterClockwise) 
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase) sta_BASYS03153   108 130112 5.39 25 24
B5
ydbK, 3330872-3327333 (CounterClockwise) 
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase) sta_BASYS03153  111 130112 5.39 26 26
222
B6
tyrB, 2974977-2973718 (CounterClockwise) 
Hypothetical Protein tyrB (putative aspartate
aminotransferase) sta_BASYS02834 77 47850 5.17 28 13
B9 isoleucyl-tRNA synthetase
630_gi|115251669|
emb|CAJ69504.1| 135 120425 5.08 21 18
B10
rpoB, 408612-412328 (Clockwise) Hypothetical 
Protein rpoB (DNA-directed RNA polymerase 
beta chain) sta_BASYS00405 86 139806 4.76 20 20
C5
infB, 1691221-1693161 (Clockwise) Translation 
initiation factor IF-2 (translation initiation factor 
IF-2) sta_BASYS01609 84 69895 4.76 30 12
C6
dnaK, 3071723-3069876 (CounterClockwise) 
Hypothetical Protein dnaK (chaperone protein) sta_BASYS02928 102 66541 4.72 33 15
C7
groL, 567992-569620 (Clockwise) Hypothetical 
Protein groL (60 kDa chaperonin) sta_BASYS00550  109 37735 4.74 50 14
C10
fusA, 417208-419274 (Clockwise) Hypothetical 
Protein fusA sta_BASYS00409  54 76076 4.91 24 12
D2
(tuf1, 402179-403372 (Clockwise) Elongation 
factor Tu (elongation factor TU) sta_BASYS00396 159 44226 4.94 49 19
D3
BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical Protein 
BASYS03269 sta_BASYS03269  128 80379 4.83 33 19
D10
aegA, 1953842-1955236 (Clockwise) Hypothetical 
Protein aegA (putative glutamate synthase 
NADPH small chain) sta_BASYS01860 75 50248 5.17 31 11
D11
atpB, 3616679-3615306 (CounterClockwise) V-
type ATP synthase beta chain (V-type sodium 
ATP synthase subunit B) sta_BASYS03388 79 50585 5.21 43 15
D12
atpD, 66340-64946 (CounterClockwise) ATP 
synthase subunit beta (ATP synthase beta chain) sta_BASYS00073  141 49817 5.18 62 19
E1
yjiR, 302052-300856 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino acid 
aminotransferase) sta_BASYS00306 61 44997 5.12 30 10
E2
yjiR, 302052-300856 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino acid 
aminotransferase) sta_BASYS00306  160 44997 5.12 65 25
E3 NAD-specific glutamate dehydrogenase
630_gi|115249189|
emb|CAJ67001.1| 81 46271 5.16 42 15
putative amino acid aminotransferase
630_gi|115252729|
emb|CAJ70573.1| 63 44997 5.12 37 14
E4
frc, 759341-760540 (Clockwise) Hypothetical 
Protein frc (isocaprenoyl-CoA:2-
hydroxyisocaproate CoA-transferase) sta_BASYS00741 87 44491 5.18 43 12
E5
atoB, 1445216-1446448 (Clockwise) Hypothetical 
Protein atoB (acetyl-CoA acetyltransferase) sta_BASYS01347  78 41005 5.56 40 13
E8
yceH, 2127930-2129066 (Clockwise) 
Uncharacterized protein yceH (putative tellurite 
resistance protein) sta_BASYS02042  106 43643 5.09 39 13
E10
BASYS00469, 475249-476328 (Clockwise) 
Hypothetical Protein BASYS00469 (putative 
oxidoreductase, thiamine diP-binding subunit) sta_BASYS00469 92 39290 5.32 54 12
E12
ackA, 473216-474295 (Clockwise) Hypothetical 
Protein ackA (butyrate kinase) sta_BASYS00466  130 38728 5.34 67 23
223
F1
yjiM, 762620-763747 (Clockwise) Hypothetical 
Protein yjiM (subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase) sta_BASYS00744  62 42993 5.27 35 12
F5 ABC transporter, substrate-binding lipoprotein
630_gi|115249887|
emb|CAJ67706.1|
62 36159 5.4 36 7
F6
BASYS03269, 3479118-3476842 
(CounterClockwise) Hypothetical Protein 
BASYS03269 sta_BASYS03269 86 80379 4.83 26 18
F7
agaY, 769977-769051 (CounterClockwise) 
Hypothetical Protein agaY (putative fructose-
bisphosphate aldolase) sta_BASYS00749 67 33069 5.16 46 9
F8
ackA, 2971240-2970170 (CounterClockwise) 
Hypothetical Protein ackA (butyrate kinase) sta_BASYS02831  73 38869 5.29 34 8
F9
cysM, 2076886-2077794 (Clockwise) 
Hypothetical Protein cysM (putative O-
acetylserine sulfhydrylase) sta_BASYS01991 102 32816 5.35 57 13
F10
cysM, 2076886-2077794 (Clockwise) 
Hypothetical Protein cysM (putative O-
acetylserine sulfhydrylase) sta_BASYS01991  98 32816 5.35 58 12
F11
prs, 113742-112792 (CounterClockwise) 
Hypothetical Protein prs (ribose-phosphate 
pyrophosphokinase) sta_BASYS00121 72 34548 5.41 36 8
G7
BASYS01569, 1654445-1655230 (Clockwise) 
Hypothetical Protein BASYS01569 (GTP-sensing 
transcriptional pleiotropic repressor) sta_BASYS01569  92 28727 5.31 48 11
H3
BASYS02832, 2971868-2971293 
(CounterClockwise) Hypothetical Protein 
BASYS02832 (putative indolepyruvate 
oxidoreductase subunit) sta_BASYS02832 85 21020 5.44 68 9
H7
rplJ, 406008-406538 (Clockwise) Hypothetical 
Protein rplJ (50S ribosomal protein L10) sta_BASYS00402 72 18582 6.2 56 9
H8
BASYS03154, 3331959-3331390 
(CounterClockwise) Propanediol Utilization 
Protein sta_BASYS03154 63 20079 5.97 52 8
I1
adhE, 3632084-3629430 (CounterClockwise) 
Hypothetical Protein adhE (aldehyde-alcohol 
dehydrogenase includes: alcohol dehydrogenase 
and pyruvate-formate-lyase deactivase) sta_BASYS03400 206 97197 5.68 47 34
I7
pflB, 1174270-1172039 (CounterClockwise) 
Hypothetical Protein pflB (formate 
acetyltransferase) sta_BASYS01106  169 83966 5.39 46 29
I8 formate acetyltransferase
630_gi|115249776|
emb|CAJ67593.1| 109 83966 5.39 46 27
I8 polyribonucleotide nucleotidyltransferase
630_gi|115250354|
emb|CAJ68176.1| 99 78172 5.3 40 23
J1
acpS, 64221-63841 (CounterClockwise) 
Hypothetical Protein acpS (holo-acyl-carrier 
protein synthase) sta_BASYS00071 56 14473 8.63 48 6
J3
BASYS01060, 1118805-1120724 (Clockwise) 
Hypothetical Protein BASYS01060 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase) sta_BASYS01060 69 69693 5.5 25 12
224
J4
BASYS01060, 1118805-1120724 (Clockwise) 
Hypothetical Protein BASYS01060 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase) sta_BASYS01060   208 69709 5.5 53 31
J5
fusA, 353018-354958 (Clockwise) Hypothetical 
Protein fusA (putative translation elongation 
factor) sta_BASYS00349 175 72577 5.45 58 31
J6
fusA, 353018-354958 (Clockwise) Hypothetical 
Protein fusA (putative translation elongation 




88 65234 5.38 36 14
J7
putative oxidoreductase, acetyl-CoA synthase 
subunit
630_gi|115249184|
emb|CAJ66996.1| 67 69298 5.41 27 13
J10 indolepyruvate oxidoreductase subunit
630_gi|115251433|
emb|CAJ69266.1| 195 68929 5.65 49 26
J12
BASYS03267, 3473846-3471975 
(CounterClockwise) Hypothetical Protein 
BASYS03267 (cell surface protein (putative S-
layer protein precursor)) sta_BASYS03267 155 66427 6.2 47 22
K1
BASYS01063, 1122044-1123738 (Clockwise) 
Hypothetical Protein BASYS01063 (formate--
tetrahydrofolate ligase) sta_BASYS01063 162 60894 5.53 56 26
K2
thiH, 2730080-2731456 (Clockwise) Hypothetical 
Protein thiH (radical SAM-superfamily protein) sta_BASYS02617  94 52653 5.56 43 17
K3
thiH, 2730080-2731456 (Clockwise) Hypothetical 
Protein thiH (radical SAM-superfamily protein) sta_BASYS02617  103 52653 5.56 51 19
K4
thiH, 2730080-2731456 (Clockwise) Hypothetical 
Protein thiH (radical SAM-superfamily protein) sta_BASYS02617 84 52653 5.56 38 12
K5 glucose-6-phosphate isomerase
630_gi|115252341|
emb|CAJ70182.1| 86 50677 5.48 50 15
K6 putative transcriptional regulator
630_gi|115252733|
emb|CAJ70577.1| 75 50203 5.56 39 18
tyrS2, 1934471-1935679 (Clockwise) Tyrosyl-
tRNA synthetase 2 (tyrosyl-tRNA synthetase) sta_BASYS01844  98 45703 5.42 42 14
K7
thiH, 2730080-2731456 (Clockwise) Hypothetical 
Protein thiH (radical SAM-superfamily protein) sta_BASYS02617  94 52653 5.56 43 17
K9
ackA, 1545979-1547175 (Clockwise) Acetate 
kinase (acetate kinase) sta_BASYS01450  100 43619 5.4 56 21
K11
putative dual-specificity prolyl/cysteinyl-tRNA 
synthetase
630_gi|115249053|
emb|CAJ66864.1| 86 59419 5.22 39 16
K11
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase complex, 
dihydrolipoyl dehydrogenase subunit
630_gi|115249740|
emb|CAJ67557.1| 68 50103 5.27 36 12
L1
BASYS02792, 2934707-2933211 
(CounterClockwise) Hypothetical Protein 
BASYS02792 (gamma-aminobutyrate 
metabolism dehydratase/isomerase includes: 4-
hydroxybutyryl-coa dehydratase; vinylacetyl-




(CounterClockwise) Hypothetical Protein 
BASYS02792 (gamma-aminobutyrate 
metabolism dehydratase/isomerase includes: 4-
hydroxybutyryl-coa dehydratase; vinylacetyl-
coa-delta-isomerase) sta_BASYS02792 56 55865 5.8 26 9
L5
glyA, 3392427-3391183 (CounterClockwise) 
Hypothetical Protein glyA (putative serine 
hydroxymethyltransferase) sta_BASYS03201  149 46078 5.67 46 16
L7
iscS, 1657961-1659169 (Clockwise) Hypothetical 
Protein iscS (cysteine desulfurase) sta_BASYS01574 106 44552 5.9 33 15
L8
caiA, 763783-764928 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) sta_BASYS00745 160 41469 5.88 54 19
L9
caiA, 763783-764928 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) sta_BASYS00745 90 41469 5.88 23 8
L11
ydiO, 1440421-1441557 (Clockwise) Hypothetical 
Protein ydiO (butyryl-CoA dehydrogenase) sta_BASYS01342 131 41348 5.7 51 17
L12
gapC, 3929194-3928187 (CounterClockwise) 
Hypothetical Protein gapC (glyceraldehyde-3-
phosphate dehydrogenase 2) sta_BASYS03662 69 36239 5.75 31 9
M1
paaH, 1444341-1445186 (Clockwise) 
Hypothetical Protein paaH (3-hydroxybutyryl-
CoA dehydrogenase) sta_BASYS01346 127 30887 5.8 49 13
M2
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598 65 34354 6.51 36 8
M3
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598  95 34354 6.51 44 12
M4
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598   88 34354 6.51 44 13
M5
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598 92 34354 6.51 41 12
M6
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598 72 34354 6.51 37 8
M7
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598 63 34354 6.51 35 8
M8
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598 61 34354 6.51 33 6
M9
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC sta_BASYS00598  59 34354 6.51 31 6
M11 putative flagellar hook-associated protein
630_gi|115249239|
emb|CAJ67052.1| 68 48018 4.94 41 12
M12
metF, 1126186-1127067 (Clockwise) 
Methylenetetrahydrofolate Reductase (putative 
methylenetetrahydrofolate reductase) sta_BASYS01067  63 31776 5.81 30 9
N1
BASYS00470, 476328-477080 (Clockwise) 
Hypothetical Protein BASYS00470 (putative 
subunit of oxidoreductase) sta_BASYS00470  79 27031 6.38 38 8
N3
rpsB, 2712313-2711600 (CounterClockwise) 30S 
ribosomal protein S2 (30S ribosomal protein S2) sta_BASYS02601  63 26940 6.19 44 10
N4
yjiL, 760570-761379 (Clockwise) Hypothetical 
Protein yjiL (activator of 2-hydroxyisocaproyl-
CoA dehydratase) sta_BASYS00742  82 28948 6.35 40 9
226
N5
spo0A, 1583111-1583935 (Clockwise) Stage 0 
sporulation protein A homolog sta_BASYS01490  119 30888 6.33 57 14
N7






clpB, 357405-359852 (Clockwise) Hypothetical 
Protein clpB (ATP-dependent Clp protease) sta_BASYS00354  209 91292 5.85 46 32
N9
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072 186 64664 4.76 51 24
N10
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03073 stb_BASYS03072 191 64664 4.76 57 27
N12
caiA, 763783-764928 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) sta_BASYS00745 92 41469 5.88 41 13
R1
BASYS01062, 1121034-1121813 (Clockwise) 
Hypothetical Protein BASYS01062 (putative 
carbon monoxide dehydrogenase accessory 
protein) sta_BASYS01062 98 28728 5.69 50 13
R3
ydiA, 3015428-3014586 (CounterClockwise) 
Putative phosphotransferase CD2411 (conserved 
hypothetical protein) sta_BASYS02873 120 32006 5.95 55 15
R4
BASYS00467, 474264-474962 (Clockwise) 
Hypothetical Protein CHY (putative ATP/GTP-
binding protein) sta_BASYS00467  57 26529 8.37 33 7
R7
ydiO, 1440421-1441557 (Clockwise) Hypothetical 
Protein ydiO sta_BASYS01342 183 41348 5.7 74 22
R8
ypdF, 2942563-2941484 (CounterClockwise) 
Hypothetical Protein ypdF (putative Xaa-Pro 
dipeptidase) sta_BASYS02798  82 40623 5.5 38 11
R11
ygfH, 2932777-2931470 (CounterClockwise) 
Hypothetical Protein ygfH sta_BASYS02790 100 58257 5.6 36 13
P1
gcvP, 2151957-2153414 (Clockwise) Hypothetical 
Protein gcvP (glycine cleavage system P protein) sta_BASYS02061 96 53865 5.55 38 17
P2
glgA, 1304868-1306310 (Clockwise) Hypothetical 
Protein glgA (glgA, 1304868-1306310 
(Clockwise) Hypothetical Protein glgA) sta_BASYS01234  96 55873 5.6 34 14
P4
ypdF, 2851729-2849936 (CounterClockwise) 
Hypothetical Protein ypdF sta_BASYS02718 152 68494 5.11 54 25
aspS, 3407936-3406149 (CounterClockwise) 
Hypothetical Protein aspS sta_BASYS03216 60 67951 5.04 33 16
P5
metG, 139988-138051 (CounterClockwise) 
Hypothetical Protein metG (methionyl-tRNA 
synthetase) sta_BASYS00146 65 74724 5.21 23 12
P6
thrS, 918695-920725 (Clockwise) Hypothetical 
Protein thrS (threonyl-tRNA synthetase) sta_BASYS00884 121 78293 5.42 39 21
P7
ygbD, 2298860-2297229 (CounterClockwise) 
Hypothetical Protein ygbD sta_BASYS02209 114 59060 5.49 34 16
P10
ptsI, 3427518-3425806 (CounterClockwise) 
Hypothetical Protein ptsI 
(phosphoenolpyruvate-protein 
phosphotransferase) sta_BASYS03230 182 63296 4.81 52 25
P11
groL, 567992-569620 (Clockwise) Hypothetical 
Protein groL (60 kDa chaperonin) sta_BASYS00550 142 57747 4.74 48 19
P11 ppaC, 724318-722720 (CounterClockwise) sta_BASYS00711 86 59727 4.86 30 14
227
Probable manganese-dependent inorganic 
pyrophosphatase
Strain B-1
Protein ID no A B C D E
A1
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072 289 64664 4.76 65 40
A2 ATP synthase alpha chain
630_gi|115252530|
emb|CAJ70373.1| 214 54688 4.91 54 27
A2 putative aminoacyl-histidine dipeptidase
630_gi|115249724|
emb|CAJ67541.1| 74 53053 4.89 35 15
A3
ppaC, 1051638-1053236 (Clockwise) Probable 
manganese-dependent inorganic 
pyrophosphatase stb_BASYS01013  167 59668 4.89 46 23
A5 electron transfer flavoprotein alpha-subunit
630_gi|115249407|
emb|CAJ67222.1| 203 37353 5.03 61 24
A6 (R)-2-hydroxyisocaproate dehydrogenase
630_gi|115249400|
emb|CAJ67215.1| 191 36552 5.07 62 20
A7 electron transfer flavoprotein beta-subunit
630_gi|115249406|
emb|CAJ67221.1| 197 28767 4.87 80 21
A8
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072   67 64664 4.76 24 12
A9
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072  93 64664 4.76 26 15
A10
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072 353 64664 4.76 65 37
A11
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072 stb_BASYS03072 259 64664 4.76 59 29
A12 acyl-CoA dehydrogenase, short-chain specific
630_gi|115249405|
emb|CAJ67220.1| 224 41009 6.41 72 33
B1 pyruvate-flavodoxin oxidoreductase
630_gi|115251733|
emb|CAJ69568.1| 155 130112 5.39 23 21
B2 pyruvate-flavodoxin oxidoreductase
630_gi|115251733|
emb|CAJ69568.1| 231 130112 5.39 38 35
B3 pyruvate-flavodoxin oxidoreductase
630_gi|115251733|
emb|CAJ69568.1| 270 130112 5.39 39 40
B5 pyruvate-flavodoxin oxidoreductase
630_gi|115251733|
emb|CAJ69568.1| 256 130112 5.39 36 35
B6
tyrB, 2681281-2680022 (CounterClockwise) 
Hypothetical Protein tyrB (putative aspartate 
aminotransferase) stb_BASYS02592 70 47863 5.29 26 9
B9
ileS, 2959099-2955983 (CounterClockwise) 
Hypothetical Protein ileS (isoleucyl-tRNA 
synthetase) stb_BASYS02845  117 120425 5.08 25 18
B11 putative alanyl-tRNA synthetase
630_gi|115250316|
emb|CAJ68138.1| 74 99077 4.94 17 12
B12 putative nitric oxide reductase flavoprotein
630_gi|115250664|
emb|CAJ68488.1| 178 94987 4.92 29 21
C1
pheT, 1093175-1095568 (Clockwise) 
Phenylalanyl-tRNA synthetase beta chain stb_BASYS00688 122 89576 4.87 24 15
C2 translation elongation factor G
630_gi|115249074|
emb|CAJ66885.1| 205 76076 4.91 47 24
228
C3 translation elongation factor G
630_gi|115249074|
emb|CAJ66885.1| 210 76076 4.91 45 23
C6 chaperone protein
630_gi|115251515|




htpG, 312628-310691 (CounterClockwise) 
Hypothetical Protein htpG (chaperone protein 
(heat shock protein))
630_gi|115249282|




atpD, 3370184-3368406 (CounterClockwise) 
Hypothetical Protein atpD (V-type sodium ATP 




glyS, 3040737-3038671 (CounterClockwise) 
Hypothetical Protein glyS (glycyl-tRNA 









subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase
630_gi|115249403|
emb|CAJ67218.1| 177 47133 5
51
% 25
D2 elongation factor TU
630_gi|115249061|




glycine reductase complex component B alpha 
and beta subunits
630_gi|115251407|




rpsA, 1080759-1082033 (Clockwise) Hypothetical 




oligopeptide ABC transporter, substrate-binding 
lipoprotein
630_gi|115249872|




oligopeptide ABC transporter, substrate-binding 
lipoprotein
630_gi|115249872|




oligopeptide ABC transporter, substrate-binding 
protein
630_gi|115251723|




glycine/sarcosine/betaine reductase complex 
component C beta subunit
630_gi|115251404|
emb|CAJ69236.1| 130 55464 5.27
56
% 23
D8 GMP synthase glutamine-hydrolyzing
630_gi|115249206|




glycine/sarcosine/betaine reductase complex 
component C beta subunit
630_gi|115251404|




aegA, 1712608-1714002 (Clockwise) Hypothetical 
Protein aegA (putative glutamate synthase 





emb|CAJ69042.1| 158 48558 5.17
39
% 14
D12 ATP synthase beta chain
630_gi|115252528|
emb|CAJ70371.1| 251 49817 5.18
87
% 32
E1 putative amino acid aminotransferase
630_gi|115252729|
emb|CAJ70573.1| 125 44997 5.12
50
% 18
E2 putative amino acid aminotransferase
630_gi|115252729|
emb|CAJ70573.1| 170 44997 5.12
62
% 29
E3 NAD-specific glutamate dehydrogenase
630_gi|115249189|












emb|CAJ67900.1| 198 41005 5.2
71
% 24
E6 NAD-specific glutamate dehydrogenase
630_gi|115249189|
emb|CAJ67001.1| 106 46271 5.16
44
% 18
E6 putative amino acid aminotransferase
630_gi|115252729|
emb|CAJ70573.1| 88 44997 5.12
51
% 19




hisC, 2820848-2821951 (Clockwise) Hypothetical 
Protein hisC (putative histidinol-phosphate 
aminotransferase) stb_BASYS02725 153 42016 5.09
58
% 17
E8 putative tellurite resistance protein
630_gi|115250680|
emb|CAJ68504.1| 212 43646 5.09
72
% 24
E9 elongation factor Ts
630_gi|115251193|




putative oxidoreductase, thiamine diP-binding 
subunit
630_gi|115249125|









putative oxidoreductase, thiamine diP-binding 
subunit
630_gi|115249125|




subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase
630_gi|115249404|
emb|CAJ67219.1| 200 42966 5.27
71
% 29
F2 electron transfer flavoprotein alpha-subunit
630_gi|115249407|
emb|CAJ67222.1| 202 37353 5.03
55
% 17
F3 electron transfer flavoprotein alpha-subunit
630_gi|115250077|





emb|CAJ69241.1| 128 34471 4.91
48
% 14
F5 ABC transporter, substrate-binding lipoprotein
630_gi|115249887|
emb|CAJ67706.1| 210 36159 5.4
78
% 20
F6 flagellar hook protein
630_gi|115249263|
emb|CAJ67076.1| 147 34568 5.24
56
% 14
F7 putative fructose-bisphosphate aldolase
630_gi|115249409|
emb|CAJ67224.1| 220 33069 5.16
81
% 19
F8 putative O-acetylserine sulfhydrylase
630_gi|115250635|
emb|CAJ68459.1| 143 32816 5.35
60
% 15
F10 nitrilase (carbon-nitrogen hydrolase)
630_gi|115251895|





emb|CAJ70418.1| 107 34548 5.41
50
% 13
G1 electron transfer flavoprotein beta-subunit
630_gi|115249406|












fliY, 2449549-2448746 (CounterClockwise) 
Hypothetical Protein fliY (probable amino-acid 
ABC transporter,substrate-binding protein) stb_BASYS02377 147 30120 5.22
53
% 13
G4 electron transfer flavoprotein beta-subunit
630_gi|115249406|












GTP-sensing transcriptional pleiotropic 
repressor
630_gi|115250309|
emb|CAJ68131.1| 126 28727 5.31
49
% 14
G9 putative sigma 54 modulation protein
630_gi|115251497|




glycine reductase complex component B alpha 
and beta subunits
630_gi|115251407|
emb|CAJ69239.1| 158 46436 4.95
50
% 18
G12 putative subunit of oxidoreductase
630_gi|115249127|




putative dehydrogenase, electron transfer 
subunit
630_gi|115250577|




H3 putative indolepyruvate oxidoreductase subunit
630_gi|115251432|
emb|CAJ69265.1| 82 21020 5.44
52
% 7
H6 putative phosphosugar isomerase
630_gi|115252083|




adhE, 3383815-3381161 (CounterClockwise) 
Hypothetical Protein adhE ( aldehyde-alcohol 
dehydrogenase includes: alcohol dehydrogenase 
and pyruvate-formate-lyase deactivase ) stb_BASYS03189 289 97214 5.63 54 41
I3 chaperone
630_gi|115251074|
emb|CAJ68905.1| 103 97722 5.35 29 23
I6 formate acetyltransferase
630_gi|115249776|
emb|CAJ67593.1| 76 83966 5.36 25 15
I7
pnp, 1460101-1462203 (Clockwise) Hypothetical 
Protein pnp (polyribonucleotide 
nucleotidyltransferase) stb_BASYS01433  75 77769 5.37 19 12
I8 peptidase
630_gi|115251315|
emb|CAJ69146.1| 113 68523 5.14 37 16
I10 threonyl-tRNA synthetase
630_gi|115249589|
emb|CAJ67406.1| 67 73783 5.3 24 12
I11 indolepyruvate oxidoreductase 
630_gi|115251433|





emb|CAJ70309.1| 112 69458 5.25 37 18
J4
putative bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase
630_gi|115249733|
emb|CAJ67550.1| 74 69709 5.5 34 18
J5 putative translation elongation factor
630_gi|115249025|
emb|CAJ66836.1| 61 72577 5.45 32 14
J6 putative translation elongation factor
630_gi|115249025|
emb|CAJ66836.1| 171 72577 5.45 46 27
J7
putative oxidoreductase, acetyl-CoA synthase 
subunit
630_gi|115249184|
emb|CAJ66996.1| 228 69298 5.41 49 32
J8
putative oxidoreductase, acetyl-CoA synthase 
subunit
630_gi|115249184|





emb|CAJ70309.1| 76 69458 5.25 24 14
K1 formate--tetrahydrofolate ligase
630_gi|115249735|
emb|CAJ67552.1| 206 60347 5.61 55 25
K2 formate--tetrahydrofolate ligase
630_gi|115249735|
emb|CAJ67552.1| 92 60347 5.61 38 17
K3 radical SAM-superfamily protein
630_gi|115251209|





emb|CAJ69229.1| 157 51163 5.56 50 21
K5 radical SAM-superfamily protein
630_gi|115251209|
emb|CAJ69040.1| 137 15653 5.56 51 21
K6 glucose-6-phosphate isomerase
630_gi|115252341|
emb|CAJ70182.1| 102 50677 5.48 33 13
K7 tyrosyl-tRNA synthetase
630_gi|115250562|
emb|CAJ68386.1| 194 45703 5.42 51 22
K8 threonine dehydratase catabolic
630_gi|115251567|




emb|CAJ68028.1| 124 43691 5.4 53 18
K10 alanine racemase
630_gi|115252523|
emb|CAJ70366.1| 191 43568 5.41 64 21
K11
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase complex, 
alpha subunit
630_gi|115249743|
emb|CAJ67560.1| 146 50477 5.32 37 16
K12
putative dual-specificity prolyl/cysteinyl-tRNA 
synthetase
630_gi|115249053|
emb|CAJ66864.1| 112 55737 5.29 43 19
K12 inosine-5'-monophosphate dehydrogenase
630_gi|115251390|














emb|CAJ69228.1| 109 55864 5.8 33 12
L5 putative serine hydroxymethyltransferase
630_gi|115251778|
emb|CAJ69613.1| 148 46051 5.67 48 20
L7
iscS, 1418080-1419288 (Clockwise) Hypothetical 
Protein iscS (cysteine desulfurase) stb_BASYS01389 113 44510 5.9 39 14
L8 acyl-CoA dehydrogenase, short-chain specific
630_gi|115249405|
emb|CAJ67220.1| 128 41009 6.41 45 17
L9
caiA, 1012108-1010963 (CounterClockwise) 
Hypothetical Protein caiA (acyl-CoA 
dehydrogenase, short-chain specific) stb_BASYS00979 56 41469 5.88 29 12
L10 cyclopropane-fatty-acyl-phospholipid synthase
630_gi|115249187|
emb|CAJ66999.1| 108 46459 5.9 40 16
acyl-CoA dehydrogenase, short-chain specific
630_gi|115249405|
emb|CAJ67220.1| 89 41009 6.41 31 12
L11 butyryl-CoA dehydrogenase
630_gi|115250075|
emb|CAJ67895.1| 185 41390 5.71 72 23
L12 glyceraldehyde-3-phosphate dehydrogenase 2
630_gi|115252231|
emb|CAJ70071.1| 183 36239 5.72 58 19
M1
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 137 34339 7.82 51 16
M2
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 94 34339 7.82 44 11
M3
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368  110 34339 7.82 44 12
M4
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 84 34339 7.82 47 13
M5
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 70 34339 7.82 47 12
M6
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 133 34339 7.82 47 13
M7
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 126 34339 7.82 55 17
M8
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 114 34339 7.82 51 17
M9
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 99 34339 7.82 47 17
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M10
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 158 34339 7.82 57 21
M11 phosphate butyryltransferase
630_gi|115249121|
emb|CAJ66932.1| 134 32670 5.61 63 19
fliC, 615650-616609 (Clockwise) Hypothetical 
Protein fliC (flagellin subunit) stb_BASYS00368 107 34339 7.82 52 15
M12 3-hydroxybutyryl-CoA dehydrogenase
630_gi|115250079|
emb|CAJ67899.1| 148 30887 5.8 56 14
N1 putative subunit of oxidoreductase
630_gi|115249126|
emb|CAJ66937.1| 130 27031 6.38 59 10
N2
fliC, 349752-348793 (CounterClockwise) 
Hypothetical Protein fliC stb_BASYS00368 87 34339 7.82 42 11
N3 30S ribosomal protein S2
630_gi|115251194|
emb|CAJ69025.1| 93 26940 6.19 50 12
N4
activator of 2-hydroxyisocaproyl-CoA 
dehydratase
630_gi|115249402|
emb|CAJ67217.1| 120 28948 6.35 43 13
N7
BASYS03019, 3175744-3173333 
(CounterClockwise) Hypothetical Protein 
BASYS03019 (cell surface protein (putative cell 
surface-associated cysteine protease)) stb_BASYS03019 152 87454 7.49 34 21
N8 ATP-dependent Clp protease
630_gi|115249029|
emb|CAJ66840.1| 88 91292 8.85 28 20
Strain Tra5/5
Protein ID no A B C D E
A1
BASYS02898, 3050518-3048248 
(CounterClockwise) Hypothetical Protein 
BASYS02898 stt_BASYS02898  57 80379 4.83 34 18
A2
atpA, 3871191-3869689 (CounterClockwise) ATP 
synthase subunit alpha stt_BASYS03613 154 54688 4.91 48 23
A3
ppaC, 409388-407790 (CounterClockwise) 
Probable manganese-dependent inorganic 
pyrophosphatase stt_BASYS00431  70 59668 4.89 31 10
A5
fixB, 450899-451936 (Clockwise) Hypothetical 
Protein fixB (electron transfer flavoprotein 
alpha-subunit) stt_BASYS00466 98 57353 5.03 44 14
A6
ldhA, 443798-442800 (CounterClockwise) 
Hypothetical Protein ldhA (R)-2-
hydroxyisocaproate dehydrogenase) stt_BASYS00458 98 36552 5.07 41 12
A9
tig, 3643244-3641901 (CounterClockwise) 
Hypothetical Protein tig (trigger factor) stt_BASYS03407 82 50540 4.61 35 11
A11
caiA, 448917-450062 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) stt_BASYS00464 113 41469 5.88 46 17
A12
caiA, 448917-450062 (Clockwise) Hypothetical 
Protein caiA stt_BASYS00464 69 41469 5.88 39 12
B1
pyc, 12964-16395 (Clockwise) Pyruvate 
carboxylase stt_BASYS00016 92 129243 5.5 17 18
B2
ydbK, 2906795-2903256 (CounterClockwise) 
Hypothetical Protein ydbK stt_BASYS02779  113 130118 5.39 32 34
B3
ydbK, 2906795-2903256 (CounterClockwise) 
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase0 stt_BASYS02779  143 130118 5.39 29 33
B4
ydbK, 2906795-2903256 (CounterClockwise) 
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase1 stt_BASYS02779 108 130118 5.39 27 27
B5 ydbK, 2906795-2903256 (CounterClockwise) stt_BASYS02779 87 130118 5.39 28 21
233
Hypothetical Protein ydbK (pyruvate-flavodoxin 
oxidoreductase2
B6
tyrB, 2547350-2546091 (CounterClockwise) 
Hypothetical Protein tyrB (putative aspartate 
aminotransferase) stt_BASYS02457 99 47849 5.29 28 13
B8
carB, 3998253-3995047 (CounterClockwise) 
Hypothetical Protein carB stt_BASYS03737 95 120071 4.98 17 16
B9
ileS, 2826892-2823776 (CounterClockwise) 
Hypothetical Protein ileS (isoleucyl-tRNA 
synthetase) stt_BASYS02709 208 120833 5.08 42 35
B12
norV, 1741635-1744166 (Clockwise) Hypothetical 
Protein norV (putative nitric oxide reductase 
flavoprotein) stt_BASYS01695 122 94959 4.92 34 18
C1
pheT, 835717-838110 (Clockwise) Phenylalanyl-
tRNA synthetase beta chain stt_BASYS00839 164 89576 4.87 56 34
C2
fusA, 77070-79136 (Clockwise) Elongation factor 
G stt_BASYS00069 94 76076 4.91 31 15
C3
fusA, 77070-79136 (Clockwise) Elongation factor 
G stt_BASYS00069 174 76076 4.91 51 27
C4
BASYS00871, 876652-878778 (Clockwise) 
Hypothetical Protein BASYS00871 stt_BASYS00871 172 77451 4.69 35 27
C5
infB, 1392980-1394920 (Clockwise) Translation 
initiation factor IF-2 stt_BASYS01361 78 69895 4.76 40 13
C6
dnaK, 2642740-2640893 (CounterClockwise) 
Chaperone protein dnaK stt_BASYS02546 213 66541 4.72 57 26
C7
groL, 204704-206332 (Clockwise) 60 kDa 
chaperonin (60 kDa chaperonin) stt_BASYS00202 230 57735 4.74 62 27
C8
htpG, 289359-291296 (Clockwise) Hypothetical 
Protein htpG (chaperone protein (heat shock 
protein)) stt_BASYS00289 227 75476 4.91 43 25
C9
atpA, 3180789-3179011 (CounterClockwise) V-
type ATP synthase alpha chain stt_BASYS03006 155 65712 4.89 46 23
C10
glyS, 2611727-2609661 (CounterClockwise) 
Hypothetical Protein glyS (glycyl-tRNA 
synthetase beta chain) stt_BASYS02514 95 78493 4.97 32 15
C11
glyS, 2611727-2609661 (CounterClockwise) 
Hypothetical Protein glyS (glycyl-tRNA 
synthetase beta chain) stt_BASYS02514 208 78493 4.97 43 27
D1
BASYS00462, 446522-447754 (Clockwise) 




40 5 40 21
D2 elongation factor TU
630_gi|115249061|
emb|CAJ66872.1| 123 44226 4.94 52 19
D3
rpsA, 1074685-1075959 (Clockwise) Hypothetical 
Protein rpsA (putative 30S ribosomal protein S1) stt_BASYS01053 168 48455 4.98 59 21
D3 elongation factor TU
630_gi|115249061|
emb|CAJ66872.1| 80 44226 4.94 39 13
D4
BASYS02894, 3042534-3040699 
(CounterClockwise) Hypothetical Protein 
BASYS02894 stt_BASYS02894 75 67041 5.14 30 13
D4
aegA, 1647197-1648591 (Clockwise) Hypothetical 
Protein aegA (putative glutamate synthase 
NADPH small chain) stt_BASYS01605  154 50248 5.12 52 18
234
D5
yddS, 2891711-2893306 (Clockwise) Hypothetical 
Protein yddS (oligopeptide ABC transporter, 
substrate-binding protein) stt_BASYS02768  98 58299 5.51 24 11
D6
aegA, 1647197-1648591 (Clockwise) Hypothetical 
Protein aegA (putative glutamate synthase 
NADPH small chain) stt_BASYS01605 100 50248 5.12 30 14
D7
putative dual-specificity prolyl/cysteinyl-tRNA 
synthetase
630_gi|115249053|
emb|CAJ66864.1| 92 49417 5.22 33 16
D8
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase complex, 
dihydrolipoyl dehydrogenase subunit
630_gi|115249740|
emb|CAJ67557.1| 83 50061 5.27 34 14
D8
putative carbon monoxide 




91 50061 5.27 39 14
D9
putative dual-specificity prolyl/cysteinyl-tRNA 
synthetase
630_gi|115249053|
emb|CAJ66864.1| 74 59417 5.22 34 17
D9
atpB, 3179014-3177641 (CounterClockwise) V-
type ATP synthase beta chain stt_BASYS03005 105 50585 5.21 39 12
D10
atpB, 3179014-3177641 (CounterClockwise) V-
type ATP synthase beta chain (V-type sodium 
ATP synthase subunit B) stt_BASYS03005 149 50585 5.21 68 22
D11
atpD, 3868770-3867376 (CounterClockwise) ATP 
synthase subunit beta (ATP synthase beta chain)
630_gi|115252528|
emb|CAJ70371.1| 176 49817 5.18 79 28
D12
atpB, 3179014-3177641 (CounterClockwise) V-
type ATP synthase beta chain
630_gi|115252011|
emb|CAJ69847.1| 109 50585 5.21 61 21
D12 elongation factor TU
630_gi|115249061|
emb|CAJ66872.1| 80 44226 4.94 39 13
E1
yjiR, 4076689-4075493 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino acid 
aminotransferase) stt_BASYS03814 75 44997 5.12 47 17
E2
yjiR, 4076689-4075493 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino acid 
aminotransferase) stt_BASYS03814  138 44997 5.12 61 26
E2
gluD, 189677-190942 (Clockwise) NAD-specific 
glutamate dehydrogenase stt_BASYS00188 60 46271 5.16 45 15
E3
gluD, 189677-190942 (Clockwise) NAD-specific 
glutamate dehydrogenase stt_BASYS00188 113 46271 5.16 57 22
E4
frc, 444475-445674 (Clockwise) Hypothetical 
Protein frc (isocaprenoyl-CoA:2-
hydroxyisocaproate CoA-transferase) stt_BASYS00460 78 44491 5.18 40 12
E5
atoB, 1171926-1173158 (Clockwise) Hypothetical 
Protein atoB (acetyl-CoA acetyltransferase) stt_BASYS01130 92 43350 5.56 54 17
E6
yjiR, 302052-300856 (CounterClockwise) 
Hypothetical Protein yjiR (putative amino acid 
aminotransferase) stt_BASYS03814 137 44997 5.12 58 26
E7
yfbQ, 3096018-3097217 (Clockwise) Hypothetical 
Protein yfbQ (putative aromatic amino acid 
aminotransferase) stt_BASYS02934 189 45056 5.01 63 21
E8
hisC, 2688605-2689708 (Clockwise) Hypothetical 
Protein hisC (putative histidinol-phosphate 
aminotransferase) stt_BASYS02589 96 42016 5.09 46 13
E9
tsf, 2273991-2273080 (CounterClockwise) 
Elongation factor Ts (elongation factor Ts) stt_BASYS02200  96 33290 5.21 52 16
235
E10
BASYS00118, 108979-110058 (Clockwise) 
Hypothetical Protein BASYS00118 (putative 
oxidoreductase, thiamine diP-binding subunit) stt_BASYS00118 119 39290 5.32 71 23
E11
BASYS00118, 108979-110058 (Clockwise) 
Hypothetical Protein BASYS00118 (putative 
oxidoreductase, thiamine diP-binding subunit) stt_BASYS00118 88 39290 5.32 65 16
E12
ackA, 106946-108025 (Clockwise) Hypothetical 
Protein ackA (butyrate kinase) stt_BASYS00115 166 38728 5.34 68 25
F1
atoB, 1171926-1173158 (Clockwise) Hypothetical 
Protein atoB (acetyl-CoA acetyltransferase) stt_BASYS01130 69 43350 5.56 39 14
F2
fixB, 450899-451936 (Clockwise) Hypothetical 
Protein fixB (electron transfer flavoprotein 
alpha-subunit) stt_BASYS00466 153 37353 5.03 43 17
F3
ydiR, 1169127-1170137 (Clockwise) Hypothetical 
Protein ydiR (electron transfer flavoprotein 
alpha-subunit) stt_BASYS01127 101 36221 5.11 48 13
F5
ldhA, 443798-442800 (CounterClockwise) 
Hypothetical Protein ldhA ((R)-2-
hydroxyisocaproate dehydrogenase) stt_BASYS00458  99 36552 5.07 40 12
F6
BASYS02898, 3050518-3048248 
(CounterClockwise) Hypothetical Protein 
BASYS02898 stt_BASYS02898 88 79874 4.79 35 21
F7
agaY, 455111-454185 (CounterClockwise) 
Hypothetical Protein agaY (putative fructose-
bisphosphate aldolase) stt_BASYS00468 90 33053 5.16 78 15
F8
cysM, 1712319-1713227 (Clockwise) 
Hypothetical Protein cysM (putative O-
acetylserine sulfhydrylase) stt_BASYS01663 148 32816 5.35 73 20
F8
BASYS03008, 3182193-3181216 
(CounterClockwise) Hypothetical Protein 
BASYS03008 (V-type sodium ATP synthase 
subunit C) stt_BASYS03008 70 37383 5.42 52 16
F9
cysM, 1712319-1713227 (Clockwise) 
Hypothetical Protein cysM (putative O-
acetylserine sulfhydrylase) stt_BASYS01663 132 32816 5.35 69 17
F10
galU, 2947127-2946183 (CounterClockwise) 
Hypothetical Protein galU stt_BASYS02813 55 35957 6.5 33 9
F11
prs, 3916457-3915507 (CounterClockwise) 
Hypothetical Protein prs (ribose-phosphate 
pyrophosphokinase) stt_BASYS03658 82 34548 5.41 45 9
F12
ycgM, 996287-997189 (Clockwise) Hypothetical 
Protein ycgM (putative hydrolase) stt_BASYS00983 116 33967 5.07 75 15
G1
ydiQ, 450095-450880 (Clockwise) Hypothetical 
Protein ydiQ (electron transfer flavoprotein beta-
subunit) stt_BASYS00465 100 28767 4.87 57 12
G2
metH, 875789-876595 (Clockwise) Hypothetical 
Protein metH (putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex,methyltransferase subunit) stt_BASYS00870  79 29762 4.78 51 14
G3
ydiQ, 450095-450880 (Clockwise) Hypothetical 
Protein ydiQ (electron transfer flavoprotein beta-
subunit) stt_BASYS00465 147 28767 4.87 57 15
G4
paaF, 1170156-1170953 (Clockwise) Hypothetical 
Protein paaF (3-hydroxybutyryl-CoA 
dehydratase) stt_BASYS01128 85 28628 4.97 53 10
G5 BASYS01173, 1213229-1214098 (Clockwise) stt_BASYS01173 98 32880 5.24 56 12
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Hypothetical Protein BASYS01173 
(nitroreductase-family protein)
G6
BASYS00867, 872607-873377 (Clockwise) 
Hypothetical Protein BASYS00867 (putative 
carbon monoxide dehydrogenase/acetyl-CoA 
synthase complex,nickel-inserting subunit) stt_BASYS00867  89 28419 5.22 48 11
G7
BASYS01321, 1356204-1356989 (Clockwise) 
Hypothetical Protein BASYS01321 (GTP-sensing 
transcriptional pleiotropic repressor) stt_BASYS01321 79 28727 5.31 40 8
G8
BASYS01847, 1900865-1901566 (Clockwise) 
Cytoplasmic Protein (conserved hypothetical 
protein) stt_BASYS01847  149 27008 5.16 82 19
G9
yhbH, 2621911-2621330 (CounterClockwise) 
Hypothetical Protein yhbH (putative sigma 54 
modulation protein) stt_BASYS02527 82 22538 5.01 64 8
G11
efp, 1322094-1322666 (Clockwise) Hypothetical 
Protein efp (elongation factor P) stt_BASYS01289  66 21572 4.93 48 7
G12
BASYS00120, 110811-111368 (Clockwise) 
Hypothetical Protein BASYS00120 (putative 
subunit of oxidoreductase) stt_BASYS00120  122 19942 4.97 91 13
H1
BASYS01604, 1646289-1647197 (Clockwise) 
Hypothetical Protein BASYS01604 (putative 
dehydrogenase, electron transfer subunit) stt_BASYS01604 112 33943 5.29 61 16
H2
BASYS00862, 867899-868531 (Clockwise) 
Hypothetical Protein BASYS00862 
(methenyltetrahydrofolate cyclohydrolase) stt_BASYS00862 96 23091 5.33 53 11
H3
BASYS02455, 2544241-2543666 
(CounterClockwise) Hypothetical Protein 
BASYS02455 (putative indolepyruvate 
oxidoreductase subunit) stt_BASYS02455 87 21020 5.44 59 8
H4
tktA, 2483057-2482245 (CounterClockwise) 
Hypothetical Protein tktA (transketolase) stt_BASYS02393 91 29182 5.54 42 8
H7
rplJ, 65691-66221 (Clockwise) Hypothetical 
Protein rplJ (50S ribosomal protein L10) stt_BASYS00061 82 19581 6.2 51 8
H8
BASYS02780, 2907882-2907313 
(CounterClockwise) Propanediol Utilization 
Protein (putative propanediol utilization 
protein) stt_BASYS02780 86 20079 5.97 56 9
H11
BASYS01708, 1757727-1758305 (Clockwise) 
Hypothetical Protein BASYS01708 (tellurium 
resistance protein) stt_BASYS01708  103 21633 4.56 53 9
I1
adhE, 3194458-3191768 (CounterClockwise) 
Hypothetical Protein adhE (aldehyde-alcohol 
dehydrogenase includes: alcohol dehydrogenase 
and pyruvate-formate-lyase deactivase) stt_BASYS03018 150 98613 5.69 40 30
I2
adhE, 3194458-3191768 (CounterClockwise) 
Hypothetical Protein adhE (aldehyde-alcohol 
dehydrogenase includes: alcohol dehydrogenase 
and pyruvate-formate-lyase deactivase) stt_BASYS03018 109 98613 5.69 30 21
I5
leuS, 2716913-2714493 (CounterClockwise) 
Hypothetical Protein leuS (leuS, 3140547-
3138127 (CounterClockwise) Hypothetical 
Protein leuS) stt_BASYS02608 133 92973 5.13 32 21
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I6
pflB, 913824-911593 (CounterClockwise) 
Hypothetical Protein pflB (pflB, 913824-911593 
(CounterClockwise) Hypothetical Protein pflB) stt_BASYS00902 145 83966 5.39 46 29
I7
pflB, 913824-911593 (CounterClockwise) 
Hypothetical Protein pflB (pflB, 913824-911593 
(CounterClockwise) Hypothetical Protein pflB) stt_BASYS00902 209 83966 5.39 57 37
I8
ypdF, 2419026-2417233 (CounterClockwise) 
Hypothetical Protein ypdF (peptidase) stt_BASYS02329 93 68523 5.14 39 13
I9
thrS, 662786-664816 (Clockwise) Hypothetical 
Protein thrS (threonyl-tRNA synthetase) stt_BASYS00693 116 78305 5.42 47 28
I10
thrS, 662786-664816 (Clockwise) Hypothetical 
Protein thrS (threonyl-tRNA synthetase) stt_BASYS00693 84 78305 5.42 29 15
I11
nuoF, 3794945-3796831 (Clockwise) Hypothetical 
Protein nuoF (putative iron-only 
hydrogenase,electron-transferring subunit) stt_BASYS03544 99 69458 5.25 33 18
I12
BASYS02815, 2949551-2947560 
(CounterClockwise) Hypothetical Protein 
BASYS02815 stt_BASYS02815 112 78379 5.33 48 27
J3
BASYS00858, 862861-864780 (Clockwise) 
Hypothetical Protein BASYS00858 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase) stt_BASYS00858 99 69693 5.5 36 20
J4
BASYS00858, 862861-864780 (Clockwise) 
Hypothetical Protein BASYS00858 (putative 
bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase) stt_BASYS00858 123 69693 5.5 42 28
J5
fusA, 16625-18565 (Clockwise) Hypothetical 
Protein fusA (putative translation elongation 
factor) stt_BASYS00017 221 72577 5.45 64 41
J6
fusA, 16625-18565 (Clockwise) Hypothetical 
Protein fusA (putative translation elongation 
factor) stt_BASYS00017 192 72577 5.45 57 36
J7
BASYS00183, 183555-185456 (Clockwise) 
Hypothetical Protein BASYS00183 (putative 
oxidoreductase, acetyl-CoA synthase subunit) stt_BASYS00183 75 69298 5.41 27 16
J8
BASYS00183, 183555-185456 (Clockwise) 
Hypothetical Protein BASYS00183 (putative 
oxidoreductase, acetyl-CoA synthase subunit) stt_BASYS00183 110 69298 5.41 33 20
J9
glmS, 113151-114983 (Clockwise) Hypothetical 
Protein glmS (glucosamine--fructose-6-
phosphate aminotransferase isomerizing) stt_BASYS00122 196 67613 5.2 52 26
J11
BASYS02456, 2546072-2544243 
(CounterClockwise) Hypothetical Protein 
BASYS02456 (indolepyruvate oxidoreductase 
subunit) stt_BASYS02456 102 68911 5.65 43 22
J12
BASYS02896, 3045252-3043381 
(CounterClockwise) Hypothetical Protein 
BASYS02896 (cell surface protein (putative S-
layer protein precursor)) stt_BASYS02896 178 66363 6.47 57 30
K1
BASYS00861, 866100-867794 (Clockwise) 
Hypothetical Protein BASYS00861 (formate--
tetrahydrofolate ligase) stt_BASYS00861 132 60894 5.53 48 24
K2
BASYS00861, 866100-867794 (Clockwise) 
Hypothetical Protein BASYS00861 stt_BASYS00861 129 60894 5.53 49 23
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K3
thiH, 2292548-2293924 (Clockwise) Hypothetical 
Protein thiH (radical SAM-superfamily protein) stt_BASYS02217  55 52653 5.56 44 15
K4
gcvP, 1787909-1789366 (Clockwise) Hypothetical 
Protein gcvP (glycine cleavage system P protein) stt_BASYS01732 92 53820 5.55 46 17
K5
gcvP, 1787909-1789366 (Clockwise) Hypothetical 
Protein gcvP stt_BASYS01732 83 53820 5.55 47 17
K5
glgA, 1043461-1044903 (Clockwise) Hypothetical 
Protein glgA stt_BASYS01026 73 55774 5.5 43 16
K8
tdcB, 2704099-2702858 (CounterClockwise) 
Threonine dehydratase catabolic (threonine 
dehydratase catabolic) stt_BASYS02601 142 44317 5.2 53 19
K9
ackA, 1264632-1265828 (Clockwise) Acetate 
kinase (acetate kinase) stt_BASYS01228 148 43691 5.4 64 20
K10
tyrS2, 1627797-1629005 (Clockwise) Tyrosyl-
tRNA synthetase 2 (tyrosyl-tRNA synthetase) stt_BASYS01589  193 45703 5.42 60 22
K11
lpdA, 871151-872551 (Clockwise) Hypothetical 
Protein lpdA (putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase complex, 
dihydrolipoyl dehydrogenase subunit) stt_BASYS00866 109 50061 5.27 44 12
K12
BASYS00869, 874372-875739 (Clockwise) 
Hypothetical Protein BASYS00869 (putative 
carbon monoxide dehydrogenase/acetyl-CoA 
synthase complex, alpha subunit) stt_BASYS00869 143 50477 5.32 49 17
L1
BASYS02414, 2507063-2505567 
(CounterClockwise) Hypothetical Protein 
BASYS02414 (gamma-aminobutyrate 
metabolism dehydratase/isomerase includes: 4-
hydroxybutyryl-coa dehydratase; vinylacetyl-
coa-delta-isomerase) stt_BASYS02414  94 55864 5.8 36 15
L2
BASYS02414, 2507063-2505567 
(CounterClockwise) Hypothetical Protein 
BASYS02414 (gamma-aminobutyrate 
metabolism dehydratase/isomerase includes: 4-
hydroxybutyryl-coa dehydratase; vinylacetyl-
coa-delta-isomerase) stt_BASYS02414  95 55864 5.8 38 14
L5
glyA, 2963788-2962544 (CounterClockwise) 
Hypothetical Protein glyA (putative serine 
hydroxymethyltransferase) stt_BASYS02828 71 46065 5.67 31 9
L6
iscS, 1359720-1360928 (Clockwise) Hypothetical 
Protein iscS (cysteine desulfurase) stt_BASYS01326 78 44510 5.9 23 9
L7
iscS, 1359720-1360928 (Clockwise) Hypothetical 
Protein iscS (cysteine desulfurase) stt_BASYS01326 138 44510 5.9 58 24
L8
caiA, 448917-450062 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) stt_BASYS00464  149 41469 5.88 69 24
L9
caiA, 448917-450062 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) stt_BASYS00464 102 41469 5.88 50 17
L10
caiA, 448917-450062 (Clockwise) Hypothetical 
Protein caiA (acyl-CoA dehydrogenase, short-
chain specific) stt_BASYS00464 110 41469 5.88 59 19
L10
cfa, 188449-187262 (CounterClockwise) 
Hypothetical Protein cfa (cyclopropane-fatty-
acyl-phospholipid synthase) stt_BASYS00186 80 46517 5.9 47 18
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L11
caiA, 1167131-1168267 (Clockwise) Hypothetical 
Protein caiA (butyryl-CoA dehydrogenase) stt_BASYS01125 140 41390 5.71 55 15
L12
gapC, 3482040-3481033 (CounterClockwise) 
Hypothetical Protein gapC (239lyceraldehydes-
3-phosphate dehydrogenase 2) stt_BASYS03262 176 36239 5.72 57 19
M1
metF, 870169-871122 (Clockwise) 
Methylenetetrahydrofolate Reductase (putative 
methylenetetrahydrofolate reductase) stt_BASYS00865 76 34785 8.9 41 8
M2
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250 89 34339 7.82 41 12
M3
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250  92 34339 7.82 41 10
M4
pta, 861343-862254 (Clockwise) Hypothetical 
Protein pta (putative phosphate 
butyryltransferase) stt_BASYS00857 140 32850 5.76 62 20
M5
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250  83 34339 7.82 41 10
M6
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250 74 34339 7.82 41 10
M7
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250  82 34339 7.82 40 8
M8
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250 87 34339 7.82 51 13
M9
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250 79 34339 7.82 44 11
M10
fliC, 252235-253194 (Clockwise) Hypothetical 
Protein fliC stt_BASYS00250 68 34339 7.82 42 10
M11
pta, 105971-106924 (Clockwise) Hypothetical 
Protein pta (phosphate butyryltransferase) stt_BASYS00114 91 35126 8.35 48 11
M12
pgi, 3620557-3619208 (CounterClockwise) 
Hypothetical Protein pgi stt_BASYS03385  83 50663 5.47 41 13
N1
BASYS00119, 110058-110810 (Clockwise) 
Hypothetical Protein BASYS00119 (putative 
subunit of oxidoreductase0 stt_BASYS00119 50 27031 6.38 38 9
N2
BASYS00119, 110058-110810 (Clockwise) 
Hypothetical Protein BASYS00119 stt_BASYS00119 77 27031 6.38 54 10
N3
rpsB, 2274783-2274070 (CounterClockwise) 30S 
ribosomal protein S2 (30S ribosomal protein S2) stt_BASYS02201 85 26940 6.19 56 11
N4
yjiL, 445704-446513 (Clockwise) Hypothetical 
Protein yjiL (activator of 2-hydroxyisocaproyl-
CoA dehydratase) stt_BASYS00461 118 28948 6.35 51 11
N5
paaH, 1171051-1171896 (Clockwise) 
Hypothetical Protein paaH (3-hydroxybutyryl-
CoA dehydrogenase) stt_BASYS01129 122 30887 5.8 46 14
N6
paaH, 1171051-1171896 (Clockwise) 
Hypothetical Protein paaH stt_BASYS01129 79 30887 5.8 43 9
N7
rnfC, 1226332-1227669 (Clockwise) Hypothetical 
Protein rnfC (electron transport complex 
protein) stt_BASYS01187  82 48962 6.3 38 13
N8
clpB, 21011-23458 (Clockwise) Hypothetical 
Protein clpB (ATP-dependent Clp protease) stt_BASYS00021 188 91292 5.83 48 36
N9
aroA, 1980984-1981985 (Clockwise) Hypothetical 
Protein aroA (3-phosphoshikimate 1-
carboxyvinyltransferase) stt_BASYS01918 99 38093 7.51 42 12
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N10
yjeK, 2408425-2407157 (CounterClockwise) 
Hypothetical Protein yjeK (L-lysine 2,3-
aminomutase) stt_BASYS02321 92 49419 6.08 37 16
N11
kdsA, 1978885-1979898 (Clockwise) 
Hypothetical Protein kdsA (v0 stt_BASYS01916 117 36868 6.15 59 17
N12
BASYS00868, 873397-874341 (Clockwise) 
Hypothetical Protein BASYS00868 (putative 
carbon monoxide dehydrogenase/acetyl-CoA 
synthase complex, small subunit) stt_BASYS00868  127 34041 4.77 75 16
R1
BASYS00860, 865090-865869 (Clockwise) 
Hypothetical Protein BASYS00860 (putative 
carbon monoxide dehydrogenase accessory 
protein) stt_BASYS00860 79 28728 5.69 50 11
R3
ydiA, 2586352-2585510 (CounterClockwise) 
Putative phosphotransferase CD2411 (conserved 
hypothetical protein) stt_BASYS02492 136 32006 5.95 74 23
R5
ydiB, 1984601-1985410 (Clockwise) Hypothetical 
Protein ydiB (shikimate dehydrogenase) stt_BASYS01922  135 30246 6.34 59 12
R6
spo0A, 1301769-1302593 (Clockwise) Stage 0 
sporulation protein A homolog stt_BASYS01268 104 30888 6.33 64 12
R8
paaH, 1171051-1171896 (Clockwise) 
Hypothetical Protein paaH (3-hydroxybutyryl-
CoA dehydrogenase)
630_gi|115250247|
emb|CAJ68068.1| 96 30887 5.8 43 11
R9
caiA, 1167131-1168267 (Clockwise) Hypothetical 
Protein caiA (butyryl-CoA dehydrogenase) stt_BASYS01125  150 41390 5.71 72 21
R10
ATIC, 997288-998463 (Clockwise) Bifunctional 
purine biosynthesis protein PURH (putative 




serS, 1987-3258 (Clockwise) Hypothetical Protein 
serS (v0 stt_BASYS00003 101 48781 5.68 43 15
R12
ygfH, 2505133-2503826 (CounterClockwise) 
Hypothetical Protein ygfH (4-hydroxybutyrate 
CoA transferase) stt_BASYS02412  116 48257 5.6 50 20
P1
BASYS00861, 866100-867794 (Clockwise) 
Hypothetical Protein BASYS00861 (formate--
tetrahydrofolate ligase) stt_BASYS00861 115 60894 5.53 41 19
P2
folD, 868623-869495 (Clockwise) Bifunctional 
protein folD (putative FolD bifunctional protein 
includes: methylenetetrahydrofolate 
dehydrogenase; methenyltetrahydrofolate 
cyclohydrolase) stt_BASYS00863 81 31610 5.67 36 10
P4
BASYS02896, 3045252-3043381 
(CounterClockwise) Hypothetical Protein 
BASYS02896 (v0 stt_BASYS02896  69 66363 6.47 28 12
P6
secA, 3048012-3045667 (CounterClockwise) 
Hypothetical Protein secA (preprotein 
translocase SecA subunit) stt_BASYS02897 120 89352 5.68 31 22
P10
lysS, 3955558-3954029 (CounterClockwise) 
Lysyl-tRNA synthetase (lysyl-tRNA synthetase) stt_BASYS03698 50 58539 5.12 28 10
P12
ackA, 2543613-2542543 (CounterClockwise) 
Hypothetical Protein ackA (butyrate kinase) stt_BASYS02454 86 38869 5.29 35 10
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Table A2 – Proteins identified by 1D GE followed by LC-MS/MS analysis with 
identification number, predicted mass and number of unique peptides detected for each 
strain. The number of proteins of different types are show as follows; metabolic (M), 




No. unique peptides 
A B-1 Tra5/5
1 2 1 2 1 2
All strains – 332 proteins M = 207, s/v = 18, h = 24, R = 42, t= 12, r = 29





(CounterClockwise) Hypothetical Protein 
ydbK
pyruvate-flavodoxin oxidoreductase
630_gi|115251733 129 28 21 22 19 17 19
stb_BASYS02909




(CounterClockwise) Hypothetical Protein 
BASYS00732
(toxin A)
BASYS00995, 1036085-1040797 (Clockwise) 
Hypothetical Protein BASYS00995 (toxin 
A)
stb_BASYS00732
(115249677) 308 41 16 34 39 0 3
sta_BASYS00995 
(115249677) 178 4 3 0 1 0 0
5
acyl-CoA dehydrogenase, short-chain 
specific 630_gi|115249405 41 13 10 11 13 9 8
6
fliC, 615650-616609 (Clockwise) 
Hypothetical Protein fliC sta_BASYS00598 34 19 11 17 15 5 4
7 elongation factor TU 630_gi|115249061 44 12 8 11 11 7 8
8
ABC transporter, substrate-binding 
lipoprotein 630_gi|115249887 36 15 11 12 10 3 4
9 putative translation elongation factor 630_gi|115249025 72 16 14 16 16 13 12
10 putative amino acid aminotransferase 630_gi|115252729 45 15 8 10 10 7 8
11
electron transfer flavoprotein alpha-
subunit 630_gi|115249407 37 14 11 12 9 6 5
12 putative rubrerythrin 630_gi|115250565 20 12 4 5 4 3 3
13




(115249735) 61 14 10 10 13 12 11
14
activator of 2-hydroxyisocaproyl-CoA 
dehydratase 630_gi|115249402 29 9 9 9 9 9 8
16
DNA-directed RNA polymerase beta 
chain 630_gi|115249070 139 16 13 17 18 14 12
17 50S ribosomal protein L5 630_gi|115249089 20 11 8 10 10 5 11
18 acetyl-CoA acetyltransferase 630_gi|115250080 41 15 13 8 9 6 9
19 NAD-specific glutamate dehydrogenase 630_gi|115249189 46 10 7 11 8 10 8
20
putative oxidoreductase, thiamine diP-
binding subunit 630_gi|115249125 39 8 6 4 5 3 5
21
pyc, 12964-16395 (Clockwise) Pyruvate 
carboxylase stt_BASYS00016 129 18 12 10 13 12 11
22 ATP synthase alpha chain 630_gi|115252530 55 11 12 10 11 7 8
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23 3-hydroxybutyryl-CoA dehydrogenase 630_gi|115250079 31 11 6 7 7 5 7
24
groL, 567992-569620 (Clockwise) 
Hypothetical Protein groL sta_BASYS00550 58 15 12 10 11 6 8
25 electron transfer flavoprotein beta-subunit 630_gi|115250076 29 13 8 10 10 9 9
26
putative bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase 630_gi|115249733 69 12 10 5 6 10 10
27
adhE, 3383815-3381161 




(115252023) 97 6 6 11 11 11 10
29
subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase 630_gi|115249404 42 6 5 8 8 8 8
30
BASYS02833, 2973699-2971870 




(115251433) 68 12 9 10 12 8 9
31 30S ribosomal protein S7 630_gi|115249073 18 9 5 9 6 6 5
32 30S ribosomal protein S10 630_gi|115249076 12 5 2 5 5 4 1
34
atpD, 3370184-3368406 
(CounterClockwise) Hypothetical Protein 
atpD
(V-type ATP synthase subunit A)
stb_BASYS03178
(115452012) 66 9 8 8 9 9 9
35
glyceraldehyde-3-phosphate 
dehydrogenase 2 630_gi|115252231 36 8 5 6 3 5 4
36 isoleucyl-tRNA synthetase 630_gi|115251669 120 16 8 7 8 8 8
37
putative oxidoreductase, acetyl-CoA 
synthase subunit 630_gi|115249184 68 9 5 11 13 6 8
38
putative dehydrogenase, electron transfer 
subunit 630_gi|115250577 33 9 4 8 10 7 8
39
427
putative glutamate synthase NADPH 
small chain
aegA, 1953842-1955236 (Clockwise) 
Hypothetical Protein aegA
putative oxidoreductase
630_gi|115250578 50 6 5 9 8 8 8
sta_BASYS01860
(115250578) 50 2 2 0 0 0 0
40
cell surface protein (putative penicillin-
binding protein) 630_gi|115250510 111 11 16 7 6 3 3
41 formate acetyltransferase 630_gi|115249776 84 8 9 10 9 10 8
42 30S ribosomal protein S2 630_gi|115251194 27 6 5 7 5 5 6
43 (R)-2-hydroxyisocaproate dehydrogenase 630_gi|115249400 37 11 6 7 3 3 3
44 chaperone protein 630_gi|115251515 66 4 3 3 3 4 2
45
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex,methyltransferase subunit 630_gi|115249744 29 8 8 7 6 9 7
46 ATP synthase beta chain 630_gi|115252528 50 10 10 12 11 5 9
47 translation elongation factor G 630_gi|115249074 76 13 8 7 9 6 6
48 butyryl-CoA dehydrogenase 630_gi|115250075 41 8 7 5 4 7 4
49 putative calcium-transporting ATPase 630_gi|115250678 101 13 6 10 13 1 7
50
glycine reductase complex component B 
alpha and beta subunits 630_gi|115251407 46 7 4 10 10 1 1
51 flagellin subunit 630_gi|115249247 31 1 1 2 2 1 1
52
oligopeptide ABC transporter, substrate-





Utilization Protein sta_BASYS03154 20 8 5 4 6 2 3
54
rpsH, 87631-88029 (Clockwise) 30S 
ribosomal protein S8 stt_BASYS00086 15 5 5 4 5 3 1
55
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, alpha subunit 630_gi|115249743 50 5 3 4 4 5 5
56
carbamoyl-phosphate 
synthase,pyrimidine-specific, large chain 630_gi|115252654 119 8 5 12 12 8 7
57
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, beta subunit 630_gi|115249745 77 9 8 3 4 8 7
58
454
ptsG, 3311616-3309544 (counter clockwise) 
Hypothetical protein ptsG (PTS system, 
glucose specific IIBC component)
ptsG, 3012861-3010912 
(CounterClockwise) Hypothetical Protein 
ptsG
PTS system, glucose-specific IIbc 
component
sta_BASYS03136
(115251718) 75 5 1 5 6 2 4
stb_BASYS02893
(115251718) 70 0 0 1 1 0 0
60
proS2, 53161-54693 (Clockwise) Prolyl-
tRNA synthetase 2 stt_BASYS00046 59 3 6 3 6 7 9
61 30S ribosomal protein S5 630_gi|115249094 18 6 3 6 5 1 5
62 50S ribosomal protein L4 630_gi|115249078 24 9 2 4 6 2 3
63 putative universal stress protein 630_gi|115249829 15 8 2 7 5 5 0
64 enolase 630_gi|115252227 46 6 6 4 6 4 4
65
BASYS02800, 2945591-2944029 
(CounterClockwise) Hypothetical Protein 
BASYS02800
(glycine/sarcosine/betaine reductase 
complex component C beta subunit)
sta_BASYS02800
(115251404) 56 4 4 6 7 4 4
66 preprotein translocase SecA subunit 630_gi|115249152 102 8 8 3 6 9 8
67
GTP-sensing transcriptional pleiotropic 
repressor 630_gi|115250309 29 5 4 6 6 5 4
68 50S ribosomal protein L9 630_gi|115252722 17 7 4 7 5 1 3
70
putative bi-functional glycine 
dehydrogenase/aminomethyl transferase 
protein 630_gi|115250698 92 11 4 2 4 8 9
71
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, dihydrolipoyl dehydrogenase 
subunit 630_gi|115249740 49 6 9 4 4 6 11
72 proline reductase subunit proprotein 630_gi|115252300 68 6 3 4 7 3 4
73 butyrate kinase 630_gi|115249122 39 7 8 7 5 3 3
74 cell surface protein 630_gi|115251820 78 8 5 6 8 1 1
75
oligopeptide ABC transporter, substrate-
binding protein 630_gi|115251723 58 6 5 6 10 2 3
76 cysteine desulfurase 630_gi|115250313 44 6 2 2 5 4 4
77
putative iron-only hydrogenase, catalytic 
subunit 630_gi|115252467 65 6 8 6 6 5 5
78
DNA-directed RNA polymerase beta' 
chain 630_gi|115249071 130 9 6 6 7 5 4
79 putative subunit of oxidoreductase 630_gi|115249127 20 5 4 2 6 3 3
80 AsnC-family transcriptional regulator 630_gi|115252605 16 7 6 5 6 3 2





reductase 630_gi|115249739 32 7 5 2 4 6 6
83 putative alanyl-tRNA synthetase 630_gi|115250316 98 6 3 5 6 6 6
84 ribose-phosphate pyrophosphokinase 630_gi|115252575 34 10 3 4 4 3 4
85 50S ribosomal protein L13 630_gi|115249112 16 4 1 3 2 1 2
86





(115249401) 44 8 3 4 4 4 2
87
putative aliphatic sulfonates ABC 
transporter,substrate-binding lipoprotein 630_gi|115250525 36 5 7 6 4 2 2
90 butyrate kinase 630_gi|115251431 39 9 5 5 5 4 3
91 putative O-acetylserine sulfhydrylase 630_gi|115250635 33 9 4 4 3 3 4
92 putative formate acetyltransferase 630_gi|115252338 89 8 4 0 1 4 5
94 threonine dehydratase catabolic 630_gi|115251567 43 5 4 2 2 6 6
95 50S ribosomal protein L10 630_gi|115249067 19 7 3 6 3 2 2
96 30S ribosomal protein S3 630_gi|115249083 30 4 2 4 4 3 3
97 stage 0 sporulation protein A 630_gi|115250247 31 6 2 5 3 2 3
98 50S ribosomal protein L21 630_gi|115250193 11 4 1 3 3 2 1
99
electron transfer flavoprotein alpha-
subunit 630_gi|115250077 36 6 4 5 5 3 1




pepD, 849602-848151 (CounterClockwise) 
Hypothetical Protein pepD
putative aminoacyl-histidine
630_gi|115249724 53 4 3 6 2 5 5
stt_BASYS00847
(115249724) 53 0 0 0 0 1 1
102 chaperone protein (heat shock protein) 630_gi|115249282 75 5 2 4 8 3 6
103 putative fructose-bisphosphate aldolase 630_gi|115249409 33 5 2 5 4 2 3
104 ATP-dependent Clp protease 630_gi|115249029 91 9 4 3 1 5 5
105
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex,nickel-inserting subunit 630_gi|115249741 28 5 2 4 4 3 3
106 10  chaperonin 630_gi|115249203 10 5 2 5 6 2 0
107 tellurium resistance protein 630_gi|115250676 22 4 4 3 4 3 3
108 leucyl-tRNA synthetase 630_gi|115251575 92 4 2 1 0 7 9
109 putative membrane protein 630_gi|115249895 39 2 2 3 3 2 3
110 cell surface protein 630_gi|115251837 73 9 7 5 3 1 3
111 DNA-binding protein HU 630_gi|115252557 10 2 3 3 2 3 0
112
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, small subunit 630_gi|115249742 34 9 3 4 4 2 0
113
norV, 2106146-2108677 (Clockwise) 
Hypothetical Protein norV
(putative nitric oxide reductase 
flavoprotein)
sta_BASYS02024
(115250664) 94 3 3 6 6 4 2
114
ATP-dependent Clp protease proteolytic 




(CounterClockwise) Hypothetical Protein 
BASYS03019
(cell surface protein (putative cell surface-
associated cysteine protease)
cell surface protein (putative cell surface-
associated cysteine protease)
stb_BASYS03019
(115251840) 87 5 3 4 7 0 1
630_gi|115251840 87 2 2 0 0 0 0
116 30S ribosomal protein S4 630_gi|115249105 24 4 2 3 4 3 4
117 putative phage-related cell wall hydrolase 630_gi|115250945 29 3 3 4 3 1 2
245
(endolysin)
118 putative phosphate butyryltransferase 630_gi|115249732 33 8 3 5 4 2 3
119 putative tellurite resistance protein 630_gi|115250680 44 3 2 4 5 4 4
120 phosphate butyryltransferase 630_gi|115249121 32 6 3 3 3 2 3
121
(CounterClockwise) Hypothetical Protein 
rho
(transcription termination factor Rho) 115252548 61 3 3 2 3 4 3
122 NifU-like protein 630_gi|115250314 16 4 4 4 3 2 1
123 50S ribosomal protein L15 630_gi|115249096 16 1 2 2 1 2 2
124 30S ribosomal protein S13 630_gi|115249103 14 1 1 3 2 2 0
126
putative histidinol-phosphate 
aminotransferase 630_gi|115251555 42 3 3 5 3 3 3
127 4-hydroxybutyrate CoA transferase 630_gi|115251394 48 5 5 3 3 2 2
128 putative ATP/GTP-binding protein 630_gi|115249123 25 5 2 4 5 3 2
129 30S ribosomal protein S9 630_gi|115249113 15 2 2 2 4 2 1
130




(115252362) 51 2 3 3 3 4 4
131 electron transport complex protein 630_gi|115250173 34 3 2 3 3 2 3
132 peptidyl-prolyl cis-trans isomerase 630_gi|115249340 19 3 3 3 3 2 3
133 putative transcriptional regulator 630_gi|115250535 23 2 2 2 2 2 2
134 putative RNA-binding protein 630_gi|115249151 21 5 2 3 4 2 1
135




(115249604) 79 8 3 1 3 1 6
136
glucosamine--fructose-6-phosphate 
aminotransferase isomerizing 630_gi|115249129 67 4 2 2 3 3 3
138
pheT, 835717-838110 (Clockwise) 
Phenylalanyl-tRNA synthetase beta chain stt_BASYS00839 89 2 2 2 4 5 5
139 rubrerythrin 630_gi|115249842 21 5 2 3 2 2 2
140 3-hydroxybutyryl-CoA dehydratase 630_gi|115250078 28 5 2 2 2 2 3
141 proline reductase 630_gi|115252298 26 4 2 4 4 2 2
142
putative carbon monoxide dehydrogenase 
accessory protein 630_gi|115249734 29 2 3 2 0 3 4
143
ppiC, 1744732-1743947 




(115250393) 30 2 0 8 7 1 0
144




(115251376) 35 5 1 3 3 3 3
145 dihydrodipicolinate synthase 630_gi|115252280 32 6 2 4 4 2 1
146 anti-sigma F factor 630_gi|115249788 16 3 2 5 4 2 0
147 nitroreductase-family protein 630_gi|115250155 33 3 1 3 4 5 2
148 50S ribosomal protein L6 630_gi|115249092 20 2 2 2 4 1 2
149 V-type sodium ATP synthase subunit B 630_gi|115252011 51 4 3 4 3 1 3
150
succinate-semialdehyde dehydrogenase 
NAD(P)+ 630_gi|115251397 51 2 3 2 0 3 4
152
803





(115251074) 98 4 2 3 3 4 5
630_gi|115251074 98 0 0 0 1 0 0
153 DNA gyrase subunit A 630_gi|115249009 91 4 2 1 4 3 5
154
formylglycinamidine ribonucleotide 
synthetase 630_gi|115249233 141 7 4 3 4 1 1
155 shikimate kinase 630_gi|115250884 20 4 1 4 4 1 3
156 aspartate aminotransferase 630_gi|115250375 45 7 3 2 0 4 1
246
157 conserved hypothetical protein 630_gi|115252525 17 4 3 3 4 1 0
158




(115249907) 56 0 1 2 5 5 4
159 thioredoxin reductase 630_gi|115251409 34 3 2 4 4 1 1





vinylacetyl-coa-delta-isomerase 630_gi|115251396 55 4 3 4 4 0 1
162 conserved hypothetical protein 630_gi|115251617 13 4 1 2 4 1 0
163
carbamoyl-phosphate 
synthase,pyrimidine-specific, large chain 630_gi|115252652 119 4 3 3 2 3 3
164 conserved hypothetical protein 630_gi|115250810 27 2 2 1 2 3 3
165 50S ribosomal protein L14 630_gi|115249087 13 3 1 3 3 2 0
169
manganese-dependent inorganic 
pyrophosphatase 630_gi|115249342 59 4 3 2 4 3 2
170 triosephosphate isomerase 630_gi|115252229 27 2 2 3 3 0 4
171
rubredoxin oxidoreductase 
(desulfoferrodoxin) 630_gi|115249844 14 3 2 2 2 2 0
172
BASYS00303, 304111-304506 (Clockwise) 
NimC/NimA Family Protein stt_BASYS00303 15 3 1 1 2 1 0
173 conserved hypothetical protein 630_gi|115249812 26 1 2 2 2 3 1
174 electron transport complex protein 630_gi|115250168 48 2 1 1 1 3 2
175 cell surface protein 630_gi|115250068 37 4 5 1 3 3 1
176
2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N-succinyltransferase 630_gi|115252284 25 0 3 2 3 4 4
177




(115250279) 22 3 2 1 2 0 2
178 putative alanine racemase 630_gi|115251674 27 2 1 2 4 2 2
179




(115249561) 24 2 2 3 2 1 2
180
valS, 4034578-4031912 (CounterClockwise) 
Valyl-tRNA synthetase sta_BASYS03755 103 2 3 0 1 3 3
181 lysyl-tRNA synthetase 630_gi|115252615 58 2 2 2 2 3 3
182 putative phosphatase 630_gi|115251616 60 3 2 2 2 2 1
183





(115250793) 44 2 2 2 1 1 2
184 putative nitroreductase 630_gi|115251628 25 6 2 1 2 1 1
185 uracil phosphoribosyltransferase 630_gi|115252539 23 4 1 1 3 1 1
186
norV, 1245992-1244799 
(CounterClockwise) Hypothetical Protein 
norV
(putative anaerobic nitric oxide reductase 
flavorubredoxin)
stt_BASYS01207
(115250189) 45 1 1 1 1 1 1
187 putative cold shock protein 630_gi|115250391 7 1 1 1 1 1 1
189 ABC transporter, ATP-binding protein 630_gi|115249888 28 6 1 3 3 1 2
190 translation initiation factor IF-2 630_gi|115250345 70 5 1 1 4 1 1
191 conserved hypothetical protein 630_gi|115251463 32 4 0 4 4 2 2
192
rpsK, 94194-94592 (Clockwise) 30S 
ribosomal protein S11 stt_BASYS00099 14 2 2 3 2 2 0
193 ATP synthase B chain 630_gi|115252532 20 3 1 2 2 1 0








(115252371) 20 3 1 4 5 1 2
196 ribulose-phosphate 3-epimerase 630_gi|115251631 24 2 3 3 2 1 3
197 V-type sodium ATP synthase subunit E 630_gi|115252015 21 5 2 2 2 1 1
BASYS01064, 1123843-1124475 
(Clockwise) Hypothetical Protein 
BASYS01064
(methenyltetrahydrofolate cyclohydrolase) sta_BASYS01064
(115249736) 23 8 1 1 1 1 1
199 V-type sodium ATP synthase subunit K 630_gi|115252016 16 2 1 1 1 1 1
200 peptidase 630_gi|115251315 68 3 3 2 2 2 0
201
putative indolepyruvate oxidoreductase 
subunit 630_gi|115251432 21 4 2 3 2 1 0
202 putative ATP-binding protein 630_gi|115250774 29 3 0 3 3 1 1
203 putative membrane protein 630_gi|115249537 42 1 1 1 1 1 1
204





(115249069) 28 0 2 5 5 1 1
207 dihydrodipicolinate synthase 630_gi|115252282 32 3 2 3 2 2 3
208 LysR-family transcriptional regulator 630_gi|115250103 35 2 3 2 2 3 3
209 methionyl-tRNA synthetase 630_gi|115252601 74 4 2 1 2 2 1
210 elongation factor Ts 630_gi|115251193 33 5 2 0 1 1 2
211 putative membrane protein 630_gi|115250814 41 3 1 2 3 0 2
212
minD, 1239260-1240057 (Clockwise) 
Hypothetical Protein mind
septum site-determining protein (cell 
division inhibitor)
stt_BASYS01200
(115250182) 29 3 1 3 3 1 2
213
rplA, 64794-65492 (Clockwise) 
Hypothetical Protein rplA
(50S ribosomal protein L1)
stt_BASYS00060
(115249066) 25 2 1 2 2 3 1
214
putative ABC transporter, permease
protein 630_gi|115250570 45 4 2 2 1 0 3
216 glycogen synthase 630_gi|115249898 56 2 2 2 2 2 2
217
BASYS02493, 2586997-2586359 
(CounterClockwise) CBS Domain Protein
(Conserved hypothetical protein)
stt_BASYS02493
(115251464) 23 2 2 2 2 1 2
218 GMP synthase glutamine-hydrolyzing 630_gi|115249206 57 4 2 1 3 1 1
219 polyribonucleotide nucleotidyltransferase 630_gi|115250354 78 4 2 1 2 1 1
220
pip, 3469683-3468751 (CounterClockwise) 
Proline iminopeptidase stb_BASYS03264 36 2 1 3 3 3 1
221 ribose-5-phosphate isomerase 2 630_gi|115252540 16 2 2 2 2 3 0
223 acetate kinase 630_gi|115250207 43 3 2 1 1 2 2
224





(115249116) 89 2 2 1 4 1 2
248
225




(115250064) 137 3 2 2 3 1 3
226





(115251808) 63 1 1 1 1 1 3
227
metallo beta-lactamase superfamily 
protein 630_gi|115250323 62 3 1 0 3 2 3
228 heat shock protein 630_gi|115251516 24 2 0 4 3 1 3
229 shikimate dehydrogenase 630_gi|115250883 30 1 0 2 3 2 3
234 tyrosyl-tRNA synthetase 630_gi|115250562 46 2 2 2 1 3 2
235 putative cyclase 630_gi|115251016 24 4 1 3 2 1 2
236
fliY, 2754011-2753208 (CounterClockwise) 
Hypothetical Protein fliY
(probable amino-acid ABC transporter, 
substrate-binding protein
sta_BASYS02640
(115251230) 30 2 2 2 2 1 1
237
probable amino-acid ABC 
transporter,substrate-binding protein 630_gi|115251227 29 1 1 2 4 2 4
238
ATP-dependent Clp protease ATP-binding 
subunit 630_gi|115252360 46 1 1 2 2 3 3
239 putative surface protein 630_gi|115251769 98 3 1 3 3 0 2
240 ATP synthase subunit gamma 630_gi|115252529 32 1 1 3 4 2 0
241




(115250515) 20 3 1 1 1 1 0
243 transcription antitermination protein 630_gi|115249064 20 3 1 3 2 2 2
244 30S ribosomal protein S19 630_gi|115249081 11 2 1 2 2 1 1
245 S-adenosylmethionine synthetase 630_gi|115249139 44 1 1 1 1 2 2
246
UTP--glucose-1-phosphate 
uridylyltransferase 630_gi|115251766 33 2 1 3 3 1 1
247
UDP-N-acetylenolpyruvoylglucosamine 
reductase 630_gi|115252462 33 1 1 2 2 1 1
248 pyruvate kinase 630_gi|115252454 63 3 1 1 2 1 1
249 cell-division initiation protein 630_gi|115251670 20 1 0 4 5 1 1
250 electron transfer flavoprotein beta-subunit 630_gi|115249821 29 1 1 1 1 1 1
251 ferritin 630_gi|115251248 20 1 1 1 1 1 1
252 putative membrane protein 630_gi|115249847 43 3 1 2 2 0 1
253 putative membrane protein 630_gi|115249032 40 3 1 1 2 0 1
256
BASYS00309, 303323-302691 
(CounterClockwise) Hypothetical Protein 
PG
(conserved hypothetical protein-selenium 
metabolism protein YedF
sta_BASYS00309
(115252732) 23 1 2 2 2 1 2
257 4-aminobutyrate aminotransferase 630_gi|115251211 48 3 1 2 2 1 1
258
transketolase, thiamine disphosphate-
binding subunit 630_gi|115252520 30 1 1 3 1 1 1
259 excinuclease ABC subunit A 630_gi|115252471 105 3 4 0 1 2 2
260 putative cytosine permease 630_gi|115251790 45 2 1 3 3 0 1
261




(115250215) 27 1 1 2 2 0 1
262 50S ribosomal protein L20 630_gi|115249703 13 2 0 3 2 2 0
263 putative DNA-binding protein 630_gi|115249180 23 4 1 2 1 0 1
264
BASYS00438, 424036-418979 
(CounterClockwise) Hypothetical Protein 
stt_BASYS00438




266 DNA mismatch repair protein 630_gi|115251023 109 2 2 1 2 2 2
267 orotate phosphoribosyltransferase 630_gi|115249197 21 2 1 3 2 1 2
268 SpoIIIJ-associated protein 630_gi|115252741 24 2 1 2 2 1 1
269
putative imidazole glycerol phosphate 
synthase subunit 630_gi|115250592 23 2 1 2 2 1 1







(115250794) 27 4 1 0 1 2 2
272 putative 30S ribosomal protein S1 630_gi|115250007 48 0 1 1 2 1 5
273
sigma-54-dependent transcriptional 
regulator 630_gi|115249408 63 0 1 3 3 1 0
274 threonyl-tRNA synthetase 630_gi|115249589 74 2 0 0 2 1 3
275 50S ribosomal protein L24 630_gi|115249088 11 1 1 1 1 1 0
276 50S ribosomal protein L3 630_gi|115249077 22 1 0 3 2 0 3
283
glycine reductase complex component B 
gamma subunit 630_gi|115251405 47 1 1 2 2 1 1
284
putative iron-only hydrogenase,electron-
transferring subunit 630_gi|115252466 68 4 1 0 2 1 1
285 putative tRNA binding protein 630_gi|115251499 17 1 1 1 1 1 1
287 cell division protein 630_gi|115251697 41 1 1 1 1 1 1
288
yjiY, 2940632-2939211 (CounterClockwise) 
Hypothetical Protein yjiY
(putative carbon starvation protein)
stb_BASYS02828
(115251657) 51 1 1 2 3 0 1
289
biotin carboxyl carrier protein of acetyl-
CoA carboxylase 630_gi|115250985 17 2 1 1 1 0 1
290 pyruvate, phosphate dikinase 630_gi|115251462 97 1 0 0 1 4 3
296 DNA polymerase I 630_gi|115250159 101 2 1 1 1 1 1
297 uridylate kinase 630_gi|115251192 26 2 1 1 1 1 1
298 UDP-glucose 4-epimerase 630_gi|115251765 37 2 2 2 1 0 1
299 V-type sodium ATP synthase subunit D 630_gi|115252010 26 1 1 2 1 0 2
300
putative homocysteine S-
methyltransferase 630_gi|115252660 87 0 1 2 1 3 4




imidazole-4-carboxamide isomerase 630_gi|115250593 27 2 1 1 1 1 0
303 ferredoxin 630_gi|115252670 6 1 1 1 1 1 0
93 ferredoxin 630_gi|115249124 8 3 5 5 1 0 0
727
BASYS01993, 2078571-2078759 (Clockwise) 
Hypothetical Protein BASYS01993
ferredoxin [Clostridium difficile QCD-
23m63 sta_BASYS01993 7 1 0 0 0 0 0
308 two-component response regulator 630_gi|115251774 27 1 1 2 1 1 1
309 ABC transporter, ATP-binding protein 630_gi|115251122 62 1 1 1 0 3 1









(115252582) 42 1 3 1 1 1 1
630_gi|115252582 40 0 0 0 0 0 1
321
BASYS00366, 346535-344658 
(CounterClockwise) Glycosyltransferase stb_BASYS00366 72 1 1 1 2 1 1
322 rimM, 1332629-1333144 (Clockwise) stt_BASYS01299 20 2 1 2 2 1 0
250
Hypothetical Protein rimM
(putative 16S rRNA-processing protein)
(115250289)
323 NH3-dependent NAD(+) synthetase 630_gi|115249811 28 2 1 1 1 0 2
324 translation initiation factor IF-3 630_gi|115249701 19 1 2 0 2 1 2
325 cell division protein 630_gi|115252622 74 2 1 2 1 0 1
326




(115252357) 89 1 1 0 1 1 2
327
putative NAD-dependent deacetylase 
(Sir2-family regulatory) 630_gi|115250338 27 1 0 2 1 1 1
328 putative NUDIX-family hydrolase 630_gi|115249807 17 1 1 1 1 1 0
329 imidazoleglycerol-phosphate dehydratase 630_gi|115250591 22 1 1 1 1 0 1
330 conserved hypothetical protein 630_gi|115250439 23 3 0 1 3 0 1
332
putative glycine cleavage system H 
protein 630_gi|115249746 14 0 2 2 1 2 0
333 putative membrane protein 630_gi|115251110 63 3 1 1 1 0 1
335 putative aldose epimerase 630_gi|115252500 34 1 0 2 2 1 0
340
putative exported carboxy-terminal 
processing protease 630_gi|115252515 42 1 0 1 0 1 0
346
UDP-N-acetylmuramoylalanine--D-
glutamate ligase 630_gi|115251704 50 2 1 1 1 1 1
347
eutG, 2503854-2502688 





(115250967) 44 1 1 1 1 1 1
348 ABC transporter, ATP-binding protein 630_gi|115249802 59 1 1 2 1 0 1
349 conserved hypothetical protein 630_gi|115250191 27 1 1 1 2 1 1
350 hypothetical protein 630_gi|115251768 78 1 1 0 1 2 1
351 putative transaldolase 630_gi|115251384 23 1 1 1 1 0 1
353 conserved hypothetical protein 630_gi|115252075 17 1 1 1 1 1 0
354
putative translation inhibitor 
endoribonuclease 630_gi|115251566 14 2 0 1 1 1 0
359
DNA-directed RNA polymerase alpha 
chain 630_gi|115249106 35 5 0 1 0 1 0
364
phenylalanyl-tRNA synthetase alpha 
chain 630_gi|115249715 38 0 1 1 1 1 1
365 two-component system response regulator 630_gi|115251168 25 1 1 1 2 0 1
366
putative imidazole glycerol phosphate 
synthase subunit 630_gi|115250594 28 1 0 2 2 0 1




phosphofructokinase stt_BASYS03533 34 1 0 2 1 1 0
370 putative L-asparaginase 630_gi|115251569 36 0 1 1 2 3 0
372
BASYS01830, 1919083-1918436 




(115250551) 24 3 1 1 0 0 1
384
putative metal dependent 
phosphohydrolase 630_gi|115251577 22 1 1 1 1 0 1
385
putative inorganic polyphosphate/ATP-
NAD kinase 630_gi|115250070 30 0 1 1 1 1 1
386 peptide deformylase 2 630_gi|115251641 16 1 1 1 1 1 0
387 putative transcriptional repressor 630_gi|115252578 32 0 2 1 2 0 2
388
hcr, 624539-622545 (CounterClockwise) 
Hypothetical Protein Mbar A
stb_BASYS00654
(115249747) 74 1 1 0 1 0 1
251
(putative iron-sulfur protein) 
389 putative sigma 54 modulation protein 630_gi|115251497 22 1 0 1 1 1 0
391 inosine-5'-monophosphate dehydrogenase 630_gi|115251390 55 0 1 0 0 2 2
400 glycerol dehydratase 630_gi|115250149 89 0 1 2 1 1 1
401 putative phosphoglucomutase 630_gi|115250617 64 2 2 0 1 1 1
402
rplK, 64298-64723 (Clockwise) 50S
ribosomal protein L11 stt_BASYS00059 15 1 1 1 1 1 0
406 ABC transporter, ATP-binding protein 630_gi|115252673 27 2 1 0 1 0 1
408 conserved hypothetical protein 630_gi|115252608 28 1 0 1 1 1 1
411 conserved hypothetical protein 630_gi|115250280 17 1 0 1 2 0 1
419 putative acetyltransferase 630_gi|115249853 19 1 0 2 0 0 1
431 putative membrane protein 630_gi|115250415 17 1 1 1 1 0 1
432 V-type sodium ATP synthase subunit I 630_gi|115252017 72 1 1 1 1 0 1
433 putative hydrolase 630_gi|115251794 23 1 1 0 1 1 0
434 glucose-6-phosphate isomerase 630_gi|115252341 51 1 0 1 0 1 2
435 putative signal recognition particle 630_gi|115250284 47 0 1 1 1 0 1
438 conserved hypothetical protein 630_gi|115250440 24 1 1 0 1 0 1
440
sigma-54-dependent transcriptional 
activator 630_gi|115252301 67 1 1 0 1 1 1
442




(115250190) 67 1 1 0 1 0 1
458
BASYS00601, 620689-622851 (Clockwise) 
Streptomycin Biosynthesis StrF Domain 
Protein sta_BASYS00601 84 1 0 1 1 1 0
459 ribonuclease R 630_gi|115252220 82 1 1 1 0 1 0
460
cobalt-precorrin-3b c(17)-
methyltransferase 630_gi|115252484 27 0 1 2 0 1 1
465 conserved hypothetical protein 630_gi|115251601 68 1 0 1 0 1 1
526 putative GTP cyclohydrolase I 630_gi|115250490 21 0 1 0 1 1 0
560 transcription-repair coupling factor 630_gi|115252562 130 1 0 0 1 1 0




TatD Family sta_BASYS00737 23 1 0 1 0 0 1
673
glycine betaine/carnitine/choline ABC 




(CounterClockwise) Hypothetical Protein 
secA
(pre protein translocase secA)
secA, 3237442-3235100 
(CounterClockwise) Hypothetical Protein 
secA
preprotein translocates secA subunit
stt_BASYS02897
(115251845) 89 3 2 0 0 1 3
stb_BASYS03071





(CounterClockwise) Hypothetical Protein 
BASYS00362
Ornithine cyclodeaminase
630_gi|115249560 36 2 0 0 0 1 0




No. unique peptides 
A B-1 Tra5/5T
1 2 1 2 1 2
Strains A and B-1 M = 70, s/v = 13, h = 23, R = 19, t= 8, r = 11
15
399





(115249675) 269 29 18 11 9 0 0
630_gi|115249675 270 0 0 3 3 0 0
88 putative subunit of oxidoreductase 630_gi|115249126 27 8 1 4 2 0 0
125 stage IV sporulation protein A 630_gi|115251680 56 8 3 0 1 0 0
137 putative 5-nitroimidazole reductase 630_gi|115250500 18 7 4 1 2 0 0
151 conserved hypothetical protein 630_gi|115250755 12 4 0 3 2 0 0
166 single-strand binding protein 630_gi|115252727 16 4 4 4 4 0 0
167 conserved hypothetical protein 630_gi|115252018 11 3 5 4 2 0 0
215




(115249720) 22 2 1 1 1 0 0
222
ABC transporter, substrate-binding 
protein 630_gi|115252047 35 1 3 3 3 0 0
230
putative iron-only hydrogenase,electron-
transferring subunit 630_gi|115252465 18 3 2 2 2 0 0
232 putative ATPase 630_gi|115251304 32 3 0 6 3 0 0
254 anti-sigma F factor antagonist 630_gi|115249787 13 1 4 2 2 0 0
277 putative exported protein 630_gi|115250249 32 1 1 1 1 0 0
278
DNA-directed RNA polymerase omega 
chain 630_gi|115251644 10 1 0 4 3 0 0
279 50S ribosomal protein L22 630_gi|115249082 12 1 0 4 4 0 0
280 putative regulatory protein 630_gi|115250940 19 5 2 1 0 0 0
281




(115249602) 10 1 1 1 0 0 0
286 probable hydrolase 630_gi|115251629 24 3 1 2 2 0 0
304 putative exported protein 630_gi|115252734 21 2 1 1 1 0 0
305 putative reductase 630_gi|115249773 24 4 0 1 2 0 0
311 putative tRNA/rRNA methyltransferase 630_gi|115249058 27 1 1 0 1 0 0
312 ABC transporter, permease protein 630_gi|115249889 32 2 0 2 2 0 0
313 putative ferrous iron transport protein B 630_gi|115252330 71 3 0 2 3 0 0
314
putative phosphoribosylaminoimidazole-
succinocarboxamide synthase 630_gi|115249503 25 3 0 1 2 0 0
315 ferrous iron transport protein B 630_gi|115250520 78 1 0 3 4 0 0
331 succinyl-CoA:coenzyme A transferase 630_gi|115251398 56 4 2 1 2 0 0
336




(115251209) 52 1 1 3 1 0 0
337 putative oligopeptide transporter 630_gi|115250443 67 3 0 2 2 0 0
338 conserved hypothetical protein 630_gi|115249879 33 1 0 1 1 0 0
339 putative regulatory protein 630_gi|115250392 18 2 0 2 2 0 0
341 PTS system, IIb component 630_gi|115252071 11 2 0 1 4 0 0
342 putative beta-lactamase repressor 630_gi|115251442 15 1 0 2 1 0 0
352 probable amino acid racemase 630_gi|115251082 26 2 1 2 2 0 0
355 dipicolinate synthase, B chain 630_gi|115252025 21 3 1 1 1 0 0
356 tellurium resistance protein 630_gi|115250845 21 2 0 2 2 0 0
357 conserved hypothetical protein 630_gi|115250233 13 2 0 1 2 0 0
253
358 flagellar hook protein 630_gi|115249263 35 3 0 4 1 0 0
480 flagellar basal body-associated protein 630_gi|115249267 17 1 0 1 1 0 0
363 putative membrane protein 630_gi|115252518 39 3 0 1 0 0 0
371 putative nucleic acid-binding protein 630_gi|115250365 59 3 1 1 1 0 0
373
ABC transporter, ATP-binding/permease 
protein 630_gi|115251265 83 2 0 2 2 0 0
374 ATP synthase subunit delta 630_gi|115252531 21 2 0 1 2 0 0
375 putative membrane protein 630_gi|115249607 14 1 0 2 2 0 0
376 putative exported protein 630_gi|115249010 11 1 0 2 1 0 0
377
histidine biosynthesis bifunctional protein 
includes: phosphoribosyl-AMP 
cyclohydrolase and phosphoribosyl-ATP 
pyrophosphatase 630_gi|115250595 26 1 0 2 3 0 0
390 putative cardiolipin synthetase 630_gi|115252464 57 2 1 1 1 0 0
392 cobalt-precorrin-8x methylmutase 630_gi|115252490 23 1 1 2 1 0 0
393 conserved hypothetical protein 630_gi|115251576 13 1 1 1 1 0 0
394 conserved hypothetical protein 630_gi|115249575 22 2 0 1 1 0 0
395
rpmC, 425747-425962 (Clockwise) 
Hypothetical Protein rpmC
(50S ribosomal protein L29)
sta_BASYS00420
(115249085) 8 1 2 2 0 0 0
396 trans-2-enoyl-ACP reductase 630_gi|115250213 33 1 0 1 1 0 0
404 DNA polymerase III alpha subunit 630_gi|115252456 136 1 1 2 1 0 0
405 ribose-5-phosphate isomerase 1 630_gi|115251375 16 2 1 1 1 0 0
409 ABC transporter, ATP-binding protein 630_gi|115250569 25 1 1 1 1 0 0
412 50S ribosomal protein L7/L12 630_gi|115249068 13 3 0 1 2 0 0
413
phosphoribosylaminoimidazole 
carboxylase catalytic subunit 630_gi|115249226 17 2 1 0 2 0 0
414 50S ribosomal protein L18 630_gi|115249093 14 1 0 1 1 0 0
415 conserved hypothetical protein 630_gi|115249462 14 1 0 2 1 0 0
417 hypothetical protein 630_gi|115252039 74 1 0 2 2 0 0
418 50S ribosomal protein L17 630_gi|115249107 13 1 0 1 1 0 0
421




(115251791) 67 3 1 0 1 0 0
422 cell surface protein 630_gi|115251764 72 2 0 0 1 0 0
436
UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 1 630_gi|115249132 45 1 1 1 1 0 0
437 xanthine phosphoribosyltransferase 630_gi|115251385 21 1 1 1 1 0 0
441 glutamyl-tRNA synthetase 630_gi|115249054 57 1 1 1 1 0 0
445 conserved hypothetical protein 630_gi|115251612 20 1 1 2 0 0 0
446 conserved hypothetical membrane protein 630_gi|115250847 31 1 0 2 1 0 0
448 electron transport complex protein 630_gi|115250169 35 1 1 0 1 0 0
449




(115249154) 81 3 0 0 1 0 0
450
BASYS02718, 2834398-2834129 




(115251678) 10 0 2 1 0 0 0
452 V-type sodium ATP synthase subunit C 630_gi|115252014 37 1 0 4 0 0 0
456 V-type sodium ATP synthase subunit G 630_gi|115252013 12 1 1 1 1 0 0
463 50S ribosomal protein L30 630_gi|115249095 7 1 1 1 2 0 0
254
464
fabD, 1551856-1552806 (Clockwise) 
Hypothetical Protein fabD
malonyl CoA-acyl carrier protein 
transacylase)
sta_BASYS01457 
(115250214) 34 2 1 0 1 0 0
466
yaeC, 1591483-1592274 (Clockwise) 
Hypothetical Protein yaeC
(putative D-methionine ABC transporter, 
substrate binding lipoprotein)
stt_BASYS01553
(11525032) 29 0 1 2 2 0 0
467
2-C-methyl-D-erythritol 2,4-
cyclodiphosphate synthase 630_gi|115249051 17 2 1 1 0 0 0
469 ATP-dependent nuclease subunit B 630_gi|115250061 134 1 0 1 1 0 0
470 GntR-family transcriptional regulator 630_gi|115250423 24 1 0 1 1 0 0
471
putative sugar transporter, substrate-
binding lipoprotein 630_gi|115251604 48 1 0 1 1 0 0
472
BASYS03031, 3208770-3207811 
(CounterClockwise) Hypothetical Protein 
CTC (conserved hypothetical protein)
stt_BASYS03031
(115252038) 37 1 0 1 1 0 0
473
putative peptidoglycan-binding exported 
protein 630_gi|115252020 52 1 0 1 3 0 0
475 hypothetical protein 630_gi|115249824 14 1 0 1 1 0 0
476
rplS, 1334033-1334383 (Clockwise) 50S 
ribosomal protein L19 stt_BASYS01301 13 2 0 0 2 0 0
479
rpsF, 4075279-4075001 (CounterClockwise) 
30S ribosomal protein S6 stt_BASYS03813 ? 0 2 1 0 0 0
483 phosphopantetheine adenylyltransferase 630_gi|115251613 18 2 0 1 0 0 0
485
BASYS02045, 2108881-2108549 




(115251040) 12 0 2 1 0 0 0
495




(115249289) 8 0 2 1 0 0 0
499 putative rod shape-determining protein 630_gi|115250178 32 0 2 1 2 0 0
500
putative ethanolamine/propanediol 
utilization protein 630_gi|115250972 18 0 1 1 2 0 0
505 50S ribosomal protein L2 630_gi|115249080 30 1 0 1 1 0 0
507 rod shape-determining protein 630_gi|115249136 36 1 0 1 1 0 0





(CounterClockwise) Hypothetical Protein 
BASYS01487
putative acetyltransferase
630_gi|115250244 18 1 0 1 1 0 0
sta_BASYS01487
(115250244) 20 1 0 0 0 0 0
511 putative ATP phosphoribosyltransferase 630_gi|115250589 23 1 0 1 1 0 0
512 cytidylate kinase 630_gi|115250861 24 1 0 1 1 0 0
513 putative acyltransferase 630_gi|115250862 23 1 0 1 1 0 0
514 conserved hypothetical protein 630_gi|115250980 14 1 0 1 1 0 0
515 GTP-binding protein 630_gi|115251490 34 1 0 1 1 0 0
517 conserved hypothetical protein 630_gi|115250815 159 1 1 1 2 0 0
518 630_gi|115250181|emb|CAJ68002.1|-R 630_gi|115250181 ? 1 0 1 1 0 0
519 anti-sigma-B factor (serine-protein kinase) 630_gi|115249013 15 1 0 1 1 0 0
522 cobyric acid synthase 630_gi|115252495 57 0 2 2 0 0 0
523 30S ribosomal protein S17 630_gi|115249086 10 1 0 1 1 0 0
529 ribosome-binding factor A 630_gi|115250346 14 1 0 1 1 0 0
530 putative proline racemase 630_gi|115252294 36 2 0 1 0 0 0
532 nitrilase (carbon-nitrogen hydrolase) 630_gi|115251895 34 2 0 1 0 0 0
255
540 ADP-ribose pyrophosphatase 630_gi|115250253 20 1 0 2 0 0 0
543 DNA gyrase subunit B 630_gi|115249008 71 1 0 0 2 0 0
546
probable carbohydrate hydrolase (N-
terminus) 630_gi|115252061 11 0 1 1 1 0 0
548
4-hydroxyphenylacetate decarboxylase, 
regulatory subunit 630_gi|115249163 10 0 1 2 0 0 0
553 GntR-family transcriptional regulator 630_gi|115249663 26 1 1 1 1 0 0
554 putative xanthine/uracil permease 630_gi|115251161 48 1 0 2 1 0 0
555 cell surface protein 630_gi|115249861 34 1 1 2 0 0 0
559 PTS system, IIbc component 630_gi|115251563 56 1 0 1 1 0 0
561
putative FolD bifunctional protein 
includes: methylenetetrahydrofolate 
dehydrogenase; methenyltetrahydrofolate 
cyclohydrolase 630_gi|115249737 31 2 0 1 0 0 0
565




(115249827) 20 2 0 0 1 0 0
568 probable peptidase 630_gi|115251664 40 2 0 1 0 0 0
573 GntR-family transcriptional regulator 630_gi|115250658 14 2 0 0 1 0 0
597 putative membrane protein 630_gi|115250318 80 0 2 1 0 0 0
598 ferric uptake regulation protein 630_gi|115250321 18 1 0 0 1 0 0
599 putative endoribonuclease 630_gi|115250431 13 1 0 0 1 0 0
600 two-component response regulator 630_gi|115250731 26 1 0 0 1 0 0
601
putative copper-transporting P-type 
ATPase 630_gi|115251169 89 1 0 0 1 0 0
602 putative regulatory protein 630_gi|115251736 67 1 0 0 1 0 0
603
ybaK, 1165955-1166422 (Clockwise) 
YbaK/Prolyl-TRNA Synthetase Associated 
Region stt_BASYS01124 17 1 0 0 1 0 0
623 putative polysaccharide deacetylase 630_gi|115250355 28 1 0 0 1 0 0
629




(115249901) 26 0 1 0 1 0 0
630
putative aconitase/3-isopropylmalate 
dehydratase 630_gi|115249850 69 0 1 1 0 0 0
634 putative membrane protein 630_gi|115250109 42 1 0 0 1 0 0
635
branched chain amino acid transport 
system carrier protein 630_gi|115250294 45 1 0 0 1 0 0
636 ABC transporter, permease protein 630_gi|115250568 45 1 0 0 1 0 0
642 putative nitroreductase 630_gi|115252261 22 2 0 1 0 0 0
643 aspartokinase 630_gi|115251108 43 1 0 1 0 0 0
648 conserved hypothetical protein 630_gi|115251027 11 0 2 1 0 0 0
672
PTS system, lichenan-specific IIa 
component 630_gi|115251933 12 0 1 1 0 0 0
675 two-component response regulator 630_gi|115250828 28 1 0 1 0 0 0
676 conserved hypothetical protein 630_gi|115252306 21 1 0 1 0 0 0
677 undecaprenyl pyrophosphate synthetase 630_gi|115251189 28 1 0 0 1 0 0
680
putative methyl accpeting chemotaxis 





smc, 1623439-1626993 (Clockwise) 
Chromosome partition protein smc
630_gi|115250283 137 0 0 1 1 0 0
sta_BASYS01540
115250283












(115251842) 68 0 0 1 1 0 0
sta_BASYS032651(









(115251839) 57 0 0 0 1 0 0
630_gi|115251839 57 1 0 0 0 0 0
318
477
N-acetylmuramoyl-L-alanine amidase (cell 
wall hydrolase) (partial) region relative to 
most database matches.
BASYS01205, 1238455-1239267 (Clockwise) 
N-Acetylmuramoyl-L-Alanine Amidase
630_gi|115251237 20 4 3 0 0 0 0
stb_BASYS01205
(115251237) 30 0 0 2 2 0 0
570
790
BASYS01676, 1758384-1763561 (Clockwise) 
Hypothetical Protein BASYS01676
Hypothetical protein
RPGR, 1516218-1521539 (Clockwise) X-
linked retinitis pigmentosa GTPase 
regulator
sta_BASYS01676
(115250412) 191 1 2 0 0 0 0
stb_BASYS01490
115250412
198 0 0 1 0 0 0
Identification Number Mass No. unique peptides 
A B-1 Tra5/5
1 2 1 2 1 2
Strains A and Tra5/5 M = 15, s/v = 2, h = 2, R = 1, t= 1, r = 0
69
BASYS03269, 3479118-3476842 








(115251852) 80 42 36 0 0 15 15
stt_BASYS02898
(115251852) 80 0 0 0 0 9 9
28
amino acid ABC transporter, substrate-




(CounterClockwise) Hypothetical Protein 
BASYS03267
(cell surface protein(putative S-layer 
protein precursor)
BASYS02896, 3045252-3043381 
(CounterClockwise) Hypothetical Protein 
BASYS02896
Cell surface protein (putative S-layer 
protein precursor)
sta_BASYS03267
(115251844) 66 19 11 0 0 6 9
stt_BASYS02896
(115251844) 66 0 0 0 0 1 0
231 gcvP, 2151957-2153414 (Clockwise) sta_BASYS02061 54 0 1 0 0 2 3
257
Hypothetical Protein gcvP
(glycine cleavage system P protein)
(115250699)
265 putative GTP-binding protein 630_gi|115251683 50 0 1 0 0 1 6
291 putative carbon-nitrogen hydrolase 630_gi|115249501 31 2 3 0 0 3 1
457
putative pyridine nucleotide-disulfide 
oxidoreductase 630_gi|115250843 59 1 1 0 0 2 1
461 3-oxoacyl-acyl-carrier protein reductase 630_gi|115250215 27 1 1 0 0 1 1
468




(115250177) 36 2 1 0 0 1 0
501 conserved hypothetical protein 630_gi|115252618 28 2 0 0 0 1 1
502 aspartate--ammonia ligase 630_gi|115251746 39 1 1 0 0 1 0
506 glycyl-tRNA synthetase alpha chain 630_gi|115251486 34 0 1 0 0 1 1
516 putative oxidoreductase subunit 630_gi|115251479 20 1 1 0 0 1 0
520 adenine phosphoribosyltransferase 630_gi|115251797 19 1 0 0 0 1 1
596 putative DNA translocase 630_gi|115250360 88 0 1 0 0 0 1
633 serine acetyltransferase 630_gi|115250636 22 0 1 0 0 0 1
641
ybgG, 3687856-3685256 




(115252069) 100 1 0 0 0 0 1
646 putative amino acid amidase 630_gi|115250435 30 0 1 0 0 0 1
679
ydcR, 2601886-2600678 




(115251476) 45 0 1 0 0 1 0
685 conserved hypothetical protein 630_gi|115249738 24 1 0 0 0 0 1
859
898
crr, 3807137-3806646 (CounterClockwise) 
Hypothetical Protein crr
putative PTS syste, IIa component [
putative PTS syste, IIa component
sta_BASYS03551
(115252157) 18 1 0 0 0 0 0
630_gi|115252157 18 0 0 0 0 1 0
Identification Number Mass No. unique peptides 
A B-1 Tra5/5
1 2 1 2 1 2
Strains B-1 and Tra5/5 M = 16, s/v = 2, h = 4, R = 3, t= 2, r = 0
188 60  chaperonin 630_gi|115249204 58 0 0 2 2 2 2
233
glycine/sarcosine/betaine reductase 





00004 33 0 0 5 5 0 2
334 putative acetyltransferase 630_gi|115250223 20 0 0 3 2 1 1
368
putative sulfonate ABC transporter,solute-
binding lipoprotein 630_gi|115251417 40 0 0 1 1 0 1
403 conserved hypothetical protein 630_gi|115250029 32 0 0 1 2 1 1




cell surface protein (putative 
hemagglutinin/adhesin)
BASYS00903, 928449-925966 
(CounterClockwise) Hypothetical Protein 
BASYS00903
Cell surface protein (putative 
hemagglutinin/adhesin
630_gi|115249532 167 0 0 0 1 1 2
stb_BASYS00903
(115249532) 86 0 0 0 1 0 0
416
BASYS01206, 1239342-1239710 (Clockwise) 
Hypothetical Protein BASYS01206 stb_BASYS01206 14 0 0 1 1 1 0
443 putative aspartate aminotransferase 630_gi|115251434 47 0 0 2 0 1 2
444
putative oxidoreductase, NAD/FAD 
binding subunit 630_gi|115249186 46 0 0 1 2 1 0
447





(115249162) 101 0 0 0 1 2 1
462 putative selenocysteine lyase 630_gi|115252735 42 0 0 1 1 1 1
498 putative zinc-binding dehydrogenase 630_gi|115251896 36 0 0 1 1 1 1
509 guanylate kinase 630_gi|115251645 23 0 0 1 1 0 1
521 conserved hypothetical protein 630_gi|115251116 38 0 0 1 1 0 1
538
porphyrin biosynthesis protein includes: 
uroporphyrinogen-III methyltransferase 
and uroporphyrinogen-III synthase 630_gi|115252480 56 0 0 0 2 0 1
556 conserved hypothetical protein 630_gi|115251115 24 0 0 1 1 1 0
557
putative extracellular solute-binding 
protein 630_gi|115251696 48 0 0 1 1 1 0
558
low molecular weight protein-tyrosine-
phosphatase 630_gi|115252541 17 0 0 1 1 1 0
563 putative ribulose-phosphate 3-epimerase 630_gi|115251374 25 0 0 0 1 1 1
590 methionyl-tRNA formyltransferase 630_gi|115251640 34 0 0 0 1 1 0
614 Spo0B-associated GTP-binding protein 630_gi|115250196 47 0 0 1 1 0 1
632 dihydrodipicolinate reductase 630_gi|115252286 28 0 0 0 1 0 1
647 GTP-binding elongation factor 630_gi|115251521 67 0 0 1 0 1 0
674
amino acid ABC transporter, substrate-




BASYS01924, 1985976-1986815 (Clockwise) 
Hypothetical Protein BASYS01924
Putative prephenate dehydrogenase
630_gi|115250885 31 0 0 1 0 0 0
stt_BASYS01924
(115250885) 31 0 0 0 0 1 1
Identification Number Mass No. unique peptides 
A B-1 Tra5/5
1 2 1 2 1 2
Strain Tra5/5 only M = 33, s/v = 1, h = 6, R = 3, t= 2, r = 0
295 seryl-tRNA synthetase 630_gi|115249017 49 0 0 0 0 1 1
316
fdhF, 2319506-2317329 




(115251232) 83 0 0 0 0 2 2
360
yiaJ, 3855532-3856284 (Clockwise) 
Hypothetical Protein yiaJ stt_BASYS03597 ? 0 0 0 0 3 4
362
putative molybdenum-binding subunit of 
oxidoreductase 630_gi|115251153 82 0 0 0 0 2 4
378 putative electron transfer protein 630_gi|115252303 47 0 0 0 0 2 3
380 asparaginyl-tRNA synthetase 630_gi|115251299 54 0 0 0 0 2 4
259
451




(115249055) 54 0 0 0 0 2 2
481
putative chorismate biosynthesis-related 
protein includes: phospho-2-dehydro-3-
deoxyheptonate aldolase and chorismate 
mutase 630_gi|115250878 37 0 0 0 0 2 1
527
putative FAD-binding subunit of 
oxidoreductase 630_gi|115251155 30 0 0 0 0 1 2
539
dihydroorotate dehydrogenase, catalytic 
subunit 630_gi|115249196 32 0 0 0 0 2 1
542 putative aminopeptidase 630_gi|115250096 51 0 0 0 0 1 1
547 threonine synthase 630_gi|115251172 56 0 0 0 0 1 2
572 putative radical SAM family protein 630_gi|115251801 53 0 0 0 0 1 1
591
phosphoglucomutase/phosphomannomut
ase mutase 630_gi|115249128 51 0 0 0 0 1 1
592 conserved hypothetical protein 630_gi|115250761 39 0 0 0 0 1 1
593 N-carbamoyl-L-amino acid hydrolase 630_gi|115251081 44 0 0 0 0 1 1
594 putative thymidylate kinase 630_gi|115252611 27 0 0 0 0 1 1




phospholyase) 630_gi|115250881 39 0 0 0 0 1 1
658 putative ATP/GTP-binding protein 630_gi|115249805 48 0 0 0 0 0 2
690
P-protein includes: chorismate mutase and 
prephenate dehydratase 630_gi|115250882 46 0 0 0 0 1 1
691 UDP-N-acetylmuramate--L-alanine ligase 630_gi|115252579 50 0 0 0 0 0 1
707 dihydrodipicolinate reductase 630_gi|115252283 27 0 0 0 0 1 0
728 radical SAM-superfamily protein 630_gi|115250362 51 0 0 0 0 0 1
729 glutamine synthetase 630_gi|115250379 72 0 0 0 0 0 1
730
UDP-N-acetylmuramoyl-tripeptide--D-
alanyl-D-alan ine ligase 630_gi|115251706 51 0 0 0 0 0 1
731 putative GTP pyrophosphokinase 630_gi|115251796 85 0 0 0 0 0 1
732
galU, 3885914-3884934 
(CounterClockwise) Hypothetical Protein 
galU stt_BASYS03633 ? 0 0 0 0 0 1
760
oppF, 1277546-1278490 (Clockwise) 
Hypothetical Protein oppF
ABC-type oligopeptide transport system, 
ARPase component sta_BASYS01208 36 0 0 0 0 1 1
791 putative 2-nitropropane dioxygenase 630_gi|115251174 38 0 0 0 0 1 0
792
potG, 466136-466891 (Clockwise) 
Hypothetical Protein potG
ABC transporter, ATP-binding protein
stb_BASYS00509
(115249891) 28 0 0 0 0 1 0
795 putative DNA mismatch repair protein 630_gi|115249725 88 0 0 0 0 0 1
822 DNA repair protein 630_gi|115249030 50 0 0 0 0 0 1
823 putative hydantoinase 630_gi|115250762 56 0 0 0 0 0 1
824 PhoH-like protein 630_gi|115251494 38 0 0 0 0 0 1
825 cinserved hypothetical protein 630_gi|115251677 47 0 0 0 0 0 1









(115252228) 56 0 0 0 0 0 1
830




(115249228) 51 0 0 0 0 0 1
866 hydrogenase 630_gi|115252370 51 0 0 0 0 0 1
873 conserved hypothetical protein 630_gi|115250624 11 0 0 0 0 1 0
877
hsdM, 3719141-3716964 
(CounterClockwise) Hypothetical Protein 
hsdM
type I restriction-modification system 
specificity subunit stt_BASYS03486 83 0 0 0 0 1 0
882
cyclopropane-fatty-acyl-phospholipid 
synthase 630_gi|115249187 46 0 0 0 0 0 1
895 putative deoxyribonuclease 630_gi|115252600 29 0 0 0 0 1 0
925 cell surface protein 630_gi|115251246 51 0 0 0 0 0 1
Identification Number Mass No. unique peptides 
A B-1 Tra5/5
1 2 1 2 1 2
Strain B-1 only M = 68, s/v = 12, h = 56, R = 17, t= 5, r = 3
33
BASYS03072, 3239516-3237684 
(CounterClockwise) Hypothetical Protein 
BASYS03072
Cell surface protein (S-layer precursor 
protein)
stb_BASYS03072
(115251846) 65 0 0 24 20 0 0
168 putative carbon-nitrogen hydrolase 630_gi|115251789 31 0 0 7 6 0 0
255 transcription antiterminator 630_gi|115252086 32 0 0 4 5 0 0
317
BASYS00003, 1394-2224 (Clockwise) 
Hypothetical Protein BASYS00003
Stbphage1_BASYS
00003 33 0 0 3 4 0 0
343 conserved hypothetical protein 630_gi|115252214 30 0 0 3 2 0 0
344
ybhF, 1494368-1495099 (Clockwise) 
Hypothetical Protein ybhF
putative lantibiotic ABC transporter,ATP-
binding protein
stb_BASYS01462
(115250385) 27 0 0 3 4 0 0
361
sopA, 5108-4290 (CounterClockwise) 
Hypothetical Protein sopA
Stbphage1_BASYS
00008 32 0 0 2 4 0 0
379




(115249020) 13 0 0 3 3 0 0
397
putative oxidoreductase, electron transfer 




galE, 2294153-2293197 (CounterClockwise) 
Hypothetical Protein gale
putative L-threonine dehydrogenase
630_gi|115250838 36 0 0 2 2 0 0
sta_BASYS02203
(115250838) 36 1 0 0 0 0 0
420
BASYS02421, 2523005-2522130 




(115251013) 34 0 0 2 2 0 0
261
423




(115249246) 13 0 0 3 3 0 0
425
BASYS00012, 9275-9622 (Clockwise) 
Hypothetical Protein BASYS00012
Stbphage1_BASYS
00012 14 0 0 2 3 0 0
426 putative phosphosugar isomerase 630_gi|115252083 21 0 0 2 2 0 0
429 dihydropteroate synthase 630_gi|115250491 30 0 0 3 1 0 0
430 conserved hypothetical protein 630_gi|115249635 9 0 0 1 0 0 0
453 PTS system, IIabc component 630_gi|115252143 52 0 0 1 1 0 0
474
putative 3-mercaptopyruvate 
sulfurtransferase 630_gi|115250576 32 0 0 2 2 0 0
482




(115249688) 23 0 0 1 3 0 0
484




00060 17 0 0 1 2 0 0
486 thioredoxin 630_gi|115251408 12 0 0 1 2 0 0




phosphoribosyltransferase 630_gi|115252499 37 0 0 1 0 0 0
503 conserved hypothetical protein 630_gi|115251009 30 0 0 1 1 0 1
504 peptide chain release factor 1 630_gi|115252544 40 0 0 1 0 0 0
524
BASYS02039, 2122887-2123531 (Clockwise) 
Hypothetical Protein BASYS02039
Tellurium resistance protein 
sta_BASYS02039
(115250677) 24 0 0 2 2 0 0
525
rRNA adenine N-6-methyltransferase 
(erythromycin resistance protein) 630_gi|115251058 29 0 0 2 2 0 0
531 putative membrane protein 630_gi|115249794 29 0 0 1 2 0 0
533 conserved hypothetical protein 630_gi|115252657 22 0 0 1 2 0 0
534
BASYS00477, 430146-431189 (Clockwise) 
Hypothetical Protein BASYS00477
No  c. difficile match by BLAST stb_BASYS00477 41 0 0 1 2 0 0
535 thioredoxin reductase 630_gi|115250734 33 0 0 1 2 0 0
536 putative ATP-binding protein 630_gi|115250457 25 0 0 1 0 0 0
541
BASYS03056, 3218968-3215420 
(CounterClockwise) Hypothetical Protein 
BASYS03056 stb_BASYS03056 139 0 0 1 2 0 0
544 PTS system, IIa component 630_gi|115251565 17 0 0 1 1 0 0
562
cobalt-precorrin-6a reductase; precorrin-6x 
reductase 630_gi|115252483 28 0 0 2 2 0 0
564 signal recognition particle protein 630_gi|115250286 50 0 0 1 1 0 0
566 50S ribosomal protein L23 630_gi|115249079 11 0 0 1 2 0 0
567
acetyl-coenzyme A carboxylase carboxyl 
transferase subunit beta 630_gi|115250983 32 0 0 1 2 0 0
571 putative flagellar motor switch protein 630_gi|115249279 33 0 0 1 1 0 0
702
fliN, 608925-609239 (Clockwise) 
Hypothetical Protein fliN
flagellar motor switch protein
sta_BASYS00587 
(115249236) 12 0 0 1 0 0 0
710 putative flagellar motor switch protein 630_gi|115249280 14 0 0 0 1 0 0
575 conserved hypothetical protein 630_gi|115250343 11 0 0 1 1 0 0
576 probable esterase 630_gi|115251258 30 0 0 1 1 0 0
577 conserved hypothetical protein 630_gi|115249911 14 0 0 1 1 0 0
578 50S ribosomal protein L27 630_gi|115250195 10 0 0 1 1 0 0
262
580 pyrroline-5-carboxylate reductase 630_gi|115250536 29 0 0 1 1 0 0
581
glycine/sarcosine/betaine reductase 
complex component A 630_gi|115251406 17 0 0 1 1 0 0
582 putative transcription antiterminator 630_gi|115251719 33 0 0 1 1 0 0
583 cell surface protein 630_gi|115251849 67 0 0 1 1 0 0
584
PTS system, maltose and glucose-specific 
IIbc component 630_gi|115252085 57 0 0 1 1 0 0
585 putative stage 0 sporulation protein 630_gi|115252738 30 0 0 1 1 0 0
586






(115250964) 53 0 0 1 1 0 0
587
BASYS03023, 3180249-3179710 
(CounterClockwise) Hypothetical Protein 
Lmo
Conjugative transposon conserved 
hypothetical protein
stb_BASYS03023
(115249366) 21 0 0 1 1 0 0
589
BASYS03016, 3189040-3188357 




(115252021) 26 0 0 1 1 0 0
604
381
BASYS00474, 429093-429458 (Clockwise) 
Hypothetical Protein BASYS00474
Putative phage regulatory protein (XRE 
family transcriptional regulator)
BASYS00015, 10793-10440 
(CounterClockwise) Hypothetical Protein 
BASYS00015
Transcriptional regulator, xre family 
protein
stb_BASYS00474
(115251071) 14 0 0 1 1 0 0
Stbphage1_BASYS
00015 14 0 0 2 2 0 0
611 transcription elongation factor 630_gi|115252616 18 0 0 2 0 0 0
612 30S ribosomal protein S16 630_gi|115250287 10 0 0 2 0 0 0
613 flavodoxin 630_gi|115251047 16 0 0 2 0 0 0
619
rffG, 606774-607757 (Clockwise) 
Hypothetical Protein rffG
(dTDP-glucose 4,6-dehydratase) sta_BASYS00584 38 0 0 1 1 0 0
620 homoserine kinase 630_gi|115251173 33 0 0 1 1 0 0
624 putative small-molecule-binding protein 630_gi|115249015 20 0 0 1 1 0 0
625 ATP-dependent nuclease subunit A 630_gi|115250062 147 0 0 1 1 0 0
626 putative tRNA modification GTPase 630_gi|115252740 51 0 0 1 1 0 0
627
BASYS03349, 3561478-3560975 
(CounterClockwise) Hypothetical Protein 
BASYS03349
No match by BLAST stb_BASYS03349 19 0 0 1 1 0 0
644




(115252486) 29 0 0 1 1 0 0
645




(115249958) 13 0 0 1 1 0 0
649 PTS system, IIa component 630_gi|115252072 17 0 0 1 1 0 0
650 stage V sporulation protein G 630_gi|115252577 10 0 0 2 0 0 0
651 hypothetical protein 630_gi|115252299 11 0 0 1 1 0 0
653 hypothetical protein 630_gi|115251805 26 0 0 0 1 0 0
654
acetyl-coenzyme A carboxylase carboxyl 
transferase subunit alpha 630_gi|115250982 35 0 0 1 0 0 0
263
660 putative exported protein 630_gi|115251418 17 0 0 0 1 0 0
661 conserved hypothetical protein 630_gi|115251421 12 0 0 1 0 0 0
662
BASYS00184, 156070-156327 (Clockwise) 
Hypothetical Protein BASYS00184
No match to BLAST stb_BASYS00184 10 0 0 1 0 0 0
663
BASYS01737, 1767940-1768269 (Clockwise) 
Hypothetical Protein BASYS01737
No match to BLAST stb_BASYS01737 13 0 0 1 0 0 0
667 conserved hypothetical protein 630_gi|115249350 16 0 0 1 1 0 0
668 conserved hypothetical protein 630_gi|115249339 28 0 0 1 1 0 0
669
putative chorismate biosynthesis-related 
protein includes: phospho-2-dehydro-3-
deoxyheptonate aldolase and chorismate 
mutase 630_gi|115250494 29 0 0 1 1 0 0
670 cysteine synthase A 630_gi|115250707 35 0 0 1 1 0 0
671
BASYS03069, 3232315-3231857 
(CounterClockwise) Hypothetical Protein 
BASYS03069
No match by BLAST stb_BASYS03069 17 0 0 1 1 0 0
682 tellurium resistance protein 630_gi|115250846 21 0 0 1 0 0 0
692 putative serine hydroxymethyltransferase 630_gi|115251778 46 0 0 1 0 0 0
693 conserved hypothetical protein 630_gi|115250202 47 0 0 1 1 0 0
696
putative phage positive regulator of late 
transcription 630_gi|115249641 11 0 0 1 0 0 0
697 conserved hypothetical protein 630_gi|115250817 14 0 0 1 0 0 0
698
PTS system, glucose-specific IIa 
component 630_gi|115252082 17 0 0 1 0 0 0
699
putative 5-formyltetrahydrofolate cyclo-
ligase 630_gi|115252516 22 0 0 1 0 0 0
700 ATP synthase epsilon chain (partial) 630_gi|115252527 9 0 0 1 0 0 0
703
BASYS00188, 157642-158154 (Clockwise) 
Hypothetical Protein BASYS00188
Putative phage repressor stb_BASYS00188 20 0 0 1 0 0 0
704
ydhO, 1281410-1282705 (Clockwise) 
Hypothetical Protein ydhO
putative cell wall hydrolase
stb_BASYS01250
(115250166) 45 0 0 1 0 0 0
705
891
rfbC, 3226199-3225627 (CounterClockwise) 
Hypothetical Protein rfbC
(dTDP-4-dehydrorhamnose 3,5-epimerase)
rfbC, 606179-606736 (Clockwise) 
Hypothetical Protein rfbC
dTDP-4-dehydrorhamnose 3,5-epimerase
stb_BASYS03063 22 0 0 1 0 0 0
sta_BASYS00583 22 0 0 1 0 0 0
706
BASYS03448, 3677647-3677129 




(115252412) 20 0 0 1 0 0 0
708 DNA polymerase III subunit gamma/tau 630_gi|115249019 63 0 0 0 1 0 0
709
dihydroorotate dehydrogenase electron 
transfer subunit 630_gi|115249195 26 0 0 0 1 0 0
711 putative nucleotide phosphodiesterase 630_gi|115249706 72 0 0 0 1 0 0
712 conserved hypothetical protein 630_gi|115250366 70 0 0 0 1 0 0
713
putative dinitrogenase iron-molybdenum 
cofactor 630_gi|115250736 13 0 0 0 1 0 0
714 ABC transporter, ATP-binding protein 630_gi|115251007 24 0 0 0 1 0 0
715 putative aromatic compounds hydrolase 630_gi|115251234 29 0 0 0 1 0 0
717
probable cobalt-precorrin-6y C(5)-




synthase,pyrimidine-specific, small chain 630_gi|115252653 39 0 0 0 1 0 0
719 sporulation initiation inhibitor 630_gi|115252737 28 0 0 0 1 0 0
720
BASYS00599, 616624-618843 (Clockwise) 
Glycosyl Transferase Group 2 Family 
Protein
sta_BASYS00599 
(115249248) 89 0 0 0 1 0 0
721
BASYS00167, 150151-149381 
(CounterClockwise) Hypothetical Protein 
BASYS00167




Regulator Cro/CI Family stb_BASYS01138 16 0 0 0 1 0 0
761 MarR-family transcriptional regulator 630_gi|115250333 17 0 0 0 1 0 0
766
rpoN, 3932428-3931073 
(CounterClockwise) Hypothetical Protein 
rpoN
RNA polymerase sigme-54 factor
sta_BASYS03664
(115252233) 52 0 0 1 0 0 0
775 conserved hypothetical protein 630_gi|115250436 18 0 0 0 1 0 0
776 hypothetical phage protein 630_gi|115249959 9 0 0 1 0 0 0
777 putative phage major capsid protein 630_gi|115249966 34 0 0 1 0 0 0
778
ABC transporter, substrate-binding 
lipoprotein 630_gi|115250020 36 0 0 1 0 0 0
779 3-oxoacyl-acyl-carrier-protein synthase III 630_gi|115250212 35 0 0 1 0 0 0
780 hypothetical protein 630_gi|115250621 19 0 0 1 0 0 0
781 conserved hypothetical protein 630_gi|115251130 42 0 0 1 0 0 0
782 conserved hypothetical protein 630_gi|115251487 22 0 0 1 0 0 0
783 putative exported protein 630_gi|115251537 39 0 0 1 0 0 0
784
coenzyme A biosynthesis bifunctional 
protein 630_gi|115251643 44 0 0 1 0 0 0
785 conserved hypothetical protein 630_gi|115252035 21 0 0 1 0 0 0
786 putative preprotein translocase 630_gi|115252635 19 0 0 1 0 0 0
787 conserved hypothetical protein 630_gi|115252672 33 0 0 1 0 0 0
788
gidB, 310295-309567 (CounterClockwise) 
Hypothetical Protein gidB
methyl transferase sta_BASYS00316 27 0 0 1 0 0 0
789




(115249256) 56 0 0 1 0 0 0
794 trehalose-6-phosphate hydrolase 630_gi|115252145 66 0 0 1 0 0 0
796 chemotaxis protein 630_gi|115249265 30 0 0 0 1 0 0
797 conserved hypothetical protein 630_gi|115249689 27 0 0 0 1 0 0
798 hypothetical protein 630_gi|115249753 14 0 0 0 1 0 0
799
putative ribonucleotide-diphosphate 
reductase 630_gi|115250295 83 0 0 0 1 0 0
800 630_gi|115250446|emb|CAJ68269.1|-R 630_gi|115250446 ? 0 0 0 1 0 0
801 molybdenum cofactor biosynthesis protein 630_gi|115250758 17 0 0 0 1 0 0
802 DNA mismatch repair protein 630_gi|115251022 75 0 0 0 1 0 0




mutase 630_gi|115251833 64 0 0 0 1 0 0
806
putative DNA repair protein (nucleotide 
pyrophosphatase) 630_gi|115252458 16 0 0 0 1 0 0
807 excinuclease ABC subunit B 630_gi|115252472 76 0 0 0 1 0 0
808
nusA, 1689456-1690610 (Clockwise) 
Hypothetical Protein nusA
sta_BASYS01606





(CounterClockwise) Hypothetical Protein 
BASYS00420
hypothetical stb_BASYS00420 28 0 0 0 1 0 0
812
deaD, 915268-916881 (Clockwise) 
Hypothetical Protein dead
putative ATP-dependent RNA helicase
stt_BASYS00904
(115249778) 61 0 0 0 1 0 0
814 putative ferrous iron transport protein A 630_gi|115250789 8 0 0 1 0 0 0
864 prolyl-tRNA synthetase 630_gi|115249052 64 0 0 0 1 0 0
865 transcriptional antiterminator 630_gi|115251564 32 0 0 0 1 0 0
867
putative DNA polymerase III, delta' 
subunit 630_gi|115252610 36 0 0 1 0 0 0
868




(115249158) 17 0 0 0 1 0 0
874 ABC transporter, ATP-binding protein 630_gi|115250659 27 0 0 0 1 0 0
876




(115250058) 75 0 0 0 1 0 0
878 phosphoglycerate kinase 630_gi|115252230 43 0 0 0 1 0 0
883 conserved hypothetical protein 630_gi|115252219 19 0 0 1 0 0 0
886




(115249322) 86 0 0 1 0 0 0
888 chromosomal replication initiator protein 630_gi|115249004 50 0 0 1 0 0 0
890
ompR, 2456141-2455449 
(CounterClockwise) Hypothetical Protein 
ompR
two-component system response regulator
stt_BASYS02359 
(115251341) 27 0 0 0 1 0 0
893 conserved hypothetical protein 630_gi|115251465 46 0 0 1 0 0 0
896 putative aminotransferase 630_gi|115251747 46 0 0 1 0 0 0
901
BASYS03068, 3231844-3230237 
(CounterClockwise) Hypothetical Protein 
BASYS03068
No match by BLAST stb_BASYS03068 61 0 0 1 0 0 0
902 putative flagellar biosynthesis protein 630_gi|115249238 16 0 0 1 0 0 0
904 putative helicase 630_gi|115250059 87 0 0 0 1 0 0
906 putative lipoprotein 630_gi|115250384 21 0 0 0 1 0 0
908 630_gi|115249949|emb|CAJ67769.1|-R 630_gi|115249949 ? 0 0 0 1 0 0
909 putative phage-related protein 630_gi|115250413 5 0 0 1 0 0 0
910 conserved hypothetical protein 630_gi|115249410 13 0 0 1 0 0 0
911
BASYS00592, 612382-612774 (Clockwise) 
Hypothetical Protein BASYS00592
Hypothetical protein
(Flagellar assembly factor FliW)
sta_BASYS00592 
115249241 15 0 0 1 0 0 0
915
recT, 153449-152616 (CounterClockwise) 
Hypothetical Protein recT
recombination and repair protein RecT 
[Clostridium difficile QCD-63q42] stb_BASYS00175 31 0 0 0 1 0 0
921 putative esterase 630_gi|115250430 66 0 0 1 0 0 0
Identification Number Mass
(kDa)
No. unique peptides 
A B-1 Tra5/5
1 2 1 2 1 2
Strain A only M = 66, s/v = 14, h = 30, R = 11, t= 10, r = 1
293 putative bifunctional protein: 630_gi|115250474 81 6 1 0 0 0 0
266
peroxiredoxin/chitinase
294 putative membrane protein 630_gi|115250974 52 8 1 0 0 0 0
306
probable proton-dependent oligopeptide 
transporter 630_gi|115251316 50 3 2 0 0 0 0
307 putative cell wall hydrolase 630_gi|115252630 59 5 1 0 0 0 0
319 single-stranded DNA binding protein 630_gi|115252292 25 4 1 0 0 0 0
345
BASYS01831, 1920387-1919473 




(115250552) 35 4 0 0 0 0 0
382




(115249605) 199 5 1 0 0 0 0
424
BASYS03447, 3680327-3679458 




(115252065) 33 2 2 0 0 0 0
428
BASYS01825, 1915638-1914313 




(115250546) 49 3 2 0 0 0 0
455
glycine betaine/carnitine/choline ABC 
transporter, substrate-binding protein 630_gi|115249915 57 3 0 0 0 0 0
488
putative pyruvate formate-lyase 3 
activating enzyme 630_gi|115252339 34 2 1 0 0 0 0
489 conserved hypothetical protein 630_gi|115252583 51 2 1 0 0 0 0
490 putative oxidoreductase 630_gi|115249453 39 2 1 0 0 0 0
491 putative esterase/halogenase 630_gi|115251917 30 2 1 0 0 0 0
492
BASYS03271, 3480933-3479344




(115251847) 58 1 3 0 0 0 0
493
BASYS00861, 893869-892595 




47 1 2 0 0 0 0
496 stage V sporulation protein T 630_gi|115252560 20 4 0 0 0 0 0
497 putative protein translocase subunit 630_gi|115251854 11 2 0 0 0 0 0
537
BASYS01931, 1999997-1998948 
(CounterClockwise) Hypothetical Protein 
BB
ABC transporter substrate-binding protein 
[Clostridium difficile QCD-63q42] stt_BASYS01931 38 2 1 0 0 0 0
549
glnS, 2609350-2611014 (Clockwise) 
Glutaminyl-tRNA synthetase
sta_BASYS02511
115251113 64 3 0 0 0 0 0
550 rubrerythrin 630_gi|115251898 22 3 0 0 0 0 0
551 conserved hypothetical protein 630_gi|115252644 29 2 0 0 0 0 0
552
phosphoribosylaminoimidazole-
succinocarboxamide synthase 630_gi|115249227 27 1 0 0 0 0 0
569 D-ornithine aminomutase E component 630_gi|115249457 83 2 1 0 0 0 0
608 putative sugar-phosphate kinase 630_gi|115249217 48 1 1 0 0 0 0
609 ABC transporter, ATP-binding protein 630_gi|115251510 42 2 0 0 0 0 0
610 thioredoxin 630_gi|115250733 12 0 1 0 0 0 0
618 putative manganese-containing catalase 630_gi|115250607 25 2 1 0 0 0 0
638 putative stage II sporulation protein P 630_gi|115251523 38 1 1 0 0 0 0
267
639
putative aromatic amino acid 




GNAT Family sta_BASYS03656 19 1 1 0 0 0 0
652
inosine-uridine preferring nucleoside 
hydrolase 630_gi|115250725 36 1 0 0 0 0 0
655 conserved hypothetical protein 630_gi|115251175 20 2 0 0 0 0 0
657
deoxyuridine 5'-triphosphate 
nucleotidohydrolase 630_gi|115251455 16 2 0 0 0 0 0
664 putative fumarate hydratase, subunit B 630_gi|115250025 20 1 0 0 0 0 0
665 putative membrane protein 630_gi|115250482 32 1 0 0 0 0 0
666 putative membrane protein 630_gi|115252127 20 1 0 0 0 0 0
678 putative ATP/GTP-binding protein 630_gi|115252354 41 1 1 0 0 0 0
683 putative penicillin-binding protein 630_gi|115250180 111 1 1 0 0 0 0
687 PTS system, IIb component 630_gi|115250107 10 0 1 0 0 0 0
688 low-specificity L-threonine aldolase 630_gi|115251648 38 2 0 0 0 0 0
689 conserved hypothetical protein 630_gi|115252296 17 1 0 0 0 0 0
694
sodium:dicarboxylate symporter family 
protein 630_gi|115251595 50 1 0 0 0 0 0
695 putative lipoate-protein ligase 630_gi|115250695 38 1 0 0 0 0 0
723 putative lipoprotein 630_gi|115250265 32 0 1 0 0 0 0
724 IclR-family transcriptional regulator 630_gi|115251483 29 0 1 0 0 0 0
725
putative dihydroorotate dehydrogenase, 
catalytic subunit 630_gi|115252236 39 0 1 0 0 0 0
726




115250916 31 0 1 0 0 0 0
733
E3 component of acetoin dehydrogenase 
enzyme system (dihydrolipoyl 
dehydrogenase) 630_gi|115249042 62 1 0 0 0 0 0
734 flagellar export protein 630_gi|115249272 76 1 0 0 0 0 0
735 PTS system, IIb component 630_gi|115249506 17 1 0 0 0 0 0
736 putative transcriptional regulator 630_gi|115249644 25 1 0 0 0 0 0
737 conserved hypothetical protein 630_gi|115250341 18 1 0 0 0 0 0
738
putative sigma-54-dependent 
transcriptional regulator (partial) 630_gi|115250478 22 1 0 0 0 0 0
739 putative deoxyribose-phosphate aldolase 630_gi|115250542 24 1 0 0 0 0 0
740 putative ferrous ion transport protein 630_gi|115250558 78 1 0 0 0 0 0
741 conserved hypothetical protein 630_gi|115250804 33 1 0 0 0 0 0
742 two-component response regulator 630_gi|115250957 22 1 0 0 0 0 0
743 conserved hypothetical protein 630_gi|115251114 34 1 0 0 0 0 0
744 putative membrane protein 630_gi|115251282 30 1 0 0 0 0 0
745 putative germination-specific protease 630_gi|115251301 61 1 0 0 0 0 0
746 conserved hypothetical protein 630_gi|115251313 13 1 0 0 0 0 0
747
putative aliphatic sulfonate ABC 
transporter,ATP-binding protein 630_gi|115251414 30 1 0 0 0 0 0
748 conserved hypothetical protein 630_gi|115251427 11 1 0 0 0 0 0
749 histidine triad nucleotide-binding protein 630_gi|115251501 13 1 0 0 0 0 0
750 30S ribosomal protein S20 630_gi|115251527 10 1 0 0 0 0 0
751 putative phosphoribosyltransferase 630_gi|115251742 20 1 0 0 0 0 0
753 dipicolinate synthase, A chain 630_gi|115252026 32 1 0 0 0 0 0
754 delta-aminolevulinic acid dehydratase 630_gi|115252479 36 1 0 0 0 0 0
755
putative RNA/single-stranded DNA 
exonuclease 630_gi|115252723 76 1 0 0 0 0 0








(115252365) 77 2 0 0 0 0 0
758




21 1 0 0 0 0 0
759




29 1 0 0 0 0 0
763 putative exported protein 630_gi|115252517 16 1 0 0 0 0 0
767
yecS, 1915939-1916550 (Clockwise) 
Hypothetical Protein yecS
amino acid ABC transporter, permease 
protein
stt_BASYS01858 
(115250821) 23 2 0 0 0 0 0
770 stage V sporulation protein S 630_gi|115250981 9 0 1 0 0 0 0
771
832
BASYS00233, 228947-229429 (Clockwise) 
Glyoxalase
putative glyoxalase
sta_BASYS00233 19 0 1 0 0 0 0
630_gi|115249166 18 1 0 0 0 0 0
773
PTS system, mannitol-specific IIbc 
component 630_gi|115251389 50 0 1 0 0 0 0
815
bifunctional purine biosynthesis protein 
includes: 
phosphoribosylaminoimidazolecarboxami
de formyltransferase and IMP 
cyclohydrolase 630_gi|115249231 57 0 1 0 0 0 0
816 methylglyoxal synthase 630_gi|115250185 15 0 1 0 0 0 0
817
putative muramoyltetrapeptide 
carboxypeptidase 630_gi|115250438 33 0 1 0 0 0 0
818 cell surface protein 630_gi|115251848 59 0 1 0 0 0 0
819 conserved hypothetical protein 630_gi|115252555 10 0 1 0 0 0 0
820
manX, 3750702-3750208 
(CounterClockwise) Hypothetical Protein 
manX
PTS system, IIB component
sta_BASYS03509 
(11525212) 18 0 1 0 0 0 0
821
BASYS03604, 3866978-3865935 
(CounterClockwise) Hypothetical Protein 
BASYS03604
Hypothetical protein sta_BASYS03604 39 0 1 0 0 0 0
831 putative exported protein 630_gi|115250383 41 1 0 0 0 0 0
833 putative spore-coat protein 630_gi|115249613 21 1 0 0 0 0 0
834 conserved hypothetical protein 630_gi|115250402 17 1 0 0 0 0 0
835 putative signaling protein 630_gi|115250461 66 1 0 0 0 0 0
836
putative molybdenum cofactor 
biosynthesis protein 630_gi|115250756 18 1 0 0 0 0 0
837 putative glutamyl-aminopeptidase 630_gi|115251205 39 1 0 0 0 0 0
838 putative oxidoreductase subunit 630_gi|115251480 26 1 0 0 0 0 0
839 conserved hypothetical protein 630_gi|115251531 36 1 0 0 0 0 0
840 uracil-DNA glycosylase 630_gi|115251535 26 1 0 0 0 0 0
841
PyrR bifunctional protein includes: 
pyrimidine operon regulatory protein; 
uracil phosphoribosyltransferase 630_gi|115251652 20 1 0 0 0 0 0
842 tryptophanyl-tRNA synthetase 630_gi|115251661 38 1 0 0 0 0 0
843 putative ATP-binding protein 630_gi|115251691 18 1 0 0 0 0 0
844 oligopeptide ABC transporter, permease 630_gi|115251724 35 1 0 0 0 0 0
269
protein
845 probable polysaccharide deacetylase 630_gi|115251771 36 1 0 0 0 0 0
846 conserved hypothetical protein 630_gi|115251862 12 1 0 0 0 0 0
847 conserved hypothetical protein 630_gi|115252126 20 1 0 0 0 0 0
848 putative flavodoxin 630_gi|115252176 29 1 0 0 0 0 0
849
probable sigma54-dependent 
transcriptional regulator 630_gi|115252242 69 1 0 0 0 0 0
850 putative membrane protein 630_gi|115252285 36 1 0 0 0 0 0
851 hypoxanthine phosphoribosyltransferase 630_gi|115252288 20 1 0 0 0 0 0
852 probable GTP-binding protein 630_gi|115252356 22 1 0 0 0 0 0
853 GntR-family transcriptional regulator 630_gi|115252628 25 1 0 0 0 0 0
854 conserved hypothetical protein 630_gi|115252676 17 1 0 0 0 0 0
855
BASYS00041, 40158-39427 




(115249290) 28 1 0 0 0 0 0
856
BASYS00235, 229993-230559 (Clockwise) 
Hypothetical Protein BASYS00235
signal peptide [Clostridium difficile QCD-
66c26] sta_BASYS00235 22 1 0 0 0 0 0
860
BASYS03583, 3840546-3841103 (Clockwise) 
Transcriptional Regulator PadR-Like 
Family sta_BASYS03583 22 1 0 0 0 0 0
861
msbA, 3084615-3082825 
(CounterClockwise) Hypothetical Protein 
msbA
ABC transporter, ATP-binding/permease 
protein
stt_BASYS02922 
(115251870) 67 1 0 0 0 0 0
869
ydgP, 1509321-1509890 (Clockwise) 
Electron Transport Complex Protein RnfG
sta_BASYS01412
115250170
20 0 1 0 0 0 0
870 conserved hypothetical protein 630_gi|115249704 20 1 0 0 0 0 0
872 putative transcriptional regulator 630_gi|115250151 21 0 1 0 0 0 0
875
putative membrane-associated neutral 
zinc metallopeptidase 630_gi|115251638 26 0 1 0 0 0 0
879 arginyl-tRNA synthetase 630_gi|115249727 65 1 0 0 0 0 0
881
putative multidrug efflux pump, 
membrane protein 630_gi|115251459 113 1 0 0 0 0 0
884 putative arsenate reductase 630_gi|115250823 14 1 0 0 0 0 0
885 conserved hypothetical protein 630_gi|115249717 22 1 0 0 0 0 0
894 aspartokinase 630_gi|115250358 45 1 0 0 0 0 0
897
ABC transporter, ATP-binding/permease 
protein 630_gi|115250108 65 1 0 0 0 0 0
899 putative sensor histidine kinase 630_gi|115251546 105 1 0 0 0 0 0
905 penicillin-binding protein 630_gi|115249798 97 0 1 0 0 0 0
907 putative gluconate permease 630_gi|115250781 43 1 0 0 0 0 0
916
DeoR-family transcriptional regulator 
(fatty acid and phospholipid biosynthesis 
regulator) 630_gi|115250210 21 1 0 0 0 0 0
917
PTS system, mannitol-specific IIa 





Hypothetical protein sta_BASYS03298 11 1 0 0 0 0 1
927 putative AMP-binding protein 630_gi|115252027 53 1 0 0 0 0 0
270
928 putative histidyl-tRNA synthetase 630_gi|115251792 48 1 0 0 0 0 0
929 sta_BASYS02525-R sta_BASYS02525 ? 1 0 0 0 0 0
271
Table A3 – Proteins identified by 2D reference mapping but not 1D GE LC-MS/MS.
Identification Number Mass Mascot score 1D 
detected
A B-1 Tra5/5
1 indolepyruvate oxidoreductase subunit
630_gi|115251433|









frc, 759341-760540 (Clockwise) 
Hypothetical Protein frc (isocaprenoyl-
CoA:2-hydroxyisocaproate CoA-




thiH, 2730080-2731456 (Clockwise) 
Hypothetical Protein thiH (radical SAM-




gcvP, 1787909-1789366 (Clockwise) 
Hypothetical Protein gcvP (glycine 




norV, 1741635-1744166 (Clockwise) 
Hypothetical Protein norV (putative nitric 




glyS, 3040737-3038671 (CounterClockwise) 
Hypothetical Protein glyS (glycyl-tRNA 




acpS, 64221-63841 (CounterClockwise) 
Hypothetical Protein acpS (holo-acyl-
carrier protein synthase) sta_BASYS00071 14473 56
-
A












(CounterClockwise) Hypothetical Protein 




ptsI, 3427518-3425806 (CounterClockwise) 
Hypothetical Protein ptsI 
(phosphoenolpyruvate-protein 









fliY, 2449549-2448746 (CounterClockwise) 
Hypothetical Protein fliY (probable amino-
acid ABC transporter,substrate-binding 












(CounterClockwise) Hypothetical Protein 
atpD (V-type sodium ATP synthase 




BASYS00871, 876652-878778 (Clockwise) 





(CounterClockwise) V-type ATP synthase 
alpha chain stt_BASYS03006 65712 155
-
T
19 rpsA, 1074685-1075959 (Clockwise) stt_BASYS01053 48455 168 -
272




prs, 3916457-3915507 (CounterClockwise) 
Hypothetical Protein prs (ribose-




ycgM, 996287-997189 (Clockwise) 
Hypothetical Protein ycgM (putative 




efp, 1322094-1322666 (Clockwise) 
Hypothetical Protein efp (elongation factor 




pgi, 3620557-3619208 (CounterClockwise) 




aroA, 1980984-1981985 (Clockwise) 
Hypothetical Protein aroA (3--
phosphoshikimate 1----




yjeK, 2408425-2407157 (CounterClockwise) 
Hypothetical Protein yjeK (L-lysine 2,3-




ATIC, 997288-998463 (Clockwise) 
Bifunctional purine biosynthesis protein 




Table A4 – Proteins with significantly differing expression between the three strains as 
identified by correlation analysis using the SameSpots software with anova probability 
scores, Fold differences and the normalised volumes in each strain.
Rank Anova (p) Fold Notes Average Normalised Volumes 
B-1 A Tra5/5
1 1.185e-006 43.7 ID: 105 0.124 5.414 0.488
2 0.004 33.4 ID: 002 0.076 0.800 2.539
3 1.506e-008 27.0 ID: 041 7.465 0.820 0.276
4 1.493e-008 22.6 ID: 270 2.268 0.128 0.100
5 3.865e-005 22.4 ID: 345 3.817 0.171 0.316
6 8.095e-004 21.1 ID: 351 3.918 0.186 0.577
7 7.514e-007 19.1 ID: 328 0.205 3.450 0.181
8 2.581e-004 17.8 ID: 360 0.522 0.111 1.970
9 1.271e-005 16.7 ID: 283 0.426 7.130 1.307
10 0.002 14.3 ID: 354 4.714 0.514 0.330
11 0.002 12.2 ID: 043 3.757 0.308 0.850
12 0.002 12.2 ID: 043 3.748 0.307 0.850
13 3.359e-004 11.4 ID: 042 1.804 0.158 0.731
14 0.026 11.1 ID: 257 0.374 2.843 4.149
15 2.994e-004 10.4 ID: 325 0.101 0.300 1.045
16 2.291e-004 9.7 ID: 044 1.110 0.114 0.505
17 3.979e-006 9.7 ID: 231 4.021 1.321 0.416
18 2.321e-004 9.6 ID: 359 0.383 3.672 0.707
19 0.010 9.6 ID: 323 0.132 0.342 1.271
20 0.001 9.3 ID: 005 0.843 5.510 0.590
21 0.009 8.8 ID: 336 0.189 0.594 1.652
22 4.595e-004 8.7 ID: 419 3.076 0.354 0.921
23 8.066e-004 8.2 ID: 024 0.507 4.142 0.663
24 0.042 7.9 ID: 006 0.229 0.373 1.810
25 0.002 7.9 ID: 282 5.609 0.711 1.223
26 2.892e-005 7.7 ID: 046 2.890 4.112 0.536
27 0.025 7.6 ID: 220 0.485 0.466 3.551
28 0.014 7.5 ID: 423 0.258 0.389 1.936
29 2.424e-004 7.4 ID: 070 0.640 4.725 1.434
30 0.004 7.4 ID: 132 1.870 0.253 1.413
31 0.003 7.1 ID: 122 0.543 3.835 1.396
32 3.935e-004 6.9 ID: 097 3.766 0.627 0.545
33 5.689e-004 6.8 ID: 020 4.634 0.686 0.742
34 2.526e-004 6.7 ID: 184 3.448 0.803 0.511
274
Rank Anova (p) Fold Notes Average Normalised Volumes 
B-1 A Tra5/5
35 0.005 6.7 ID: 394 0.389 1.054 2.623
36 3.765e-004 6.7 ID: 288 2.411 0.442 0.362
37 1.768e-005 6.6 ID: 198 4.716 0.769 0.717
38 0.015 6.5 ID: 066 4.719 0.724 1.015
39 0.015 6.4 ID: 348 0.755 2.135 0.334
40 0.035 6.3 ID: 098 0.346 0.646 2.168
41 0.005 6.0 ID: 340 2.923 0.484 0.592
42 0.002 6.0 ID: 392 0.417 2.506 0.507
43 0.002 5.8 ID: 067 0.475 2.771 1.632
44 0.041 5.8 ID: 156 2.988 0.513 2.423
45 0.016 5.6 ID: 188 1.022 4.016 0.711
46 5.077e-005 5.6 ID: 403 3.427 1.038 0.611
47 0.020 5.6 ID: 093 1.454 5.309 0.954
48 0.033 5.5 ID: 034 1.364 0.569 3.148
49 0.003 5.3 ID: 338 0.754 4.022 1.536
50 1.378e-004 5.3 ID: 054 0.794 4.218 0.867
51 2.726e-004 5.3 ID: 061 0.613 3.218 1.250
52 0.003 5.0 ID: 237 0.320 1.612 0.750
53 0.026 5.0 ID: 168 0.802 0.653 3.240
54 0.035 4.9 ID: 026 1.187 0.240 0.973
55 0.002 4.7 ID: 253 2.885 0.614 0.945
56 6.130e-005 4.7 ID: 135 0.706 3.313 0.994
57 0.002 4.6 ID: 191 2.171 0.512 0.472
58 0.003 4.6 ID: 402 0.788 3.589 2.287
59 0.001 4.5 ID: 395 1.350 0.348 1.583
60 0.007 4.5 ID: 344 0.587 2.068 0.464
61 0.005 4.4 ID: 350 1.265 3.161 0.719
62 0.013 4.4 ID: 365 0.447 0.656 1.947
63 0.005 4.3 ID: 173 1.985 0.636 2.740
64 0.002 4.3 ID: 341 0.584 2.230 0.523
65 0.009 4.2 ID: 021 4.142 0.992 1.086
66 0.002 4.1 ID: 045 0.889 0.214 0.782
67 0.005 4.1 ID: 440 3.453 0.846 1.410
68 6.251e-004 3.8 ID: 421 2.836 2.635 0.752
69 0.019 3.7 ID: 126 2.155 0.576 0.824
70 0.017 3.7 ID: 387 0.504 0.943 1.880
71 0.016 3.7 ID: 106 1.126 2.165 0.581
72 0.003 3.7 ID: 193 1.432 1.814 0.488
73 0.049 3.7 ID: 072 1.315 2.001 0.543
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Rank Anova (p) Fold Notes Average Normalised Volumes 
B-1 A Tra5/5
74 0.037 3.5 ID: 311 0.338 0.411 1.175
75 0.020 3.4 ID: 146 2.963 0.864 1.569
76 0.029 3.4 ID: 037 1.573 0.979 0.461
77 0.021 3.4 ID: 092 0.190 0.274 0.642
78 0.012 3.3 ID: 233 2.301 1.559 0.707
79 0.006 3.1 ID: 211 1.982 1.539 0.643
80 0.002 3.1 ID: 117 1.254 3.344 1.088
81 0.009 3.1 ID: 049 1.125 0.600 1.843
82 0.048 3.1 ID: 130 2.944 0.981 0.961
83 0.014 3.0 ID: 408 2.706 2.112 0.901
84 0.026 2.9 ID: 162 0.378 0.404 1.095
85 0.018 2.9 ID: 051 1.970 0.685 0.817
86 0.027 2.8 ID: 166 2.000 0.702 1.493
87 0.009 2.8 ID: 127 1.603 0.575 1.102
88 0.006 2.8 ID: 194 2.080 0.776 0.752
89 0.002 2.7 ID: 241 2.926 2.654 1.071
90 0.003 2.7 ID: 239 1.851 0.851 0.682
91 0.005 2.7 ID: 225 1.045 1.801 0.670
92 0.015 2.7 ID: 136 0.462 1.232 0.848
93 0.007 2.6 ID: 453 1.775 0.683 0.909
94 1.744e-007 2.5 ID: 205 1.613 1.560 0.653
95 0.030 2.5 ID: 003 0.970 1.715 0.697
96 0.037 2.4 ID: 399 0.737 1.481 0.613
97 0.030 2.4 ID: 017 0.313 0.361 0.752
98 0.015 2.3 ID: 251 0.886 2.081 1.004
100 0.010 2.3 ID: 235 1.497 0.638 0.717
101 0.012 2.3 ID: 295 0.738 0.433 1.014
102 0.035 2.3 ID: 389 1.780 0.765 1.105
103 0.040 2.3 ID: 058 0.724 1.675 1.203
104 0.008 2.3 ID: 385 1.891 0.823 1.229
105 0.013 2.3 ID: 062 0.466 0.774 1.066
106 0.012 2.3 ID: 100 0.658 1.484 1.007
107 0.005 2.2 ID: 401 2.298 1.310 1.058
108 0.030 2.1 ID: 103 1.200 1.351 0.631
109 0.041 2.0 ID: 086 1.756 1.782 0.901
110 0.013 2.0 ID: 185 0.933 0.945 1.827
190 0.050 3.8 ID: 302 0.305 0.327 1.144
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Table A5 – Proteins identified in strain A ProteoMiner treated broth extracts by 1D GE 
followed by LC-MS/MS analysis with identification number, predicted mass and number 
of unique peptides detected in each sample. Theoretical pI values are also included for 
proteins identified only in treated fractions
The number of proteins of different types are show as follows; metabolic (m), surface 
and virulence (s/v), hypothetical (h), regulatory (R), transporter (t) and ribosomal (r).  
Identification Number Mass No. unique peptides 
E-beads SE-beads Crude
224 proteins  - m=145, s/v=5, r=43, h=11, t=3, R=17 1 2 1 2 1
All samples
1
acyl-CoA dehydrogenase, short-chain 
specific 630_gi|115249405 41 kDa 28 25 23 25 21
2 pyruvate-flavodoxin oxidoreductase 630_gi|115251733 129 kDa 21 19 35 27 20
3
isocaprenoyl-CoA:2-hydroxyisocaproate 
CoA-transferase 630_gi|115249401 44 kDa 22 19 18 18 14
4 electron transfer flavoprotein alpha-subunit 630_gi|115249407 37 kDa 18 14 12 16 16
5 30S ribosomal protein S3 630_gi|115249083 30 kDa 6 5 15 15 2
6 elongation factor TU 630_gi|115249061 44 kDa 17 15 16 10 13
7 electron transfer flavoprotein beta-subunit 630_gi|115249406 29 kDa 9 10 10 6 9
8 30S ribosomal protein S7 630_gi|115249073 18 kDa 14 17 12 10 9
9 putative amino acid aminotransferase 630_gi|115252729 45 kDa 24 19 17 17 14
10 putative rubrerythrin 630_gi|115250565 20 kDa 8 6 10 7 7
11 50S ribosomal protein L18 630_gi|115249093 14 kDa 5 3 8 6 1
12
subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase 630_gi|115249403 47 kDa 20 19 13 10 18
13 acetyl-CoA acetyltransferase 630_gi|115250080 41 kDa 11 12 16 15 18
14 50S ribosomal protein L4 630_gi|115249078 24 kDa 6 7 12 10 4
15
subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase 630_gi|115249404 42 kDa 20 14 12 8 16
16 30S ribosomal protein S5 630_gi|115249094 18 kDa 7 8 12 10 6
17 30S ribosomal protein S4 630_gi|115249105 24 kDa 12 10 8 7 7
18
putative oxidoreductase, thiamine diP-
binding subunit 630_gi|115249125 39 kDa 12 9 7 10 5
19




115252023 97 kDa 17 14 20 12 21
20
succinate-semialdehyde dehydrogenase 
NAD(P)+ 630_gi|115251397 51 kDa 11 10 16 13 20
21 50S ribosomal protein L19 630_gi|115250291 13 kDa 6 5 9 7 4
22 50S ribosomal protein L24 630_gi|115249088 11 kDa 3 2 4 5 2
23 50S ribosomal protein L13 630_gi|115249112 16 kDa 2 2 8 6 1
24 butyryl-CoA dehydrogenase 630_gi|115250075 41 kDa 11 10 10 9 12
25 50S ribosomal protein L1 630_gi|115249066 25 kDa 12 10 9 9 4
26





115251393 44 kDa 11 12 8 9 8
27 DNA-directed RNA polymerase beta' chain 630_gi|115249071 130 kDa 8 6 28 17 13
28 30S ribosomal protein S9 630_gi|115249113 15 kDa 8 8 9 9 6
29 50S ribosomal protein L17 630_gi|115249107 13 kDa 2 2 5 4 1
30 NAD-specific glutamate dehydrogenase 630_gi|115249189 46 kDa 9 7 11 11 18
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31 50S ribosomal protein L5 630_gi|115249089 20 kDa 13 12 7 8 9
32
BASYS02800, 2945591-2944029 
(CounterClockwise) Hypothetical Protein 
BASYS02800 glycine/sarcosine/betaine 
reductase complex component C beta    
subunit [Clostridium difficile 630].
sta_BASYS02800
115251404 56 kDa 6 5 14 11 7
33
rpsJ, 420934-421245 (Clockwise) 
Hypothetical Protein rpsJ
30S ribosomal protein S10
sta_BASYS00411
115249076 12 kDa 6 4 5 5 3
34 30S ribosomal protein S20 630_gi|115251527 10 kDa 5 3 2 2 2




yqjB, 3369095-3367134 (CounterClockwise) 
Uncharacterized protein yqjB
cell surface protein
630_gi|115251764 72 kDa 6 4 19 13 3
sta_BASYS03185
115251764 72 kDa 0 0 1 1 0
37 30S ribosomal protein S17 630_gi|115249086 10 kDa 4 3 4 2 2
38 aspartate aminotransferase 630_gi|115250375 45 kDa 17 12 9 8 11
39 30S ribosomal protein S13 630_gi|115249103 14 kDa 12 9 7 5 4
40 50S ribosomal protein L14 630_gi|115249087 13 kDa 3 4 7 4 1
41
putative oxidoreductase, acetyl-CoA 
synthase subunit 630_gi|115249184 68 kDa 12 8 12 11 13
42 50S ribosomal protein L2 630_gi|115249080 30 kDa 7 7 7 7 2
43 50S ribosomal protein L6 630_gi|115249092 20 kDa 4 4 6 5 5
44 50S ribosomal protein L27 630_gi|115250195 10 kDa 4 3 7 5 2
45 stage 0 sporulation protein A 630_gi|115250247 31 kDa 5 4 12 13 6
46
norV, 2106146-2108677 (Clockwise) 
Hypothetical Protein norV
putative nitric oxide reductase flavoprotein
sta_BASYS02024 
115250664 94 kDa 12 12 7 4 16
47 50S ribosomal protein L15 630_gi|115249096 16 kDa 8 4 7 6 4
48
glyS, 3040737-3038671 (CounterClockwise) 
Hypothetical Protein glyS
glycyl-tRNA synthetase beta chain
sta_BASYS02895
115251485 78 kDa 8 4 20 13 8
49 30S ribosomal protein S8 630_gi|115249091 15 kDa 4 5 6 5 6
50 50S ribosomal protein L22 630_gi|115249082 12 kDa 7 7 6 6 4
51 50S ribosomal protein L3 630_gi|115249077 22 kDa 8 7 6 3 5
52 putative ruberythrin 630_gi|115250515 20 kDa 4 4 4 2 3
53
glyceraldehyde-3-phosphate dehydrogenase 
2 630_gi|115252231 36 kDa 7 8 9 5 7
54 50S ribosomal protein L21 630_gi|115250193 11 kDa 5 4 5 4 4
55 30S ribosomal protein S11 630_gi|115249104 14 kDa 4 5 4 2 4
56 50S ribosomal protein L16 630_gi|115249084 16 kDa 2 2 4 2 1
57 (R)-2-hydroxyisocaproate dehydrogenase 630_gi|115249400 37 kDa 9 7 6 6 10
58




115252338 91 kDa 12 9 10 5 12
59
proS2, 389555-391087 (Clockwise) Prolyl-
tRNA synthetase 2 
putative dual-specificity prolyl/cysteinyl-
tRNA synthetase sta_BASYS00379
115249053 59 kDa 9 7 8 7 5
60 30S ribosomal protein S19 630_gi|115249081 11 kDa 1 1 4 3 1
61
glycine reductase complex component B 
alpha and beta subunits 630_gi|115251407 46 kDa 8 9 6 6 12




(CounterClockwise) Hypothetical Protein 
BASYS03269
cell surface protein (S-layer precursor 
protein)
sta_BASYS03269
115251846 80 kDa 1 1 2 0 32
64




115249204 58 kDa 16 15 2 2 18
65 indolepyruvate oxidoreductase subunit 630_gi|115251433 66 kDa 9 7 6 7 7
66 electron transfer flavoprotein beta-subunit 630_gi|115250076 29 kDa 8 7 5 3 7
67
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex,methyltransferase subunit 630_gi|115249744 29 kDa 9 9 6 4 6
68 putative aminoacyl-histidine dipeptidase 630_gi|115249724 53 kDa 9 5 7 4 7
69
putative anaerobic nitric oxide reductase 
flavorubredoxin 630_gi|115250189 45 kDa 6 5 3 1 5
70 metallo beta-lactamase superfamily protein 630_gi|115250323 62 kDa 10 7 8 8 3
71 putative subunit of oxidoreductase 630_gi|115249127 20 kDa 4 4 5 1 4
72
activator of 2-hydroxyisocaproyl-CoA 
dehydratase 630_gi|115249402 29 kDa 7 5 3 2 6
73 electron transfer flavoprotein alpha-subunit 630_gi|115250077 36 kDa 12 6 8 7 6
74 phosphate butyryltransferase 630_gi|115249121 32 kDa 2 7 5 4 5
75
lpdA, 1127096-1128496 (Clockwise) 
Hypothetical Protein lpdA 
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, dihydrolipoyl dehydrogenase 
subunit
sta_BASYS01068
115249740 50 kDa 4 4 12 13 1
76 conserved hypothetical protein 630_gi|115252289 45 kDa 6 6 5 3 5





vinylacetyl-coa-delta-isomerase 630_gi|115251396 55 kDa 3 2 5 4 13
79 putative translation elongation factor 630_gi|115249025 72 kDa 9 7 10 3 12
80




115249247 34 kDa 6 6 9 6 5
81 translation initiation factor IF-3 630_gi|115249701 19 kDa 3 3 9 8 3
82
putative glutamate synthase NADPH small 
chain 630_gi|115250578 50 kDa 9 6 6 3 7
83 pyruvate, phosphate dikinase 630_gi|115251462 97 kDa 10 6 10 5 8
84 PTS system, IIb component 630_gi|115252071 11 kDa 2 1 4 3 1
85
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, alpha subunit 630_gi|115249743 50 kDa 5 3 5 2 4
86 isoleucyl-tRNA synthetase 630_gi|115251669 120 kDa 6 5 12 9 6
87
glycine/sarcosine/betaine reductase complex 
component C alpha subunit 630_gi|115251403 41 kDa 7 4 2 2 13
88 threonine dehydratase catabolic 630_gi|115251567 43 kDa 4 4 5 4 10
89 translation elongation factor G 630_gi|115249074 76 kDa 6 7 2 3 13
90 ferredoxin 630_gi|115249124 8 kDa 4 3 5 5 3
91 50S ribosomal protein L10 630_gi|115249067 19 kDa 3 5 6 4 8
92 enolase 630_gi|115252227 46 kDa 9 7 3 3 5
279
93




115252362 51 kDa 2 2 8 5 5
94 putative electron transfer protein 630_gi|115252303 47 kDa 3 4 13 9 4
95 ribose-phosphate pyrophosphokinase 630_gi|115252575 34 kDa 5 4 4 3 4
96 pyruvate carboxylase 630_gi|115249024 129 kDa 3 3 12 7 4
97




115251315 68 kDa 6 7 3 2 8
98 30S ribosomal protein S16 630_gi|115250287 10 kDa 3 2 4 3 2
100 formate--tetrahydrofolate ligase 630_gi|115249735 60 kDa 4 3 5 5 13
101 leucyl-tRNA synthetase 630_gi|115251575 92 kDa 10 8 6 4 9
102 putative GTP-binding protein 630_gi|115251683 50 kDa 8 8 4 4 1
103 ATP synthase alpha chain 630_gi|115252530 55 kDa 6 4 3 3 8
104 putative propanediol utilization protein 630_gi|115251734 20 kDa 4 3 4 3 5
105 putative 5-nitroimidazole reductase 630_gi|115250500 18 kDa 3 4 1 1 7
106 putative alanyl-tRNA synthetase 630_gi|115250316 98 kDa 7 7 6 5 6
108 putative RNA-binding protein 630_gi|115249151 21 kDa 3 3 6 5 2
109 50S ribosomal protein L20 630_gi|115249703 13 kDa 3 3 3 3 2
110 rubrerythrin 630_gi|115249842 21 kDa 4 4 2 1 4
112 succinyl-CoA:coenzyme A transferase 630_gi|115251398 56 kDa 5 3 6 4 11
113 probable peptidase 630_gi|115251664 40 kDa 6 4 2 2 4
114 DNA gyrase subunit A 630_gi|115249009 91 kDa 2 1 14 7 5
115 DNA-directed RNA polymerase alpha chain 630_gi|115249106 35 kDa 8 6 8 6 3
116
oligopeptide ABC transporter, substrate-
binding lipoprotein 630_gi|115249872 59 kDa 5 3 6 5 7
117 threonyl-tRNA synthetase 630_gi|115249589 74 kDa 3 3 7 4 4
118 putative 2-hydroxyacyl-CoA dehydratase 630_gi|115250793 44 kDa 3 3 3 2 4
119 ATP synthase beta chain 630_gi|115252528 50 kDa 3 4 4 2 4
120
phosphoenolpyruvate-protein 
phosphotransferase 630_gi|115251808 63 kDa 5 5 3 2 8
121 50S ribosomal protein L29 630_gi|115249085 8 kDa 2 2 3 3 2
122 50S ribosomal protein L9 630_gi|115252722 17 kDa 1 2 7 7 2
123




115252337 28 kDa 5 5 3 1 2
124 putative phosphate butyryltransferase 630_gi|115249732 33 kDa 3 4 4 4 6
126




115252312 103 kDa 6 3 4 3 4
127
manganese-dependent inorganic 
pyrophosphatase 630_gi|115249342 59 kDa 7 7 1 1 7
128 4-hydroxybutyrate CoA transferase 630_gi|115251394 48 kDa 1 1 2 1 12
129
putative molybdenum-binding subunit of 
oxidoreductase 630_gi|115251153 82 kDa 0 1 9 8 3
131
putative bi-functional glycine 
dehydrogenase/aminomethyl transferase 
protein 630_gi|115250698 92 kDa 4 2 10 6 3
132
glucosamine--fructose-6-phosphate 
aminotransferase isomerizing 630_gi|115249129 67 kDa 2 3 3 2 7
133 transcription termination factor Rho 630_gi|115252548 61 kDa 5 4 3 3 1
135 conserved hypothetical protein 630_gi|115252075 17 kDa 2 2 2 2 2
137 50S ribosomal protein L7/L12 630_gi|115249068 13 kDa 5 5 2 2 4
138 conserved hypothetical protein 630_gi|115249575 22 kDa 2 1 4 2 1
280
140
GTP-sensing transcriptional pleiotropic 
repressor 630_gi|115250309 29 kDa 3 3 4 4 5
141 30S ribosomal protein S6 630_gi|115252728 11 kDa 5 4 2 0 3
142
ABC transporter, substrate-binding 
lipoprotein 630_gi|115249887 36 kDa 4 3 4 5 6
143 ATP-dependent protease La 630_gi|115252357 90 kDa 2 2 4 4 3
144
putative dinitrogenase iron-molybdenum 
cofactor 630_gi|115250736 13 kDa 1 1 1 1 2
145 butyrate kinase 630_gi|115249122 39 kDa 2 2 1 0 11
148 putative ornithine cyclodeaminase 630_gi|115249560 36 kDa 4 3 3 2 2
149
UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 1 630_gi|115249132 45 kDa 2 1 6 4 1
150
putative FAD-binding subunit of 
oxidoreductase 630_gi|115251155 30 kDa 1 1 7 5 1
151 proline reductase subunit proprotein 630_gi|115252300 68 kDa 2 2 0 1 9
152




115249100 11 kDa 3 1 6 5 1
153 uracil phosphoribosyltransferase 630_gi|115252539 23 kDa 1 3 5 2 1
154




115249409 33 kDa 1 3 4 2 6
155 50S ribosomal protein L11 630_gi|115249065 15 kDa 1 1 2 2 1
156 tellurium resistance protein 630_gi|115250846 21 kDa 1 0 7 7 1
157
anaerobic ribonucleoside-triphosphate 
reductase 630_gi|115249116 89 kDa 4 2 4 2 3
158 putative NUDIX-family hydrolase 630_gi|115249807 17 kDa 2 1 3 2 3
159
putative bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase 630_gi|115249733 69 kDa 2 1 2 2 3
161 glycogen synthase 630_gi|115249898 56 kDa 4 4 1 1 1
162 conserved hypothetical protein 630_gi|115249288 15 kDa 3 2 3 2 3
163
putative dehydrogenase, electron transfer 
subunit 630_gi|115250577 33 kDa 3 4 1 0 4
164 50S ribosomal protein L23 630_gi|115249079 11 kDa 1 0 3 2 1
167 30S ribosomal protein S18 630_gi|115252726 9 kDa 3 2 1 1 0
168
glycine reductase complex component B 
gamma subunit 630_gi|115251405 47 kDa 3 1 1 1 6
172
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, small subunit 630_gi|115249742 34 kDa 3 2 2 3 2
173 S-adenosylmethionine synthetase 630_gi|115249139 44 kDa 2 1 3 4 1
174 trehalose-6-phosphate hydrolase 630_gi|115252145 66 kDa 2 3 2 1 3
175 putative DNA-binding protein 630_gi|115249180 23 kDa 2 1 4 3 2
176




115249217 48 kDa 1 1 2 2 1
177 lysyl-tRNA synthetase 630_gi|115252615 58 kDa 3 2 2 2 5
178 putative universal stress protein 630_gi|115249829 15 kDa 3 3 1 2 3
181 tellurium resistance protein 630_gi|115250676 22 kDa 1 2 3 3 3
182 pyruvate kinase 630_gi|115252454 63 kDa 2 1 2 2 6
183
putative indolepyruvate oxidoreductase 
subunit 630_gi|115251432 21 kDa 2 1 2 2 2
184
putative pyridine nucleotide-disulfide 
oxidoreductase 630_gi|115250843 59 kDa 4 3 2 1 3
281
185




115250078 28 kDa 4 2 2 1 4
187 SpoIIIJ-associated protein 630_gi|115252741 24 kDa 3 3 2 3 2
188
carbamoyl-phosphate synthase,pyrimidine-
specific, large chain 630_gi|115252652 119 kDa 3 3 2 3 4
190 V-type sodium ATP synthase subunit A 630_gi|115252012 66 kDa 3 3 0 1 2
191 putative transcriptional regulator 630_gi|115250535) 23 kDa 2 2 2 2 2
192 ribosome recycling factor 630_gi|115251191 21 kDa 1 1 2 2 3
193 RecA protein (recombinase A) 630_gi|115250364 37 kDa 1 1 2 2 1
197 cysteinyl-tRNA synthetase 630_gi|115249055 54 kDa 1 1 5 3 2
198
putative iron-only hydrogenase, catalytic 
subunit 630_gi|115252467 65 kDa 2 2 2 1 2
199 putative ATP-binding protein 630_gi|115250774 29 kDa 2 3 1 1 2
200
oligopeptide ABC transporter, substrate-
binding protein 630_gi|115251723 58 kDa 1 0 2 1 6
202 GntR-family transcriptional regulator 630_gi|115250423 24 kDa 1 0 3 3 1
203 GntR-family transcriptional regulator 630_gi|115252628 25 kDa 2 2 2 2 2
204 DNA-binding protein HU 630_gi|115252557 10 kDa 3 1 2 1 2
205




115250813 37 kDa 2 1 5 1 1
206 methionyl-tRNA synthetase 630_gi|115252601 74 kDa 3 3 1 0 4
207 3-oxoacyl-acyl-carrier-protein synthase II 630_gi|115250217 44 kDa 2 4 0 1 1
208 transketolase 630_gi|115251376 32 kDa 0 3 1 1 4
209
BASYS01830, 1919083-1918436 




115250551 24 kDa 1 3 1 1 3
213 conserved hypothetical protein 630_gi|115251617 13 kDa 3 1 2 1 2
214 putative 30S ribosomal protein S1 630_gi|115250007 48 kDa 4 2 3 0 1
215 conserved hypothetical protein 630_gi|115251576 13 kDa 1 1 1 1 1
219 conserved hypothetical protein 630_gi|115251019 48 kDa 2 1 1 1 1
220 elongation factor Ts 630_gi|115251193 33 kDa 1 1 1 1 5
221 uridylate kinase 630_gi|115251192 26 kDa 1 1 1 1 2
222 putative peptidase 630_gi|115252582 40 kDa 2 1 1 0 5
223 conserved hypothetical protein 630_gi|115250343 11 kDa 1 0 1 1 1
226 sigma-54-dependent transcriptional activator 630_gi|115252301 67 kDa 1 1 4 3 1
227




115249602 10 kDa 1 1 1 1 2
230 DNA mismatch repair protein 630_gi|115251023 109 kDa 2 1 1 1 2
231 L-aspartate-beta-decarboxylase 630_gi|115251568 62 kDa 2 3 1 0 2
232 putative ATP/GTP-binding protein 630_gi|115249123 25 kDa 1 1 1 2 1
233 nitrilase (carbon-nitrogen hydrolase) 630_gi|115251895 34 kDa 2 2 1 1 0
243 ATP-dependent nuclease subunit B 630_gi|115250061 134 kDa 1 1 2 1 2
244 seryl-tRNA synthetase 630_gi|115249017 49 kDa 1 1 1 1 1
245 excinuclease ABC subunit A 630_gi|115252471 105 kDa 2 0 2 1 2
252 putative phosphoglucomutase 630_gi|115250617 64 kDa 2 2 1 1 2
253 ATP-dependent Clp protease 630_gi|115249029 91 kDa 2 1 3 0 2
254 putative ATP-dependent RNA helicase 630_gi|115249778 61 kDa 1 2 2 2 0
255 UDP-glucose 4-epimerase 630_gi|115251765 37 kDa 1 3 1 0 2
258
formylglycinamidine ribonucleotide 
synthetase 630_gi|115249233 141 kDa 1 0 1 0 5
269 anti-sigma F factor antagonist 630_gi|115249787 13 kDa 1 1 1 0 1
282
278 amidophosphoribosyltransferase 630_gi|115249228 51 kDa 2 1 1 1 1
279 cell division protein 630_gi|115251697 41 kDa 1 1 0 1 2
280 transcription antitermination protein 630_gi|115249064 20 kDa 1 1 1 1 1
281 trans-2-enoyl-ACP reductase 630_gi|115250213 33 kDa 1 1 2 1 1
284 proline reductase 630_gi|115252298 26 kDa 1 0 1 1 1
287
putative translation inhibitor 
endoribonuclease 630_gi|115251566 14 kDa 1 1 1 0 1
296




115251791 67 kDa 0 1 2 0 3
314 aspartate-semialdehyde dehydrogenase 630_gi|115252281 37 kDa 3 1 1 0 1
316 putative tRNA modification GTPase 630_gi|115252740 51 kDa 3 1 1 1 0
319 putative D-tyrosyl-tRNA protein 630_gi|115251795 16 kDa 1 1 1 0 1
320
phosphoribosylaminoimidazole carboxylase 
catalytic subunit 630_gi|115249226 17 kDa 0 1 1 1 1
332
cyclopropane-fatty-acyl-phospholipid 
synthase 630_gi|115249187 46 kDa 1 0 1 0 1
342
putative oxidoreductase, NAD/FAD binding 
subunit 630_gi|115249186 46 kDa 1 0 0 1 2
371 3-oxoacyl-acyl-carrier protein reductase 630_gi|115250215 27 kDa 1 1 1 1 1
405 aspartate aminotransferase 630_gi|115249115 44 kDa 0 1 1 0 1
441 conserved hypothetical protein 630_gi|115249281 54 kDa 1 0 0 1 1
Identification Number Mass No. unique peptides 
E beads SE beads Crude
111 proteins  m=77, s/v=1, r=0, h=16, t=5, R=12 1 2 1 2 1
Ebeads + crude
111 asparaginyl-tRNA synthetase 630_gi|115251299 54 kDa 5 5 0 0 5
125 putative proline racemase 630_gi|115252294 36 kDa 4 5 0 0 6
130
pheT, 1093175-1095568 (Clockwise) 
Phenylalanyl-tRNA synthetase beta chain
phenylalanyl-tRNA synthetase beta chain
sta_BASYS01042
115249716 89 kDa 7 6 0 0 10
136 thioredoxin reductase 630_gi|115251409 34 kDa 2 2 0 0 6
165 GMP synthase glutamine-hydrolyzing 630_gi|115249206 57 kDa 6 2 0 0 6
169 formate acetyltransferase 630_gi|115249776 84 kDa 5 4 0 0 5
170




115251640 100 kDa 7 3 0 0 9
179 chaperone protein (heat shock protein) 630_gi|115249282 75 kDa 3 2 0 0 9
180 ribonuclease R 630_gi|115252220 82 kDa 3 5 0 0 1
186 toxin A 630_gi|115249677 308 kDa 3 2 0 0 10
189 putative aminopeptidase 630_gi|115250096 51 kDa 1 2 0 0 1
195 AsnC-family transcriptional regulator 630_gi|115252605 16 kDa 5 2 0 0 4
196 hypothetical protein 630_gi|115249824 14 kDa 1 1 0 0 1
201 single-strand binding protein 630_gi|115252727 16 kDa 3 4 0 0 4
210
amino acid ABC transporter, substrate-
binding protein 630_gi|115250820 30 kDa 2 2 0 0 6
212




115250155 33 kDa 2 0 0 0 6
216
ATP-dependent Clp protease ATP-binding 
subunit 630_gi|115252360 46 kDa 3 3 0 0 3
224 ferritin 630_gi|115251248 20 kDa 1 1 0 0 1
228 ribulose-phosphate 3-epimerase 630_gi|115251631 24 kDa 2 2 0 0 2
234 tellurium resistance protein 630_gi|115250677 23 kDa 2 3 0 0 3
283
235
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, beta subunit 630_gi|115249745 77 kDa 2 2 0 0 2
236 translation initiation factor IF-2 630_gi|115250345 70 kDa 1 1 0 0 3
238 LysR-family transcriptional regulator 630_gi|115250103 35 kDa 1 3 0 0 3




mutase 630_gi|115251833 64 kDa 2 3 0 0 2
247 putative amidohydrolase 630_gi|115252278 42 kDa 2 1 0 0 2
248 putative serine hydroxymethyltransferase 630_gi|115251778 46 kDa 1 1 0 0 1
250 ABC transporter, ATP-binding protein 630_gi|115251122 62 kDa 1 0 0 0 6
257 anti-sigma F factor 630_gi|115249788 16 kDa 2 1 0 0 2
259 putative nitroreductase 630_gi|115251628 25 kDa 1 1 0 0 5
260 putative transaldolase 630_gi|115251384 23 kDa 1 1 0 0 4
262 conserved hypothetical protein 630_gi|115250197 14 kDa 1 1 0 0 2
263 putative cold shock protein 630_gi|115250391 7 kDa 1 1 0 0 2
264 polyribonucleotide nucleotidyltransferase 630_gi|115250354 78 kDa 2 0 0 0 4
267 putative glycine cleavage system H protein 630_gi|115249746 14 kDa 2 2 0 0 2
268 single-stranded DNA binding protein 630_gi|115252292 25 kDa 1 3 0 0 3
271 putative cyclase 630_gi|115251016 24 kDa 1 1 0 0 4
273 dihydrodipicolinate synthase 630_gi|115252282 32 kDa 0 2 0 0 3
275 NifU-like protein 630_gi|115250314 16 kDa 1 0 0 0 3
283 putative L-asparaginase 630_gi|115251569 36 kDa 1 4 0 0 2
285 putative phosphatase 630_gi|115251616 60 kDa 1 1 0 0 1
286 iron-dependent hydrogenase 630_gi|115249907 56 kDa 1 1 0 0 2
288 4-aminobutyrate aminotransferase 630_gi|115251211 48 kDa 1 1 0 0 1
289 putative decarboxylase 630_gi|115251040 12 kDa 2 0 0 0 4
294 probable hydrolase 630_gi|115251629 24 kDa 2 2 0 0 1
295 conserved hypothetical protein 630_gi|115252608 28 kDa 2 2 0 0 1
297
septum site-determining protein (cell 
division inhibitor) 630_gi|115250182 29 kDa 2 1 0 0 2
298 dipicolinate synthase, B chain 630_gi|115252025 21 kDa 1 2 0 0 2
299 conserved hypothetical protein 630_gi|115252645 33 kDa 2 2 0 0 1
300
ATP-dependent Clp protease proteolytic 
subunit 630_gi|115252361 21 kDa 1 1 0 0 3
301 radical SAM-superfamily protein 630_gi|115250190 71 kDa 1 1 0 0 2
302 conserved hypothetical protein 630_gi|115250191 27 kDa 2 1 0 0 1
303 glycyl-tRNA synthetase alpha chain 630_gi|115251486 34 kDa 1 1 0 0 1
304 conserved hypothetical protein 630_gi|115252525 17 kDa 3 0 0 0 2
306




115251402 40 kDa 5 1 0 0 0




imidazole-4-carboxamide isomerase 630_gi|115250593 27 kDa 2 1 0 0 2
315
hcr, 1135233-1137227 (Clockwise) 
Hypothetical Protein Mbar A
putative iron-sulfur protein
sta_BASYS01075
115249747 74 kDa 1 1 0 0 2
322 putative transcriptional repressor 630_gi|115252578 32 kDa 1 3 0 0 2
323 conserved hypothetical protein 630_gi|115249812 26 kDa 1 1 0 0 2
324 ABC transporter, ATP-binding protein 630_gi|115252673 27 kDa 1 1 0 0 2
325 putative metal dependent phosphohydrolase 630_gi|115251577 22 kDa 2 1 0 0 1
326 electron transfer flavoprotein beta-subunit 630_gi|115249821 29 kDa 1 1 0 0 1
284
327 putative phosphoribosyltransferase 630_gi|115251742 20 kDa 1 1 0 0 1
328 L-serine dehydratase 630_gi|115252279 43 kDa 1 1 0 0 1
329
carbamoyl-phosphate synthase,pyrimidine-
specific, large chain 630_gi|115252654 119 kDa 1 1 0 0 1
330 putative selenocysteine lyase 630_gi|115252735 42 kDa 1 1 0 0 1
333
putative aliphatic sulfonates ABC 
transporter,substrate-binding lipoprotein 630_gi|115250525 36 kDa 0 1 0 0 3
338 conserved hypothetical protein 630_gi|115250029 32 kDa 1 2 0 0 1
339 threonine synthase 630_gi|115251172 56 kDa 1 1 0 0 2
340 proline iminopeptidase 630_gi|115252096 34 kDa 1 1 0 0 2
344 orotate phosphoribosyltransferase 630_gi|115249197 21 kDa 1 1 0 0 1
345 putative signal recognition particle 630_gi|115250284 47 kDa 1 1 0 0 1
346 putative NADPH-dependent FMN reductase 630_gi|115250716 23 kDa 1 1 0 0 1
347 putative carbonic anhydrase 630_gi|115251267 24 kDa 1 1 0 0 1
348 cell-division initiation protein 630_gi|115251670 20 kDa 1 1 0 0 1







115249398 23 kDa 1 1 0 0 1
362 putative tellurite resistance protein 630_gi|115250680 44 kDa 1 0 0 0 2
363 10 kDa chaperonin 630_gi|115249203 10 kDa 1 0 0 0 1
375 conserved hypothetical protein 630_gi|115250440 24 kDa 1 1 0 0 1
376 radical SAM-superfamily protein 630_gi|115251209 52 kDa 1 1 0 0 1
377 two-component response regulator 630_gi|115251774 27 kDa 1 1 0 0 1
378 conserved hypothetical protein 630_gi|115252731 10 kDa 2 0 0 0 2
380 glutamyl-tRNA synthetase 630_gi|115249054 57 kDa 1 0 0 0 2
381 hypothetical protein 630_gi|115249604 92 kDa 1 0 0 0 2
382 conserved hypothetical protein 630_gi|115252618 28 kDa 1 0 0 0 2
385 phenylalanyl-tRNA synthetase alpha chain 630_gi|115249715 38 kDa 1 0 0 0 1
386 transketolase 630_gi|115251377 29 kDa 1 0 0 0 1
403
UDP-N-acetylmuramoylalanine--D-
glutamate ligase 630_gi|115251704 50 kDa 1 1 0 0 1
404
inosine-uridine preferring nucleoside 
hydrolase 630_gi|115250725 36 kDa 1 1 0 0 1
407 putative nitrite and sulfite reductase subunit 630_gi|115250842 34 kDa 0 1 0 0 2
408 conserved hypothetical protein 630_gi|115249350 16 kDa 1 0 0 0 2
411 hydroxylamine reductase 630_gi|115251221 59 kDa 1 0 0 0 1
412 guanylate kinase 630_gi|115251645 23 kDa 1 0 0 0 1
413 ferredoxin 630_gi|115252670 6 kDa 1 0 0 0 1
414




115252734 21 kDa 1 0 0 0 1
416
(3R)-hydroxymyristoyl-acyl carrier protein 
dehydratase 630_gi|115249137 16 kDa 1 1 0 0 0
417 delta-aminolevulinic acid dehydratase 630_gi|115252479 36 kDa 1 1 0 0 0
444
putative phosphoribosylaminoimidazole-
succinocarboxamide synthase 630_gi|115249503 25 kDa 0 1 0 0 1
445
probable amino-acid ABC 
transporter,substrate-binding protein 630_gi|115251230 30 kDa 0 1 0 0 1
446
putative pyruvate formate-lyase 3 activating 
enzyme 630_gi|115252339 34 kDa 0 1 0 0 1
447 DNA polymerase III, beta chain 630_gi|115249005 46 kDa 1 0 0 0 1
448 xanthine phosphoribosyltransferase 630_gi|115251385 21 kDa 1 0 0 0 1
449 S-ribosylhomocysteinase 630_gi|115252662 17 kDa 1 0 0 0 1
462 putative ATP-binding protein 630_gi|115250457 25 kDa 1 0 0 0 1
285
486 conserved hypothetical protein 630_gi|115250280 17 kDa 1 0 0 0 1
498 phosphopantetheine adenylyltransferase 630_gi|115251613 18 kDa 0 1 0 0 1
511 putative cation transport protein 630_gi|115249713 24 kDa 1 0 0 0 1
512 hypothetical protein 630_gi|115252039 74 kDa 1 0 0 0 1
572
4-hydroxy-3-methylbut-2-en-1-yl 
diphosphate synthase 630_gi|115251182 38 kDa 1 0 0 0 1
Identification Number Mass No. unique peptides 
E beads SE beads Crude
46 proteins - m=27, s/v=0, r=0, h=13, t=2, R=4 1 2 1 2 1
Ebeads only
331 putative thiamine biosynthesis protein 630_gi|115249771
44 kDa
6.97 3 2 0 0 0
353 conserved hypothetical protein 630_gi|115252583
51 kDa
4.45 2 2 0 0 0
392 SsrA-binding protein 630_gi|115252213
19 kDa
9.64 1 1 0 0 0
437 conserved hypothetical protein 630_gi|115252126
20 kDa
5.97 0 2 0 0 0
442 conserved hypothetical protein 630_gi|115251612
20 kDa
4.75 1 2 0 0 0
443 putative phosphoserine phosphatase 630_gi|115249318
28 kDa
5.06 1 2 0 0 0
450 conserved hypothetical protein 630_gi|115251509
29 kDa
9.43 1 1 0 0 0
472
putative aromatic amino acid 
aminotransferase 630_gi|115251881
45 kDa
5.01 2 0 0 0 0
475 ferric uptake regulation protein 630_gi|115250321
18 kDa
5.22 2 0 0 0 0
480 putative transcriptional regulator 630_gi|115252733
51 kDa
5.48 0 1 0 0 0
482 glycerol dehydratase 630_gi|115250149
89 kDa
5.64 1 0 0 0 0
487 metallo-beta-lactamase superfamily protein 630_gi|115249353
35 kDa
5.38 1 1 0 0 0
488 conserved hypothetical protein 630_gi|115251511
30 kDa
5.20 1 1 0 0 0
504 aspartate--ammonia ligase 630_gi|115251746
39 kDa
4.86 0 2 0 0 0
540 conserved hypothetical protein 630_gi|115249592
22 kDa
5.11 0 1 0 0 0
541
putative radical SAM superfamily 
lipoprotein 630_gi|115251281
33 kDa
8.96 0 1 0 0 0
543
BASYS03624, 3892755-3891991 




9.11 0 1 0 0 0
545 transcription elongation protein 630_gi|115250342
44 kDa
4.59 1 0 0 0 0
546 conserved hypothetical protein 630_gi|115250366
70 kDa
5.19 1 0 0 0 0
547 PTS system, lichenan-specific IIa component 630_gi|115251933
12 kDa









6.29 1 0 0 0 0
614 aspartokinase 630_gi|115250358
45 kD
4.95 0 1 0 0 0
615 putative sigma 54 modulation protein 630_gi|115251497
22 kDa
4.99 0 1 0 0 0
616 glucokinase 630_gi|115251513
34 kDa





6.91 0 1 0 0 0
618 conserved hypothetical protein 630_gi|115252038
35 kDa
6.79 0 1 0 0 0
619 prolyl-tRNA synthetase 630_gi|115249052
64 kDa
5.11 1 0 0 0 0
620 putative amidohydrolase 630_gi|115249796
41 kDa
5.16 1 0 0 0 0
621 exonuclease subunit C 630_gi|115250064
136 kDa
6.63 1 0 0 0 0
622 conserved hypothetical protein 630_gi|115250233
13 kDa
5.21 1 0 0 0 0
623 putative pyridoxine kinase 630_gi|115250389
31 kDa
4.53 1 0 0 0 0
624 tRNA pseudouridine synthase 2 630_gi|115250830
29 kDa
9.14 1 0 0 0 0
625
putative ethanolamine/propanediol 
utilization cobalamin adenosyltransferase 630_gi|115250966
30 kDa





5.15 1 0 0 0 0
627 putative amidohydrolase 630_gi|115251748
41 kDa
5.53 1 0 0 0 0
628 putative esterase/halogenase 630_gi|115251917
30 kDa
5.11 1 0 0 0 0
629




5.36 1 0 0 0 0
635
BASYS02150, 2243043-2243318 (Clockwise) 
Hypothetical Protein BASYS02150 sta_BASYS02150
10 kDa
10.76 0 1 0 0 0
639 tRNA pseudouridine synthase 1 630_gi|115249111
27 kDa
8.99 0 1 0 0 0
654 conserved hypothetical protein 630_gi|115251206
9 kDa
7.70 1 0 0 0 0
679 probable esterase 630_gi|115251258
30 kDa
5.18 1 0 0 0 0
690 ABC transporter, ATP-binding protein 630_gi|115251001
25 kDa
7.78 1 0 0 0 0
700
putative sulfonate ABC transporter,solute-
binding lipoprotein 630_gi|115251417
40 kDa
5.79 1 0 0 0 0
707 cobalt transport protein 630_gi|115249335
27 kDa
8.98 1 0 0 0 0
287
711 putative tRNA/rRNA methyltransferase 630_gi|115249058
27 kDa
6.60 1 0 0 0 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
19 proteins - m=15, s/v=1, r=1, h=3, t=0, R=0 1 2 1 2 1
Ebeads and SE beads
99 30S ribosomal protein S15 630_gi|115250352
10 kDa
10.19 7 7 5 2 0
107 adenylosuccinate lyase 630_gi|115250370
55 kDa
5.82 3 2 9 5 0
261 putative GTP pyrophosphokinase 630_gi|115251796
85 kDa
8.81 1 1 2 0 0
318 probable GTP-binding protein 630_gi|115252356
22 kDa
8.91 0 1 2 2 0
321 glycine cleavage system P protein 630_gi|115250699
54 kDa
5.55 1 1 1 1 0
372 glucose inhibited division protein A 630_gi|115252739
71 kDa
6.26 1 0 2 1 0
373 putative 16S rRNA processing protein 630_gi|115250289
20 kDa
5.07 1 1 0 2 0
387 signal recognition particle protein 630_gi|115250286
50 kDa
9.26 1 0 1 0 0
415 undecaprenyl pyrophosphate synthetase 630_gi|115251189
28 kDa
8.62 0 1 1 1 0
439 putative radical SAM family protein 630_gi|115251801
53 kDa
5.04 1 1 1 0 0
440 Spo0B-associated GTP-binding protein 630_gi|115250196
47 kDa





6.44 1 0 0 1 0
455 hypothetical protein 630_gi|115252720
12 kDa
4.77 1 0 1 0 0
490 GTP-binding protein 630_gi|115251490
34 kDa
8.33 0 1 1 0 0
491 putative molybdopterin biosynthesis protein 630_gi|115251123
37 kDa
5.42 1 0 1 0 0
492
BASYS02918, 3060611-3059598 





5.58 1 0 1 0 0
493
biotin carboxylase (acetyl-CoA carboxylase 
subunit A) 630_gi|115250984
51 kDa
5.37 0 1 1 0 0
510 peptidase T 630_gi|115250067
45 kDa
4.86 1 0 1 0 0
551 conserved hypothetical protein 630_gi|115250989
11 kDa
4.34 1 0 0 1 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
22 proteins m=14, s/v=2, r=0, h=4, t=0, R=2 1 2 1 2 1
SE beads and crude
134
BASYS03267, 3473846-3471975 
(CounterClockwise) Hypothetical Protein 
BASYS03267
cell surface protein (putative S-layer protein 
precursor)
sta_BASYS03267
115251844 66 kDa 0 0 6 4 11
288
146 conserved hypothetical protein 630_gi|115249020 12 kDa 0 0 5 5 1
229 preprotein translocase SecA subunit 630_gi|115249152 102 kDa 0 0 4 1 3
256




115249289 8 kDa 0 0 2 2 1
270
putative thiol peroxidase (bacterioferritin 
comigratory protein) 630_gi|115250867 18 kDa 0 0 2 1 3
274 TetR-family transcriptional regulator 630_gi|115251558 35 kDa 0 0 1 1 1
282
porphyrin biosynthesis protein includes: 
uroporphyrinogen-III methyltransferase and 
uroporphyrinogen-III synthase 630_gi|115252480 56 kDa 0 0 2 2 1
290 glycyl-tRNA synthetase beta chain 630_gi|115251485 78 kDa 0 0 2 2 0
291
secA, 3476606-3474261 (CounterClockwise) 
Hypothetical Protein secA
preprotein translocase SecA subunit
sta_BASYS03268 
115251845 89 kDa 0 0 2 1 1
305 riboflavin biosynthesis protein 630_gi|115250350 35 kDa 0 0 3 2 0
309 thioredoxin 630_gi|115250733 12 kDa 0 0 1 0 3
341 ATP synthase subunit delta 630_gi|115252531 21 kDa 0 0 2 1 1
357
transketolase, thiamine disphosphate-
binding subunit 630_gi|115252520 30 kDa 0 0 1 1 1
358 conserved hypothetical protein 630_gi|115251463 32 kDa 0 0 3 0 1
374 conserved hypothetical protein 630_gi|115251464 23 kDa 0 0 1 1 2
379
putative methylenetetrahydrofolate 
reductase 630_gi|115249739 32 kDa 0 0 1 1 1
406 two-component response regulator 630_gi|115250828 28 kDa 0 0 1 1 1
409 penicillin-binding protein 630_gi|115249798 97 kDa 0 0 1 0 2
410




115252229 27 kDa 0 0 1 0 2
453
PyrR bifunctional protein includes: 
pyrimidine operon regulatory protein; uracil 
phosphoribosyltransferase 630_gi|115251652 20 kDa 0 0 1 0 1
454
cell surface protein (putative cell surface-
associated cysteine protease) 630_gi|115251840 87 kDa 0 0 1 0 1
497 fibronectin-binding protein 630_gi|115251649 68 kDa 0 0 0 1 1
Identification Number Mass No. unique peptides 
E beads SE beads Crude











7.66 0 0 6 5 0
sta_BASYS00343
115249022 41 kDa 0 0 1 1 0
160 RNA polymerase sigma factor (sigma-43) 630_gi|115250496
44 kDa
5.12 0 0 7 6 0
166 putative subunit of oxidoreductase 630_gi|115249126
27 kDa
6.38 0 0 4 1 0
171 conserved hypothetical protein 630_gi|115250341
18 kDa
4.82 0 0 3 1 0
211 30S ribosomal protein S21 630_gi|115251500
7 kDa
10.78 0 0 3 3 0
217 ABC transporter, ATP-binding protein 630_gi|115251510
42 kDa
5.98 0 0 2 2 0
218 putative formate dehydrogenase 630_gi|115251232
83 kDa
8.71 0 0 3 2 0
289
225






5.34 0 0 4 2 0
240 V-type sodium ATP synthase subunit D 630_gi|115252010
26 kDa
9.08 0 0 4 3 0
241 50S ribosomal protein L32 630_gi|115250209
6 kDa
9.84 0 0 1 1 0
242 putative RNA-binding protein 630_gi|115252556
10 kDa
9.44 0 0 1 1 0
249
DeoR-family transcriptional regulator (fatty 
acid and phospholipid biosynthesis 
regulator) 630_gi|115250210
21 kDa
9.11 0 0 3 3 0
265
BASYS02843, 2985540-2985163 






6.91 0 0 3 2 0
266 putative membrane protein 630_gi|115250942
14 kDa
9.52 0 0 2 2 0
272 putative glycosyltransferase 630_gi|115250250
26 kDa
9.07 0 0 4 2 0
334 conserved hypothetical protein 630_gi|115252730
7 kDa
9.51 0 0 2 2 0
336 putative DNA topoisomerase 630_gi|115251327
81 kDa
9.43 0 0 1 1 0
351
putative capsular polysaccharide 
biosynthesis glycosyl transferase 630_gi|115251823
41 kDa







9.46 0 0 2 2 0
354 histidinol dehydrogenase 630_gi|115250622
47 kDa
5.46 0 0 2 2 0
359 putative competence protein 630_gi|115250449
46 kDa





5.28 0 0 2 1 0
361 cell surface protein 630_gi|115251032
52 kDa
9.40 0 0 2 1 0
383 conserved hypothetical protein 630_gi|115249751
7 kDa
4.61 0 0 2 2 0
384 GntR-family transcriptional regulator 630_gi|115251077
14 kDa
5.11 0 0 2 1 0
388 50S ribosomal protein L30 630_gi|115249095
7 kDa
9.87 0 0 1 1 0
389 SOS regulatory protein 630_gi|115250977
24 kDa
5.38 0 0 1 1 0
390 conserved hypothetical protein 630_gi|115251876
53 kDa
6.19 0 0 1 1 0
418 translation initiation factor IF-1 630_gi|115249101
8 kDa
9.25 0 0 1 1 0
420 putative transcriptional regulator 630_gi|115250685
21 kDa
6.11 0 0 1 1 0
421 conserved hypothetical protein 630_gi|115251421
12 kDa




subunit 2 (D-alanyl carrier protein) 630_gi|115251904
9 kDa
4.05 0 0 1 1 0
423 conserved hypothetical protein 630_gi|115252658
36 kDa
6.21 0 0 1 1 0
425
BASYS03265, 3471128-3469293 






5.30 0 0 1 1 0
456 NUDIX-family protein 630_gi|115251029
24 kDa
6.12 0 0 1 1 0
457 putative radical SAM superfamily protein 630_gi|115251502
50 kDa
7.01 0 0 1 1 0
458 conserved hypothetical protein 630_gi|115252542
39 kDa
6.88 0 0 1 1 0
463 electron transport complex protein 630_gi|115250168
48 kDa
6.30 0 0 3 0 0
479 putative DNA-binding protein 630_gi|115249855
12 kDa
9.05 0 0 1 1 0
494 RRF2-family transcriptional regulator 630_gi|115250312
16 kDa
7.60 0 0 1 1 0
495 stage IV sporulation protein A 630_gi|115251680
56 kDa
4.97 0 0 1 1 0
496 queuine tRNA-ribosyltransferase 630_gi|115251855
43 kDa
8.06 0 0 1 1 0
506
BirA bifunctional protein includes: biotin 
operon repressor and biotin--acetyl-CoA-
carboxylase synthetase 630_gi|115252621
37 kDa
6.07 0 0 1 0 0
550 putative toxic anion resistance protein 630_gi|115251391
44 kDa
5.60 0 0 0 1 0
553 30S ribosomal protein S12 630_gi|115249072
16 kDa
11.09 0 0 1 0 0
554 putative flagellar protein 630_gi|115249264
8 kDa
9.57 0 0 1 0 0
555 putative DNA mismatch repair protein 630_gi|115249725
88 kDa
6.08 0 0 1 0 0
556 conserved hypothetical protein 630_gi|115250444
14 kDa
6.09 0 0 1 0 0
557 putative ferrous iron transport protein A 630_gi|115250789
8 kDa
9.82 0 0 1 0 0
558 stage V sporulation protein S 630_gi|115250981
9 kDa
7.89 0 0 1 0 0
559 conserved hypothetical protein 630_gi|115251395
10 kDa
6.07 0 0 1 0 0
560 ATP synthase epsilon chain (partial) 630_gi|115252527
9 kDa
6.57 0 0 1 0 0
561






9.79 0 0 1 0 0
562
BASYS02498, 2595334-2595041 






5.36 0 0 1 0 0
573 putative tellurium resistance protein 630_gi|115250693
22 kDa
7.71 0 0 1 0 0
291
575
fabD, 1551856-1552806 (Clockwise) 
Hypothetical Protein fabD





5.25 0 0 1 0 0
576 L-lysine 2,3-aminomutase 630_gi|115251307
49 kDa
6.08 0 0 1 0 0
630 putative iron-sulfur protein 630_gi|115250509
48 kDa
8.27 0 0 0 1 0
631 conserved hypothetical protein 630_gi|115250815
159 kDa
7.63 0 0 0 1 0
632 putative ATP-dependent RNA helicase 630_gi|115251160
43 kDa
9.46 0 0 0 1 0
633 chaperone protein 630_gi|115251514
42 kDa
8.85 0 0 0 1 0
634
carbamoyl-phosphate synthase,pyrimidine-
specific, small chain 630_gi|115252653
39 kDa
5.79 0 0 0 1 0
642 flagellar protein FliS 630_gi|115249243
16 kDa
9.07 0 0 1 0 0
643 penicillinase repressor 630_gi|115249484
15 kDa
6.62 0 0 1 0 0
644 fatty acid/phospholipid synthesis protein 630_gi|115250211
37 kDa
5.97 0 0 1 0 0
645 putative ribosomal protein 630_gi|115250344
11 kDa
9.62 0 0 1 0 0
646
cell surface protein (putative cell surface-
associated cysteine protease) 630_gi|115250795
87 kDa
6.49 0 0 1 0 0
647 ribonuclease Ph 630_gi|115252364
50 kDa
6.99 0 0 1 0 0
648 dimethyladenosine transferase 630_gi|115252584
32 kDa
6.47 0 0 1 0 0
649
ydhO, 1504418-1505713 (Clockwise) 
Hypothetical Protein ydhO




9.47 0 0 1 0 0
653 conserved hypothetical protein 630_gi|115252701
35 kDa
6.22 0 0 0 1 0
656 putative phosphatase 630_gi|115250093
31 kDa
5.11 0 0 0 1 0
660
BASYS02611, 2724090-2723929 





9.46 0 0 1 0 0
662 50S ribosomal protein L33 630_gi|115249062
6 kDa
9.91 0 0 0 1 0
667 putative oxidoreductase 630_gi|115250433
49 kDa
6.35 0 0 1 0 0
668 cell division protein 630_gi|115252622
74 kDa
5.61 0 0 1 0 0
671 anti-sigma-B factor antagonist 630_gi|115249012
12 kDa
6.08 0 0 1 0 0
683 putative helicase 630_gi|115250059
87 kDa
5.78 0 0 1 0 0
686
coenzyme A biosynthesis bifunctional 
protein 630_gi|115251643
44 kDa
7.59 0 0 1 0 0
703 ABC transporter, ATP-binding protein 630_gi|115249108
31 kDa
4.89 0 0 0 1 0
292
708 rod shape-determining protein 630_gi|115250177
38 kDa
4.99 0 0 1 0 0
709





5.43 0 0 1 0 0
717 PadR-family transcriptional regulator 630_gi|115250186
13 kDa
9.08 0 0 0 1 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
138 proteins m=88, s/v=12, r=0, h=22, t=4, 
R=12
1 2 1 2 1
Crude only
147 chaperone protein 630_gi|115251515 66 kDa 0 0 0 0 10
237 60 kDa chaperonin 630_gi|115249204 58 kDa 1 1 0 0 2
251 acetate kinase 630_gi|115250207 43 kDa 0 0 0 0 5
276
cell surface protein (putative penicillin-
binding protein) 630_gi|115250510 111 kDa 0 0 0 0 5
292 6-phosphofructokinase 630_gi|115252455 34 kDa 0 0 0 0 4
293 elongation factor P 630_gi|115250279 21 kDa 0 0 0 0 2
310 inosine-5'-monophosphate dehydrogenase 630_gi|115251390 55 kDa 0 0 0 0 5
311 conserved hypothetical protein 630_gi|115251601 68 kDa 0 0 0 0 5
312
BASYS02898, 3050518-3048248 




115251488 80 kDa 0 0 0 0 3
313 conserved hypothetical protein 630_gi|115252732 22 kDa 0 0 0 0 3
337 cell surface protein 630_gi|115249861 34 kDa 0 0 0 0 4
367 putative peptidyl-prolyl isomerase 630_gi|115250393 28 kDa 0 0 0 0 3
368 adenylate kinase 630_gi|115249098 24 kDa 0 0 0 0 4
369 transcription elongation factor 630_gi|115252616 18 kDa 0 0 0 0 4
370 butyrate kinase 630_gi|115251431 39 kDa 0 0 0 0 3
391




- 11 kDa 0 0 0 0 1
393 hypothetical protein 630_gi|115251768 78 kDa 0 0 0 0 4
394 arginyl-tRNA synthetase 630_gi|115249727 65 kDa 0 0 0 0 3
395
putative histidinol-phosphate 
aminotransferase 630_gi|115251555 42 kDa 0 0 0 0 3
396
2,3-bisphosphoglycerate-independent 
phosphoglycerate mutase 630_gi|115252228 56 kDa 0 0 0 0 3
397 conserved hypothetical protein 630_gi|115249879 33 kDa 0 0 0 0 2
398 uracil-DNA glycosylase 630_gi|115251535 26 kDa 0 0 0 0 2
399 putative alanine racemase 630_gi|115251674 27 kDa 0 0 0 0 2
400 glucose-6-phosphate isomerase 630_gi|115252341 51 kDa 0 0 0 0 2
401 putative tRNA binding protein 630_gi|115251499 17 kDa 0 0 0 0 2
427
dihydroorotate dehydrogenase, catalytic 
subunit 630_gi|115249196 32 kDa 0 0 0 0 4
428




115251074 98 kDa 0 0 0 0 3
429 V-type sodium ATP synthase subunit B 630_gi|115252011 51 kDa 0 0 0 0 3
430 putative phosphoglucomutase 630_gi|115251373 56 kDa 0 0 0 0 3
431 ABC transporter, ATP-binding protein 630_gi|115249802 59 kDa 0 0 0 0 2
432 PTS system, IIb component 630_gi|115249296 18 kDa 0 0 0 0 2
433 peptidyl-prolyl cis-trans isomerase 630_gi|115249340 19 kDa 0 0 0 0 2
293
434 DNA polymerase I 630_gi|115250159 101 kDa 0 0 0 0 2
435 aspartokinase 630_gi|115251108 43 kDa 0 0 0 0 2
436 conserved hypothetical protein 630_gi|115251678 10 kDa 0 0 0 0 2
438 tellurium resistance protein 630_gi|115250675 21 kDa 0 0 0 0 1
464
dihydroorotate dehydrogenase electron 
transfer subunit 630_gi|115249195 26 kDa 0 0 0 0 2
465 conserved hypothetical protein 630_gi|115249410 13 kDa 0 0 0 0 2
466 putative carbon-nitrogen hydrolase 630_gi|115249501 31 kDa 0 0 0 0 2
467 RpiR-family transcriptional regulator 630_gi|115251102 33 kDa 0 0 0 0 2
468 putative glutamyl-aminopeptidase 630_gi|115251205 39 kDa 0 0 0 0 2
469 thioredoxin 630_gi|115251408 12 kDa 0 0 0 0 2
470 heat shock protein 630_gi|115251516 24 kDa 0 0 0 0 2
471 cell surface protein 630_gi|115251837 73 kDa 0 0 0 0 2
473 dihydrodipicolinate reductase 630_gi|115252283 27 kDa 0 0 0 0 2
474
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate 
N-succinyltransferase 630_gi|115252284 25 kDa 0 0 0 0 2
476
UDP-N-acetylenolpyruvoylglucosamine 
reductase 630_gi|115252462 33 kDa 0 0 0 0 2
478 HPr(Ser) kinase/phosphorylase 630_gi|115252469 36 kDa 0 0 0 0 1
483 conserved hypothetical protein 630_gi|115250701 12 kDa 0 0 0 0 1
499 conserved hypothetical protein 630_gi|115249349 195 kDa 0 0 0 0 2
500
cell surface protein (putative 
hemagglutinin/adhesin) 630_gi|115249532 167 kDa 0 0 0 0 2
501 conserved hypothetical protein 630_gi|115249797 34 kDa 0 0 0 0 2
502 tyrosyl-tRNA synthetase 630_gi|115250562 46 kDa 0 0 0 0 2
503 probable peptidase 630_gi|115251712 48 kDa 0 0 0 0 2
505




115249854 21 kDa 0 0 0 0 2
507
purH, 597466-598998 (Clockwise) 
Hypothetical Protein purH




            cyclohydrolase]
sta_BASYS00576
115249231 57 kDa 0 0 0 0 1
508 putative manganese-containing catalase 630_gi|115250607 25 kDa 0 0 0 0 1
509 putative FMN-dependent dehydrogenase 630_gi|115250297 36 kDa 0 0 0 0 2
513
phosphoglucomutase/phosphomannomutas
e mutase 630_gi|115249128 51 kDa 0 0 0 0 1
514 cell surface protein 630_gi|115249450 41 kDa 0 0 0 0 1
515 putative membrane protein 630_gi|115249537 42 kDa 0 0 0 0 1
516
rubredoxin oxidoreductase 
(desulfoferrodoxin) 630_gi|115249844 14 kDa 0 0 0 0 1
517
putative aconitase/3-isopropylmalate 
dehydratase 630_gi|115249850 69 kDa 0 0 0 0 1
518 ABC transporter, permease protein 630_gi|115249889 32 kDa 0 0 0 0 1
519 cold shock protein 630_gi|115249906 7 kDa 0 0 0 0 1
520
putative inorganic polyphosphate/ATP-
NAD kinase 630_gi|115250070 30 kDa 0 0 0 0 1
521
putative ribonucleotide-diphosphate 
reductase 630_gi|115250295 83 kDa 0 0 0 0 1
294
522
putative bifunctional protein: 
peroxiredoxin/chitinase 630_gi|115250474 81 kDa 0 0 0 0 1
523
putative imidazole glycerol phosphate 
synthase subunit 630_gi|115250592 23 kDa 0 0 0 0 1
524 putative lipoate-protein ligase 630_gi|115250695 38 kDa 0 0 0 0 1
525 putative membrane protein 630_gi|115250814 41 kDa 0 0 0 0 1
526
biotin carboxyl carrier protein of acetyl-CoA 
carboxylase 630_gi|115250985 17 kDa 0 0 0 0 1
527 fructose-6-phosphate aldolase 2 630_gi|115251164 25 kDa 0 0 0 0 1
528 ribose-5-phosphate isomerase 1 630_gi|115251375 16 kDa 0 0 0 0 1
529 histidine triad nucleotide-binding protein 630_gi|115251501 13 kDa 0 0 0 0 1
530 PTS system, glucose-specific IIa component 630_gi|115251717 18 kDa 0 0 0 0 1
531 PTS system, IIc component 630_gi|115252070 39 kDa 0 0 0 0 1
532 PTS system, IIa component 630_gi|115252072 17 kDa 0 0 0 0 1
533 PTS system, IIb component 630_gi|115252122 18 kDa 0 0 0 0 1
534 phosphoglycerate kinase 630_gi|115252230 43 kDa 0 0 0 0 1
535 putative nitroreductase 630_gi|115252261 22 kDa 0 0 0 0 1
536 alanine racemase 630_gi|115252523 43 kDa 0 0 0 0 1
537 ribose-5-phosphate isomerase 2 630_gi|115252540 16 kDa 0 0 0 0 1
538
BASYS00822, 847137-847451 (Clockwise) 
Hypothetical Protein BASYS00822
cell surface protein (putative 
hemagglutinin/adhesin) sta_BASYS00822 11 kDa 0 0 0 0 1
570 precorrin-4 C(11)-methyltransferase 630_gi|115252486 28 kDa 0 0 0 0 1
571 putative RNA-binding protein 630_gi|115250347 36 kDa 0 0 0 0 1
581
2-C-methyl-D-erythritol 2,4-
cyclodiphosphate synthase 630_gi|115249051 17 kDa 0 0 0 0 1
582
NADP-dependent 7-alpha-hydroxysteroid 
dehydrogenase 630_gi|115249069 28 kDa 0 0 0 0 1
583
putative FolD bifunctional protein includes: 
methylenetetrahydrofolate dehydrogenase; 
methenyltetrahydrofolate cyclohydrolase 630_gi|115249737 31 kDa 0 0 0 0 1
584 GntR-family transcriptional regulator 630_gi|115249901 25 kDa 0 0 0 0 1
585 conserved hypothetical protein 630_gi|115249912 57 kDa 0 0 0 0 1
586 methylglyoxal synthase 630_gi|115250185 15 kDa 0 0 0 0 1
587
branched chain amino acid transport system 
carrier protein 630_gi|115250294 45 kDa 0 0 0 0 1
588 cysteine desulfurase 630_gi|115250313 44 kDa 0 0 0 0 1
589
putative ATP phosphoribosyltransferase 
regulatory subunit 630_gi|115250588 37 kDa 0 0 0 0 1
590
histidine biosynthesis bifunctional protein 
includes: phosphoribosyl-AMP 
cyclohydrolase and phosphoribosyl-ATP 
pyrophosphatase 630_gi|115250595 26 kDa 0 0 0 0 1
591 probable sugar O-acetyltransferase 630_gi|115250709 20 kDa 0 0 0 0 1
592 pyrrolidone-carboxylate peptidase 630_gi|115250718 24 kDa 0 0 0 0 1
593 putative lipoprotein 630_gi|115250827 53 kDa 0 0 0 0 1
594 cytidylate kinase 630_gi|115250861 24 kDa 0 0 0 0 1
595
putative phage-related cell wall hydrolase 
(endolysin) 630_gi|115250945 29 kDa 0 0 0 0 1
596 putative glutaminyl-tRNA synthetase 630_gi|115251113 64 kDa 0 0 0 0 1
597
putative 2Fe-2S-binding subunit of 
oxidoreductase 630_gi|115251154 17 kDa 0 0 0 0 1
295
598 radical SAM-superfamily protein 630_gi|115251208 42 kDa 0 0 0 0 1
599 cell surface protein 630_gi|115251246 51 kDa 0 0 0 0 1
600 cinserved hypothetical protein 630_gi|115251677 47 kDa 0 0 0 0 1
601 putative histidyl-tRNA synthetase 630_gi|115251792 48 kDa 0 0 0 0 1
602 conserved hypothetical protein 630_gi|115252018 11 kDa 0 0 0 0 1
603 hypoxanthine phosphoribosyltransferase 630_gi|115252288 20 kDa 0 0 0 0 1
604 conserved hypothetical protein 630_gi|115252296 17 kDa 0 0 0 0 1
605 putative endopeptidase; pz-peptidase 630_gi|115252325 69 kDa 0 0 0 0 1
606 ATP synthase subunit gamma 630_gi|115252529 32 kDa 0 0 0 0 1
607 conserved hypothetical protein 630_gi|115252657 22 kDa 0 0 0 0 1
608




115252484 26 kDa 0 0 0 0 1
609




115249244 14 kDa 0 0 0 0 1
610
BASYS00600, 618867-620744 (Clockwise) 
Glycosyltransferase
glycosyl transferase family protein sta_BASYS00600 72 kDa 0 0 0 0 1
611
BASYS00604, 625190-626143 (Clockwise) 
Hypothetical Protein BASYS00604
ornithine cyclodeaminase sta_BASYS00604 37 kDa 0 0 0 0 1
612




115249573 64 kDa 0 0 0 0 1
613
BASYS03517, 3762887-3762459 
(CounterClockwise) Hypothetical Protein 
BASYS03517
putative beta-glucoside bgl operon 
transcription antiterminator
sta_BASYS03517 
115252171 17 kDa 0 0 0 0 1
636 purine nucleoside phosphorylase 630_gi|115250257 29 kDa 0 0 0 0 1
637 putative membrane protein 630_gi|115249643 23 kDa 0 0 0 0 1
638
N-acetyl-gamma-glutamyl-phosphate 
reductase 630_gi|115251088 38 kDa 0 0 0 0 1
652 methenyltetrahydrofolate cyclohydrolase 630_gi|115249736 23 kDa 0 0 0 0 1






- 12 kDa 0 0 0 0 1
672
probable proton-dependent oligopeptide 
transporter 630_gi|115251316 50 kDa 0 0 0 0 1
673 signal peptidase I 630_gi|115249570 20 kDa 0 0 0 0 1
674 conserved hypothetical protein 630_gi|115250755 12 kDa 0 0 0 0 1
677 putative regulatory protein 630_gi|115250392 18 kDa 0 0 0 0 1
680 conserved hypothetical protein 630_gi|115252343 59 kDa 0 0 0 0 1








46 kDa 0 0 0 0 1
693




- 55 kDa 0 0 0 0 1
694
putative component of D-ornithine 
aminomutase 630_gi|115249458 52 kDa 0 0 0 0 1
695 toxin B 630_gi|115249675 270 kDa 0 0 0 0 1
296
699




115251932 18 kDa 0 0 0 0 1
710 peptide deformylase 2 630_gi|115251641 16 kDa 0 0 0 0 1
713 putative RNA-binding protein 630_gi|115249154 81 kDa 0 0 0 0 1
297
Table A6 – Proteins identified In strain B-1 ProteoMiner treated broth extracts by 1D 
GE followed by LC-MS/MS analysis with identification number, predicted mass and 
number of unique peptides detected in each sample. The number of proteins of 
different types are show as follows; metabolic (m), surface and virulence (s/v), 
hypothetical (h), regulatory (R), transporter (t) and ribosomal (r).
Identification Number Mass No. unique peptides 
E beads SE beads Crude
165 protiens   m=107, r=32, h=8, R=13, s/v=4, t=1 1 2 1 2 1
All samples
acyl-CoA dehydrogenase, short-chain 
specific 630_gi|115249405 41 kDa 23 18 15 14 19
2
subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase 630_gi|115249404 42 kDa 20 19 14 14 22
3
isocaprenoyl-CoA:2-hydroxyisocaproate 
CoA-transferase 630_gi|115249401 44 kDa 18 16 6 6 16
4 pyruvate-flavodoxin oxidoreductase 630_gi|115251733 129 kDa 19 17 11 14 17
5 30S ribosomal protein S7 630_gi|115249073 18 kDa 13 11 18 13 5
6
subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA dehydratase 630_gi|115249403 47 kDa 20 16 9 12 16
7 electron transfer flavoprotein alpha-subunit 630_gi|115249407 37 kDa 10 6 5 5 17
8 50S ribosomal protein L19 630_gi|115250291 13 kDa 5 4 8 7 1
9 electron transfer flavoprotein beta-subunit 630_gi|115249406 29 kDa 9 7 6 5 9
10 50S ribosomal protein L15 630_gi|115249096 16 kDa 3 3 8 5 2
11 50S ribosomal protein L5 630_gi|115249089 20 kDa 12 7 14 16 9
12 putative amino acid aminotransferase 630_gi|115252729 45 kDa 13 13 5 6 16
13
putative oxidoreductase, acetyl-CoA 
synthase subunit 630_gi|115249184 68 kDa 14 12 8 11 17
14 putative ruberythrin 630_gi|115250515 20 kDa 5 4 3 3 6
15
adhE, 3383815-3381161 (CounterClockwise) 
Hypothetical Protein adhE
aldehyde-alcohol dehydrogenase [includes: 
alcohol dehydrogenase and  pyruvate-
formate-lyase deactivase
stb_BASYS03189 
115252023 97 kDa 17 16 8 9 19
16 30S ribosomal protein S4 630_gi|115249105 24 kDa 9 9 12 11 7
17 butyryl-CoA dehydrogenase 630_gi|115250075 41 kDa 14 13 7 10 10
18
putative oxidoreductase, thiamine diP-
binding subunit 630_gi|115249125 39 kDa 6 7 7 5 6
19
glyceraldehyde-3-phosphate dehydrogenase 
2 630_gi|115252231 36 kDa 9 8 8 8 10
20 50S ribosomal protein L1 630_gi|115249066 25 kDa 7 6 4 6 4
21
succinate-semialdehyde dehydrogenase 
NAD(P)+ 630_gi|115251397 51 kDa 9 9 7 10 21
22 30S ribosomal protein S9 630_gi|115249113 15 kDa 7 5 5 6 4
23 50S ribosomal protein L24 630_gi|115249088 11 kDa 2 2 4 4 2
24 NAD-specific glutamate dehydrogenase 630_gi|115249189 46 kDa 10 10 3 5 16
25
glycine/sarcosine/betaine reductase complex
component C beta subunit 630_gi|115251404 55 kDa 6 6 5 5 8
26 30S ribosomal protein S5 630_gi|115249094 18 kDa 6 6 10 8 2
27 50S ribosomal protein L6 630_gi|115249092 20 kDa 5 3 10 13 3
28 acetyl-CoA acetyltransferase 630_gi|115250080 41 kDa 6 6 7 8 12
29 30S ribosomal protein S10 630_gi|115249076 12 kDa 4 4 4 4 3
298
30
glycine/sarcosine/betaine reductase complex 
component C alpha subunit 630_gi|115251403 41 kDa 10 9 5 6 11
31




- 44 kDa 8 8 4 4 8
32 50S ribosomal protein L13 630_gi|115249112 16 kDa 1 1 4 4 1
33 putative translation elongation factor 630_gi|115249025 72 kDa 12 12 6 10 11
34 50S ribosomal protein L4 630_gi|115249078 24 kDa 5 4 5 6 3
35 60 kDa chaperonin 630_gi|115249204 58 kDa 15 16 6 6 20
36 elongation factor TU 630_gi|115249061 44 kDa 9 6 3 4 9
37 rubrerythrin 630_gi|115249842 21 kDa 5 4 2 3 4
38 aspartate aminotransferase 630_gi|115250375 45 kDa 11 13 5 7 11
39 50S ribosomal protein L3 630_gi|115249077 22 kDa 6 5 4 5 5
40




115252019 72 kDa 6 4 11 10 1
41 (R)-2-hydroxyisocaproate dehydrogenase 630_gi|115249400 37 kDa 5 4 3 5 9
42 DNA-directed RNA polymerase beta chain 630_gi|115249070 139 kDa 16 12 5 10 4
44 50S ribosomal protein L21 630_gi|115250193 11 kDa 4 5 4 4 3
45
norV, 2106146-2108677 (Clockwise) 
Hypothetical Protein norV
putative nitric oxide reductase flavoprotein
sta_BASYS02024 
115250664 94 kDa 11 10 0 1 13
46
229





115249247 34 kDa 8 6 8 6 9
630_gi|115249247 31 kDa 1 1 1 1 0
47 30S ribosomal protein S13 630_gi|115249103 14 kDa 4 4 5 5 2
48 putative subunit of oxidoreductase 630_gi|115249127 20 kDa 5 3 1 1 3
49 30S ribosomal protein S20 630_gi|115251527 10 kDa 2 2 2 2 1
50
glycine reductase complex component B 
alpha and beta subunits 630_gi|115251407 46 kDa 9 5 3 3 12
51 30S ribosomal protein S11 630_gi|115249104 14 kDa 4 3 5 3 2
52 stage 0 sporulation protein A 630_gi|115250247 31 kDa 4 2 9 7 5
53 threonine dehydratase catabolic 630_gi|115251567 43 kDa 4 4 6 6 9
54
activator of 2-hydroxyisocaproyl-CoA 
dehydratase 630_gi|115249402 29 kDa 4 4 2 3 6
55 30S ribosomal protein S8 630_gi|115249091 15 kDa 5 2 5 4 3
56
putative anaerobic nitric oxide reductase 
flavorubredoxin 630_gi|115250189 45 kDa 6 5 1 1 3
57 putative rubrerythrin 630_gi|115250565 20 kDa 3 2 1 1 2
58 50S ribosomal protein L2 630_gi|115249080 30 kDa 5 4 4 4 2
59




115252289 47 kDa 5 4 4 5 10
60 30S ribosomal protein S3 630_gi|115249083 30 kDa 2 3 4 3 1
61 toxin A 630_gi|115249677 308 kDa 8 2 2 1 22
62 ATP synthase beta chain 630_gi|115252528 50 kDa 5 4 2 3 4
63 50S ribosomal protein L22 630_gi|115249082 12 kDa 5 4 7 7 2
64 phosphate butyryltransferase 630_gi|115249121 32 kDa 7 4 4 2 5
65 DNA-directed RNA polymerase beta' chain 630_gi|115249071 130 kDa 8 5 4 7 1
66 putative aminoacyl-histidine dipeptidase 630_gi|115249724 53 kDa 7 5 0 1 7
67
glyS, 3040737-3038671 (CounterClockwise) 
Hypothetical Protein glyS
glycyl-tRNA synthetase beta chain
sta_BASYS02895 
115251485 78 kDa 9 8 6 9 4
299
69
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex,methyltransferase subunit 630_gi|115249744 29 kDa 7 7 1 1 3
70
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, alpha subunit 630_gi|115249743 50 kDa 5 4 2 3 6
71 translation initiation factor IF-3 630_gi|115249701 19 kDa 1 1 6 7 1





vinylacetyl-coa-delta-isomerase 630_gi|115251396 55 kDa 3 2 0 1 11
75 putative proline racemase 630_gi|115252294 36 kDa 6 4 2 4 7
76 4-hydroxybutyrate CoA transferase 630_gi|115251394 48 kDa 3 2 1 2 11
77 translation elongation factor G 630_gi|115249074 76 kDa 7 3 0 3 13
78 3-hydroxybutyryl-CoA dehydrogenase 630_gi|115250079 31 kDa 5 4 3 3 4
79
glycine reductase complex component B 
gamma subunit 630_gi|115251405 47 kDa 1 2 2 2 7
80 thioredoxin reductase 630_gi|115251409 34 kDa 6 3 1 1 10
81 30S ribosomal protein S19 630_gi|115249081 11 kDa 1 1 2 2 1
82 formate--tetrahydrofolate ligase 630_gi|115249735 60 kDa 2 3 3 4 9
83 butyrate kinase 630_gi|115249122 39 kDa 3 2 3 3 13
85
putative glutamate synthase NADPH small 
chain 630_gi|115250578 50 kDa 5 3 1 1 7
86
putative dual-specificity prolyl/cysteinyl-
tRNA synthetase 630_gi|115249053 55 kDa 3 3 2 2 3
87 putative ornithine cyclodeaminase 630_gi|115249560 36 kDa 2 3 5 3 2
88
putative oxidoreductase, NAD/FAD binding 
subunit 630_gi|115249186 46 kDa 5 5 2 2 10
89
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, dihydrolipoyl dehydrogenase 
subunit 630_gi|115249740 49 kDa 2 2 5 4 2
94
oligopeptide ABC transporter, substrate-
binding lipoprotein 630_gi|115249872 59 kDa 4 4 2 2 6
95 chaperone protein 630_gi|115251515 66 kDa 1 1 2 3 9
96 pyruvate, phosphate dikinase 630_gi|115251462 97 kDa 8 5 0 1 2
97 leucyl-tRNA synthetase 630_gi|115251575 92 kDa 9 7 0 3 4
98
putative dehydrogenase, electron transfer 
subunit 630_gi|115250577 33 kDa 4 4 0 1 4
100 DNA-directed RNA polymerase alpha chain 630_gi|115249106 35 kDa 5 5 4 2 6
102 30S ribosomal protein S2 630_gi|115251194 27 kDa 4 3 3 4 2
103 ribose-phosphate pyrophosphokinase 630_gi|115252575 34 kDa 4 2 2 1 2
104 enolase 630_gi|115252227 46 kDa 4 4 2 2 7
105 trigger factor 630_gi|115252362 48 kDa 2 1 3 4 7
106 electron transfer flavoprotein alpha-subunit 630_gi|115250077 36 kDa 5 3 1 0 5
107 formate acetyltransferase 630_gi|115249776 84 kDa 6 3 1 0 8
108 putative propanediol utilization protein 630_gi|115251734 20 kDa 3 1 4 4 5
109 putative 2-hydroxyacyl-CoA dehydratase 630_gi|115250793 44 kDa 3 2 1 2 3
110 electron transfer flavoprotein beta-subunit 630_gi|115250076 29 kDa 4 4 0 1 4
111 30S ribosomal protein S17 630_gi|115249086 10 kDa 2 2 2 3 1
112 ferredoxin 630_gi|115249124 8 kDa 3 3 2 3 2
113 50S ribosomal protein L10 630_gi|115249067 19 kDa 5 5 1 3 3
115 putative phosphate butyryltransferase 630_gi|115249732 33 kDa 4 3 3 2 4
300
120
GTP-sensing transcriptional pleiotropic 
repressor 630_gi|115250309 29 kDa 2 1 4 3 3
123 putative electron transfer protein 630_gi|115252303 47 kDa 2 1 5 6 2
124 30S ribosomal protein S6 630_gi|115252728 11 kDa 3 2 3 3 3
125 50S ribosomal protein L9 630_gi|115252722 17 kDa 1 1 3 6 1
126





115249069 28 kDa 4 3 0 1 5
129 putative transcriptional regulator 630_gi|115250535 23 kDa 2 2 2 2 2
130
glucosamine--fructose-6-phosphate 
aminotransferase isomerizing 630_gi|115249129 67 kDa 3 3 0 1 7
134 metallo beta-lactamase superfamily protein 630_gi|115250323 62 kDa 4 4 2 3 3
135 conserved hypothetical protein 630_gi|115249288 15 kDa 2 2 3 3 2
139 putative universal stress protein 630_gi|115249829 15 kDa 5 3 1 1 2
141 UDP-glucose 4-epimerase 630_gi|115251765 37 kDa 3 2 4 1 4
142 50S ribosomal protein L29 630_gi|115249085 8 kDa 2 2 2 2 1
143




115252312 103 kDa 3 2 1 1 1
144 methionyl-tRNA synthetase 630_gi|115252601 74 kDa 3 3 0 1 3
145 putative RNA-binding protein 630_gi|115249151 21 kDa 1 1 1 1 1
146 putative nogalamycin resistance protein 630_gi|115252273 83 kDa 1 1 1 1 1
147 ATP synthase subunit delta 630_gi|115252531 21 kDa 2 0 3 4 2
148




115249409 33 kDa 3 3 0 1 5
150 tellurium resistance protein 630_gi|115250846 21 kDa 1 0 3 6 1
153 pyruvate kinase 630_gi|115252454 63 kDa 2 2 1 1 2
158
BASYS04047, 4321907-4321278 




115252741 24 kDa 3 2 1 2 2
159 conserved hypothetical protein 630_gi|115252075 17 kDa 2 2 2 2 1
160 putative FMN-dependent dehydrogenase 630_gi|115250297 36 kDa 2 2 2 0 3
161 putative NUDIX-family hydrolase 630_gi|115249807 17 kDa 3 0 2 2 2
162 tyrosyl-tRNA synthetase 630_gi|115250562 46 kDa 1 2 0 3 5
163 hypothetical protein 630_gi|115249824 14 kDa 1 1 1 1 1
164 single-strand binding protein 630_gi|115252727 16 kDa 4 3 0 1 1
167
glyceraldehyde-3-phosphate dehydrogenase 
1 630_gi|115250813 37 kDa 1 2 1 2 2
168 cysteinyl-tRNA synthetase 630_gi|115249055 54 kDa 1 1 1 2 4
169
putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase 
complex, small subunit 630_gi|115249742 34 kDa 1 1 1 1 1
170 isoleucyl-tRNA synthetase 630_gi|115251669 120 kDa 4 1 0 1 1
171 50S ribosomal protein L7/L12 630_gi|115249068 13 kDa 2 2 1 3 1
175 nitroreductase-family protein 630_gi|115250155 33 kDa 1 1 0 1 2
176 elongation factor Ts 630_gi|115251193 33 kDa 1 0 0 1 7
179 putative tellurite resistance protein 630_gi|115250680 44 kDa 2 2 1 2 3
180 putative 30S ribosomal protein S1 630_gi|115250007 48 kDa 1 0 2 2 3
183 putative aminopeptidase 630_gi|115250096 51 kDa 1 1 0 1 1
186 ribosome recycling factor 630_gi|115251191 21 kDa 1 1 1 1 2
187 butyrate kinase 630_gi|115251431 39 kDa 1 1 1 0 2
301
193 DNA gyrase subunit A 630_gi|115249009 91 kDa 2 1 2 2 2
196 DNA polymerase III, beta chain 630_gi|115249005 46 kDa 0 2 1 1 2
201 acetate kinase 630_gi|115250207 43 kDa 1 0 0 1 8
204 putative cold shock protein 630_gi|115250391 7 kDa 1 1 1 1 1
205
ATP-dependent Clp protease ATP-binding 
subunit 630_gi|115252360 46 kDa 2 1 0 1 2
212 DNA-binding protein HU 630_gi|115252557 10 kDa 1 1 1 2 1
214 electron transfer flavoprotein beta-subunit 630_gi|115249821 29 kDa 1 1 1 1 1
215 uridylate kinase 630_gi|115251192 26 kDa 1 1 0 1 2
220
4-hydroxy-3-methylbut-2-en-1-yl 
diphosphate synthase 630_gi|115251182 38 kDa 1 1 1 1 1
221
putative dinitrogenase iron-molybdenum 
cofactor 630_gi|115250736 13 kDa 3 1 0 1 1
223 putative selenocysteine lyase 630_gi|115252735 42 kDa 1 1 0 1 1
227 seryl-tRNA synthetase 630_gi|115249017 49 kDa 1 1 1 1 1
228 orotate phosphoribosyltransferase 630_gi|115249197 21 kDa 1 1 0 1 2
231
UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 1 630_gi|115249132 45 kDa 1 1 0 1 1
232 aspartate aminotransferase 630_gi|115249115 44 kDa 1 1 0 1 1
246 conserved hypothetical protein 630_gi|115250551 24 kDa 0 1 1 2 1
247 glucose-6-phosphate isomerase 630_gi|115252341 51 kDa 0 1 1 1 2
266 threonine synthase 630_gi|115251172 56 kDa 1 1 0 1 1
273 10 kDa chaperonin 630_gi|115249203 10 kDa 1 0 0 1 1
287 uracil phosphoribosyltransferase 630_gi|115252539 23 kDa 1 0 1 1 1
296 conserved hypothetical protein 630_gi|115250191 27 kDa 0 1 0 1 1
297 nitrilase (carbon-nitrogen hydrolase) 630_gi|115251895 34 kDa 2 0 1 0 1
Identification Number Mass No. unique peptides 
E beads SE beads Crude
92 protiens   m=68, r=0, h=10, R=9, s/v=1, t=4 1 2 1 2 1
Ebeads + crude
101 peptidase 630_gi|115251315 68 kDa 7 5 0 0 6
114 GMP synthase glutamine-hydrolyzing 630_gi|115249206 57 kDa 3 4 0 0 6
116 indolepyruvate oxidoreductase subunit 630_gi|115251433 66 kDa 6 4 0 0 2
117 proline reductase subunit proprotein 630_gi|115252300 68 kDa 4 1 0 0 6
119
ABC transporter, substrate-binding 
lipoprotein 630_gi|115249887 36 kDa 4 2 0 0 7
127 succinyl-CoA:coenzyme A transferase 630_gi|115251398 56 kDa 4 3 0 0 7
131 threonyl-tRNA synthetase 630_gi|115249589 74 kDa 3 3 0 0 2
132 phenylalanyl-tRNA synthetase beta chain 630_gi|115249716 89 kDa 4 3 0 0 5
140 AsnC-family transcriptional regulator 630_gi|115252605 16 kDa 5 3 0 0 3
151 putative glycosyl hydrolase 630_gi|115252069 100 kDa 4 4 0 0 4
152 chaperone protein (heat shock protein) 630_gi|115249282 75 kDa 3 2 0 0 6
154 V-type sodium ATP synthase subunit A 630_gi|115252012 66 kDa 3 3 0 0 3
155
phosphoenolpyruvate-protein 
phosphotransferase 630_gi|115251808 63 kDa 3 2 0 0 5
157 glycogen synthase 630_gi|115249898 56 kDa 4 4 0 0 1
165 putative peptidase 630_gi|115252582 40 kDa 2 1 0 0 5
174 cell division protein 630_gi|115251697 41 kDa 2 2 0 0 3
177 putative transaldolase 630_gi|115251384 23 kDa 2 0 0 0 5
181 conserved hypothetical protein 630_gi|115252618 28 kDa 3 3 0 0 2
182 proline iminopeptidase 630_gi|115252096 34 kDa 2 2 0 0 2




pyrophosphatase 630_gi|115249342 59 kDa 4 3 0 0 2
189 GntR-family transcriptional regulator 630_gi|115252628 25 kDa 3 3 0 0 2
190
putative aliphatic sulfonates ABC 
transporter,substrate-binding lipoprotein 630_gi|115250525 36 kDa 2 2 0 0 3
191 putative amidohydrolase 630_gi|115252278 42 kDa 2 2 0 0 3
194
rubredoxin oxidoreductase 
(desulfoferrodoxin) 630_gi|115249844 14 kDa 2 2 0 0 3
195 conserved hypothetical protein 630_gi|115249797 34 kDa 1 2 0 0 2
197
oligopeptide ABC transporter, substrate-
binding protein 630_gi|115251723 58 kDa 1 1 0 0 4
199
cyclopropane-fatty-acyl-phospholipid 
synthase 630_gi|115249187 46 kDa 1 1 0 0 2
200 glycyl-tRNA synthetase alpha chain 630_gi|115251486 34 kDa 3 1 0 0 1




imidazole-4-carboxamide isomerase 630_gi|115250593 27 kDa 2 2 0 0 2
210 dihydrodipicolinate synthase 630_gi|115252282 32 kDa 2 0 0 0 4
216 6-phosphofructokinase 630_gi|115252455 34 kDa 1 1 0 0 4
219 phosphoglycerate kinase 630_gi|115252230 43 kDa 1 0 0 0 5
222
LacI-family transcriptional regulator 
(catabolite control protein) 630_gi|115250088 38 kDa 1 2 0 0 2
224 putative alanyl-tRNA synthetase 630_gi|115250316 98 kDa 3 1 0 0 1
225
putative bifunctional carbon monoxide 
dehydrogenase/acetyl-CoA synthase 630_gi|115249733 69 kDa 1 1 0 0 1
226 heat shock protein 630_gi|115251516 24 kDa 1 0 0 0 4
233




- 41 kDa 2 1 0 0 1
234 putative glutamine amidotransferase 630_gi|115252147 28 kDa 2 0 0 0 2
235 putative DNA-binding protein 630_gi|115249180 23 kDa 2 0 0 0 2
236 ribulose-phosphate 3-epimerase 630_gi|115251631 24 kDa 2 0 0 0 2
239
putative sulfonate ABC transporter,solute-
binding lipoprotein 630_gi|115251417 40 kDa 2 1 0 0 0
240 transketolase 630_gi|115251376 32 kDa 1 0 0 0 4
241 conserved hypothetical protein 630_gi|115251115 24 kDa 1 0 0 0 3
248 thioredoxin 630_gi|115250733 12 kDa 2 1 0 0 2
249 anti-sigma F factor 630_gi|115249788 16 kDa 2 2 0 0 1
252 putative phosphatase 630_gi|115251616 60 kDa 1 1 0 0 2
253 putative acetyltransferase 630_gi|115249853 19 kDa 2 1 0 0 1
255 anti-sigma F factor antagonist 630_gi|115249787 13 kDa 1 1 0 0 1
256 putative amidohydrolase 630_gi|115249796 41 kDa 1 1 0 0 1
258 probable peptidase 630_gi|115251664 40 kDa 2 0 0 0 3
260 tellurium resistance protein 630_gi|115250677 23 kDa 2 0 0 0 2
261 putative alanine racemase 630_gi|115251674 27 kDa 1 0 0 0 4
262 tellurium resistance protein 630_gi|115250676 22 kDa 1 0 0 0 3
267 glycerol dehydratase 630_gi|115250149 89 kDa 1 2 0 0 2
269
histidine biosynthesis bifunctional protein 
includes: phosphoribosyl-AMP 
cyclohydrolase and phosphoribosyl-ATP 
pyrophosphatase 630_gi|115250595 26 kDa 1 1 0 0 4
270 conserved hypothetical protein 630_gi|115251019 48 kDa 1 1 0 0 2
271 putative molybdopterin biosynthesis protein 630_gi|115251123 37 kDa 1 1 0 0 2
303
272 putative aldose epimerase 630_gi|115252500 34 kDa 1 1 0 0 2
274 low-specificity L-threonine aldolase 630_gi|115251648 38 kDa 1 0 0 0 2
275 conserved hypothetical protein 630_gi|115249812 26 kDa 0 1 0 0 2
276 cysteine desulfurase 630_gi|115250313 44 kDa 1 0 0 0 3
278




115251345 4 kDa 1 1 0 0 1
279
putative indolepyruvate oxidoreductase 
subunit 630_gi|115251432 21 kDa 1 0 0 0 1
288 glutamyl-tRNA synthetase 630_gi|115249054 57 kDa 1 1 0 0 2







115249398 23 kDa 1 1 0 0 1
292
BASYS03545, 3789976-3788798 




- 46 kDa 1 1 0 0 1
294 L-serine dehydratase 630_gi|115252279 43 kDa 1 1 0 0 1
298




115251568 62 kDa 1 0 0 0 2




phosphoribosyltransferase 630_gi|115252499 37 kDa 1 0 0 0 1
305 cell-division initiation protein 630_gi|115251670 20 kDa 1 0 0 0 2
313 ferritin 630_gi|115251248 20 kDa 1 1 0 0 1
314 putative aspartyl aminopeptidase 630_gi|115249338 48 kDa 1 1 0 0 1
324 putative aspartate aminotransferase 630_gi|115251434 47 kDa 0 1 0 0 1
325 putative 5-nitroimidazole reductase 630_gi|115250500 18 kDa 1 0 0 0 1
342
rRNA adenine N-6-methyltransferase 
(erythromycin resistance protein) 630_gi|115251058 29 kDa 1 1 0 0 1
343 conserved hypothetical protein 630_gi|115251617 13 kDa 1 1 0 0 1
345
utp--glucose-1-phosphate 
uridylyltransferase (general stress protein 
33) 630_gi|115252549 36 kDa 2 0 0 0 1
347 conserved hypothetical protein 630_gi|115252038 35 kDa 1 0 0 0 1
351 putative DNA-binding protein 630_gi|115249031 40 kDa 0 1 0 0 1
355 probable sugar O-acetyltransferase 630_gi|115250709 20 kDa 1 0 0 0 1
356 probable amino acid racemase 630_gi|115251082 26 kDa 1 0 0 0 1
357 delta-aminolevulinic acid dehydratase 630_gi|115252479 36 kDa 1 0 0 0 1
358
bifunctional adenosylcobalamin biosynthesis 
protein includes: adenosylcobinamide kinase 
and adenosylcobinamide-phosphate 
guanylyltransferase 630_gi|115252498 22 kDa 1 0 0 0 1
360 phenylalanyl-tRNA synthetase alpha chain 630_gi|115249715 38 kDa 1 0 0 0 1
362 putative metal dependent phosphohydrolase 630_gi|115251577 22 kDa 1 0 0 0 1
392 RecA protein (recombinase A) 630_gi|115250364 37 kDa 1 0 0 0 1
397 conserved hypothetical protein 630_gi|115252731 10 kDa 1 0 0 0 1
398 putative aspartyl-tRNA synthetase 630_gi|115251791 67 kDa 1 0 0 0 1
304
Identification Number Mass No. unique peptides 
E beads SE beads Crude
60 protiens   m=37, r=1, h=16, R=6, s/v=0, t=0 1 2 1 2 1
Ebeads only
268
BASYS00003, 1394-2224 (Clockwise) 
Hypothetical Protein BASYS00003
Stbphage1_BASYS0
0003 33 kDa 2 2 0 0
166 ribonuclease R 630_gi|115252220 82 kDa 5 5 0 0 0
202 conserved hypothetical protein 630_gi|115250197 14 kDa 3 2 0 0 0
209 putative GTP-binding protein 630_gi|115251683 50 kDa 3 3 0 0 0
259 putative glycine cleavage system H protein 630_gi|115249746 14 kDa 2 2 0 0 0
264 4-aminobutyrate aminotransferase 630_gi|115251211 48 kDa 1 1 0 0 0
295 putative transcriptional repressor 630_gi|115252578 32 kDa 2 1 0 0 0
315 LysR-family transcriptional regulator 630_gi|115250103 35 kDa 2 1 0 0 0
318 conserved hypothetical protein 630_gi|115251507 39 kDa 1 1 0 0 0
319
BASYS01206, 1239342-1239710 (Clockwise) 
Hypothetical Protein BASYS01206
stb_BASYS01206 
- 14 kDa 1 1 0 0 0
322 SsrA-binding protein 630_gi|115252213 19 kDa 1 1 0 0 0
340 conserved hypothetical protein 630_gi|115252645 33 kDa 1 1 0 0 0
344 pyruvate carboxylase 630_gi|115249024 129 kDa 2 1 0 0 0
348
formylglycinamidine ribonucleotide 
synthetase 630_gi|115249233 141 kDa 1 0 0 0 0
349 hypothetical protein 630_gi|115249752 14 kDa 1 1 0 0 0
350
putative aromatic amino acid 
aminotransferase 630_gi|115251881 45 kDa 1 1 0 0 0
379 translation initiation factor IF-2 630_gi|115250345 70 kDa 1 0 0 0 0
384 putative RNA-binding mediating protein 630_gi|115249006 8 kDa 1 1 0 0 0
385 metallo-beta-lactamase superfamily protein 630_gi|115249353 35 kDa 1 1 0 0 0
386 conserved hypothetical protein 630_gi|115251511 30 kDa 1 1 0 0 0
387 putative amino acid racemase 630_gi|115251872 40 kDa 1 1 0 0 0
388 putative glycosyl hydrolase 630_gi|115252139 101 kDa 1 1 0 0 0
389
BASYS00184, 156070-156327 (Clockwise) 
Hypothetical Protein BASYS00184
stb_BASYS00184
- 10 kDa 1 1 0 0 0
399
BASYS00600, 618867-620744 (Clockwise) 
Glycosyltransferase sta_BASYS00600 72 kDa 1 1 0 0 0
400 rod shape-determining protein 630_gi|115250177 38 kDa 1 1 0 0 0
409 putative iron-sulfur protein 630_gi|115249747 72 kDa 2 0 0 0 0
414 putative fructose-1,6-bisphosphatase 630_gi|115250224 76 kDa 0 1 0 0 0
415
putative ribonucleotide-diphosphate 
reductase 630_gi|115250295 83 kDa 0 1 0 0 0
416
septum site-determining protein (cell 
division inhibitor) 630_gi|115250182 29 kDa 1 0 0 0 0
446 S-ribosylhomocysteinase 630_gi|115252662 17 kDa 1 0 0 0 0
449 conserved hypothetical protein 630_gi|115250029 32 kDa 0 1 0 0 0
450 putative pyridoxine kinase 630_gi|115250389 31 kDa 0 1 0 0 0
451 N-carbamoyl-L-amino acid hydrolase 630_gi|115251081 44 kDa 0 1 0 0 0
452 putative carbonic anhydrase 630_gi|115251267 24 kDa 0 1 0 0 0
453
D-alanine--poly(phosphoribitol) ligase 
subunit 2 (D-alanyl carrier protein) 630_gi|115251904 9 kDa 0 1 0 0 0
454
carbamoyl-phosphate synthase,pyrimidine-
specific, large chain 630_gi|115252652 119 kDa 0 1 0 0 0
455
carbamoyl-phosphate synthase,pyrimidine-
specific, large chain 630_gi|115252654 119 kDa 0 1 0 0 0




(CounterClockwise) Hypothetical Protein 
NE
stb_BASYS03059
- 36 kDa 0 1 0 0 0
458 conserved hypothetical protein 630_gi|115249592) 22 kDa 1 0 0 0 0
459 methylglyoxal synthase 630_gi|115250185 15 kDa 1 0 0 0 0
460 GTP-binding protein 630_gi|115251490 34 kDa 1 0 0 0 0
461 conserved hypothetical protein 630_gi|115251612 20 kDa 1 0 0 0 0
462 putative GTP pyrophosphokinase 630_gi|115251796 85 kDa 1 0 0 0 0
463 proline reductase 630_gi|115252298 26 kDa 1 0 0 0 0
464 ATP-dependent protease La 630_gi|115252357 90 kDa 1 0 0 0 0
465
putative iron-only hydrogenase,electron-
transferring subunit 630_gi|115252465 18 kDa 1 0 0 0 0
466 putative nicotinate phosphribosyltransferase 630_gi|115252604 54 kDa 1 0 0 0 0
467 30S ribosomal protein S18 630_gi|115252726 9 kDa 1 0 0 0 0
468
rmlA1, 3228225-3227347 (CounterClockwise) 
Hypothetical Protein rmlA1
stb_BASYS03065
- 33 kDa 1 0 0 0 0
470 xanthine phosphoribosyltransferase 630_gi|115251385 21 kDa 1 0 0 0 0
508 conserved hypothetical protein 630_gi|115249912 57 kDa 1 0 0 0 0
510 conserved hypothetical protein 630_gi|115250233 13 kDa 1 0 0 0 0
515 3-hydroxybutyryl-CoA dehydratase 630_gi|115250078 28 kDa 1 0 0 0 0
516 putative transcription antiterminator 630_gi|115251388 82 kDa 1 0 0 0 0
517
putative exported carboxy-terminal 
processing protease 630_gi|115252515 42 kDa 0 1 0 0 0
518
N-acetyl-gamma-glutamyl-phosphate 
reductase 630_gi|115251088 38 kDa 1 0 0 0 0
520 conserved hypothetical protein 630_gi|115252126 20 kDa 1 0 0 0 0
539




- 37 kDa 1 0 0 0 0
540 putative glycosyl hydrolase 630_gi|115251625 103 kDa 1 0 0 0 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
28 protiens   m=10, r=10, h=4, R=4, s/v=0, t=0 1 2 1 2 1
Ebeads and SE beads
84 50S ribosomal protein L27 630_gi|115250195 10 kDa 3 1 3 5 0
90 30S ribosomal protein S15 630_gi|115250352 10 kDa 5 4 6 6 0
91 putative ribosomal protein 630_gi|115249100 11 kDa 3 2 4 6 0
92 50S ribosomal protein L16 630_gi|115249084 16 kDa 1 2 2 2 0
93 30S ribosomal protein S16 630_gi|115250287 10 kDa 1 1 5 4 0
99 50S ribosomal protein L17 630_gi|115249107 13 kDa 1 1 2 2 0
121 50S ribosomal protein L18 630_gi|115249093 14 kDa 1 1 3 4 0
122 50S ribosomal protein L11 630_gi|115249065 15 kDa 1 1 1 1 0
133 50S ribosomal protein L14 630_gi|115249087 13 kDa 0 1 3 4 0
136 PTS system, IIb component 630_gi|115252071 11 kDa 1 1 2 3 0
149 50S ribosomal protein L20 630_gi|115249703 13 kDa 1 1 1 2 0
172




- 13 kDa 2 2 2 3 0
173 transcription termination factor Rho 630_gi|115252548 61 kDa 3 3 1 1 0
192 putative serine hydroxymethyltransferase 630_gi|115251778 46 kDa 1 1 1 1 0
198 GntR-family transcriptional regulator 630_gi|115250423 24 kDa 1 0 2 2 0
306
207 3-oxoacyl-acyl-carrier-protein synthase II 630_gi|115250217 44 kDa 2 1 1 1 0
213 conserved hypothetical protein 630_gi|115251576 13 kDa 2 1 1 2 0
217 putative beta-lactamase repressor 630_gi|115251442 15 kDa 1 0 2 1 0
230 conserved hypothetical protein 630_gi|115250755 12 kDa 1 1 1 1 0
238 geranyltranstransferase 630_gi|115250238 33 kDa 0 1 1 1 0
251
phosphoribosylaminoimidazole carboxylase 
catalytic subunit 630_gi|115249226 17 kDa 1 1 0 2 0
254 adenylosuccinate lyase 630_gi|115250370 55 kDa 1 1 0 1 0
289
ATP-dependent Clp protease proteolytic 
subunit 630_gi|115252361 21 kDa 1 1 0 1 0
326
BASYS02591, 2703866-2703633 




115251185 9 kDa 0 1 1 0 0
346 conserved hypothetical protein 630_gi|115250624 11 kDa 1 0 1 0 0
390
putative component of D-ornithine 
aminomutase 630_gi|115249458 52 kDa 1 0 1 0 0
391 putative D-tyrosyl-tRNA protein 630_gi|115251795 16 kDa 1 0 0 1 0
396 preprotein translocase SecA subunit 630_gi|115249152 102 kDa 1 0 0 1 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
7 protiens   m=1, r=0, h=1, R=0, s/v=5, t=0 1 2 1 2 1
SE beads and crude
Identification Number Mass No. unique peptides 
E beads SE beads Crude
1 2 1 2 1
74
ydhO, 1281410-1282705 
(Clockwise) Hypothetical Protein 
ydhO
putative cell wall hydrolase
stb_BASYS01250







115251842 68 kDa 0 0 1 1 1
277 conserved hypothetical protein 630_gi|115251464 23 kDa 0 0 1 0 2
293 putative signal recognition particle 630_gi|115250284 47 kDa 0 0 1 1 1
301 cell surface protein 630_gi|115251820 78 kDa 0 0 0 1 1
303 cell surface protein 630_gi|115251246 51 kDa 0 0 0 1 1
321
putative phage-related cell wall 
hydrolase (endolysin) 630_gi|115250945 29 kDa 0 0 1 0 1
Identification Number Mass No. unique peptides 
E beads SE beads Crude
38 protiens   m=17, r=3, h=7, R=6, s/v=2, t=3 1 2 1 2 1
SE beads only
118 ribosome-binding factor A 630_gi|115250346 14 kDa 0 0 3 4 0









115252101 80 kDa 0 0 0 8 0
211
RNA polymerase sigma factor 
(sigma-43) 630_gi|115250496 44 kDa 0 0 1 3 0







115251847 58 kDa 0 0 2 2 0
242 conserved hypothetical protein 630_gi|115250343 11 kDa 0 0 1 1 0
263
putative thiol peroxidase 
(bacterioferritin comigratory 
protein) 630_gi|115250867 18 kDa 0 0 1 3 0
300
putative histidinol-phosphate 
aminotransferase 630_gi|115250590 40 kDa 0 0 1 1 0
304
putative FAD-binding subunit of 
oxidoreductase 630_gi|115251155 30 kDa 0 0 1 1 0
306
putative mannosyl-glycoprotein 
endo-beta-N-acetylglucosamidase 630_gi|115250339 66 kDa 0 0 3 0 0
320
GntR-family transcriptional 
regulator 630_gi|115250658 14 kDa 0 0 1 1 0
327
putative 16S rRNA processing 
protein 630_gi|115250289 20 kDa 0 0 1 1 0
328
putative tellurium resistance 
protein 630_gi|115250693 22 kDa 0 0 1 1 0
334 conserved hypothetical protein 630_gi|115252624 16 kDa 0 0 0 2 0
335 conserved hypothetical protein 630_gi|115252730 7 kDa 0 0 0 2 0
352 RNA polymerase sigma-B factor 630_gi|115249014 30 kDa 0 0 1 1 0
353 penicillinase repressor 630_gi|115249484 15 kDa 0 0 1 1 0
367 putative ribosomal protein 630_gi|115250344 11 kDa 0 0 0 2 0
376 putative signaling protein 630_gi|115250887 132 kDa 0 0 1 1 0
377
putative antibiotic resistance ABC 





cell surface protein (S-layer 
precursor protein)
stt_BASYS02898
115251846 80 kDa 0 0 0 2 0
410 conserved hypothetical protein 630_gi|115249575 22 kDa 0 0 0 1 0
412
ABC transporter, permease 
protein 630_gi|115250021 30 kDa 0 0 1 0 0
418




acetyltransferase 630_gi|115252576 50 kDa 0 0 1 0 0
419
orotidine 5'-phosphate 
decarboxylase 630_gi|115252656 26 kDa 0 0 1 0 0
420 queuine tRNA-ribosyltransferase 630_gi|115251855 43 kDa 0 0 0 1 0
442 putative tRNA binding protein 630_gi|115251499 17 kDa 0 0 1 0 0
445
ABC transporter, ATP-binding 
protein 630_gi|115251001 25 kDa 0 0 1 0 0
308
471 ATP-dependent Clp protease 630_gi|115249029 91 kDa 0 0 1 0 0
472 conserved hypothetical protein 630_gi|115249281 54 kDa 0 0 1 0 0
473
V-type sodium ATP synthase 
subunit D 630_gi|115252010 26 kDa 0 0 1 0 0
474
aspartate-semialdehyde 
dehydrogenase 630_gi|115252281 37 kDa 0 0 1 0 0
477
putative capsular polysaccharide 
biosynthesis glycosyl transferase 630_gi|115251823 41 kDa 0 0 0 1 0
478 putative acetyltransferase 630_gi|115252032 17 kDa 0 0 0 1 0
521 anti-sigma-B factor antagonist 630_gi|115249012 12 kDa 0 0 0 1 0
524
potassium-transporting ATPase C 








- 14 kDa (1) 0 3 2 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
113 protiens   m=68, r=0, h=20, R=12, s/v=9, t=4 1 2 1 2 1
Crude only
244 trehalose-6-phosphate hydrolase 630_gi|115252145 66 kDa 0 0 0 0 5
245 alanine racemase 630_gi|115252523 43 kDa 0 0 0 0 5
265
polyribonucleotide 
nucleotidyltransferase 630_gi|115250354 78 kDa 0 0 0 0 3







- 33 kDa 0 0 0 0 4
282
putative carbon-nitrogen 
hydrolase 630_gi|115251789 31 kDa 0 0 0 0 3
283 HPr(Ser) kinase/phosphorylase 630_gi|115252469 36 kDa 0 0 0 0 3
284
methenyltetrahydrofolate 









115251840 87 kDa 0 0 0 0 2
286 conserved hypothetical protein 630_gi|115252732 22 kDa 0 0 0 0 2
307 putative RNA-binding protein 630_gi|115250347 36 kDa 0 0 0 0 1







115252229 27 kDa 0 0 0 0 3
310 arginyl-tRNA synthetase 630_gi|115249727 65 kDa 0 0 0 0 3
311 uracil-DNA glycosylase 630_gi|115251535 26 kDa 0 0 0 0 3
323
ABC transporter, ATP-binding 
protein 630_gi|115252673 27 kDa 0 0 0 0 2
329 lysyl-tRNA synthetase 630_gi|115252615 58 kDa 0 0 0 0 3
330 cinserved hypothetical protein 630_gi|115251677 47 kDa 0 0 0 0 3
331 cell surface protein 630_gi|115251849 67 kDa 0 0 0 0 2
309
332 conserved hypothetical protein 630_gi|115249635 9 kDa 0 0 0 0 2
333
V-type sodium ATP synthase 
subunit B 630_gi|115252011 51 kDa 0 0 0 0 2
338 tellurium resistance protein 630_gi|115250675 21 kDa 0 0 0 0 1
339 conserved hypothetical protein 630_gi|115249879 33 kDa 0 0 0 0 1
363 chaperone 630_gi|115251074 98 kDa 0 0 0 0 3
364 adenylate kinase 630_gi|115249098 24 kDa 0 0 0 0 2
365 putative lipoprotein 630_gi|115249561 23 kDa 0 0 0 0 2
366 DNA polymerase I 630_gi|115250159 101 kDa 0 0 0 0 2
368
putative glutaminyl-tRNA 
synthetase 630_gi|115251113 64 kDa 0 0 0 0 2
369 conserved hypothetical protein 630_gi|115251678 10 kDa 0 0 0 0 2
370 dihydrodipicolinate synthase 630_gi|115252280 32 kDa 0 0 0 0 2
371
putative endopeptidase; pz-
peptidase 630_gi|115252325 69 kDa 0 0 0 0 2
372 hypothetical protein 630_gi|115251768 78 kDa 0 0 0 0 2
373
ABC transporter, ATP-binding 
protein 630_gi|115251122 62 kDa 0 0 0 0 2
374 putative peptidyl-prolyl isomerase 630_gi|115250393 28 kDa 0 0 0 0 2
375 putative cyclase 630_gi|115251016 24 kDa 0 0 0 0 2
378 putative ATP/GTP-binding protein 630_gi|115249123 25 kDa 0 0 0 0 1
380
two-component response 
regulator 630_gi|115250828 28 kDa 0 0 0 0 1
381
inosine-5'-monophosphate 
dehydrogenase 630_gi|115251390 55 kDa 0 0 0 0 1
382
histidine triad nucleotide-binding 
protein 630_gi|115251501 13 kDa 0 0 0 0 1
383 ferredoxin 630_gi|115252670 6 kDa 0 0 0 0 1
401 flagellar hook protein 630_gi|115249263 35 kDa 0 0 0 0 2








- 51 kDa 0 0 0 0 2
405
probable amino-acid ABC 
transporter,substrate-binding 
protein 630_gi|115251230 30 kDa 0 0 0 0 2
406 transcription elongation factor 630_gi|115252616 18 kDa 0 0 0 0 2
407 cell surface protein 630_gi|115249861 34 kDa 0 0 0 0 2
413
putative aconitase/3-
isopropylmalate dehydratase 630_gi|115249850 69 kDa 0 0 0 0 1
422
bifunctional purine biosynthesis 
protein includes: 
phosphoribosylaminoimidazolecar
boxamide formyltransferase and 
IMP cyclohydrolase 630_gi|115249231 57 kDa 0 0 0 0 1
423 putative membrane protein 630_gi|115249537 42 kDa 0 0 0 0 1




regulatory subunit 630_gi|115250588 37 kDa 0 0 0 0 1
426
putative imidazole glycerol 
phosphate synthase subunit 630_gi|115250592 23 kDa 0 0 0 0 1
427 putative phosphoglucomutase 630_gi|115250617 64 kDa 0 0 0 0 1
310
428 putative membrane protein 630_gi|115250814 41 kDa 0 0 0 0 1
429
putative nitrite and sulfite 
reductase subunit 630_gi|115250842 34 kDa 0 0 0 0 1
430 SOS regulatory protein 630_gi|115250977 24 kDa 0 0 0 0 1
431
UDP-N-acetylmuramoylalanine--
D-glutamate ligase 630_gi|115251704 50 kDa 0 0 0 0 1
432
PTS system, glucose-specific IIa 
component 630_gi|115252082 17 kDa 0 0 0 0 1




mutase 630_gi|115252228 56 kDa 0 0 0 0 1
435 putative nitroreductase 630_gi|115252261 22 kDa 0 0 0 0 1
436 ATP synthase subunit gamma 630_gi|115252529 32 kDa 0 0 0 0 1
437




- 38 kDa 0 0 0 0 1






- 33 kDa 0 0 0 0 1
441 cell surface protein 630_gi|115251837 73 kDa 0 0 0 0 1
443
transcription antitermination 
protein 630_gi|115249064 20 kDa 0 0 0 0 1
447 transketolase 630_gi|115251377 29 kDa 0 0 0 0 1
479 putative aldo/keto reductase 630_gi|115249577 38 kDa 0 0 0 0 1
480 toxin B 630_gi|115249675 270 kDa 0 0 0 0 1
481
NH3-dependent NAD(+) 
synthetase 630_gi|115249811 28 kDa 0 0 0 0 1
482 putative oxidative stress protein 630_gi|115249845 53 kDa 0 0 0 0 1
483
putative homocitrate/2-
isopropylmalate synthase 630_gi|115249849 44 kDa 0 0 0 0 1
484 putative formyltransferase 630_gi|115249858 44 kDa 0 0 0 0 1
485
GntR-family transcriptional 
regulator 630_gi|115249901 25 kDa 0 0 0 0 1
486
glucosamine-6-phosphate 
deaminase 630_gi|115250032 28 kDa 0 0 0 0 1
487
fatty acid/phospholipid synthesis 
protein 630_gi|115250211 37 kDa 0 0 0 0 1
488 putative GTP cyclohydrolase I 630_gi|115250490 21 kDa 0 0 0 0 1
489 conserved hypothetical protein 630_gi|115250679 60 kDa 0 0 0 0 1
490
putative NADPH-dependent FMN 
reductase 630_gi|115250716 23 kDa 0 0 0 0 1
491
inosine-uridine preferring 
nucleoside hydrolase 630_gi|115250725 36 kDa 0 0 0 0 1
492 tellurium resistance protein 630_gi|115250845 21 kDa 0 0 0 0 1
493 cytidylate kinase 630_gi|115250861 24 kDa 0 0 0 0 1
494
RpiR-family transcriptional 
regulator 630_gi|115251102 33 kDa 0 0 0 0 1
495 fructose-6-phosphate aldolase 2 630_gi|115251164 25 kDa 0 0 0 0 1
496 N-acetylneuraminate lyase 630_gi|115251294 33 kDa 0 0 0 0 1
497 conserved hypothetical protein 630_gi|115251601 68 kDa 0 0 0 0 1
498 guanylate kinase 630_gi|115251645 23 kDa 0 0 0 0 1
499 probable peptidase 630_gi|115251712 48 kDa 0 0 0 0 1
311
500
PTS system, glucose-specific IIa 
component 630_gi|115251717 18 kDa 0 0 0 0 1
501 hypothetical protein 630_gi|115251805 26 kDa 0 0 0 0 1
502 PTS system, IIa component 630_gi|115252072 17 kDa 0 0 0 0 1
503
putative D-isomer specific 2-
hydroxyacid dehydrogenase 630_gi|115252366 36 kDa 0 0 0 0 1
504 porphobilinogen deaminase 630_gi|115252481 33 kDa 0 0 0 0 1
506











- 39 kDa 0 0 0 0 1
511
aspartate carbamoyltransferase 
catalytic chain 630_gi|115249194 35 kDa 0 0 0 0 1
513 radical SAM-superfamily protein 630_gi|115250190 71 kDa 0 0 0 0 1
522 conserved hypothetical protein 630_gi|115251487 22 kDa 0 0 0 0 1
527
anaerobic ribonucleoside-
triphosphate reductase 630_gi|115249116 89 kDa 0 0 0 0 1







115250980 15 kDa 0 0 0 0 1
532 adenylosuccinate synthetase 630_gi|115252719 47 kDa 0 0 0 0 1
535
putative sigma 54 modulation 
protein 630_gi|115251497 22 kDa 0 0 0 0 1
542 PTS system, IId component 630_gi|115249298 31 kDa 0 0 0 0 1







- 16 kDa 0 0 0 0 1
549
ABC transporter, ATP-binding 
protein 630_gi|115249802 59 kDa 0 0 0 0 1
550
LacI-family transcriptional 
regulator 630_gi|115249813 37 kDa 0 0 0 0 1
553 cell surface protein 630_gi|115249450 41 kDa 0 0 0 0 1
555 putative flavodoxin 630_gi|115251878 20 kDa 0 0 0 0 1
556 conserved hypothetical protein 630_gi|115250439 23 kDa 0 0 0 0 1
557





cyclohydrolase 630_gi|115249737 31 kDa 0 0 0 0 1
312
Table A7 – Proteins identified in strain Tra5/5 ProteoMiner treated broth extracts by 1D 
GE followed by LC-MS/MS analysis with identification number, predicted mass and 
number of unique peptides detected in each sample. The number of proteins of 
different types are show as follows; metabolic (m), surface and virulence (s/v), 
hypothetical (h), regulatory (R), transporter (t) and ribosomal (r).
Identification Number Mass No. unique peptides 
E beads SE beads Crude
200 proteins   m=118, r=41, h=17, R=15, s/v=6, t=3 1 2 1 2 1
All samples
acyl-CoA dehydrogenase, short-




transferase 630_gi|115249401 44 kDa 22 23 15 10 20
3 acetyl-CoA acetyltransferase 630_gi|115250080 41 kDa 14 13 15 15 26
4 30S ribosomal protein S7 630_gi|115249073 18 kDa 12 11 10 10 11
5
subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA 
dehydratase 630_gi|115249403 47 kDa 19 19 12 10 16
6
electron transfer flavoprotein 
alpha-subunit 630_gi|115249407 37 kDa 17 15 13 12 11
7
subunit of oxygen-sensitive 2-
hydroxyisocaproyl-CoA 
dehydratase 630_gi|115249404 42 kDa 24 23 17 17 19
8
electron transfer flavoprotein beta-
subunit 630_gi|115249406 29 kDa 14 14 11 10 10
9 putative rubrerythrin 630_gi|115250565 20 kDa 15 15 10 9 10
10
pyruvate-flavodoxin 
oxidoreductase 630_gi|115251733 129 kDa 33 31 27 21 22
11
NAD-specific glutamate 
dehydrogenase 630_gi|115249189 46 kDa 18 17 11 10 21
12
putative amino acid 
aminotransferase 630_gi|115252729 45 kDa 21 19 14 12 19
13 30S ribosomal protein S3 630_gi|115249083 30 kDa 11 11 13 11 2
14 30S ribosomal protein S19 630_gi|115249081 11 kDa 5 5 5 4 3
15 elongation factor TU 630_gi|115249061 44 kDa 18 16 11 9 11
16 30S ribosomal protein S4 630_gi|115249105 24 kDa 11 10 8 8 4
17 50S ribosomal protein L1 630_gi|115249066 25 kDa 10 10 9 9 6
18 30S ribosomal protein S5 630_gi|115249094 18 kDa 6 6 8 9 3
19 50S ribosomal protein L24 630_gi|115249088 11 kDa 4 4 5 5 1
20 50S ribosomal protein L19 630_gi|115250291 13 kDa 3 4 8 8 2
21 50S ribosomal protein L13 630_gi|115249112 16 kDa 8 7 7 7 2










115252023 97 kDa 17 17 16 16 26
313
24
rpsJ, 420934-421245 (Clockwise) 
Hypothetical Protein rpsJ
30S ribosomal protein S10
sta_BASYS00411 
115249076 12 kDa 7 7 5 5 4
25 butyryl-CoA dehydrogenase 630_gi|115250075 41 kDa 13 15 15 13 15
26 50S ribosomal protein L4 630_gi|115249078 24 kDa 10 8 9 7 5
27 putative ruberythrin 630_gi|115250515 20 kDa 6 7 4 4 4
28 30S ribosomal protein S16 630_gi|115250287 10 kDa 3 3 4 4 3
29 50S ribosomal protein L21 630_gi|115250193 11 kDa 4 3 3 3 2
30 50S ribosomal protein L2 630_gi|115249080 30 kDa 7 7 8 8 3
31 30S ribosomal protein S8 630_gi|115249091 15 kDa 5 5 6 6 6
32 30S ribosomal protein S20 630_gi|115251527 10 kDa 2 2 2 2 2
33 50S ribosomal protein L5 630_gi|115249089 20 kDa 10 9 11 11 6
34
putative oxidoreductase, thiamine 








115251393 44 kDa 11 11 7 3 6
36
glycine/sarcosine/betaine 
reductase complex component C 
beta subunit 630_gi|115251404 55 kDa 10 11 9 9 13
37 50S ribosomal protein L6 630_gi|115249092 20 kDa 5 4 8 9 1
38 50S ribosomal protein L15 630_gi|115249096 16 kDa 5 7 7 7 3
39 aspartate aminotransferase 630_gi|115250375 45 kDa 15 14 9 8 17
40
succinate-semialdehyde 
dehydrogenase NAD(P)+ 630_gi|115251397 51 kDa 15 14 15 12 17
41
electron transfer flavoprotein 
alpha-subunit 630_gi|115250077 36 kDa 12 11 8 8 13
42
electron transfer flavoprotein beta-
subunit 630_gi|115250076 29 kDa 8 10 4 2 14
43
3-hydroxybutyryl-CoA 
dehydrogenase 630_gi|115250079 31 kDa 7 7 6 5 12
44
(R)-2-hydroxyisocaproate 
dehydrogenase 630_gi|115249400 37 kDa 10 10 8 5 12
45 50S ribosomal protein L3 630_gi|115249077 22 kDa 12 12 11 10 5
46 30S ribosomal protein S11 630_gi|115249104 14 kDa 4 3 4 3 2
47 50S ribosomal protein L17 630_gi|115249107 13 kDa 2 2 3 2 1
48 cell surface protein 630_gi|115251764 72 kDa 7 10 16 17 2
49
glycine reductase complex 
component B alpha and beta 
subunits 630_gi|115251407 46 kDa 8 8 6 4 14






vinylacetyl-coa-delta-isomerase 630_gi|115251396 55 kDa 8 9 7 6 14
52 30S ribosomal protein S13 630_gi|115249103 14 kDa 6 7 5 4 3
55




115249247 34 kDa 8 7 8 9 2
56 rubrerythrin 630_gi|115249842 21 kDa 4 4 2 2 6
314
57
DNA-directed RNA polymerase 
beta chain 630_gi|115249070 139 kDa 19 21 21 10 20








115249724 53 kDa 10 10 4 3 10
60 50S ribosomal protein L14 630_gi|115249087 13 kDa 5 4 4 4 1
61 translation initiation factor IF-3 630_gi|115249701 19 kDa 5 5 11 13 1
62 50S ribosomal protein L29 630_gi|115249085 8 kDa 3 3 4 3 2
63 50S ribosomal protein L27 630_gi|115250195 10 kDa 3 4 5 6 1
64 50S ribosomal protein L16 630_gi|115249084 16 kDa 2 2 3 2 1
65 putative proline racemase 630_gi|115252294 36 kDa 10 10 7 5 11
66 50S ribosomal protein L22 630_gi|115249082 12 kDa 5 5 6 6 4
67 formate--tetrahydrofolate ligase 630_gi|115249735 60 kDa 3 2 5 6 20
68
putative oxidoreductase, acetyl-
CoA synthase subunit 630_gi|115249184 68 kDa 11 13 10 8 5
69
DNA-directed RNA polymerase 
beta' chain 630_gi|115249071 130 kDa 7 11 21 11 9
70 50S ribosomal protein L10 630_gi|115249067 19 kDa 7 7 6 6 6
71
norV, 2106146-2108677 
(Clockwise) Hypothetical Protein 
norV
putative nitric oxide reductase 
flavoprotein
sta_BASYS02024 
115250664 94 kDa 8 11 3 1 20
72 translation elongation factor G 630_gi|115249074 76 kDa 11 13 7 5 19
73 putative formate acetyltransferase 630_gi|115252338 89 kDa 15 15 6 3 12
74
putative propanediol utilization 
protein 630_gi|115251734 20 kDa 3 3 4 3 6
75 probable peptidase 630_gi|115251664 40 kDa 9 9 4 1 3
76 enolase 630_gi|115252227 46 kDa 8 8 2 2 9
77
indolepyruvate oxidoreductase 
subunit 630_gi|115251433 66 kDa 9 8 5 4 19
78
glyceraldehyde-3-phosphate 










glycyl-tRNA synthetase beta chain
stt_BASYS02514
115251485 78 kDa 9 16 16 11 9
stb_BASYS02649
115251485 78 kDa 0 0 1 1 0
80
putative dinitrogenase iron-
molybdenum cofactor 630_gi|115250736 13 kDa 3 4 2 2 4
81
glycine/sarcosine/betaine 
reductase complex component C 
alpha subunit 630_gi|115251403 41 kDa 8 7 6 6 10
82
putative dual-specificity 
prolyl/cysteinyl-tRNA synthetase 630_gi|115249053 55 kDa 8 8 4 3 2
83 isoleucyl-tRNA synthetase 630_gi|115251669 120 kDa 11 10 7 2 6






cell surface protein (S-layer 
precursor protein)
stt_BASYS02898
115251846 80 kDa 3 2 2 4 27
86 30S ribosomal protein S15 630_gi|115250352 10 kDa 5 5 5 2 3
87 50S ribosomal protein L36 630_gi|115249102 4 kDa 1 1 1 1 1
88




subunit 630_gi|115249744 29 kDa 8 8 3 1 8
89
putative anaerobic nitric oxide 
reductase flavorubredoxin 630_gi|115250189 45 kDa 8 7 2 1 1
90 putative subunit of oxidoreductase 630_gi|115249127 20 kDa 4 3 2 2 2
91 30S ribosomal protein S2 630_gi|115251194 27 kDa 6 7 7 6 1
92 chaperone protein 630_gi|115251515 66 kDa 1 1 1 2 15
93 60 kDa chaperonin 630_gi|115249204 58 kDa 9 8 2 5 11
94 conserved hypothetical protein 630_gi|115249288 15 kDa 1 2 2 3 4
95
putative phosphate 
butyryltransferase 630_gi|115249732 33 kDa 4 5 7 5 8
96
3-hydroxybutyryl-CoA 
dehydratase 630_gi|115250078 28 kDa 3 3 1 1 8
98 PTS system, IIb component 630_gi|115252071 11 kDa 2 2 3 4 3
99 putative NUDIX-family hydrolase 630_gi|115249807 17 kDa 2 3 6 5 7
100 threonine dehydratase catabolic 630_gi|115251567 43 kDa 9 8 8 6 4
101 putative RNA-binding protein 630_gi|115249151 21 kDa 6 5 5 4 2
102 50S ribosomal protein L9 630_gi|115252722 17 kDa 3 3 9 9 2
103
activator of 2-hydroxyisocaproyl-
CoA dehydratase 630_gi|115249402 29 kDa 5 5 3 3 5
104
glycine reductase complex 
component B gamma subunit 630_gi|115251405 47 kDa 3 2 2 2 12
105 threonyl-tRNA synthetase 630_gi|115249589 74 kDa 5 8 5 3 1
107 50S ribosomal protein L11 630_gi|115249065 15 kDa 1 2 1 2 1
108
putative translation inhibitor 
endoribonuclease 630_gi|115251566 14 kDa 1 1 1 1 1
109 conserved hypothetical protein 630_gi|115251678 10 kDa 2 2 1 1 6
110
putative glutamate synthase 
NADPH small chain 630_gi|115250578 50 kDa 7 6 1 4 14
112 trigger factor 630_gi|115252362 48 kDa 6 5 5 5 5
113 conserved hypothetical protein 630_gi|115252289 45 kDa 4 4 3 4 4
114
proline reductase subunit 
proprotein 630_gi|115252300 68 kDa 5 5 3 1 10
115 formate acetyltransferase 630_gi|115249776 84 kDa 7 9 2 0 15
116
oligopeptide ABC transporter, 
substrate-binding lipoprotein 630_gi|115249872 59 kDa 6 6 4 3 11
117 50S ribosomal protein L20 630_gi|115249703 13 kDa 3 3 2 1 2
118
4-hydroxybutyrate CoA 
transferase 630_gi|115251394 48 kDa 3 3 3 1 12
119 tellurium resistance protein 630_gi|115250846 21 kDa 3 3 7 7 4
121
putative 2-hydroxyacyl-CoA 
dehydratase 630_gi|115250793 44 kDa 3 3 2 2 1
316
122
putative carbon monoxide 
dehydrogenase/acetyl-CoA 
synthase complex, dihydrolipoyl 
dehydrogenase subunit 630_gi|115249740 49 kDa 3 2 4 3 15
123 putative universal stress protein 630_gi|115249829 15 kDa 4 6 3 2 7
124
DNA-directed RNA polymerase 
alpha chain 630_gi|115249106 35 kDa 6 9 6 7 2
125 leucyl-tRNA synthetase 630_gi|115251575 92 kDa 6 8 3 0 6
128 putative ribosomal protein 630_gi|115249100 11 kDa 4 4 5 5 2
129
putative translation elongation 
factor 630_gi|115249025 72 kDa 4 7 6 3 8
130 peptidase 630_gi|115251315 68 kDa 6 9 4 2 3
132 conserved hypothetical protein 630_gi|115252075 17 kDa 3 2 2 2 2
133
putative indolepyruvate 
oxidoreductase subunit 630_gi|115251432 21 kDa 3 3 0 1 4
134
putative carbon monoxide 
dehydrogenase/acetyl-CoA 
synthase complex, alpha subunit 630_gi|115249743 50 kDa 2 2 5 3 7
135
ribose-phosphate 







115251748 41 kDa 5 7 1 0 5
137
GTP-sensing transcriptional 
pleiotropic repressor 630_gi|115250309 29 kDa 4 6 5 5 5
138 DNA-binding protein HU 630_gi|115252557 10 kDa 2 2 1 1 3







115252601 ? 6 8 2 0 3
142
AsnC-family transcriptional 
regulator 630_gi|115252605 16 kDa 2 3 1 1 6
143 proline reductase 630_gi|115252298 26 kDa 1 1 1 1 4
144 ATP synthase alpha chain 630_gi|115252530 55 kDa 4 3 2 2 3
145 tellurium resistance protein 630_gi|115250676 22 kDa 1 1 2 1 4
148 30S ribosomal protein S6 630_gi|115252728 11 kDa 2 3 1 1 3
150 conserved hypothetical protein 630_gi|115251421 12 kDa 2 2 1 1 3
152 asparaginyl-tRNA synthetase 630_gi|115251299 54 kDa 5 8 1 0 2
154
V-type sodium ATP synthase 
subunit A 630_gi|115252012 66 kDa 1 1 1 0 10







115252337 28 kDa 6 7 1 1 1
161 conserved hypothetical protein 630_gi|115249575 22 kDa 1 1 2 1 1
162 putative decarboxylase 630_gi|115251040 12 kDa 2 2 1 0 7
163
putative serine 
hydroxymethyltransferase 630_gi|115251778 46 kDa 4 3 4 2 2
164 transketolase 630_gi|115251376 32 kDa 4 5 1 4 4
317
167
putative bi-functional glycine 
dehydrogenase/aminomethyl 
transferase protein 630_gi|115250698 92 kDa 3 3 4 1 7
168
putative fructose-bisphosphate 
aldolase 630_gi|115249409 33 kDa 5 5 2 1 1
172 valyl-tRNA synthetase 630_gi|115252312 103 kDa 4 6 2 1 1
175
ABC transporter, substrate-
binding lipoprotein 630_gi|115249887 36 kDa 4 3 1 2 6
176 butyrate kinase 630_gi|115249122 39 kDa 2 2 2 4 6
177 stage V sporulation protein G 630_gi|115252577 10 kDa 2 2 1 0 2
179 cysteinyl-tRNA synthetase 630_gi|115249055 54 kDa 1 2 2 4 6
181 putative DNA-binding protein 630_gi|115249180 23 kDa 2 3 5 4 3
183 glycogen synthase 630_gi|115249898 56 kDa 3 4 1 1 1
185 thioredoxin 630_gi|115250733 12 kDa 2 2 1 1 3
187
putative dehydrogenase, electron 
transfer subunit 630_gi|115250577 33 kDa 4 4 1 0 5
191 conserved hypothetical protein 630_gi|115250551 24 kDa 2 3 3 3 2
192
putative 5-nitroimidazole 
reductase 630_gi|115250500 18 kDa 3 4 1 1 2
194 hypothetical protein 630_gi|115249824 14 kDa 1 2 1 1 1
197 putative transcriptional regulator 630_gi|115250535 23 kDa 2 2 2 2 2
198
putative 16S rRNA processing 
protein 630_gi|115250289 20 kDa 4 4 3 2 2
199
succinyl-CoA:coenzyme A 
transferase 630_gi|115251398 56 kDa 2 3 2 0 2
200 conserved hypothetical protein 630_gi|115250197 14 kDa 3 4 2 0 2
201
oligopeptide ABC transporter, 
substrate-binding protein 630_gi|115251723 58 kDa 1 1 1 1 8
204 pyruvate carboxylase 630_gi|115249024 129 kDa 2 2 7 2 1
205 conserved hypothetical protein 630_gi|115251576 13 kDa 1 1 2 2 2
206 ribosome recycling factor 630_gi|115251191 21 kDa 0 1 2 3 4
207 DNA gyrase subunit A 630_gi|115249009 91 kDa 1 1 5 5 1
210 adenylosuccinate lyase 630_gi|115250370 55 kDa 2 2 3 2 1
211 elongation factor Ts 630_gi|115251193 33 kDa 3 4 1 1 3
212 conserved hypothetical protein 630_gi|115251617 13 kDa 3 2 1 1 1
218 ATP synthase subunit delta 630_gi|115252531 21 kDa 2 1 3 3 2







115251677 48 kDa 2 1 1 0 8
226 PTS system, IIb component 630_gi|115249296 18 kDa 0 1 1 1 3
229 SpoIIIJ-associated protein 630_gi|115252741 24 kDa 2 4 1 1 1
230 seryl-tRNA synthetase 630_gi|115249017 49 kDa 1 1 3 1 4
231 conserved hypothetical protein 630_gi|115250233 13 kDa 1 1 1 1 2
232 putative acetyltransferase 630_gi|115249853 19 kDa 1 2 1 0 3
241 uracil phosphoribosyltransferase 630_gi|115252539 23 kDa 3 3 3 3 2
242
phosphoribosylaminoimidazole 
carboxylase catalytic subunit 630_gi|115249226 17 kDa 2 2 2 1 2
244 lysyl-tRNA synthetase 630_gi|115252615 58 kDa 0 1 3 2 2
245 glycine cleavage system P protein 630_gi|115250699 54 kDa 1 1 1 1 1
248 pyruvate kinase 630_gi|115252454 63 kDa 1 1 1 0 4
250 aspartate aminotransferase 630_gi|115249115 44 kDa 2 2 2 1 1
251 putative regulatory protein 630_gi|115251119 15 kDa 1 1 2 1 1
318
274 putative 30S ribosomal protein S1 630_gi|115250007 48 kDa 2 2 1 3 1
275 hypothetical protein 630_gi|115250298 10 kDa 1 1 1 0 2
276 transketolase 630_gi|115251377 29 kDa 1 1 1 1 1
289
GntR-family transcriptional 
regulator 630_gi|115250423 24 kDa 1 1 3 2 1
290
D-alanine--poly(phosphoribitol) 
ligase subunit 2 (D-alanyl carrier 
protein) 630_gi|115251904 9 kDa 2 2 1 0 2
291 putative aspartyl-tRNA synthetase 630_gi|115251791 67 kDa 1 2 0 2 3
293 tellurium resistance protein 630_gi|115250677 23 kDa 2 2 1 0 3
294 tyrosyl-tRNA synthetase 630_gi|115250562 46 kDa 2 0 1 1 4
305 putative tellurite resistance protein 630_gi|115250680 44 kDa 2 1 0 3 2
308
putative bifunctional carbon 
monoxide dehydrogenase/acetyl-
CoA synthase 630_gi|115249733 69 kDa 1 1 1 0 1
318 anti-sigma F factor antagonist 630_gi|115249787 13 kDa 2 2 1 0 1
328
BASYS01206, 1239342-1239710 




- 14 kDa 0 2 1 0 1
349 putative D-tyrosyl-tRNA protein 630_gi|115251795 16 kDa 1 1 1 0 1
354 conserved hypothetical protein 630_gi|115250343 11 kDa 1 0 1 1 1
Identification Number Mass No. unique peptides 
E beads SE beads Crude
67 proteins   m=47, r=0, h=12, R=8, s/v=0, t=0 1 2 1 2 1
Ebeads + crude
127 acetate kinase 630_gi|115250207 43 kDa 4 2 0 0 11
146 putative cold shock protein 630_gi|115250391 7 kDa 1 1 0 0 1
147
putative aspartate 
aminotransferase 630_gi|115251434 47 kDa 0 1 0 0 12
149
rubredoxin oxidoreductase 
(desulfoferrodoxin) 630_gi|115249844 14 kDa 1 2 0 0 4





ATP-dependent Clp protease 
proteolytic subunit
stt_BASYS03406
115252361 21 kDa 3 3 0 0 8
158 ribulose-phosphate 3-epimerase 630_gi|115251631 24 kDa 2 2 0 0 2
174 putative cyclase 630_gi|115251016 24 kDa 1 0 0 0 8
178
putative carbon monoxide 
dehydrogenase/acetyl-CoA 







115252229 27 kDa 2 1 0 0 7
188 NifU-like protein 630_gi|115250314 16 kDa 2 3 0 0 3
195 nitroreductase-family protein 630_gi|115250155 33 kDa 4 3 0 0 4
202 butyrate kinase 630_gi|115251431 39 kDa 2 2 0 0 9








115252069 100 kDa 3 5 0 0 4
223 ribose-5-phosphate isomerase 2 630_gi|115252540 16 kDa 1 2 0 0 5
224 ferredoxin 630_gi|115252670 6 kDa 1 1 0 0 1
203
BASYS00907, 938664-938939 




115249602 10 kDa 2 2 1 1 2
227
inosine-uridine preferring 
nucleoside hydrolase 630_gi|115250725 36 kDa 2 2 0 0 1
233 putative transaldolase 630_gi|115251384 23 kDa 3 2 0 0 3
235 orotate phosphoribosyltransferase 630_gi|115249197 21 kDa 1 1 0 0 3
246
polyribonucleotide 








115249716 89 kDa 3 3 0 0 4
252 conserved hypothetical protein 630_gi|115249812 26 kDa 1 2 0 0 3
253
electron transfer flavoprotein beta-
subunit 630_gi|115249821 29 kDa 1 1 0 0 1
259
methenyltetrahydrofolate 
cyclohydrolase 630_gi|115249736 23 kDa 1 2 0 0 4
266
putative glycine cleavage system 
H protein 630_gi|115249746 14 kDa 2 1 0 0 2
268 heat shock protein 630_gi|115251516 24 kDa 2 0 0 0 6
270 ribose-5-phosphate isomerase 1 630_gi|115251375 16 kDa 0 1 0 0 5
278 putative peptidase 630_gi|115252582 40 kDa 1 1 0 0 3
281
putative sigma 54 modulation 
protein 630_gi|115251497 22 kDa 2 4 0 0 1
282 anti-sigma F factor 630_gi|115249788 16 kDa 0 3 0 0 4
285 ferritin 630_gi|115251248 20 kDa 1 1 0 0 1
286
BASYS00512, 475629-475835 




- 8 kDa 1 1 0 0 1
297 translation initiation factor IF-2 630_gi|115250345 70 kDa 2 3 0 0 1
298 conserved hypothetical protein 630_gi|115252525 17 kDa 1 2 0 0 2
300
nitrilase (carbon-nitrogen 
hydrolase) 630_gi|115251895 34 kDa 1 1 0 0 2
302 hypothetical protein 630_gi|115249752 14 kDa 1 1 0 0 1
307
putative 
phosphoribosyltransferase 630_gi|115251742 20 kDa 2 2 0 0 1







- 14 kDa 1 1 0 0 1
326 conserved hypothetical protein 630_gi|115252038 35 kDa 2 2 0 0 2
332 probable sugar O-acetyltransferase 630_gi|115250709 20 kDa 1 1 0 0 1
334 adenylate kinase 630_gi|115249098 24 kDa 1 0 0 0 3
320
335 conserved hypothetical protein 630_gi|115250701 12 kDa 0 2 0 0 3
336
putative glycine reductase 
complex component 630_gi|115251410 14 kDa 0 1 0 0 3
337 hypothetical protein 630_gi|115252299 11 kDa 1 1 0 0 1
350 dihydrodipicolinate synthase 630_gi|115252282 32 kDa 1 1 0 0 2
351
glycine/sarcosine/betaine 
reductase complex component A 630_gi|115251406 17 kDa 1 1 0 0 1
356 putative iron-sulfur protein 630_gi|115249747 72 kDa 1 0 0 0 3
358
biotin carboxyl carrier protein of 
acetyl-CoA carboxylase 630_gi|115250985 17 kDa 0 1 0 0 1
363
putative glutaminyl-tRNA 
synthetase 630_gi|115251113 64 kDa 1 1 0 0 2
372 putative phosphoesterase 630_gi|115250069 21 kDa 1 1 0 0 1
376 conserved hypothetical protein 630_gi|115249350 16 kDa 1 0 0 0 3
377 putative alanine racemase 630_gi|115251674 27 kDa 1 0 0 0 3
378 putative regulatory protein 630_gi|115250392 18 kDa 0 1 0 0 2
379 putative ATP-binding protein 630_gi|115250774 29 kDa 1 1 0 0 0
391
putative carbon monoxide 
dehydrogenase/acetyl-CoA 
synthase complex, beta subunit 630_gi|115249745 77 kDa 1 1 0 0 1
398 methylglyoxal synthase 630_gi|115250185 15 kDa 0 1 0 0 2
402
phosphopantetheine 
adenylyltransferase 630_gi|115251613 18 kDa 1 1 0 0 1
415 putative preprotein translocase 630_gi|115252635 19 kDa 1 1 0 0 1
423
putative metal dependent 
phosphohydrolase 630_gi|115251577 22 kDa 0 2 0 0 1
429 phosphoglycerate kinase 630_gi|115252230 43 kDa 0 1 0 0 2
452
anti-sigma-B factor (serine-protein 
kinase) 630_gi|115249013 15 kDa 1 1 0 0 1
457 6-phosphofructokinase 630_gi|115252455 34 kDa 1 0 0 0 1
474 hypothetical protein 630_gi|115252039 74 kDa 0 1 0 0 1
500 conserved hypothetical protein 630_gi|115249281 54 kDa 0 1 0 0 1
Identification Number Mass No. unique peptides 
E beads SE beads crude
58 proteins   m=34, r=1, h=12, R=9, s/v=1, t=1 1 2 1 2 1
Ebeads only
216 ribonuclease R 630_gi|115252220 82 kDa 3 5 0 0 0
261 conserved hypothetical protein 630_gi|115251612 20 kDa 3 4 0 0 0
311
putative 23S RNA and tRNA 
pseudouridine synthase 630_gi|115251104 27 kDa 1 3 0 0 0
312
glycyl-tRNA synthetase alpha 
chain 630_gi|115251486 34 kDa 2 3 0 0 0
322 ferric uptake regulation protein 630_gi|115250321 18 kDa 1 3 0 0 0
323
putative RNA-binding mediating 
protein 630_gi|115249006 8 kDa 1 1 0 0 0




chain 630_gi|115252652 119 kDa 2 3 0 0 0
353
putative tRNA/rRNA 
methyltransferase 630_gi|115249058 27 kDa 2 2 0 0 0





subunit 630_gi|115252466 68 kDa 2 2 0 0 0
369 conserved hypothetical protein 630_gi|115252583 51 kDa 2 2 0 0 0
388
biotin carboxylase (acetyl-CoA 
carboxylase subunit A) 630_gi|115250984 51 kDa 2 2 0 0 0
399 putative Xaa-Pro dipeptidase 630_gi|115251402 41 kDa 2 1 0 0 0
400 L-aspartate-beta-decarboxylase 630_gi|115251568 62 kDa 2 1 0 0 0
403 putative regulatory protein 630_gi|115250074 17 kDa 1 1 0 0 0
417 cell division protein 630_gi|115251697 41 kDa 1 2 0 0 0
424 conserved hypothetical protein 630_gi|115250804 33 kDa 1 1 0 0 0
425 conserved hypothetical protein 630_gi|115251493 18 kDa 1 1 0 0 0
426
precorrin-4 C(11)-












115249187 46 kDa 1 1 0 0 0
458
putative oxidoreductase, electron 
transfer subunit 630_gi|115249185 18 kDa 1 1 0 0 0
459 amidophosphoribosyltransferase 630_gi|115249228 51 kDa 1 1 0 0 0
460 radical SAM-superfamily protein 630_gi|115250727 27 kDa 1 1 0 0 0
461
putative molybdopterin 
biosynthesis protein 630_gi|115251123 37 kDa 1 1 0 0 0
462
putative ribosomal protein L11 
methyltransferase 630_gi|115251504 35 kDa 1 1 0 0 0







115252720 12 kDa 1 2 0 0 0
476 stage V sporulation protein T 630_gi|115252560 20 kDa 1 1 0 0 0
478 putative acetyltransferase 630_gi|115250244 18 kDa 1 1 0 0 0
480 conserved hypothetical protein 630_gi|115251531 36 kDa 1 1 0 0 0
487
septum site-determining protein 
(cell division inhibitor) 630_gi|115250182 29 kDa 1 1 0 0 0
488 probable hydrolase 630_gi|115251629 24 kDa 1 1 0 0 0
489
UTP--glucose-1-phosphate 
uridylyltransferase 630_gi|115251766 33 kDa 1 1 0 0 0
490
glucose inhibited division protein 
A 630_gi|115252739 71 kDa 1 1 0 0 0
495 chaperone 630_gi|115251074 98 kDa 0 2 0 0 0
496
N-carbamoyl-L-amino acid 
hydrolase 630_gi|115251081 44 kDa 2 0 0 0 0
499 conserved hypothetical protein 630_gi|115251511 30 kDa 1 1 0 0 0
535 cold shock protein 630_gi|115251036 7 kDa 1 1 0 0 0
537
single-stranded DNA binding 
protein 630_gi|115252292 25 kDa 0 1 0 0 0




bisphosphatase 630_gi|115250224 76 kDa 0 1 0 0 0
571 conserved hypothetical protein 630_gi|115250280 17 kDa 0 1 0 0 0
572 putative transcriptional regulator 630_gi|115250685 21 kDa 0 1 0 0 0
573 guanine deaminase 630_gi|115250705 48 kDa 0 1 0 0 0
574
selenocysteine-specific elongation
factor 630_gi|115251547 72 kDa 0 1 0 0 0







115251100 12 kDa 0 2 0 0 0
579 conserved hypothetical protein 630_gi|115250029 32 kDa 0 1 0 0 0
580 conserved hypothetical protein 630_gi|115251206 9 kDa 1 0 0 0 0
589 putative sugar-phosphate kinase 630_gi|115249217 48 kDa 1 0 0 0 0
594
utp--glucose-1-phosphate 
uridylyltransferase (general stress 
protein 33) 630_gi|115252549 36 kDa 1 0 0 0 0
595 putative cation transport protein 630_gi|115249713 24 kDa 0 1 0 0 0
596
HfQ protein; RNA-binding protein 
(host factor-I protein) 630_gi|115251020 10 kDa 0 1 0 0 0
598 rod shape-determining protein 630_gi|115249136 36 kDa 1 0 0 0 0
599
putative cytidine and 
deoxycytidylate deaminase 630_gi|115252537 16 kDa 1 0 0 0 0
616 conserved hypothetical protein 630_gi|115252126 20 kDa 0 1 0 0 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
54 proteins   m=34, r=6, h=6, R=6, s/v=1, t=1 1 2 1 2 1
Ebeads and SE beads
243 putative alanyl-tRNA synthetase 630_gi|115250316 98 kDa 3 4 1 1 1
53 50S ribosomal protein L18 630_gi|115249093 14 kDa 4 4 5 5 0
54 30S ribosomal protein S17 630_gi|115249086 10 kDa 5 2 2 1 0
106 putative GTP-binding protein 630_gi|115251683 50 kDa 9 11 5 3 0
111 phosphate butyryltransferase 630_gi|115249121 32 kDa 3 4 3 2 0
120
metallo beta-lactamase 
superfamily protein 630_gi|115250323 62 kDa 4 4 6 4 0
126 pyruvate, phosphate dikinase 630_gi|115251462 97 kDa 9 10 3 1 0
139
transcription termination factor 
Rho 630_gi|115252548 61 kDa 4 4 3 3 0
151 30S ribosomal protein S21 630_gi|115251500 7 kDa 3 3 4 4 0
165 putative subunit of oxidoreductase 630_gi|115249126 27 kDa 3 4 1 0 0
169 30S ribosomal protein S18 630_gi|115252726 9 kDa 1 1 1 1 0
171
glyceraldehyde-3-phosphate 
dehydrogenase 1 630_gi|115250813 37 kDa 3 3 3 2 0
173 putative electron transfer protein 630_gi|115252303 47 kDa 1 0 7 7 0












synthase II 630_gi|115250217 44 kDa 5 4 3 3 0
189 50S ribosomal protein L32 630_gi|115250209 6 kDa 0 1 1 1 0
193 putative ornithine cyclodeaminase 630_gi|115249560 36 kDa 2 2 2 2 0




isomerizing 630_gi|115249129 67 kDa 3 5 1 1 0
214
GntR-family transcriptional 
regulator 630_gi|115252628 25 kDa 3 6 1 1 0
220
putative pyridine nucleotide-
disulfide oxidoreductase 630_gi|115250843 59 kDa 2 3 1 1 0
225 trans-2-enoyl-ACP reductase 630_gi|115250213 33 kDa 2 3 3 1 0
234
putative molybdenum-binding 
subunit of oxidoreductase 630_gi|115251153 82 kDa 0 1 7 4 0
236 50S ribosomal protein L23 630_gi|115249079 11 kDa 0 1 4 4 0
257
ycjV, 3063107-3064216 (Clockwise) 
Hypothetical Protein ycjV
ABC transporter, ATP-binding 
protein
sta_BASYS02921
115251510 42 kDa 1 1 2 2 0
258 putative membrane protein 630_gi|115250942 14 kDa 1 1 1 1 0









115249342 59 kDa 3 5 1 0 0
267
chaperone protein (heat shock 
protein) 630_gi|115249282 75 kDa 3 5 1 0 0
277 conserved hypothetical protein 630_gi|115251019 48 kDa 1 1 1 1 0
292
anaerobic ribonucleoside-
triphosphate reductase 630_gi|115249116 89 kDa 1 2 2 1 0
296 uridylate kinase 630_gi|115251192 26 kDa 1 2 1 1 0
299 putative glycosyl transferase 630_gi|115249022 45 kDa 0 1 3 2 0
320
GMP synthase glutamine-
hydrolyzing 630_gi|115249206 57 kDa 3 3 0 1 0
327
putative small-molecule-binding 
protein 630_gi|115249015 20 kDa 1 1 1 1 0
346
RRF2-family transcriptional 
regulator 630_gi|115250312 16 kDa 0 1 2 2 0
347
V-type sodium ATP synthase 




subunit 630_gi|115252465 18 kDa 1 1 1 1 0
362 UDP-glucose 4-epimerase 630_gi|115251765 37 kDa 2 2 1 2 0
364
putative oxidoreductase, 
NAD/FAD binding subunit 630_gi|115249186 46 kDa 2 1 0 1 0
371
DeoR-family transcriptional 
regulator (fatty acid and 
phospholipid biosynthesis 
regulator) 630_gi|115250210 21 kDa 1 1 1 0 0




dehydratase 630_gi|115252479 36 kDa 1 1 1 0 0
392
(3R)-hydroxymyristoyl-acyl carrier 
protein dehydratase 630_gi|115249137 16 kDa 1 1 0 1 0
416
putative ATP-dependent RNA 
helicase 630_gi|115249778 61 kDa 1 0 1 1 0
418 putative DNA topoisomerase 630_gi|115251327 81 kDa 1 1 0 1 0
443 conserved hypothetical protein 630_gi|115250288 8 kDa 2 1 0 1 0







115251842 67 kDa 1 0 0 1 0
477 conserved hypothetical protein 630_gi|115252308 9 kDa 1 0 1 0 0
486
putative iron-only hydrogenase, 
catalytic subunit 630_gi|115252467 65 kDa 1 0 1 0 0
503
ATP-dependent nuclease subunit 







115249169 55 kDa 0 1 1 0 0
Identification Number Mass No. unique peptides 
E beads SE beads Crude
14 proteins   m=5, r=1, h=4, R=3, s/v=1, t=0 1 2 1 2 1
SE beads and crude
97 conserved hypothetical protein 630_gi|115249020 12 kDa 0 0 6 6 3
237 elongation factor P 630_gi|115250279 21 kDa 0 0 1 0 4
238 50S ribosomal protein L30 630_gi|115249095 7 kDa 0 0 1 1 1
265
BASYS00644, 660422-660628 




115249289 8 kDa 0 0 3 2 1
269 putative tRNA binding protein 630_gi|115251499 17 kDa 0 0 1 0 4
306
cell surface protein (putative S-
layer protein precursor) 630_gi|115251844 66 kDa 0 0 2 3 1
313 tellurium resistance protein 630_gi|115250675 21 kDa 0 0 1 1 1
314 conserved hypothetical protein 630_gi|115249751 7 kDa 0 0 1 0 3
389
transcription antitermination 
protein 630_gi|115249064 20 kDa 0 0 1 1 1
413 conserved hypothetical protein 630_gi|115250440 24 kDa 0 0 0 1 1
419
UDP-N-acetylglucosamine 1-
carboxyvinyltransferase 1 630_gi|115249132 45 kDa 0 0 1 1 1
450 penicillinase repressor 630_gi|115249484 15 kDa 0 0 0 1 2
465
putative tRNA (Uracil-5-)-
methyltransferase 630_gi|115249412 51 kDa 0 0 1 0 1
475
putative histidinol-phosphate 
aminotransferase 630_gi|115250590 40 kDa 0 0 0 1 1
325
Identification Number Mass No. unique peptides 
E beads SE beads Crude
58 proteins   m=38, r=2, h=7, R=5, s/v=3, t=3 1 2 1 2 1
SE beads only
170
RNA polymerase sigma factor 
(sigma-43) 630_gi|115250496 44 kDa 0 0 5 6 0
215
putative FAD-binding subunit of 
oxidoreductase 630_gi|115251155 30 kDa 0 0 6 4 0
254 translation initiation factor IF-1 630_gi|115249101 8 kDa 0 0 2 1 0
280 putative helicase 630_gi|115250059 87 kDa 0 0 1 1 0
283
putative thiol peroxidase 
(bacterioferritin comigratory 
protein) 630_gi|115250867 18 kDa 0 0 4 4 0
284 riboflavin biosynthesis protein 630_gi|115250350 35 kDa 0 0 4 3 0
295 50S ribosomal protein L31 630_gi|115252547 8 kDa 0 0 2 2 0





acetylglucosamine transferase 630_gi|115251702 45 kDa 0 0 3 2 0
310
coenzyme A biosynthesis 
bifunctional protein 630_gi|115251643 44 kDa 0 0 2 2 0
330 RecA protein (recombinase A) 630_gi|115250364 37 kDa 0 0 2 2 0
333 putative formate dehydrogenase 630_gi|115251232 83 kDa 0 0 2 1 0
338
putative nogalamycin resistance 
protein 630_gi|115252273 83 kDa 0 0 1 1 0
355
preprotein translocase SecA 
subunit 630_gi|115249152 102 kDa 0 0 1 3 0
357 putative cell wall hydrolase 630_gi|115250166 45 kDa 0 0 1 2 0
365
putative mannosyl-glycoprotein 
endo-beta-N-acetylglucosamidase 630_gi|115250339 66 kDa 0 0 2 2 0
366
fatty acid/phospholipid synthesis 
protein 630_gi|115250211 37 kDa 0 0 2 2 0
370
putative capsular polysaccharide 
biosynthesis glycosyl transferase 630_gi|115251823 41 kDa 0 0 3 2 0
374
putative toxic anion resistance 
protein 630_gi|115251391 44 kDa 0 0 1 3 0
375
PTS system, glucitol/sorbitol-
specific IIb component 630_gi|115249782 13 kDa 0 0 1 2 0
394 electron transport complex protein 630_gi|115250168 48 kDa 0 0 2 1 0
395 probable GTP-binding protein 630_gi|115252356 22 kDa 0 0 2 1 0
396
putative ATP-dependent RNA 
helicase 630_gi|115251160 43 kDa 0 0 1 2 0
397 ATP-dependent protease La 630_gi|115252357 90 kDa 0 0 1 2 0
401 putative glycosyltransferase 630_gi|115250250 26 kDa 0 0 2 1 0
420 conserved hypothetical protein 630_gi|115252367 16 kDa 0 0 1 1 0
421 conserved hypothetical protein 630_gi|115252542 39 kDa 0 0 1 1 0
449 iron-dependent hydrogenase 630_gi|115249907 56 kDa 0 0 2 1 0
453 stage V sporulation protein S 630_gi|115250981 9 kDa 0 0 1 1 0
454
TetR-family transcriptional 
regulator 630_gi|115251558 35 kDa 0 0 1 1 0
326
455




acetyltransferase 630_gi|115252576 50 kDa 0 0 1 1 0
479
putative carbon monoxide 
dehydrogenase accessory protein 630_gi|115249734 29 kDa 0 0 1 0 0
491 conserved hypothetical protein 630_gi|115252624 16 kDa 0 0 1 1 0
492
putative ferrous iron transport 
protein A 630_gi|115250789 8 kDa 0 0 1 1 0
497 queuine tRNA-ribosyltransferase 630_gi|115251855 43 kDa 0 0 2 0 0
504 carbon storage regulator 630_gi|115249242 8 kDa 0 0 1 0 0
505 putative flagellar protein 630_gi|115249264 8 kDa 0 0 1 0 0
506
acetyl-coenzyme A carboxylase 
carboxyl transferase subunit beta 630_gi|115250983 32 kDa 0 0 1 0 0
507 conserved hypothetical protein 630_gi|115251395 10 kDa 0 0 1 0 0
542
Spo0B-associated GTP-binding 
protein 630_gi|115250196 47 kDa 0 0 0 1 0
543
fabD, 1551856-1552806 (Clockwise) 
Hypothetical Protein fabD
malonyl CoA-acyl carrier protein 
transacylase
sta_BASYS01457 







- 38 kDa 0 0 0 1 0
545
undecaprenyl pyrophosphate 
synthetase 630_gi|115251189 28 kDa 0 0 1 0 0
546 GTP-binding elongation factor 630_gi|115251521 67 kDa 0 0 1 0 0
547
porphyrin biosynthesis protein 
includes: uroporphyrinogen-III 
methyltransferase and 
uroporphyrinogen-III synthase 630_gi|115252480 56 kDa 0 0 1 0 0
548 putative RNA-binding protein 630_gi|115252556 10 kDa 0 0 1 0 0
549 dimethyladenosine transferase 630_gi|115252584 32 kDa 0 0 1 0 0
567
putative radical SAM superfamily 




reductase 630_gi|115249739 32 kDa 0 0 0 1 0
586 putative GTP pyrophosphokinase 630_gi|115251796 85 kDa 0 0 1 0 0
588 conserved hypothetical protein 630_gi|115249056 15 kDa 0 0 1 0 0
597
two-component sensor histidine 
kinase 630_gi|115250874 102 kDa 0 0 1 0 0
602 excinuclease ABC subunit A 630_gi|115252471 105 kDa 0 0 1 0 0
608
putative iron ABC transporter, 
ATP-binding protein 630_gi|115252591 37 kDa 0 0 0 1 0
615 conserved hypothetical protein 630_gi|115249635 9 kDa 0 0 1 0 0
617
ABC transporter, ATP-binding 
protein 630_gi|115250573 28 kDa 0 0 0 1 0
618
putative antibiotic resistance ABC 
transporter,ATP-binding protein 630_gi|115251650 63 kDa 0 0 0 1 0
620 L-lysine 2,3-aminomutase 630_gi|115251307 49 kDa 0 0 0 1 0
327
Identification Number Mass No. unique peptides 
E beads SE beads Crude
148 proteins   m=89, r=0, h=36, R=10, s/v=8, t=5 1 2 1 2 1
Crude only
131 toxin A 630_gi|115249677 308 kDa 0 0 0 0 20
156
probable carbohydrate hydrolase 
(N-terminus) 630_gi|115252061 11 kDa 0 0 0 0 6
159 10 kDa chaperonin 630_gi|115249203 10 kDa 0 0 0 0 2
166





115251555 42 kDa 0 0 0 0 16
190
putative imidazole glycerol 








115252147 28 kDa 0 0 0 0 3
209 thioredoxin 630_gi|115251408 12 kDa 0 0 0 0 3
228
putative imidazole glycerol 
phosphate synthase subunit 630_gi|115250594 28 kDa 0 0 0 0 6
239 conserved hypothetical protein 630_gi|115251115 24 kDa 0 0 0 0 7
240 peptidyl-prolyl cis-trans isomerase 630_gi|115249340 19 kDa 0 0 0 0 6
249 transcription elongation factor 630_gi|115252616 18 kDa 0 0 0 0 4
255
inosine-5'-monophosphate 
dehydrogenase 630_gi|115251390 55 kDa 0 0 0 0 5
256
imidazoleglycerol-phosphate 
dehydratase 630_gi|115250591 22 kDa 0 0 0 0 2
262 putative formyltransferase 630_gi|115249858 44 kDa 0 0 0 0 6
263 conserved hypothetical protein 630_gi|115252018 11 kDa 0 0 0 0 4
271
probable amino-acid ABC 
transporter,substrate-binding 
protein 630_gi|115251227 29 kDa 0 0 0 0 7
272 putative reductase 630_gi|115249854 20 kDa 0 0 0 0 5
273
probable amino-acid ABC 
transporter,substrate-binding 
protein 630_gi|115251230 30 kDa 0 0 0 0 5
279 putative flavodoxin 630_gi|115249827 18 kDa 0 0 0 0 3





e amino imidazole-4-carboxamide 
isomerase 630_gi|115250593 27 kDa 0 0 0 0 5
303 putative lipoprotein 630_gi|115249561 23 kDa 0 0 0 0 5
304 conserved hypothetical protein 630_gi|115250755 12 kDa 0 0 0 0 3
315
putative carbon-nitrogen 
hydrolase 630_gi|115249501 31 kDa 0 0 0 0 6
316
histidine biosynthesis bifunctional 
protein includes: phosphoribosyl-
AMP cyclohydrolase and 
phosphoribosyl-ATP 
pyrophosphatase 630_gi|115250595 26 kDa 0 0 0 0 5
328
317
putative aliphatic sulfonates ABC 
transporter,substrate-binding 
lipoprotein 630_gi|115250525 36 kDa 0 0 0 0 4
324
DNA-directed RNA polymerase 
omega chain 630_gi|115251644 10 kDa 0 0 0 0 4
325 conserved hypothetical protein 630_gi|115251027 11 kDa 0 0 0 0 2
341
cell surface protein (putative 
hemagglutinin/adhesin) 630_gi|115249532 167 kDa 0 0 0 0 4
342 uracil-DNA glycosylase 630_gi|115251535 26 kDa 0 0 0 0 4
343 conserved hypothetical protein 630_gi|115251313 13 kDa 0 0 0 0 4
344





cyclohydrolase 630_gi|115249737 31 kDa 0 0 0 0 4
345 tellurium resistance protein 630_gi|115250845 21 kDa 0 0 0 0 3
359 putative peptidyl-prolyl isomerase 630_gi|115250393 28 kDa 0 0 0 0 5
360 putative regulatory protein 630_gi|115250940 19 kDa 0 0 0 0 4















115251448 20 kDa 0 0 0 0 4
382
putative aromatic amino acid 
aminotransferase 630_gi|115251881 45 kDa 0 0 0 0 3
383 anti-sigma-B factor antagonist 630_gi|115249012 12 kDa 0 0 0 0 3
384 conserved hypothetical protein 630_gi|115250810 27 kDa 0 0 0 0 2
385 conserved hypothetical protein 630_gi|115249410 13 kDa 0 0 0 0 2
386 PTS system, IIb component 630_gi|115252122 18 kDa 0 0 0 0 2
387 conserved hypothetical protein 630_gi|115249867 8 kDa 0 0 0 0 1
393 DNA mismatch repair protein 630_gi|115251023 109 kDa 1 1 1 1 0
404
BASYS01005, 1036990-1042047 




115249349 195 kDa 0 0 0 0 4
405 putative ATP-binding protein 630_gi|115250457 25 kDa 0 0 0 0 3
406 putative acetyltransferase 630_gi|115250223 20 kDa 0 0 0 0 3
407
V-type sodium ATP synthase 
subunit B 630_gi|115252011 51 kDa 0 0 0 0 3
408 conserved hypothetical protein 630_gi|115251601 68 kDa 0 0 0 0 3
409 glucose-6-phosphate isomerase 630_gi|115252341 51 kDa 0 0 0 0 2
410 fructose-6-phosphate aldolase 2 630_gi|115251164 25 kDa 0 0 0 0 2
411 PTS system, IIc component 630_gi|115252070 39 kDa 0 0 0 0 2
412
histidine triad nucleotide-binding 
protein 630_gi|115251501 13 kDa 0 0 0 0 2








- 8 kDa 0 0 0 0 3
431
aspartate carbamoyltransferase 
catalytic chain 630_gi|115249194 35 kDa 0 0 0 0 2




succinocarboxamide synthase 630_gi|115249503 25 kDa 0 0 0 0 2
434
PTS system, galactitol-specific IIb 
component 630_gi|115251381 10 kDa 0 0 0 0 2
435 hypothetical protein 630_gi|115251805 26 kDa 0 0 0 0 2
436 putative membrane protein 630_gi|115252518 39 kDa 0 0 0 0 2
437




115250492 15 kDa 0 0 0 0 2
438
putative ATP 
phosphoribosyltransferase 630_gi|115250589 23 kDa 0 0 0 0 2
439 4-aminobutyrate aminotransferase 630_gi|115251211 48 kDa 0 0 0 0 2
440 cysteine desulfurase 630_gi|115250313 44 kDa 0 0 0 0 2
441 putative glyoxalase 630_gi|115252675 15 kDa 0 0 0 0 1
444 conserved hypothetical protein 630_gi|115251130 42 kDa 0 0 0 0 1
445 putative transferase 630_gi|115251800 18 kDa 0 0 0 0 1
446 conserved hypothetical protein 630_gi|115252732 22 kDa 0 0 0 0 1
447
BASYS00311, 304950-305525 




115252734 21 kDa 0 0 0 0 1
466
dihydroorotate dehydrogenase 




binding regulatory protein 630_gi|115252223 18 kDa 0 0 0 0 2
468 hypothetical protein 630_gi|115250585 8 kDa 0 0 0 0 2
469 conserved hypothetical protein 630_gi|115249879 33 kDa 0 0 0 0 2
470 putative membrane protein 630_gi|115249847 43 kDa 0 0 0 0 2
471
orotidine 5'-phosphate 
decarboxylase 630_gi|115252656 26 kDa 0 0 0 0 2
472 conserved hypothetical protein 630_gi|115252296 17 kDa 0 0 0 0 1
473 putative glutamyl-aminopeptidase 630_gi|115251205 39 kDa 0 0 0 0 2
481 putative phage regulatory protein 630_gi|115251071 14 kDa 0 0 0 0 1
482 peptide deformylase 2 630_gi|115251641 16 kDa 0 0 0 0 1
483 putative nitroreductase 630_gi|115252261 22 kDa 0 0 0 0 1
484 pilin 630_gi|115252574 18 kDa 0 0 0 0 1
493
2-C-methyl-D-erythritol 2,4-
cyclodiphosphate synthase 630_gi|115249051 17 kDa 0 0 0 0 2
494 putative GTP cyclohydrolase I 630_gi|115250490 21 kDa 0 0 0 0 2
498
formylglycinamidine 
ribonucleotide synthetase 630_gi|115249233 141 kDa 0 0 0 0 2
501 aspartokinase 630_gi|115251108 43 kDa 0 0 0 0 2
508 glutamyl-tRNA synthetase 630_gi|115249054 57 kDa 0 0 0 0 1
509 PTS system, IId component 630_gi|115249298 31 kDa 0 0 0 0 1
330
510
putative penicillin-binding protein 
repressor 630_gi|115249563 14 kDa 0 0 0 0 1
511
MarR-family transcriptional 
regulator 630_gi|115249852 17 kDa 0 0 0 0 1
512 conserved hypothetical protein 630_gi|115249911 14 kDa 0 0 0 0 1
513 putative flavoprotein 630_gi|115250499 21 kDa 0 0 0 0 1
514
putative molybdenum cofactor 
biosynthesis protein 630_gi|115250756 18 kDa 0 0 0 0 1
515 conserved hypothetical protein 630_gi|115250817 14 kDa 0 0 0 0 1
516 conserved hypothetical protein 630_gi|115250980 14 kDa 0 0 0 0 1
517 conserved hypothetical protein 630_gi|115251427 11 kDa 0 0 0 0 1
518
deoxyuridine 5'-triphosphate 
nucleotidohydrolase 630_gi|115251455 16 kDa 0 0 0 0 1
519 guanylate kinase 630_gi|115251645 23 kDa 0 0 0 0 1
520
putative protein translocase 
subunit 630_gi|115251854 11 kDa 0 0 0 0 1
521 putative flavodoxin 630_gi|115251878 20 kDa 0 0 0 0 1
522
V-type sodium ATP synthase 
subunit K 630_gi|115252016 16 kDa 0 0 0 0 1
523 putative PTS syste, IIa component 630_gi|115252157 18 kDa 0 0 0 0 1
524
hypoxanthine 
phosphoribosyltransferase 630_gi|115252288 20 kDa 0 0 0 0 1
525 conserved hypothetical protein 630_gi|115252297 29 kDa 0 0 0 0 1
526
ATP synthase epsilon chain 
(partial) 630_gi|115252527 9 kDa 0 0 0 0 1







- 9 kDa 0 0 0 0 1
529 putative phosphoglycerate mutase 630_gi|115250859 24 kDa 0 0 0 0 1
530 putative exported protein 630_gi|115249010 11 kDa 0 0 0 0 1
531 6-phospho-beta-glucosidase 630_gi|115252149 55 kDa 0 0 0 0 1
533
V-type sodium ATP synthase 
subunit E 630_gi|115252015 21 kDa 0 0 0 0 1







115251508 58 kDa 0 0 0 0 1
538 conserved hypothetical protein 630_gi|115251465 46 kDa 0 0 0 0 1
540 PTS system, IIa component 630_gi|115251622 17 kDa 0 0 0 0 1
550
4-hydroxyphenylacetate 
decarboxylase, regulatory subunit 630_gi|115249163 10 kDa 0 0 0 0 1
551
bifunctional purine biosynthesis 
protein includes: 
phosphoribosylaminoimidazolecar
boxamide formyltransferase and 
IMP cyclohydrolase 630_gi|115249231 57 kDa 0 0 0 0 1
552
putative PTS system, IIa 
component 630_gi|115249295 15 kDa 0 0 0 0 1
553 hypothetical protein 630_gi|115249604 92 kDa 0 0 0 0 1
554 arginyl-tRNA synthetase 630_gi|115249727 65 kDa 0 0 0 0 1
555 putative hydrolase 630_gi|115249857 33 kDa 0 0 0 0 1
331
556
branched chain amino acid 
transport system carrier protein 630_gi|115250294 45 kDa 0 0 0 0 1
557 putative phage protein 630_gi|115250400 39 kDa 0 0 0 0 1
558 putative phosphoglucomutase 630_gi|115250617 64 kDa 0 0 0 0 1
559 putative protein export chaperone 630_gi|115251317 43 kDa 0 0 0 0 1
560 conserved hypothetical protein 630_gi|115251507 39 kDa 0 0 0 0 1
561
low-specificity L-threonine 
aldolase 630_gi|115251648 38 kDa 0 0 0 0 1
562 putative amidohydrolas 630_gi|115251756 51 kDa 0 0 0 0 1
563 conserved hypothetical protein 630_gi|115252306 21 kDa 0 0 0 0 1
564 putative nitroreductase 630_gi|115252412 20 kDa 0 0 0 0 1
565
BASYS02134, 2227250-2227441 











- 17 kDa 0 0 0 0 1
581 probable carbohydrate hydrolase 630_gi|115252060 42 kDa 0 0 0 0 1
582 putative carbonic anhydrase 630_gi|115251267 24 kDa 0 0 0 0 1
584 purine nucleoside phosphorylase 630_gi|115250257 29 kDa 0 0 0 0 1
587
putative molybdenum ABC 
transporter,substrate-binding 
protein 630_gi|115249883 29 kDa 0 0 0 0 1
590 putative acetyltransferase 630_gi|115251215 20 kDa 0 0 0 0 1
591 dihydrodipicolinate reductase 630_gi|115252286 28 kDa 0 0 0 0 1




mutase 630_gi|115252228 56 kDa 0 0 0 0 1
600 conserved hypothetical protein 630_gi|115252731 10 kDa 0 0 0 0 1
601 cell surface protein 630_gi|115249861 34 kDa 0 0 0 0 1
603 electron transport complex protein 630_gi|115250172 20 kDa 0 0 0 0 1
605
V-type sodium ATP synthase 
subunit G 630_gi|115252013 12 kDa 0 0 0 0 1
612 signal peptidase I 630_gi|115249570 20 kDa 0 0 0 0 1
613
amino acid ABC transporter, 
substrate-binding protein 630_gi|115249767 30 kDa 0 0 0 0 1
621 putative amidohydrolase 630_gi|115250653 43 kDa 0 0 0 0 1
